- Sunday, October 1, 2023
4:45 PM – 6:00 PM PT
2000 - Population-Based Differences in Cancer Incidence between Immigrants and Non-Immigrants in Canada from 1992-2015Location: Hall B2Presenter: – BC Cancer and UBC
Robert Olson, MD, MS – BC Cancer and UBC ### 536114###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###BC Cancer and UBC###Presenter: – BC Cancer and UBC
### 4:45 PM – 6:00 PM PT
2001 - Could Poor Outcomes for Patients with Limited Lung Function Treated with SAbR Necessitate PULSAR?Location: Hall B2Presenter: – University of Texas Southwestern Medical Center
Maureen Aliru, MD, PhD – University of Texas Southwestern Medical Center ### 525301###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 4:45 PM – 6:00 PM PT
2002 - Clinical Efficacy and Safety of Once-Weekly Fractionation in Stereotactic Body Radiotherapy for Pulmonary Oligometastatic LesionsLocation: Hall B2Presenter: – University of Maryland Medical Center
Alexander Allen, MD – University of Maryland Medical Center ### 1972178###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Medical Center###Presenter: – University of Maryland Medical Center
### 4:45 PM – 6:00 PM PT
2003 - Impact of Lymphopenia on Treatment Outcomes in Unresectable Non Small Cell Lung CancerLocation: Hall B2Presenter: – Hospital Del Mar - Parc de Salut Mar
Francesco Amorelli, MD – Hospital Del Mar - Parc de Salut Mar ### 1972157###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Del Mar - Parc de Salut Mar###Presenter: – Hospital Del Mar - Parc de Salut Mar
### 4:45 PM – 6:00 PM PT
2004 - Utilization of Services and Clinical Outcomes among American Indian/Alaska Native (AIAN) Women with Breast Cancer at an Academic Medical Center (AMC)Location: Hall B2Presenter: – University of Washington
August Anderson, MD – University of Washington ### 2027548###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 4:45 PM – 6:00 PM PT
2005 - Multi-Parametric Chest Magnetic Resonance Imaging for Assessment of Local Recurrence of Non-Small Cell Lung Cancer after Stereotactic Body Radiation TherapyLocation: Hall B2Presenter: – Chaim Sheba Medical Center
Sarit Appel, MD – Chaim Sheba Medical Center ### 747687###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chaim Sheba Medical Center###Presenter: – Chaim Sheba Medical Center
### 4:45 PM – 6:00 PM PT
2006 - Toxicity of Patients with Ultra-Central Thoracic Tumors Treated with Stereotactic Body Radiotherapy (SBRT) with Dose of 50Gy in 5 FractionsLocation: Hall B2Presenter: – Sirio Libanes Hospital
Rie Asso, MD – Sirio Libanes Hospital ### 1972120###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sirio Libanes Hospital###Presenter: – Sirio Libanes Hospital
### 4:45 PM – 6:00 PM PT
2007 - Association of Artificial Intelligence-Screened Interstitial Lung Disease with Radiation Pneumonitis and Mortality in Locally Advanced Non-Small Cell Lung CancerLocation: Hall B2Presenter: – University of Toronto
Hannah Bacon, MD, PhD – University of Toronto ### 1972227###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Toronto###Presenter: – University of Toronto
### 4:45 PM – 6:00 PM PT
2008 - Efficacy of Postoperative Radiotherapy for Patients with New N2 Descriptors of Subclassification in Completely Resected Non-Small Cell Lung Cancer: A Real-World StudyLocation: Hall B2Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC
Yongxing Bao, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC ### 747688###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC###Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC
### 4:45 PM – 6:00 PM PT
2009 - Potentiating Local and Abscopal Antitumor Efficacy through Radiation with FAP-CD40 DARPin and Anti-PD1 TherapyLocation: Hall B2Presenter: – University of Texas MD Anderson Cancer Center
Thomas Riad, BS – University of Texas MD Anderson Cancer Center ### 2037792###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas MD Anderson Cancer Center###Presenter: – University of Texas MD Anderson Cancer Center
### 4:45 PM – 6:00 PM PT
2010 - Radiotherapy Capabilities, Population, Average Income, and Health Insurance Status as Predictors of Cancer Mortality at the County Level in the United StatesLocation: Hall B2Presenter: – Barrow Neurological Institute
Ryan Kraus, MD – Barrow Neurological Institute ### 525492###Presenter###Disclosures: Employment: University of Utah Huntsman Cancer Institute:Resident Physician:Employee;Barrow Neurological Institute:Associate Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Barrow Neurological Institute###Presenter: – Barrow Neurological Institute
### 4:45 PM – 6:00 PM PT
2011 - Assessing Depression and Anxiety Levels in English and Spanish-Speaking Patients throughout a Course of Radiation TherapyLocation: Hall B2Presenter: – Boston University School of Medicine (BUSM)
Jenny Zhao, BS – Boston University School of Medicine (BUSM) ### 2033576###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Boston University School of Medicine (BUSM)###Presenter: – Boston University School of Medicine (BUSM)
### 4:45 PM – 6:00 PM PT
2012 - Characterizing the Impact of Race and Redlining on Receipt of Guideline-Compliant Locoregional Therapy among Older Women with Breast CancerLocation: Hall B2Presenter: – Medical College of Wisconsin
Sara Beltran Ponce, MD – Medical College of Wisconsin ### 538557###Presenter###Disclosures: Employment: Medical College of Wisconsin Affiliated Hospitals:Resident Physician:Employee | Compensation: American College of Radiation Oncology: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 11/2023 | Ownership: none | Leadership: Society for Women in Radiation Oncology:Vice Chair###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 4:45 PM – 6:00 PM PT
2013 - Frequent Friers: Outcomes in Patients Who Receive Multiple Courses of Lung SBRTLocation: Hall B2Presenter: – Mount Sinai School of Medicine
Julie Bloom, MD – Mount Sinai School of Medicine ### 538366###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mount Sinai School of Medicine###Presenter: – Mount Sinai School of Medicine
### 4:45 PM – 6:00 PM PT
2014 - PET-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative RadiotherapyLocation: Hall B2
Vincent Bourbonne, MD, PhD – CHU Brest ### 747417###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###CHU Brest###Presenter: – CHU Brest
### 4:45 PM – 6:00 PM PT
2015 - A Technology-Informed Approach to Clinical Trial EquityLocation: Hall B2Presenter: – Stanford University
Eleanor Brown, BA – Stanford University ### 1972173###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 4:45 PM – 6:00 PM PT
2016 - Cardiac and Great Vessel Toxicity with Single Fraction Stereotactic Body Radiotherapy in Early Stage Lung CancerLocation: Hall B2Presenter: – Cleveland Clinic Foundation
David Buchberger, MD, MSc – Cleveland Clinic Foundation ### 1972183###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 4:45 PM – 6:00 PM PT
2017 - Hyperfractionated Reirradiation for Locally Recurrent Thoracic TumorsLocation: Hall B2Presenter: – Stanford University School of Medicine
Santino Butler, MD – Stanford University School of Medicine ### 747054###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 4:45 PM – 6:00 PM PT
2018 - A Simulation-Based Approach for Strategic Evaluation of Resource Allocation for Improving Spatial Access to Radiation OncologyLocation: Hall B2Presenter: – University of Florida
Vincent Cassidy, MD, MBA – University of Florida ### 538012###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida###Presenter: – University of Florida
### 4:45 PM – 6:00 PM PT
2019 - Determining the Ideal Time for Implementing Adaptive Radiation Therapy in the Treatment of Non-Small Cell Lung Cancer through the Analysis of Cone-Beam Computed Tomography ImagesLocation: Hall B2Presenter: – Fu Jen Catholic University Hospital
Tzu-Fang Chang, Rad.T. – Fu Jen Catholic University Hospital ### 1972220###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fu Jen Catholic University Hospital###Presenter: – Fu Jen Catholic University Hospital
### 4:45 PM – 6:00 PM PT
2020 - AI-Derived CT Body Composition in Advanced Non-Small Cell Lung Cancer: A Multicohort StudyLocation: Hall B2Presenter: – Harvard Medical School
Tafadzwa Chaunzwa, MD – Harvard Medical School ### 1972146###Presenter###Disclosures: Employment: Mass General Brigham/Harvard Medical School:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Harvard Medical School###Presenter: – Harvard Medical School
### 4:45 PM – 6:00 PM PT
2021 - The Baseline Serum Lipid Levels and Outcomes of NSCLC Patients Receiving Immunotherapy Combined or Non-Combined with Radiotherapy: A Single Center Retrospective StudyLocation: Hall B2
Dawei Chen, MD, MB ### 2029570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2022 - Whole Liver Radiotherapy for Multiple Liver Metastases in Thoracic MalignanciesLocation: Hall B2Presenter: – National Taiwan University Hospital
Ting-Fong Liu, MD – National Taiwan University Hospital ### 1972248###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Taiwan University Hospital###Presenter: – National Taiwan University Hospital
### 4:45 PM – 6:00 PM PT
2023 - Prostate Cancer in New York City: Impact of Neighborhood Level Social Determinants of CareLocation: Hall B2Presenter: – Columbia University
Justin Chestang, BS, BA – Columbia University ### 1972185###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Columbia University###Presenter: – Columbia University
### 4:45 PM – 6:00 PM PT
2026 - Association of Provider Zip Code Sociodemographic Characteristics with Radiation Therapy Modality Use in the Medicare PopulationLocation: Hall B2Presenter: – UCLA David Geffen School of Medicine/UCLA Medical Center
Patrick Courtney, MD, MAS – UCLA David Geffen School of Medicine/UCLA Medical Center ### 1972187###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA David Geffen School of Medicine/UCLA Medical Center###Presenter: – UCLA David Geffen School of Medicine/UCLA Medical Center
### 4:45 PM – 6:00 PM PT
2027 - Evaluating Geographic Access to Radiotherapy Services in CanadaLocation: Hall B2Presenter: – Alberta Health Services
Oluwaseun Davies, MD – Alberta Health Services ### 1972226###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Alberta Health Services###Presenter: – Alberta Health Services
### 4:45 PM – 6:00 PM PT
2028 - Disparities in Stage at Presentation among Hispanic and Latinx Patients with Non-Small Cell Lung CancerLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Edward Dee, MD – Memorial Sloan Kettering Cancer Center ### 1972189###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:45 PM – 6:00 PM PT
2029 - Circulating Growth Differentiation Factor 15 as a Biomarker in Patients with Unresected Locally Advanced Non-Small Cell Lung Cancer Treated with Chemo-Radiotherapy with or without MetforminLocation: Hall B2
Fiorella Di Pastena, PhD ### 1972182###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2030 - Accessibility and Impact of Telehealth in Rural Populations with a History of CancerLocation: Hall B2Presenter: – Ohio State University College of Medicine
Francisca Douglass, BS – Ohio State University College of Medicine ### 1972201###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ohio State University College of Medicine###Presenter: – Ohio State University College of Medicine
### 4:45 PM – 6:00 PM PT
2031 - Impact of the COVID-19 Pandemic on Financial Burden in Those with a Recent History of CancerLocation: Hall B2Presenter: – Ohio State University College of Medicine
Francisca Douglass, BS – Ohio State University College of Medicine ### 1972201###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ohio State University College of Medicine###Presenter: – Ohio State University College of Medicine
### 4:45 PM – 6:00 PM PT
2032 - Stage IIIA Non-Small Cell Lung Cancer Treatment and Outcomes: A Single Institution Retrospective AnalysisLocation: Hall B2Presenter: – Northwestern Feinberg School of Medicine
Richard Duan, MS – Northwestern Feinberg School of Medicine ### 1972175###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwestern Feinberg School of Medicine###Presenter: – Northwestern Feinberg School of Medicine
### 4:45 PM – 6:00 PM PT
2033 - Impact of the Affordable Care Act on Pediatric Proton Radiation Therapy AccessLocation: Hall B2Presenter: – University of Minnesota
Teresa Easwaran, MD, MS – University of Minnesota ### 1972190###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Minnesota###Presenter: – University of Minnesota
### 4:45 PM – 6:00 PM PT
2034 - Symptomatic Pneumonitis Rates Among Patients with Stage III Non-Small Cell Lung Cancer Receiving Adjuvant DurvalumabLocation: Hall B2Presenter: – University of Michigan
Donna Edwards, MD, PhD – University of Michigan ### 1972212###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 4:45 PM – 6:00 PM PT
2035 - Invited African-American Radiation Oncology Grand Rounds Speakers: DEI or Die?Location: Hall B2Presenter: – University Hospitals
Ifeanyi Ekpunobi, BS – University Hospitals ### 1972200###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospitals###Presenter: – University Hospitals
### 4:45 PM – 6:00 PM PT
2036 - Prognostic Value of Hypoxia Gene Expression Signature in Early-Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation TherapyLocation: Hall B2Presenter: – City of Hope National Medical Center
Nicholas Eustace, MD, PhD, BS – City of Hope National Medical Center ### 1972064###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 4:45 PM – 6:00 PM PT
2037 - Recovery Characteristics of Lymphocyte Subsets after Thoracic Radiotherapy: A Single Center Clinical StudyLocation: Hall B2Presenter: – Fudan University Shanghai Cancer Center
Fan Xingwen, MD, PhD – Fudan University Shanghai Cancer Center ### 525074###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 4:45 PM – 6:00 PM PT
2038 - Patterns of Failure, Volume of Disease Progression, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Treated with Definitive Chemoradiation and ConsolidatioLocation: Hall B2Presenter: – University of Pennsylvania
Cole Friedes, MD – University of Pennsylvania ### 1972210###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 4:45 PM – 6:00 PM PT
2039 - Equity of Access to Proton Beam Therapy in England: A National NHS analysisLocation: Hall B2Presenter: – The Christie NHS Foundation Trust
Simona Gaito, MD – The Christie NHS Foundation Trust ### 1995806###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Christie NHS Foundation Trust###Presenter: – The Christie NHS Foundation Trust
### 4:45 PM – 6:00 PM PT
2040 - Outcomes of Hypofractionated Radiotherapy with Induction or Sequential Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Single Institution ExperienceLocation: Hall B2Presenter: – McGill University Health Centre
Ian Gerard, MD, PhD – McGill University Health Centre ### 1972136###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGill University Health Centre###Presenter: – McGill University Health Centre
### 4:45 PM – 6:00 PM PT
2041 - Central Lung Tumors Eligible for Stereotactic Ablative Radiotherapy (SABR) Trials: Analysis of a Cohort Treated Using MR-Guided SABRLocation: Hall B2Presenter: – Amsterdam UMC
Nicolas Giraud, MD – Amsterdam UMC ### 1972155###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Amsterdam UMC###Presenter: – Amsterdam UMC
### 4:45 PM – 6:00 PM PT
2042 - Demographic Representation in Clinical Trials Sponsored by the United States Department of Veterans AffairsLocation: Hall B2Presenter: – Johns Hopkins Medicine
Gabriela Gomez, BS, MPH – Johns Hopkins Medicine ### 1972126###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Medicine###Presenter: – Johns Hopkins Medicine
### 4:45 PM – 6:00 PM PT
2043 - Five-Fraction Accelerated Partial Breast Irradiation [APBI] may Reduce Health Care Disparity in Patients Receiving Adjuvant Radiation Therapy for Breast Cancer by Overcoming Treatment Barriers of DistLocation: Hall B2
Alex Goss ### 1972180###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2044 - A Comparative Population-Based Study of Tracheal and Lung Adenoid Cystic CarcinomaLocation: Hall B2
Yu Gu, PhD ### 1972127###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2046 - Role and Modality of Combining Radiotherapy with Immunotherapy in Stage III-IV Unresectable Small Cell Lung CancerLocation: Hall B2
Y.X. Guo, MD ### 1972130###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2047 - Health System Practices and Perspectives of Social Risk Screening in OncologyLocation: Hall B2Presenter: – University of California, San Diego
Kripa Guram, MD, BS – University of California, San Diego ### 535958###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, San Diego###Presenter: – University of California, San Diego
### 4:45 PM – 6:00 PM PT
2049 - Proton and Carbon Ion Radiotherapy for Operable Early Stage Lung Cancer: 3-Year Results of a Prospective Nationwide RegistryLocation: Hall B2Presenter: – Shizuoka Cancer Center
Hideyuki Harada, MD, PhD – Shizuoka Cancer Center ### 525499###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shizuoka Cancer Center###Presenter: – Shizuoka Cancer Center
### 4:45 PM – 6:00 PM PT
2051 - Dosimetric Predictors for Acute Esophagitis during Radiation Therapy for Lung Cancer: An Update of a Large Statewide Observational StudyLocation: Hall B2Presenter: – University of Michigan
Daniel Herr, MD, PhD – University of Michigan ### 1972091###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 4:45 PM – 6:00 PM PT
2055 - Predictive Modeling of Radiation Pneumonitis Induced By Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer Using Radiomics and Clinical FeaturesLocation: Hall B2Presenter: – Hiroshima University
Nobuki Imano, MD, PhD – Hiroshima University ### 537533###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hiroshima University###Presenter: – Hiroshima University
### 4:45 PM – 6:00 PM PT
2056 - Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiotherapy (IMRT) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation: A RetLocation: Hall B2Presenter: – University of Pennsylvania
Michelle Iocolano, MD, MA – University of Pennsylvania ### 538369###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 4:45 PM – 6:00 PM PT
2057 - Change in Quality of Life after Stereotactic Body Radiation Therapy (SBRT) on a Prospective Trial of Peripheral Stage I or II Non-Small Cell Lung Cancer Predicts SurvivalLocation: Hall B2Presenter: – Roswell Park Comprehensive Cancer Center
Austin Iovoli, MD – Roswell Park Comprehensive Cancer Center ### 746611###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Roswell Park Comprehensive Cancer Center###Presenter: – Roswell Park Comprehensive Cancer Center
### 4:45 PM – 6:00 PM PT
2058 - Sinoatrial Node Irradiation is Associated with Worse Survival in Patients Undergoing Definitive Stereotactic Body Radiation Therapy (SBRT) for Central Lung CancersLocation: Hall B2Presenter: – Roswell Park Comprehensive Cancer Center
Austin Iovoli, MD – Roswell Park Comprehensive Cancer Center ### 746611###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Roswell Park Comprehensive Cancer Center###Presenter: – Roswell Park Comprehensive Cancer Center
### 4:45 PM – 6:00 PM PT
2059 - Differential Impact of Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer Based on Systemic Therapy Type and SexLocation: Hall B2Presenter: – Sutter Cancer Centers, Radiation Oncology
Vikram Jairam, MD – Sutter Cancer Centers, Radiation Oncology ### 524883###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sutter Cancer Centers, Radiation Oncology###Presenter: – Sutter Cancer Centers, Radiation Oncology
### 4:45 PM – 6:00 PM PT
2060 - Disparities in Time to Prostate Cancer Treatment Initiation before and after the Affordable Care ActLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
James Janopaul-Naylor, MD – Memorial Sloan Kettering Cancer Center ### 525069###Presenter###Disclosures: Employment: Winship Cancer Institute at Emory University:Chief Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:45 PM – 6:00 PM PT
2061 - Prognostic Value of Naples Prognostic Score on Survival in Unresectable Small Cell Lung Cancer Patients Undergoing ChemoradiotherapyLocation: Hall B2Presenter: – Nanjing Medical University Affiliated Suzhou Hospital
Shengjun Ji, MD – Nanjing Medical University Affiliated Suzhou Hospital ### 525357###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Nanjing Medical University Affiliated Suzhou Hospital###Presenter: – Nanjing Medical University Affiliated Suzhou Hospital
### 4:45 PM – 6:00 PM PT
2062 - Contralateral Esophagus Sparing is Associated with Lack of Severe Esophagitis in Patients with Limited Stage SCLC Treated with QD or BID Chemoradiotherapy RegimensLocation: Hall B2Presenter: – Massachusetts General Hospital
Florence Keane, MD – Massachusetts General Hospital ### 1972168###Presenter###Disclosures: Employment: Massachusetts General Hospital:Physician:Employee | Compensation: Siemens: Education Meeting Faculty, Honoraria-End Date: present ;UpToDate: Other, Remuneration Other-End Date: to present ;DAVA Oncology: Education Meeting Faculty, Honoraria-End Date: ongoing | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 4:45 PM – 6:00 PM PT
2063 - Gender and the Receipt of the Association of Residents in Radiation Oncology (ARRO) Educator of the Year AwardLocation: Hall B2Presenter: – University of Pennsylvania
Karishma Khullar, MD – University of Pennsylvania ### 746783###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 4:45 PM – 6:00 PM PT
2064 - Real-World Study of Overall Survival in Patients with Stage III Non-Small Cell Lung Cancer Treated with Chemoradiotherapy with or without Durvalumab and an Exploratory Analysis of Effective Radiation Location: Hall B2Presenter: – Kyoto University Hospital
Noriko Kishi, MD, PhD – Kyoto University Hospital ### 1972215###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kyoto University Hospital###Presenter: – Kyoto University Hospital
### 4:45 PM – 6:00 PM PT
2065 - Risk Factors for Symptomatic Radiation Pneumonitis after Stereotactic Body Radiotherapy (SBRT) for Early-Stage Lung CancerLocation: Hall B2Presenter: – Nagoya City University Graduate School of Medical Sciences
Nozomi Kita, MD, PhD – Nagoya City University Graduate School of Medical Sciences ### 1972229###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Nagoya City University Graduate School of Medical Sciences###Presenter: – Nagoya City University Graduate School of Medical Sciences
### 4:45 PM – 6:00 PM PT
2066 - Major Cardiovascular Events after Chemoradiotherapy with or without Durvalumab in Patients with Stage III Non-Small Cell Lung Cancer: Supplementary AnalysisLocation: Hall B2Presenter: – Kobe City Medical Center General Hospital
Masaki Kokubo, MD, PhD – Kobe City Medical Center General Hospital ### 1972217###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kobe City Medical Center General Hospital###Presenter: – Kobe City Medical Center General Hospital
### 4:45 PM – 6:00 PM PT
2068 - The Society for Women in Radiation Oncology: Where are We Five Years Later?Location: Hall B2Presenter: – University of Maryland Radiation Oncology
Rebecca Krc, DO – University of Maryland Radiation Oncology ### 1972232###Presenter###Disclosures: Employment: University of Maryland Medical Center:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: Society for Women in Radiation Oncology:Membership Chair###University of Maryland Radiation Oncology###Presenter: – University of Maryland Radiation Oncology
### 4:45 PM – 6:00 PM PT
2069 - Predictive Value of Dynamic Tumor Volume Changes in Stage III Non-Small Cell Lung Cancer Treated with Chemoradiation and Consolidative ImmunotherapyLocation: Hall B2Presenter: – Rutgers Cancer Institute of New Jersey
Ritesh Kumar, MD, MBBS – Rutgers Cancer Institute of New Jersey ### 747093###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rutgers Cancer Institute of New Jersey###Presenter: – Rutgers Cancer Institute of New Jersey
### 4:45 PM – 6:00 PM PT
2070 - Exploration of AI-Assisted On-Board Perfusion Imaging Technique on Patients Undergoing ThoraxradiotherapyLocation: Hall B2Presenter: – Hong Kong Polytechnic University
Yu Lap Lam, MS – Hong Kong Polytechnic University ### 1972128###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hong Kong Polytechnic University###Presenter: – Hong Kong Polytechnic University
### 4:45 PM – 6:00 PM PT
2071 - A Large National Study on Racial Disparities among Asian American, Native Hawaiian, and Other Pacific Islander Cancer Patients Who Refuse Radiation Therapy and SurgeryLocation: Hall B2Presenter: – Stanford University School of Medicine
Brianna Lau, BA – Stanford University School of Medicine ### 1972117###Presenter######Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 4:45 PM – 6:00 PM PT
2073 - Thoracic Radiation Dose Fractionation Schedules for Limited-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis of Randomized TrialsLocation: Hall B2Presenter: – National University Cancer Institute Singapore
Chia Ching Lee, MD – National University Cancer Institute Singapore ### 538270###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###National University Cancer Institute Singapore###Presenter: – National University Cancer Institute Singapore
### 4:45 PM – 6:00 PM PT
2074 - Identifying and Addressing Nutritional Inequities and Psychosocial Needs of Cancer Patients Residing in Zip-Code Designated Food Priority Areas (FPAs)Location: Hall B2Presenter: – University of Maryland School of Medicine
Lara LePore, BS – University of Maryland School of Medicine ### 1972195###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland School of Medicine###Presenter: – University of Maryland School of Medicine
### 4:45 PM – 6:00 PM PT
2075 - Outcome Supervised Deep Learning Model on Pathological Whole Slide Images for Survival Prediction of Immunotherapy in Non-Small Cell Lung Cancer Patients: A Multicenter StudyLocation: Hall B2Presenter: – Shandong Cancer Hospital Affiliated to Shandong First Medical University
Butuo Li, MD, MB, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University ### 747338###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital Affiliated to Shandong First Medical University###Presenter: – Shandong Cancer Hospital Affiliated to Shandong First Medical University
### 4:45 PM – 6:00 PM PT
2076 - Safety and Efficacy of Stereotactic Body Radiotherapy for Ultra-Central Thoracic TumorsLocation: Hall B2Presenter: – University of Toronto
George Li, MD – University of Toronto ### 1972236###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Toronto###Presenter: – University of Toronto
### 4:45 PM – 6:00 PM PT
2078 - Verification and Mechanism Exploration of CDK4 Alterations on Influencing Radiotherapy Sensitivity in Small Cell Lung CancerLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute
Li Li, MD, PhD, RT – Shandong Cancer Hospital and Institute ### 747153###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 4:45 PM – 6:00 PM PT
2079 - Dosimetric Analysis of CBCT-Based Weekly Online Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung CancerLocation: Hall B2Presenter: – UT Southwestern Medical Center
Ruiqi Li, PhD – UT Southwestern Medical Center ### 1972170###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 4:45 PM – 6:00 PM PT
2080 - Development and Validation of a Nomogram for Patients with Lung Large Cell Neuroendocrine CarcinomaLocation: Hall B2Presenter: – West China Hospital of Sichuan University
Yan Li, MD – West China Hospital of Sichuan University ### 1972225###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West China Hospital of Sichuan University###Presenter: – West China Hospital of Sichuan University
### 4:45 PM – 6:00 PM PT
2081 - Outcomes of Consolidative Thoracic Radiation within First-Line Chemoimmunotherapy in Extensive-Stage Small-Cell Lung Cancer: Results from a Single Cancer CenterLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute
Yuying Li, MD – Shandong Cancer Hospital and Institute ### 1972133###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 4:45 PM – 6:00 PM PT
2082 - A Pilot Trial of Consolidation Bevacizumab after Hypo-Fractionated Concurrent Chemoradiotherapy in Patients with Unresectable Locally Advanced Non-Squamous Non-Small-Cell Lung CancerLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Hui Liu – Sun Yat-Sen University Cancer Center ### 1972129###Presenter######Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 4:45 PM – 6:00 PM PT
2084 - Longitudinal Radiomics-Based Prediction of Local Recurrence after Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung CancerLocation: Hall B2Presenter: – University of Wisconsin School of Medicine and Public Health
Manlu Liu – University of Wisconsin School of Medicine and Public Health ### 1972207###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin School of Medicine and Public Health###Presenter: – University of Wisconsin School of Medicine and Public Health
### 4:45 PM – 6:00 PM PT
2085 - Assessment of Electronic Health Literacy among Patients in an Urban, Academic Radiation Therapy DepartmentLocation: Hall B2Presenter: – Montefiore Medical Center/Albert Einstein College of Medicine
Jonathan Lubin, MD – Montefiore Medical Center/Albert Einstein College of Medicine ### 1972204###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Montefiore Medical Center/Albert Einstein College of Medicine###Presenter: – Montefiore Medical Center/Albert Einstein College of Medicine
### 4:45 PM – 6:00 PM PT
2086 - Prognostic Significance of Serum Lipids in Patients with Non-Small Cell Lung Cancer Treated with Radiotherapy: A Multicenter Prospective StudyLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Jiahua Lv, MD, PhD – Sichuan Cancer Hospital and Institute ### 524727###Presenter######Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 4:45 PM – 6:00 PM PT
2088 - Attitudes and Barriers to Planned Family Building among Professionals and Trainees in Radiation OncologyLocation: Hall B2Presenter: – University of Pennsylvania
Emily MacDuffie, MD – University of Pennsylvania ### 800114###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 4:45 PM – 6:00 PM PT
2089 - A Survey Study of Practice Patterns in Management of Very Early Small Cell Lung Cancer in CanadaLocation: Hall B2Presenter: – The Ottawa Hospital & the University of Ottawa
Bayan Malakouti-Nejad, MD, MS – The Ottawa Hospital & the University of Ottawa ### 1972214###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ottawa Hospital & the University of Ottawa###Presenter: – The Ottawa Hospital & the University of Ottawa
### 4:45 PM – 6:00 PM PT
2090 - Daily Adaptive vs. Non-Adaptive External Beam Radiation Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC): A Prospective Randomized Trial of an IndividualizLocation: Hall B2Presenter: – University of Alabama Birmingham School of Medicine
Andrew McDonald, MD, MS – University of Alabama Birmingham School of Medicine ### 538110###Presenter###Disclosures: Employment: University of Alabama at Birmingham:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Alabama Birmingham School of Medicine###Presenter: – University of Alabama Birmingham School of Medicine
### 4:45 PM – 6:00 PM PT
2091 - Radiation-Induced Brachial Plexopathy (RIBP) after Stereotactic Body Radiotherapy (SBRT): Pooled Analyses of RisksLocation: Hall B2Presenter: – University of Rochester
Michael Milano, MD, PhD, FASTRO – University of Rochester ### 537716###Presenter###Disclosures: Employment: University of Rochester:Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: Int J Radiat Oncol Biol Phys:Associate Section Editor;American Radium Society:Chair of Brain Tumor Guidelines Committee###University of Rochester###Presenter: – University of Rochester
### 4:45 PM – 6:00 PM PT
2092 - Assessing Patterns of Practice in Early-Stage Lung Cancer Radiation Therapy: Findings from a Large Statewide Consortium Study on HypofractionationLocation: Hall B2Presenter: – University of Michigan
Sean Miller, MD – University of Michigan ### 747156###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 4:45 PM – 6:00 PM PT
2093 - Predictive Factors for Response to Adaptive Therapy in Thoracic Stereotactic Ablative RadiotherapyLocation: Hall B2Presenter: – UT Southwestern Medical Center
Steven Montalvo, MD – UT Southwestern Medical Center ### 1972233###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 4:45 PM – 6:00 PM PT
2094 - A U.S. Cancer Centers Interactive Cancer Education Program for Spanish-Speaking Latinos during COVID-19 PandemicLocation: Hall B2Presenter: – Aurora Health Care
Javier Mora, MD – Aurora Health Care ### 1972205###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Aurora Health Care###Presenter: – Aurora Health Care
### 4:45 PM – 6:00 PM PT
2095 - The Effect of Body Mass Index on Tumor Treating Fields (TTFields) Intensity Distribution in the LungsLocation: Hall B2
Nadav Shapira ### 2086547###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2097 - Increasing Accrual of Racial and Ethnic Minorities in Breast Cancer Clinical Trials by Partnering with Community HospitalsLocation: Hall B2Presenter: – New York Presbyterian
Joy Ogunmuyiwa, MD – New York Presbyterian ### 1972156###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###New York Presbyterian###Presenter: – New York Presbyterian
### 4:45 PM – 6:00 PM PT
2098 - Long-Term Results of a Phase II Study of Accelerated Hyperfractionated Thoracic Radiotherapy with Dose Escalation to 54 Gy for Limited-Stage Small-Cell Lung CancerLocation: Hall B2Presenter: – Hiroshima City Hiroshima Citizens Hospital
Ayaka Ono, MD – Hiroshima City Hiroshima Citizens Hospital ### 1972209###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hiroshima City Hiroshima Citizens Hospital###Presenter: – Hiroshima City Hiroshima Citizens Hospital
### 4:45 PM – 6:00 PM PT
2099 - Reducing Racial Disparities in Breast Cancer TreatmentLocation: Hall B2Presenter: – Corewell Health William Beaumont University Hospital
Jacob Oyeniyi, MD – Corewell Health William Beaumont University Hospital ### 1972202###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Corewell Health William Beaumont University Hospital###Presenter: – Corewell Health William Beaumont University Hospital
### 4:45 PM – 6:00 PM PT
2100 - Malignant Pleural Mesothelioma and Radiotherapy: Lung Toxicity Results of an Interim Analysis in Prospective Pilot TrialLocation: Hall B2Presenter: – Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS
Elisabetta Parisi, MD – Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS ### 1972222###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS###Presenter: – Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS
### 4:45 PM – 6:00 PM PT
2101 - Interim Analysis of DD3: A Phase IB/II Trial of Dose-Deescalated 3-Fraction SBRT for Centrally Located Lung CancerLocation: Hall B2Presenter: – Yale New Haven Health - Shoreline Medical Center
Gabrielle Peters, MD – Yale New Haven Health - Shoreline Medical Center ### 748070###Presenter###Disclosures: Employment: Yale School of Medicine:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Yale New Haven Health - Shoreline Medical Center###Presenter: – Yale New Haven Health - Shoreline Medical Center
### 4:45 PM – 6:00 PM PT
2101 - Interim Analysis of DD3: A Phase IB/II Trial of Dose-Deescalated 3-Fraction SBRT for Centrally Located Lung CancerLocation: Hall B1Presenter: – Yale University School of Medicine
Henry Park, MD, MPH – Yale University School of Medicine ### 1945591###Presenter###Disclosures: Employment: Yale School of Medicine:Associate Professor, Vice Chair for Clinical Research:Employee;Yale School of Medicine:Assistant Professor:Employee | Compensation: Galera Therapeutics, Inc.: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 10/1/21 ;AstraZeneca: Consultant, Honoraria-End Date: to present ;Bristol Myers Squibb: Education Meeting Faculty, Honoraria-End Date: 4/1/21 ;RefleXion Medical: Consultant, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: to present ;G1 Therapeutics: Education Meeting Faculty, Honoraria-End Date: 11/2022 ;Merck: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;ASCO Advantage: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: To present | Ownership: none | Leadership: none###Yale University School of Medicine###Presenter: – Yale University School of Medicine
### 4:45 PM – 6:00 PM PT
2102 - Barriers to Care for Pediatric Rural Medulloblastoma Patients Receiving Craniospinal Proton Radiotherapy without In-State FacilitiesLocation: Hall B2Presenter: – Brody School of Medicine
Melisa Pasli, BS – Brody School of Medicine ### 1972191###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brody School of Medicine###Presenter: – Brody School of Medicine
### 4:45 PM – 6:00 PM PT
2103 - Rural Pediatric Radiation Oncology in the Era of COVID-19: A Single Institution AnalysisLocation: Hall B2Presenter: – Brody School of Medicine
Megan Goins, MS, BS – Brody School of Medicine ### 2122548###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brody School of Medicine###Presenter: – Brody School of Medicine
### 4:45 PM – 6:00 PM PT
2104 - Disparities in Acute Radiation-Related Pain and Dermatitis between Black and White Patients with Early-Stage Breast Cancer Receiving Adjuvant Radiation Following Breast Conserving SurgeryLocation: Hall B2Presenter: – UH Seidman Cancer Center Case Western Reserve University
Rohan Patel, MD – UH Seidman Cancer Center Case Western Reserve University ### 1972147###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UH Seidman Cancer Center Case Western Reserve University###Presenter: – UH Seidman Cancer Center Case Western Reserve University
### 4:45 PM – 6:00 PM PT
2106 - Characterizing First Events in LA-NSCLC Patients Treated with ChemoradiotherapyLocation: Hall B2Presenter: – Montefiore Medical Center/Albert Einstein College of Medicine
Michael Pennock, MD, MBiot – Montefiore Medical Center/Albert Einstein College of Medicine ### 1972166###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Montefiore Medical Center/Albert Einstein College of Medicine###Presenter: – Montefiore Medical Center/Albert Einstein College of Medicine
### 4:45 PM – 6:00 PM PT
2107 - The Effect of Stereotactic Body Radiotherapy (SBRT) Dose-Fraction (fx) Schema on Non-Small Cell Lung Cancer (NSCLC)Location: Hall B2Presenter: – Fox Chase Cancer Center
Aneesh Pirlamarla, MD – Fox Chase Cancer Center ### 538282###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
### 4:45 PM – 6:00 PM PT
2108 - Cardiopulmonary Toxicity from Intensity Modulated Proton Therapy for Thymic MalignanciesLocation: Hall B2Presenter: – University of Maryland School of Medicine, Baltimore
Manaahil Rao, BS – University of Maryland School of Medicine, Baltimore ### 1972174###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland School of Medicine, Baltimore###Presenter: – University of Maryland School of Medicine, Baltimore
### 4:45 PM – 6:00 PM PT
2109 - Analysis of Racial Disparity among U.S. Patients with Gynecologic Cancers and COVID-19 InfectionLocation: Hall B2Presenter: – Case Comprehensive Cancer Center, Case Western Reserve University
Atefeh Rezaei, MD – Case Comprehensive Cancer Center, Case Western Reserve University ### 1972203###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Case Comprehensive Cancer Center, Case Western Reserve University###Presenter: – Case Comprehensive Cancer Center, Case Western Reserve University
### 4:45 PM – 6:00 PM PT
2111 - Long-Term Outcomes of Multidisciplinary Radiation Oncology Equity and Inclusion Committee Programming at an Academic Health SystemLocation: Hall B2Presenter: – Icahn School of Medicine at Mount Sinai
Carlos Rodriguez-Russo, MD – Icahn School of Medicine at Mount Sinai ### 1972134###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Icahn School of Medicine at Mount Sinai###Presenter: – Icahn School of Medicine at Mount Sinai
### 4:45 PM – 6:00 PM PT
2112 - Dosimetric Risk Estimation of Chest Wall Pain Following 5-Fraction Lung Stereotactic Body RadiotherapyLocation: Hall B2Presenter: – University of Tennessee Medical Center
Keaton Rummel, MD – University of Tennessee Medical Center ### 2070867###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Tennessee Medical Center###Presenter: – University of Tennessee Medical Center
### 4:45 PM – 6:00 PM PT
2113 - Long-Term Survival in Patients with Brain-Only Metastatic Lung Cancer Undergoing Upfront Intracranial Stereotactic Radiosurgery and Definitive Treatment to the Thoracic Primary SiteLocation: Hall B2Presenter: – Beaumont Health
Kamran Salari, MD, BS – Beaumont Health ### 1972165###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health###Presenter: – Beaumont Health
### 4:45 PM – 6:00 PM PT
2114 - Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy: Clinical Outcome and Prognostic FactorsLocation: Hall B2Presenter: – Azienda Ospedaliera Universitaria Careggi
Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi ### 1972601###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Azienda Ospedaliera Universitaria Careggi###Presenter: – Azienda Ospedaliera Universitaria Careggi
### 4:45 PM – 6:00 PM PT
2114 - Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy: Clinical Outcome and Prognostic FactorsLocation: Hall B2
Viola Salvestrini, MD ### 1972234###Presenter#########Presenter:
### 4:45 PM – 6:00 PM PT
2115 - Outcomes of Cytoreductive Stereotactic Body Radiotherapy (SBRT) in Patients with Oligometastatic or Oligoprogressive Dominant Lung Metastases from Colorectal PrimaryLocation: Hall B2Presenter: – Moffitt Cancer Center
Maria Sandoval, MD, MS – Moffitt Cancer Center ### 747614###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Moffitt Cancer Center###Presenter: – Moffitt Cancer Center
### 4:45 PM – 6:00 PM PT
2117 - Disparities in Inpatient Care Including Receipt of Radiotherapy and Mortality in Unhoused Adults with Cancer in the United StatesLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Patricia Santos, MD, MS – Memorial Sloan Kettering Cancer Center ### 1972063###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:45 PM – 6:00 PM PT
2119 - Comorbidities and Their Impact on Treatment Tolerance and Outcome in Elderly NSCLC Patients Treated with Concurrent Chemoradiation Using Proton or Photon Followed By ImmunotherapyLocation: Hall B2Presenter: – MD Anderson Cancer Center
Yuki Sasaki, MD, PhD – MD Anderson Cancer Center ### 1972151###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:45 PM – 6:00 PM PT
2120 - Dose-Escalated vs. Conventional Hypofractionated Radiotherapy for Lung Cancer Patients in Predominantly Central LocationsLocation: Hall B2Presenter: – Yale School of Medicine
Alexander Sasse, BS – Yale School of Medicine ### 1972224###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yale School of Medicine###Presenter: – Yale School of Medicine
### 4:45 PM – 6:00 PM PT
2121 - High Risk Prognostic Factors Predictive of Outcome Following Stereotactic Body Radiation Therapy (SBRT) for Early Stage Lung CancerLocation: Hall B2
Jacob Schick, MD ### 1972139###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2122 - Sexual Orientation and Gender Identity (SOGI) Data Collection: Opportunities to Advance Best Clinical Practices for LGBTQ+ Patients in Radiation OncologyLocation: Hall B2Presenter: – MD Anderson Cancer Center
Benjamin Schrank, MD, PhD – MD Anderson Cancer Center ### 1972198###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:45 PM – 6:00 PM PT
2123 - Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Patients with Pleural Metastases from Thymic MalignanciesLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Annemarie Shepherd, MD – Memorial Sloan Kettering Cancer Center ### 535837###Presenter###Disclosures: Employment: Memorial Sloan Kettering-Cancer Center:Assistant Attending:Employee;Federal Government:Project Manager:Employee | Compensation: :Role Topic Description-End Date: | Ownership: ArcellX:Stock;Doximity:Stock | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:45 PM – 6:00 PM PT
2125 - Molecular Status Predicts for Local Control in Patients with Non-Small Cell Lung Cancer Spinal Metastases Following Spine Stereotactic Body RadiotherapyLocation: Hall B2Presenter: – Sunnybrook Odette Cancer Centre
Dana Shor, MBBS – Sunnybrook Odette Cancer Centre ### 1972211###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sunnybrook Odette Cancer Centre###Presenter: – Sunnybrook Odette Cancer Centre
### 4:45 PM – 6:00 PM PT
2126 - SABRSeq: A Randomized Phase Ib Trial of SABR Sequencing with Pembrolizumab in Metastatic Non-Small Cell Lung Cancer (NSCLC)Location: Hall B2Presenter: – Peter MacCallum Cancer Centre
Ryan McMahon, MD, MBBS – Peter MacCallum Cancer Centre ### 2029571###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peter MacCallum Cancer Centre###Presenter: – Peter MacCallum Cancer Centre
### 4:45 PM – 6:00 PM PT
2127 - Combined Model Based on CT Radiomics and Clinical Parameters Predicts Risk of Cachexia in Extensive-Stage Small Cell Lung Cancer Patients Treated with First-Line ImmunotherapyLocation: Hall B2
Ruiting Song, MS ### 1972154###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2128 - Patient Advocate Presence Helps Poster Presenters Understand Clinical Significance of their Research and Increases EmpathyLocation: Hall B2Presenter: – Thomas Jefferson University
Christina Soule – Thomas Jefferson University ### 1972186###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 4:45 PM – 6:00 PM PT
2129 - Patterns of Cancer Treatment among People with HIV in the Mountain WestLocation: Hall B2Presenter: – University of Utah
Maya Stephens, MS, BS – University of Utah ### 1972197###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Utah###Presenter: – University of Utah
### 4:45 PM – 6:00 PM PT
2130 - Prospective Characterization of Circulating Tumor Cell Kinetics in Patients with Localized Lung Cancer Treated with Radiotherapy or Chemoradiotherapy with Definitive IntentLocation: Hall B2Presenter: – The University of North Carolina at Chapel Hill
Shivani Sud, MD – The University of North Carolina at Chapel Hill ### 746709###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of North Carolina at Chapel Hill###Presenter: – The University of North Carolina at Chapel Hill
### 4:45 PM – 6:00 PM PT
2131 - Survival Outcomes of Extensive Stage Small Cell Lung Cancer Patients Treated with Consolidative Thoracic Radiotherapy at a Tertiary Cancer CenterLocation: Hall B2Presenter: – Princess Margaret Cancer Center, University Health Network
Rohan Salunkhe, MD, MBBS – Princess Margaret Cancer Center, University Health Network ### 747578###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Center, University Health Network###Presenter: – Princess Margaret Cancer Center, University Health Network
### 4:45 PM – 6:00 PM PT
2132 - Association of Proton Pump Inhibitor Use and Severe Pneumonitis in Stage III Non-Small-Cell Lung Cancer Treated with Primary Chemoradiation and Adjuvant DurvalumabLocation: Hall B2Presenter: – Michigan Medicine
Grace Sun, MD, BS – Michigan Medicine ### 1972163###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Michigan Medicine###Presenter: – Michigan Medicine
### 4:45 PM – 6:00 PM PT
2134 - Analysis of the Measured FDG Uptake from the First-in-Human Clinical Trial of Biology-Guided RadiotherapyLocation: Hall B2Presenter: – Stanford University School of Medicine
Murat Surucu, PhD – Stanford University School of Medicine ### 747898###Presenter###Disclosures: Employment: Stanford University:Chief of Clinical Physics and Clinical Assocaite Professor:Employee | Compensation: RefleXion Medical Inc.: Research Grants, Research Funding, Research Salary Support, Speaker's Bureau, Grant Research Funding, Honoraria-End Date: Present | Ownership: none | Leadership: none###Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 4:45 PM – 6:00 PM PT
2135 - The Incidence of Severe Radiation-Induced Lymphopenia during Chemoradiotherapy for Stage ? Non-Small Cell Lung Cancer: A Comparative Study of Proton Versus Photon-Based RadiotherapyLocation: Hall B2Presenter: – Yokohama Municipal Citizen's Hospital
Yuya Tabuchi, MD – Yokohama Municipal Citizen's Hospital ### 1972142###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yokohama Municipal Citizen's Hospital###Presenter: – Yokohama Municipal Citizen's Hospital
### 4:45 PM – 6:00 PM PT
2136 - Dosimetric Comparison of Nodal Clinical Target Volume for Locally Advanced Non-Small Cell Lung Cancer: Options for Geometric Expansion vs. Lymph Node StationsLocation: Hall B2Presenter: – Kagawa University Hospital
Shigeo Takahashi, MD, PhD – Kagawa University Hospital ### 537938###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kagawa University Hospital###Presenter: – Kagawa University Hospital
### 4:45 PM – 6:00 PM PT
2137 - Difference in Radiosensitivity Depending on the Presence and Absence of EGFR Mutations: Clinical and In Vitro analysesLocation: Hall B2Presenter: – Yamaguchi University Graduate School of Medicine
Hidekazu Tanaka, MD, PhD – Yamaguchi University Graduate School of Medicine ### 537590###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yamaguchi University Graduate School of Medicine###Presenter: – Yamaguchi University Graduate School of Medicine
### 4:45 PM – 6:00 PM PT
2138 - Deep-Inspiration Breath-Hold Stereotactic Body Radiation Therapy by Combining Spirometer-Guided Breath-Hold and a Real-Time Tumor Tracking System: A Novel ApproachLocation: Hall B2Presenter: – Yamaguchi University Graduate School of Medicine
Hidekazu Tanaka, MD, PhD – Yamaguchi University Graduate School of Medicine ### 537590###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yamaguchi University Graduate School of Medicine###Presenter: – Yamaguchi University Graduate School of Medicine
### 4:45 PM – 6:00 PM PT
2139 - Racial Disparities in Brachytherapy Treatment among Women with Cervical and Endometrial Cancers: A United States Cohort Study between 2004-2017Location: Hall B2Presenter: – Stanford Health Care
Kekoa Taparra, MD, PhD – Stanford Health Care ### 535869###Presenter###Disclosures: Employment: Stanford Health Care:Resident Physician:Employee | Compensation: Lancet: Other, Honoraria-End Date: 6/2022 ;Stanford CARE: Other, Honoraria-End Date: 3/2023 ;MDACC: Other, Honoraria-End Date: 5/2023 | Ownership: none | Leadership: none###Stanford Health Care###Presenter: – Stanford Health Care
### 4:45 PM – 6:00 PM PT
2140 - Effects of Respiratory and Cardiac Motion on Dose to the Left Anterior Descending Artery in Patients Undergoing Radiation Therapy for Locally Advanced Lung CancerLocation: Hall B2Presenter: – Virginia Commonwealth University/MCV Massey Cancer Center
Ross Taylor, MD – Virginia Commonwealth University/MCV Massey Cancer Center ### 1972119###Presenter######Virginia Commonwealth University/MCV Massey Cancer Center###Presenter: – Virginia Commonwealth University/MCV Massey Cancer Center
### 4:45 PM – 6:00 PM PT
2141 - Using CT Radiomics and Machine Learning to Distinguish Radiotherapy vs. Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer PatientsLocation: Hall B2Presenter: – Shandong Anti-Cancer Association
Feifei Teng, MD, PhD – Shandong Anti-Cancer Association ### 746759###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 4:45 PM – 6:00 PM PT
2142 - Using MRI Radiomics to Predict the Efficacy of Immunotherapy for Brain Metastasis in Patients with Non-small Cell Lung CancerLocation: Hall B2Presenter: – Shandong Anti-Cancer Association
Feifei Teng, MD, PhD – Shandong Anti-Cancer Association ### 746759###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 4:45 PM – 6:00 PM PT
2143 - Using MRI Radiomics to Predict the Efficacy of Immunotherapy for Brain Metastasis in Patients with Small Cell Lung CancerLocation: Hall B2Presenter: – Shandong Anti-Cancer Association
Feifei Teng, MD, PhD – Shandong Anti-Cancer Association ### 746759###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 4:45 PM – 6:00 PM PT
2144 - Treatment of Thymoma and Thymic Carcinoma with Proton Beam Therapy: Outcomes from the Proton Collaborative Group Prospective RegistryLocation: Hall B2Presenter: – Winship Cancer Institute of Emory University
Sibo Tian, MD – Winship Cancer Institute of Emory University ### 537897###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Winship Cancer Institute of Emory University###Presenter: – Winship Cancer Institute of Emory University
### 4:45 PM – 6:00 PM PT
2145 - Long Term Outcomes of Conventional Palliative Radiotherapy in Bone Metastases of Lung Cancer - A Prospective StudyLocation: Hall B2Presenter: – Tata Memorial Hospital
AMIYA AGRAWAL, MD, MBBS – Tata Memorial Hospital ### 2086867###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tata Memorial Hospital###Presenter: – Tata Memorial Hospital
### 4:45 PM – 6:00 PM PT
2146 - Facility-Level Analysis of Twice Daily Radiation Utilization for Limited Stage Small Cell Lung CancerLocation: Hall B2
Ian Tsekouras, BBA – UABHSOM ### 1972228###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UABHSOM###Presenter: – UABHSOM
### 4:45 PM – 6:00 PM PT
2147 - Investigating the Influence of Cardiac Substructure Dose on Survival of Lung Cancer PatientsLocation: Hall B2Presenter: – University Medical Centre Utrecht
Luuk van der Pol, Msc – University Medical Centre Utrecht ### 1972159###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Medical Centre Utrecht###Presenter: – University Medical Centre Utrecht
### 4:45 PM – 6:00 PM PT
2148 - AI Serial Image Prediction of Progression-Free Survival (PFS) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients Treated with Chemoradiation (CRT) and Durvalumab ConsolidationLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Harini Veeraraghavan, PhD – Memorial Sloan Kettering Cancer Center ### 1972158###Presenter###Disclosures: Employment: Memorial Sloan Kettering Cancer Center:associate attending computer scientist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:45 PM – 6:00 PM PT
2149 - Survival Outcomes for Oligometastatic vs. Polymetastatic Extensive-Stage Small Cell Lung Cancer Following Consolidative Thoracic RadiotherapyLocation: Hall B2Presenter: – Yale New Haven Health
Nipun Verma, MD, PhD – Yale New Haven Health ### 1972161###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yale New Haven Health###Presenter: – Yale New Haven Health
### 4:45 PM – 6:00 PM PT
2150 - Single-Fraction Lung SBRT Outcomes for Tumors = 3cmLocation: Hall B2Presenter: – Cleveland Clinic Taussig Cancer Center
Gregory Videtic, MD, FASTRO, CM, FRCPC, FACR – Cleveland Clinic Taussig Cancer Center ### 524538###Presenter###Disclosures: Employment: Cleveland Clinic:Staff Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 4:45 PM – 6:00 PM PT
2151 - Simulation CT Features and Radiation Cardiotoxicity in Non-Small Cell Lung CancerLocation: Hall B2Presenter: – Patrick G Johnston Centre for Cancer Research
Gerard Walls, MD, PhD – Patrick G Johnston Centre for Cancer Research ### 1972143###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Patrick G Johnston Centre for Cancer Research###Presenter: – Patrick G Johnston Centre for Cancer Research
### 4:45 PM – 6:00 PM PT
2153 - Plasma Exosomal miRNAs as Response Biomarkers of Immunotherapy in Extensive-Stage Small-Cell Lung CancerLocation: Hall B2Presenter: – Fudan University Shanghai Cancer Center
Boyan Wang, MD – Fudan University Shanghai Cancer Center ### 1972179###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 4:45 PM – 6:00 PM PT
2154 - Effect of Segmental Abutting Esophagus-Sparing Technique to Reduce Severe Esophagitis in Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Hypofractionated Thoracic Radiation and CLocation: Hall B2
Jianyang Wang, MD ### 538281###Presenter#########Presenter:
### 4:45 PM – 6:00 PM PT
2155 - Anatomy-Guided Deep Learning Model for Accurate and Robust Gross Tumor Volume Segmentation in Lung Cancer Radiation TherapyLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute ### 2094333###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 4:45 PM – 6:00 PM PT
2156 - Incidence and Risk Factors for Brain Metastases in Patients with Lung Cancer: A Systematic Review and Meta-AnalysisLocation: Hall B2Presenter: – Chongqing University Cancer Hospital
Shilin Wang, MS – Chongqing University Cancer Hospital ### 1972122###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###Presenter: – Chongqing University Cancer Hospital
### 4:45 PM – 6:00 PM PT
2158 - Could Residual Disease Irradiation be Better than Involved Field Irradiation for Limited-Stage Small Cell Lung Cancer? A Failure Pattern AnalysisLocation: Hall B2Presenter: – Shandong First Medical University and Shandong Academy of Medical Science
Xinran Wang, MD, MS – Shandong First Medical University and Shandong Academy of Medical Science ### 1972131###Presenter######Shandong First Medical University and Shandong Academy of Medical Science###Presenter: – Shandong First Medical University and Shandong Academy of Medical Science
### 4:45 PM – 6:00 PM PT
2159 - Improved Prediction of Chemoradiation and Immune Checkpoint Blockade Efficacy with Dynamic bTMB Combined with ctDNA in Unresectable Locally Advanced NSCLCLocation: Hall B2Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
Yu Wang, MD – Chinese Academy of Medical Sciences and Peking Union Medical College ### 1971999###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
### 4:45 PM – 6:00 PM PT
2160 - Dose Constraints and Planning Considerations for Thoracic Radiation Therapy: Delphi Consensus from a National Survey of ExpertsLocation: Hall B2Presenter: – MD Anderson Cancer Center
Julius Weng, MD, BS – MD Anderson Cancer Center ### 1972216###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:45 PM – 6:00 PM PT
2162 - Pentoxifylline and Vitamin E in Preventing Pneumonitis Using Stereotactic Ablative Radiotherapy in Previously Irradiated PatientsLocation: Hall B2Presenter: – University of Louisville School of Medicine
Andrew Willett, BS, MS4 – University of Louisville School of Medicine ### 1972235###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Louisville School of Medicine###Presenter: – University of Louisville School of Medicine
### 4:45 PM – 6:00 PM PT
2163 - Vertebral Dose Sparing during Lung and Esophageal Radiation TherapyLocation: Hall B2Presenter: – UT Health San Antonio MD Anderson Cancer Center
Robert Wilson, MD – UT Health San Antonio MD Anderson Cancer Center ### 1972176###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Health San Antonio MD Anderson Cancer Center###Presenter: – UT Health San Antonio MD Anderson Cancer Center
### 4:45 PM – 6:00 PM PT
2164 - Socio-Economic Status in Risk of Acute Adverse Events Following RadiotherapyLocation: Hall B2Presenter: – Princess Margaret Cancer Centre
Philip Wong, MD – Princess Margaret Cancer Centre ### 536107###Presenter###Disclosures: Employment: none | Compensation: AstraZeneca: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Bristol Myers Squibb: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present | Ownership: MISO chip:Ownership Equity | Leadership: none###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
### 4:45 PM – 6:00 PM PT
2165 - Induction Immunochemotherapy Followed by Definitive Chemoradiotherapy for Unresectable Locally Advanced Non-Small Cell Lung CancerLocation: Hall B2
Leilei Wu ### 1972169###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2166 - Predicting local control with dosimetric parameters in patients receiving individualized stereotactic ablative radiotherapy for lung tumorsLocation: Hall B2Presenter: – Stanford University
Yufan (Fred) Wu, MD, BS – Stanford University ### 1972219###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 4:45 PM – 6:00 PM PT
2167 - Risk-Adapted SABR for Ultra-Central Lung Tumors Attaining High BED10 to Targets in a Steep Dose-Response Window of 72-105 Gy under Tumor Tracking: A Planning StudyLocation: Hall B2Presenter: – Penn Medicine Lancaster General Health
Hong Xiang, PhD – Penn Medicine Lancaster General Health ### 1972140###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Penn Medicine Lancaster General Health###Presenter: – Penn Medicine Lancaster General Health
### 4:45 PM – 6:00 PM PT
2168 - Pattern of Failure and Re-Irradiation for Stereotactic Radiotherapy Treated Brain Metastases from Non-Small Cell Lung Cancer (NSCLC)Location: Hall B2
Dayu Xu, MD ### 1972123###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2169 - The Causes of Death and Conditional Survival for Long-Term Survivors of ThymomaLocation: Hall B2Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
Kunpeng Xu, MD – Chinese Academy of Medical Sciences and Peking Union Medical College ### 1972121###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
### 4:45 PM – 6:00 PM PT
2170 - Prediction of Lymphopenia and Survival with Baseline Absolute Lymphocyte Count and Irradiated Dose to Immune Cells in Patients with Non-Small Cell Lung Cancer Treated with Concurrent ChemoradiotherapyLocation: Hall B2Presenter: – Yonsei Cancer Center YUMC
Gowoon Yang, MD – Yonsei Cancer Center YUMC ### 1972208###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yonsei Cancer Center YUMC###Presenter: – Yonsei Cancer Center YUMC
### 4:45 PM – 6:00 PM PT
2171 - A Randomized Controlled Phase ? Study of Nab-Paclitaxel vs. Paclitaxel plus Cisplatin in Concomitant Chemoradiotherapy for Locally Advanced Non-Small Cell Lung CancerLocation: Hall B2Presenter: – Guizhou Cancer Hospital
wengang Yang, RT – Guizhou Cancer Hospital ### 1972137###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Guizhou Cancer Hospital###Presenter: – Guizhou Cancer Hospital
### 4:45 PM – 6:00 PM PT
2173 - Salvage Thoracic Radiotherapy for Locoregional Recurrence Improves Overall Survival of Patients with Completely Resected PIIIA-N2 NSCLCLocation: Hall B2
Meng Yuan, MD – None ### 538306###Presenter######None###Presenter: – None
### 4:45 PM – 6:00 PM PT
2175 - Survival Analysis of Patients with Locally Advanced Non-Small Cell Lung Cancer Who Received Neoadjuvant ImmunotherapyLocation: Hall B2Presenter: – Shanghai Pulmonary Hospital
Yaping Xu, PhD – Shanghai Pulmonary Hospital ### 535769###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shanghai Pulmonary Hospital###Presenter: – Shanghai Pulmonary Hospital
### 4:45 PM – 6:00 PM PT
2176 - Cancer-Related Mortality Rates are Lower in U.S. States with Higher GDP per CapitaLocation: Hall B2Presenter: – University of Washington
Peter Zaki, MD – University of Washington ### 1972035###Presenter###Disclosures: Employment: University of Washington:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 4:45 PM – 6:00 PM PT
2177 - Clinical Outcomes with Thoracic Radiotherapy for Extensive-Stage Small-Cell Lung Cancer in the Era of Immunotherapy: A Retrospective Analysis.Location: Hall B2Presenter: – National Cancer Center/National Clinical Research Center for Cance
Chaonan Zhang, MD – National Cancer Center/National Clinical Research Center for Cance ### 1972231###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center/National Clinical Research Center for Cance###Presenter: – National Cancer Center/National Clinical Research Center for Cance
### 4:45 PM – 6:00 PM PT
2178 - Oligo-Residual Disease in PD-1/PD-L1 Inhibitors Treated Metastatic Non-Small Cell Lung Cancer: Incidence, Pattern of Failure and Clinical Value of Local Consolidative TherapyLocation: Hall B2
Jinmeng Zhang, MD ### 1972237###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2180 - The Value of Postoperative Radiotherapy in Thymoma with Myasthenia GravisLocation: Hall B2Presenter: – Xiangya Hospital Central South University
Rongrong Zhou, MD, DO, PhD, BSN – Xiangya Hospital Central South University ### 2082522###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Xiangya Hospital Central South University###Presenter: – Xiangya Hospital Central South University
### 4:45 PM – 6:00 PM PT
2181 - A Nomogram Based on Radiomics and Genomics Factors for Predicting Radiation Pneumonia in Patients with Limited-Stage Small Cell Lung Cancer after Definitive ChemoradiotherapyLocation: Hall B2
He Zhu, MD ### 1972149###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:45 PM – 6:00 PM PT
2182 - Contralateral Esophagus Sparing Prevents Symptomatic Esophagitis in Ultra-Central NSCLC Receiving Hypofractionated RadiotherapyLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Lin Zhu, MD, PhD – Harvard Radiation Oncology Program ### 1972145###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### - Monday, October 2, 2023
10:45 AM – 12:00 PM PT
Circadian rhythm positioned chronomodulated-SBRT with Cancer associated fibroblast elimination theranostics to harmonize the resistant high TGF-Beta stromal microenvironment with PDL-1 based immunothe
G Lohith, MD – HCG ### 1972238###Presenter######HCG###Presenter: – HCG
### 10:45 AM – 12:00 PM PT
Quality of Palliative Radiation Therapy Assessed Using Quality Indicators: A Multicenter SurveyPresenter: – Arao Municipal Hospital
Tetsuo Saito, MD, PhD – Arao Municipal Hospital ### 1972289###Presenter######Arao Municipal Hospital###Presenter: – Arao Municipal Hospital
### 10:45 AM – 12:00 PM PT
2183 - Stereotactic Body Radiotherapy (SBRT) for Adrenal Metastases: Practice Patterns at Community-Based Radiotherapy CentersLocation: Hall B2
Anesa Ahamad, MD, MB, BS, FRCR – GenesisCare ### 537892###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GenesisCare###Presenter: – GenesisCare
### 10:45 AM – 12:00 PM PT
2184 - The Feasibility of Dose-Escalated Radiation Therapy for Glioblastoma Using Biological Image Guided Adaptive Radiotherapy (BIGART)Location: Hall B2
Doaa Almeldin, MD, PhD ### 1972324###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:45 AM – 12:00 PM PT
2185 - Effect of Cobalt-60 Calibration Dose-Rate on Arteriovenous Malformation Obliteration after Stereotactic RadiosurgeryLocation: Hall B2Presenter: – Princess Margaret Cancer Center, University Health Network
Victoria Anthes, HBSc – Princess Margaret Cancer Center, University Health Network ### 1972308###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Center, University Health Network###Presenter: – Princess Margaret Cancer Center, University Health Network
### 10:45 AM – 12:00 PM PT
2186 - Hyperbaric Oxygen Therapy plus Hypofractionated Stereotactic Radiotherapy in Recurrent GlioblastomaLocation: Hall B2
DONATELLA ARPA, MD – IRCCS IRST ### 1972306###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###IRCCS IRST###Presenter: – IRCCS IRST
### 10:45 AM – 12:00 PM PT
2187 - Pre-Treatment MRI Radiomics Can Predict Distant Brain Metastases Following Stereotactic Radiosurgery/RadiotherapyLocation: Hall B2Presenter: – Stony Brook University
Joseph Bae, MS, BS – Stony Brook University ### 1972281###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stony Brook University###Presenter: – Stony Brook University
### 10:45 AM – 12:00 PM PT
2188 - Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive FactorsLocation: Hall B2Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
Jean-Paul Bahary, MD – Centre Hospitalier de l'Universite de Montreal (CHUM) ### 2037793###Presenter###Disclosures: Employment: centre hospitalier de l'universite de montreal:radiation-oncologist:Independent Contractor;university of montreal:professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: NRG:vice chair for canadian affairs###Centre Hospitalier de l'Universite de Montreal (CHUM)###Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
### 10:45 AM – 12:00 PM PT
2189 - Tumor Treating Fields (TTFields) for Newly Diagnosed Glioblastoma in the Real World: A Systematic Review and Survival Meta-AnalysisLocation: Hall B2Presenter: – West Cancer Center & Research Institute
Matthew Ballo, MD – West Cancer Center & Research Institute ### 536053###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West Cancer Center & Research Institute###Presenter: – West Cancer Center & Research Institute
### 10:45 AM – 12:00 PM PT
2190 - Leveraging Quantitative Imaging and Machine Learning to Differentiate Radionecrosis from Disease Recurrence in Patients with Brain MetastasesLocation: Hall B2Presenter: – University of Wisconsin Hospitals and Clinics
Mustafa Basree, DO, MS – University of Wisconsin Hospitals and Clinics ### 1972310###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin Hospitals and Clinics###Presenter: – University of Wisconsin Hospitals and Clinics
### 10:45 AM – 12:00 PM PT
2191 - Impact of Concurrent Targeted Therapy and Immunotherapy on the Incidence of Radiation Necrosis Following Stereotactic Radiosurgery for Brain MetastasesLocation: Hall B2Presenter: – Kaiser Permanente Los Angeles Medical Center
Adam Beighley, MD – Kaiser Permanente Los Angeles Medical Center ### 1972270###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaiser Permanente Los Angeles Medical Center###Presenter: – Kaiser Permanente Los Angeles Medical Center
### 10:45 AM – 12:00 PM PT
2192 - Spectroscopic MRI Detects Occult Glioblastoma Invasion during ChemoradiationLocation: Hall B2Presenter: – University of Miami
Jonathan Bell, MD, PhD – University of Miami ### 1972323###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami###Presenter: – University of Miami
### 10:45 AM – 12:00 PM PT
2193 - Patient-Specific Segmentation-Based Treatment Planning vs. NovoTAL for TTFields Therapy in GlioblastomaLocation: Hall B2Presenter: – Novocure - Williamsburg
Brian Berger, MD – Novocure - Williamsburg ### 1972335###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Novocure - Williamsburg###Presenter: – Novocure - Williamsburg
### 10:45 AM – 12:00 PM PT
2194 - Post-Operative Stereotactic Radiotherapy for Resected Brain Metastases: Results of the Multicenter Analysis (AURORA) of the German Working Group "Stereotactic Radiotherapy"Location: Hall B2Presenter: – Technical University of Munich (TUM), Radiation Oncology
Denise Bernhardt, MD – Technical University of Munich (TUM), Radiation Oncology ### 1972263###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Technical University of Munich (TUM), Radiation Oncology###Presenter: – Technical University of Munich (TUM), Radiation Oncology
### 10:45 AM – 12:00 PM PT
2195 - Outcomes of Brain Metastases with Suspicious Imaging Undergoing Resection to Evaluate for Radionecrosis vs. Tumor ProgressionLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Rohini Bhatia, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 538056###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 10:45 AM – 12:00 PM PT
2196 - Risk Factors Associated with Development of Peritumoral Edema Following Stereotactic Radiosurgery and Radiotherapy for Intracranial MeningiomaLocation: Hall B2Presenter: – Southern California Permanente Medical Group
Yazeed Kesbeh, MD – Southern California Permanente Medical Group ### 2083788###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Southern California Permanente Medical Group###Presenter: – Southern California Permanente Medical Group
### 10:45 AM – 12:00 PM PT
2196 - Risk Factors Associated with Development of Peritumoral Edema Following Stereotactic Radiosurgery and Radiotherapy for Intracranial MeningiomaLocation: Hall B1Presenter: – Kaiser Permanente Los Angeles Medical Center
Onita Bhattasali, MD, MPH – Kaiser Permanente Los Angeles Medical Center ### 524801###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaiser Permanente Los Angeles Medical Center###Presenter: – Kaiser Permanente Los Angeles Medical Center
### 10:45 AM – 12:00 PM PT
2197 - Phase II Randomized Trial of Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral MetastasesLocation: Hall B2Presenter: – Cleveland Clinic Foundation
Cole Billena, MD – Cleveland Clinic Foundation ### 747859###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 10:45 AM – 12:00 PM PT
2198 - Clinical Outcomes of Patients with Brain Metastases from Colorectal Cancer Treated with Stereotactic RadiosurgeryLocation: Hall B2Presenter: – Anirudh Bommireddy
Anirudh Bommireddy, MD – Anirudh Bommireddy ### 1972265###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Anirudh Bommireddy###Presenter: – Anirudh Bommireddy
### 10:45 AM – 12:00 PM PT
2199 - Clinical Outcomes for Patients with Brain Metastases from Upper Gastrointestinal Cancer Treated with Stereotactic RadiosurgeryLocation: Hall B2Presenter: – Anirudh Bommireddy
Anirudh Bommireddy, MD – Anirudh Bommireddy ### 1972265###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Anirudh Bommireddy###Presenter: – Anirudh Bommireddy
### 10:45 AM – 12:00 PM PT
2200 - Conditional Survival Estimates for Malignant Glioma Patients by RPA Class: Secondary Analysis of RTOG 9006Location: Hall B2Presenter: – University of Maryland Radiation Oncology
Matthew Brown, MD – University of Maryland Radiation Oncology ### 1972325###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Radiation Oncology###Presenter: – University of Maryland Radiation Oncology
### 10:45 AM – 12:00 PM PT
2201 - Stereotactic Body Radiotherapy for Posterior Element Only Spinal Metastases: Outcomes and Validation of Recommended Clinical Target Volume Delineation PracticeLocation: Hall B2Presenter: – Odette Cancer Centre
Laura Burgess, MD, MS – Odette Cancer Centre ### 1972337###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Odette Cancer Centre###Presenter: – Odette Cancer Centre
### 10:45 AM – 12:00 PM PT
2203 - Functional Outcomes and Toxicities Associated with SBRT to Bone Metastases Involving the Joint SpaceLocation: Hall B2Presenter: – Vanderbilt University Medical Center
Hayden Byrd, MD – Vanderbilt University Medical Center ### 1972305###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Vanderbilt University Medical Center###Presenter: – Vanderbilt University Medical Center
### 10:45 AM – 12:00 PM PT
2204 - Institutional Validation Study Inferring 2% MGMT Methylation Positive Impact on Survival in Newly Diagnosed Glioblastoma (GBM) PatientsLocation: Hall B2Presenter: – Thomas Jefferson University
Louis Cappelli, DO – Thomas Jefferson University ### 1972260###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 10:45 AM – 12:00 PM PT
2205 - Body Mass Index (BMI) at Time of Diagnosis as a Prognostic Indicator in Patients with Newly Diagnosed Glioblastoma (GBM)Location: Hall B2Presenter: – Thomas Jefferson University
Louis Cappelli, DO – Thomas Jefferson University ### 1972260###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 10:45 AM – 12:00 PM PT
2206 - Retrospective Review of the Factors Limiting Optune Initiation in GBM patientsLocation: Hall B2
Luis Carranza Pena, BS – UTHSCSA ### 1972264###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UTHSCSA###Presenter: – UTHSCSA
### 10:45 AM – 12:00 PM PT
2208 - Estimation of Conditional Neurocognitive Function Failure (NCFF) Incidence in Patients Receiving Whole Brain Radiation Therapy (WBRT) for Brain Metastases (BM): Secondary Analysis of NRG CC001Location: Hall B2Presenter: – University of Maryland Medical Center
Hua-Ren Cherng, MD – University of Maryland Medical Center ### 1972307###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Medical Center###Presenter: – University of Maryland Medical Center
### 10:45 AM – 12:00 PM PT
2209 - Frameless Fractionated Linear Accelerator-Based Stereotactic Radiotherapy for Brain Metastases: Results of a Single-Arm Phase II Multi-Institutional Clinical TrialLocation: Hall B2Presenter: – MD Anderson Cancer Center
Stephen Chun, MD – MD Anderson Cancer Center ### 1972206###Presenter###Disclosures: Employment: MD Anderson:Associate Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:45 AM – 12:00 PM PT
2210 - Cannabis Use Patterns among Patients with Early-Stage Breast Cancer in a Large Multicenter Cohort from a State with Legalized Adult Non-Medical CannabisLocation: Hall B2Presenter: – Self Regional Healthcare
Matthew Cousins, MD, PhD – Self Regional Healthcare ### 747424###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Self Regional Healthcare###Presenter: – Self Regional Healthcare
### 10:45 AM – 12:00 PM PT
2211 - A Survival Score for Patients Treated with Whole-Brain Radiotherapy plus Simultaneous Integrated Boost for Brain MetastasesLocation: Hall B2Presenter: – University of Luebeck
Florian Cremers, PhD – University of Luebeck ### 1972326###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Luebeck###Presenter: – University of Luebeck
### 10:45 AM – 12:00 PM PT
2212 - Rates of Radiosurgical Decompression for High Grade Epidural Spinal Disease due to Solid Tumor MetastasesLocation: Hall B2Presenter: – Johns Hopkins University
Anjali D'Amiano, BS – Johns Hopkins University ### 1972278###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 10:45 AM – 12:00 PM PT
2213 - A Potential Cause for Unexplained Radiation Toxicity in Proton TherapyLocation: Hall B2Presenter: – Massachusetts General Hospital
Juliane Daartz, PhD – Massachusetts General Hospital ### 1972277###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 10:45 AM – 12:00 PM PT
2214 - Stratifying Response to Stereotactic Radiosurgery for Spinal Metastases by Primary Site Genomic MutationsLocation: Hall B2Presenter: – McGovern Medical School
Ethan Damron, BS – McGovern Medical School ### 1972252###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGovern Medical School###Presenter: – McGovern Medical School
### 10:45 AM – 12:00 PM PT
2215 - Patient-Free Simulation: Analysis of Hospitalized Patients Treated without CT SimulationLocation: Hall B2Presenter: – Cleveland Clinic Taussig Cancer Center
Erik Davies, MD – Cleveland Clinic Taussig Cancer Center ### 1972302###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 10:45 AM – 12:00 PM PT
2216 - Inpatient Simulation Resource Utilization for Inpatient Radiation Oncology ConsultsLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Edward Dee, MD – Memorial Sloan Kettering Cancer Center ### 1972189###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 10:45 AM – 12:00 PM PT
2217 - Helical Tomotherapy Planning Technique Improves Dosimetry for Hippocampal-Avoidant Whole Brain Radiotherapy Compared with VMATLocation: Hall B2Presenter: – NYU Langone Health - Long Island
David DiBartolo, CMD – NYU Langone Health - Long Island ### 1972269###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Langone Health - Long Island###Presenter: – NYU Langone Health - Long Island
### 10:45 AM – 12:00 PM PT
2218 - Vertebral Compression Fracture Post Spine Stereotactic Body Radiotherapy: The Role of Vertebral EndplateLocation: Hall B2Presenter: – The James Cancer Hospital & Solove Research Institute
Khaled Dibs, MD – The James Cancer Hospital & Solove Research Institute ### 1972058###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The James Cancer Hospital & Solove Research Institute###Presenter: – The James Cancer Hospital & Solove Research Institute
### 10:45 AM – 12:00 PM PT
2219 - Inter-fractional Assessment during MR-guided Online Adaptive Radiotherapy for GlioblastomaLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Shouliang Ding, MS – Sun Yat-Sen University Cancer Center ### 1972317###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 10:45 AM – 12:00 PM PT
2220 - Influence of Eyes Movement on Lens Dose during MR-Guided Radiotherapy for Brain TumorLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Shouliang Ding, MS – Sun Yat-Sen University Cancer Center ### 1972317###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 10:45 AM – 12:00 PM PT
2221 - Upfront Osimertinib Alone vs. Osimertinib and Radiotherapy for the Treatment of EGFR-Positive NSCLC Brain Metastases: A Multi-Institutional SeriesLocation: Hall B2Presenter: – H. Lee Moffitt Cancer Center and Research Institute
Ammoren Dohm, MD – H. Lee Moffitt Cancer Center and Research Institute ### 537942###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###H. Lee Moffitt Cancer Center and Research Institute###Presenter: – H. Lee Moffitt Cancer Center and Research Institute
### 10:45 AM – 12:00 PM PT
2222 - Identification of Excellent Prognosis IDH Wildtype Glioblastomas Using Genomic and Metabolic ProfilingLocation: Hall B2Presenter: – University of Michigan
Donna Edwards, MD, PhD – University of Michigan ### 1972212###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 10:45 AM – 12:00 PM PT
2223 - The Impact of Co-Alterations on Outcomes after Local Therapy for Patients with KRAS-Mutant Lung Adenocarcinoma Brain MetastasesLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Jordan Eichholz, MS, BS – Memorial Sloan Kettering Cancer Center ### 1972275###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 10:45 AM – 12:00 PM PT
2226 - Stereotactic Radiosurgery as an Effective and Safe Treatment Modality in Central Nervous System Lymphoma, a Single Institution ExperienceLocation: Hall B2Presenter: – Roswell Park Comprehensive Cancer Center
Fatemeh Fekrmandi, MD, MS – Roswell Park Comprehensive Cancer Center ### 1972250###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Roswell Park Comprehensive Cancer Center###Presenter: – Roswell Park Comprehensive Cancer Center
### 10:45 AM – 12:00 PM PT
2227 - Validation of the Prognostic Index for Spine Metastasis (PRISM) Score for Stratifying Survival in Patients Treated with Spinal Stereotactic RadiosurgeryLocation: Hall B2Presenter: – Baylor College of Medicine
Marcus Florez, PhD – Baylor College of Medicine ### 1972268###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Baylor College of Medicine###Presenter: – Baylor College of Medicine
### 10:45 AM – 12:00 PM PT
2228 - A Phase II Trial of Intraoperative Radiotherapy after Surgical Resection of Brain Metastases: Feasibility and Efficacy NCT04847284Location: Hall B1Presenter: – Hospital Del Mar - Parc de Salut Mar
Palmira Foro, MD, PhD – Hospital Del Mar - Parc de Salut Mar ### 536085###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Del Mar - Parc de Salut Mar###Presenter: – Hospital Del Mar - Parc de Salut Mar
### 10:45 AM – 12:00 PM PT
2229 - Use of Lattice Therapy for Dose-Escalation in Palliative Treatment of Bulky Head and Neck TumorsLocation: Hall B2Presenter: – University of Cincinnati
Andrew Frankart, MD – University of Cincinnati ### 747309###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Cincinnati###Presenter: – University of Cincinnati
### 10:45 AM – 12:00 PM PT
2230 - Stereotactic Radiosurgery (SRS) for Large Brain Metastases: Dosimetric and Clinical Predictors of Local Progression and RadionecrosisLocation: Hall B2Presenter: – Mayo Clinic College of Medicine and Science Rochester
Kelsey Frechette, MD – Mayo Clinic College of Medicine and Science Rochester ### 537862###Presenter###Disclosures: Employment: Mayo Clinic:Radiation Oncology resident physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Mayo Clinic College of Medicine and Science Rochester###Presenter: – Mayo Clinic College of Medicine and Science Rochester
### 10:45 AM – 12:00 PM PT
2231 - Stereotactic Body Radiation Therapy for Large Volume Solid Tumor Spinal Metastases Involving Three or More Contiguous Vertebral LevelsLocation: Hall B2Presenter: – Johns Hopkins Hospital
Ulysses Gardner, MD, MBA – Johns Hopkins Hospital ### 1972240###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Hospital###Presenter: – Johns Hopkins Hospital
### 10:45 AM – 12:00 PM PT
2232 - Extrapulmonary Small Cell Carcinoma: A Single Institution Review of Brain Metastases, Treatment Paradigms and Patient OutcomesLocation: Hall B2Presenter: – Wake Forest Baptist Health
Sarah Glynn, DO – Wake Forest Baptist Health ### 1972285###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Wake Forest Baptist Health###Presenter: – Wake Forest Baptist Health
### 10:45 AM – 12:00 PM PT
2233 - Clinical Outcomes and Dosimetric Predictive Factors in Patients Undergoing Reirradiation for Recurrent MeningiomasLocation: Hall B2
Daniela Greto, MD ### 2004071###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:45 AM – 12:00 PM PT
2234 - Safety and Efficacy of Stereotactic Radiosurgery with Concurrent Targeted Systemic Therapy for Brain MetastasesLocation: Hall B2
Jacob Hall, MD – UNC Health ### 1972273###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UNC Health###Presenter: – UNC Health
### 10:45 AM – 12:00 PM PT
2235 - Communicating the External Beam Radiotherapy Experience (CEBRE) Discussion Guides: Real World Implementation and EvaluationLocation: Hall B2
Alicia Haydon ### 1972303###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:45 AM – 12:00 PM PT
2237 - Stereotactic Radiosurgery (SRS) for Brain Metastasis in the Era of Evolving Systemic Treatment (Immunotherapy or Targeted Therapy) in Patients with Non-Small Cell Lung Cancer (NSCLC)Location: Hall B2Presenter: – University of Kansas Cancer Center
Ying Hou, MD – University of Kansas Cancer Center ### 1972336###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kansas Cancer Center###Presenter: – University of Kansas Cancer Center
### 10:45 AM – 12:00 PM PT
2238 - Modeling Gamma Knife Radiosurgical Toxicity for Multiple Brain MetastasesLocation: Hall B2
Eric Hsu, MD, PhD – JPS Health ### 1972319###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###JPS Health###Presenter: – JPS Health
### 10:45 AM – 12:00 PM PT
2239 - Pretreatment Clinical Parameters Associated with Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi-Institutional Brain Metastases CohortLocation: Hall B2Presenter: – Duke University School of Medicine
Christina Huang, MD, MS – Duke University School of Medicine ### 747699###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University School of Medicine###Presenter: – Duke University School of Medicine
### 10:45 AM – 12:00 PM PT
2240 - CNS Control after First-Line Osimertinib in Patients with Metastatic EGFR-Mutant NSCLCLocation: Hall B2
Caressa Hui, MD, BS – Stanford ### 525476###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford###Presenter: – Stanford
### 10:45 AM – 12:00 PM PT
2242 - Quality of Palliative Radiation Therapy Assessed Using Quality Indicators: A Multicenter SurveyLocation: Hall B2Presenter: – Hiroshima University
Nobuki Imano, MD, PhD – Hiroshima University ### 537533###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hiroshima University###Presenter: – Hiroshima University
### 10:45 AM – 12:00 PM PT
2243 - A Pilot Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for Oligometastatic Hormone Sensitive Prostate CancerLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Brandon Imber, MD, MS – Memorial Sloan Kettering Cancer Center ### 536050###Presenter###Disclosures: Employment: Memorial Sloan Kettering Cancer Center:Assistant Attending Radiation Oncologist:Employee | Compensation: GT Medical Technologies: Education Meeting Faculty, Honoraria-End Date: November 2021 ;Telix Pharmaceuticals: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: November 2022 | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 10:45 AM – 12:00 PM PT
2244 - MR-Guided Stereotactic Ablative Body Radiotherapy for Pancreatic Oligometastases from Renal Cell CarcinomaLocation: Hall B2Presenter: – University Medical Center Utrecht
Martijn Intven, MD, PhD – University Medical Center Utrecht ### 1972299###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Medical Center Utrecht###Presenter: – University Medical Center Utrecht
### 10:45 AM – 12:00 PM PT
2245 - Evaluation of Brain Atrophy after One Year of Whole Brain Irradiation Using Voxel Based MorphometryLocation: Hall B2Presenter: – Nagaoka RedCross Hospital
Takeshi Ito, MD – Nagaoka RedCross Hospital ### 1972315###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Nagaoka RedCross Hospital###Presenter: – Nagaoka RedCross Hospital
### 10:45 AM – 12:00 PM PT
2246 - A Pilot Study of Simulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MR-Based and Online Adaptive PlanningLocation: Hall B2Presenter: – University of Washington School of Medicine
Kylie Kang, MD, MSCI – University of Washington School of Medicine ### 1972320###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington School of Medicine###Presenter: – University of Washington School of Medicine
### 10:45 AM – 12:00 PM PT
2247 - Exploiting Enhanced Lipid Metabolism in Glioblastoma through Diet ModificationLocation: Hall B2Presenter: – William Beaumont Hospital
Shiva Kant, PhD – William Beaumont Hospital ### 747147###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###William Beaumont Hospital###Presenter: – William Beaumont Hospital
### 10:45 AM – 12:00 PM PT
2248 - Predictors of Long-Term Survival in Patients Treated for OligometastasesLocation: Hall B2Presenter: – Good Samaritan University Hospital
Johnny Kao, MD – Good Samaritan University Hospital ### 524868###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Good Samaritan University Hospital###Presenter: – Good Samaritan University Hospital
### 10:45 AM – 12:00 PM PT
2249 - Palliative Whole Brain Radiotherapy: International State of Practice 2022Location: Hall B2Presenter: – Moffitt Cancer Center
Emily Keit, MD, BS – Moffitt Cancer Center ### 1972294###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Moffitt Cancer Center###Presenter: – Moffitt Cancer Center
### 10:45 AM – 12:00 PM PT
2250 - A Combined Phase 0/2 "Trigger" Trial Evaluating Pamiparib or Olaparib with Concurrent Radiotherapy in Patients with Newly-Diagnosed or Recurrent GlioblastomaLocation: Hall B2Presenter: – Barrow Neurological Institute
William Kennedy, MD – Barrow Neurological Institute ### 2082186###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Barrow Neurological Institute###Presenter: – Barrow Neurological Institute
### 10:45 AM – 12:00 PM PT
2251 - Hippocampal Avoidance Whole Brain Radiotherapy with Reduced Whole Brain Dose Enables Sparing of Hippocampi without Increased Risk of Distant Brain Failure in Non-Small Cell Lung CancerLocation: Hall B2Presenter: – Massachusetts General Hospital
Melin Khandekar, MD, PhD – Massachusetts General Hospital ### 1972259###Presenter###Disclosures: Employment: Mass General Physicans Organization:Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 10:45 AM – 12:00 PM PT
2252 - Frameless Fractionated Stereotactic Radiosurgery for Brain Metastases: An Institutional Series of 145 CasesLocation: Hall B2Presenter: – Arizona Oncology
Sarah Kilic, MD, MS – Arizona Oncology ### 1971995###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Arizona Oncology###Presenter: – Arizona Oncology
### 10:45 AM – 12:00 PM PT
2254 - MGMT Promoter Methylation Predicts Survival in 1p19q-Codeleted Gliomas after ChemotherapyLocation: Hall B2Presenter: – Columbia University Irving Medical Center
Connor Kinslow, MD – Columbia University Irving Medical Center ### 747725###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Columbia University Irving Medical Center###Presenter: – Columbia University Irving Medical Center
### 10:45 AM – 12:00 PM PT
2255 - Role of Fractionation in Local Control of Spinal Metastases Treated with Stereotactic RadiosurgeryLocation: Hall B2Presenter: – Stanford University Cancer Center
Daniella Klebaner, MD, BS, MPH – Stanford University Cancer Center ### 1972322###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University Cancer Center###Presenter: – Stanford University Cancer Center
### 10:45 AM – 12:00 PM PT
2256 - Escalating SBRT Dose to Hypoxic Centers of Large Pulmonary Tumors via Simultaneous Integrated Boost Confers Effective Local Control with Minimal ToxicityLocation: Hall B2Presenter: – University of Kentucky
James Knight, MD – University of Kentucky ### 1972287###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kentucky###Presenter: – University of Kentucky
### 10:45 AM – 12:00 PM PT
2257 - Progression-Free Survival in Patients with WHO-2 Meningioma Undergoing Active Surveillance Based on DOTATATE PET Evidence of Gross Total Resection: Prospective Observational StudyLocation: Hall B2Presenter: – Weill Cornell Medical College
Jonathan Knisely, MD, FASTRO – Weill Cornell Medical College ### 524458###Presenter###Disclosures: Employment: Weill Cornell Medicine:Faculty:Employee;Yale University School of Medicine:Associate Dean:Employee | Compensation: GTMedTech: Remuneration Other-End Date: to present | Ownership: none | Leadership: Neurosurgery (journal):Assistant Editor;Precision Cancer Medicine:Editorial Board member;Journal of Clinical Oncology:Associate Editor###Weill Cornell Medical College###Presenter: – Weill Cornell Medical College
### 10:45 AM – 12:00 PM PT
2258 - Classification of Patients with Painful Tumors to Predict the Response to Palliative RadiotherapyLocation: Hall B2Presenter: – Aichi Cancer Center Hospital
Yutaro Koide, MD, PhD – Aichi Cancer Center Hospital ### 1972296###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Aichi Cancer Center Hospital###Presenter: – Aichi Cancer Center Hospital
### 10:45 AM – 12:00 PM PT
2259 - Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim AnalysisLocation: Hall B2Presenter: – Miami Cancer Institute
Alonso La Rosa, MD – Miami Cancer Institute ### 2086548###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 10:45 AM – 12:00 PM PT
2259 - Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim AnalysisLocation: Hall B1Presenter: – Miami Cancer Institute
Rupesh Kotecha, MD – Miami Cancer Institute ### 537756###Presenter###Disclosures: Employment: Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida:Physician: Employee | Compensation: Electa AB: Consultant, Honoraria, Travel Expenses-End Date: ongoing ; Accuray Inc: Consultant, Honoraria, Travel Expenses-End Date: ongoing ; Novocure Inc: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Research Grants, Research Funding, Research Salary Support,Speaker's Bureau, Grant Research Funding, Honoraria, Travel Expenses, Compensation Payment-End Date: ongoing ; Viewray Inc: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria, Travel Expenses-End Date: ongoing ; Elsevier: Consultant, Honoraria-End Date: 2022 ; Brainlab: Consultant, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: ongoing ; Peerview Institute for Medical Education: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: ongoing ; Kazia Therapeutics: Advisory Board, Advisory Board Type, Advisory Board Proprietar | Ownership: none | Leadership: ViewRay Inc:Member###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 10:45 AM – 12:00 PM PT
2260 - Surgically Targeted Radiation Therapy (STaRT) for Brain Metastases: Initial Experience from a Prospective Multi-Institutional RegistryLocation: Hall B2
David Brachman, MD – GammaTile ### 2086549###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GammaTile###Presenter: – GammaTile
### 10:45 AM – 12:00 PM PT
2260 - Surgically Targeted Radiation Therapy (STaRT) for Brain Metastases: Initial Experience from a Prospective Multi-Institutional RegistryLocation: Hall B1Presenter: – Miami Cancer Institute
Rupesh Kotecha, MD – Miami Cancer Institute ### 537756###Presenter###Disclosures: Employment: Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida:Physician: Employee | Compensation: Electa AB: Consultant, Honoraria, Travel Expenses-End Date: ongoing ; Accuray Inc: Consultant, Honoraria, Travel Expenses-End Date: ongoing ; Novocure Inc: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Research Grants, Research Funding, Research Salary Support,Speaker's Bureau, Grant Research Funding, Honoraria, Travel Expenses, Compensation Payment-End Date: ongoing ; Viewray Inc: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria, Travel Expenses-End Date: ongoing ; Elsevier: Consultant, Honoraria-End Date: 2022 ; Brainlab: Consultant, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: ongoing ; Peerview Institute for Medical Education: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: ongoing ; Kazia Therapeutics: Advisory Board, Advisory Board Type, Advisory Board Proprietar | Ownership: none | Leadership: ViewRay Inc:Member###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 10:45 AM – 12:00 PM PT
2261 - Assessment of Minimum Dose As a Strong Predictor of Local Failure after Spine SBRTLocation: Hall B2Presenter: – Mayo Clinic College of Medicine and Science Rochester
Roman Kowalchuk, MD, BS – Mayo Clinic College of Medicine and Science Rochester ### 1971974###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic College of Medicine and Science Rochester###Presenter: – Mayo Clinic College of Medicine and Science Rochester
### 10:45 AM – 12:00 PM PT
2262 - Hypoxia-Inducible Transgelin-2 Confers Treatment Resistance through Activation of PI3K/Akt/GSK3ß Pathway in GlioblastomaLocation: Hall B2Presenter: – The Ohio State University-Comprehensive Cancer Center
Ashok Kumar, PhD – The Ohio State University-Comprehensive Cancer Center ### 1972283###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ohio State University-Comprehensive Cancer Center###Presenter: – The Ohio State University-Comprehensive Cancer Center
### 10:45 AM – 12:00 PM PT
2263 - A Comparison of Local Failure and Necrosis Following Different Radiosurgery Strategies for Large Brain MetastasesLocation: Hall B2Presenter: – Baptist Health South Florida
Tugce Kutuk, MD – Baptist Health South Florida ### 537429###Presenter###Disclosures: Employment: Baptist Health South Florida:Research Associate:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Baptist Health South Florida###Presenter: – Baptist Health South Florida
### 10:45 AM – 12:00 PM PT
2264 - Outcomes of Stereotactic Body Radiation Therapy (SBRT) for Femur OligometastasesLocation: Hall B2Presenter: – Dana-Farber/Brigham and Women's Cancer Center
Caitlyn Kwan, BS – Dana-Farber/Brigham and Women's Cancer Center ### 1972293###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Dana-Farber/Brigham and Women's Cancer Center###Presenter: – Dana-Farber/Brigham and Women's Cancer Center
### 10:45 AM – 12:00 PM PT
2265 - A Genomic Score to Predict Local Control among Patients with Brain Metastases Managed with RadiationLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Nayan Lamba, MD – Harvard Radiation Oncology Program ### 537685###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 10:45 AM – 12:00 PM PT
2266 - Fractionated Radiosurgery Improves Survival in Large Volume Relapsed Glioblastoma MultiformeLocation: Hall B2Presenter: – Hospital Vithas Valencia Consuelo
Luis Larrea, MD, PhD – Hospital Vithas Valencia Consuelo ### 537848###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Vithas Valencia Consuelo###Presenter: – Hospital Vithas Valencia Consuelo
### 10:45 AM – 12:00 PM PT
2267 - Long-Term Outcomes of Non-Vestibular Cranial Nerve Schwannomas Treated with Fractionated Stereotactic Radiotherapy and Stereotactic RadiosurgeryLocation: Hall B2Presenter: – Sidney Kimmel Cancer Center at Thomas Jefferson University
Talya Laufer, MD – Sidney Kimmel Cancer Center at Thomas Jefferson University ### 1972274###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sidney Kimmel Cancer Center at Thomas Jefferson University###Presenter: – Sidney Kimmel Cancer Center at Thomas Jefferson University
### 10:45 AM – 12:00 PM PT
2268 - Prospective and Comprehensive Characterization of an Inpatient Radiation Oncology Consult Service: Examining Interdisciplinary Coordination of Palliative Radiation Access and ReceiptLocation: Hall B2Presenter: – Johns Hopkins University School of Medicine
Anna LaVigne, MD – Johns Hopkins University School of Medicine ### 1972276###Presenter###Disclosures: Employment: Johns Hopkins University School of Medicine:Resident Physician:Employee | Compensation: Prostate Cancer Foundation-Pfizer: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 12/31/23 | Ownership: none | Leadership: none###Johns Hopkins University School of Medicine###Presenter: – Johns Hopkins University School of Medicine
### 10:45 AM – 12:00 PM PT
2269 - RBE Model Based Proton Planning of Stereotactic Body Radiotherapy for Spine Metastasis: A Dosimetric AnalysisLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Michael LeCompte, MD, MS – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 537854###Presenter###Disclosures: Employment: Johns Hopkins University School of Medicine:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: Association of Residents in Radiation Oncology:Executive Committee Member###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 10:45 AM – 12:00 PM PT
2270 - Adjuvant Radiotherapy in Atypical Meningioma: Are the Risks Worth the Benefit?Location: Hall B2Presenter: – Harvard Radiation Oncology Program
Grace Lee, MD – Harvard Radiation Oncology Program ### 1972314###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 10:45 AM – 12:00 PM PT
2271 - Choosing Wisely between Radiotherapy Dose-Fractionation Schedules: The Molecular Graded Prognostic Assessment (molGPA) for Elderly Glioblastoma (eGBM-molGPA)Location: Hall B2Presenter: – Seoul National University Hospital
Hye In Lee, MD – Seoul National University Hospital ### 1972037###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University Hospital###Presenter: – Seoul National University Hospital
### 10:45 AM – 12:00 PM PT
2272 - A Prospective Study Assessing the Efficacy and Toxicity of Stereotactic Body Radiation Therapy for Oligometastatic Bone MetastasesLocation: Hall B2Presenter: – Case Western Reserve School of Medicine
Joyce Lee, BS – Case Western Reserve School of Medicine ### 1972311###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Case Western Reserve School of Medicine###Presenter: – Case Western Reserve School of Medicine
### 10:45 AM – 12:00 PM PT
2273 - Clinical Outcomes with Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer: Results from a Prospective Registry TrialLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Katie Lee, MD, PhD – Harvard Radiation Oncology Program ### 1972295###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 10:45 AM – 12:00 PM PT
2274 - Spatially Resolved Whole Transcriptome Analysis of Histologically-Characterized Tissue Microarray of Patient-Matched Primary and Recurrent Glioblastomas to Identify Underlying Mechanisms of Treatment Location: Hall B2Presenter: – University of Alabama Birmingham School of Medicine
Christopher Willey, MD, PhD – University of Alabama Birmingham School of Medicine ### 525421###Presenter###Disclosures: Employment: The University of Alabama at Birmingham:Professor of Radiation Oncology:Employee;University of Alabama Health Services Foundation:Professor of Radiation Oncology:Employee | Compensation: LifeNet Health: Consultant, Compensation Payment-End Date: Present ;Varian Medical Systems/Siemens corporation: Education Meeting Faculty, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: Present ;OMS Foundation: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: Present ;AACR-Novocure: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;Mureva: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;Tactile Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;National Institutes of Health: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: none | Leadership: American Cancer Society:Study Section Co-Chair for CDP###University of Alabama Birmingham School of Medicine###Presenter: – University of Alabama Birmingham School of Medicine
### 10:45 AM – 12:00 PM PT
2275 - Immune Checkpoint Inhibition and Single Fraction Stereotactic Radiosurgery in Non-Small Cell Lung Cancer Brain Metastases: An International Multicenter Study of 395 PatientsLocation: Hall B2
Eric Lehrer, MD, MS – Mayo Clinic ### 535893###Presenter###Disclosures: Employment: Mayo Clinic Rochester:Senior Associate Consultant/Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 10:45 AM – 12:00 PM PT
2276 - Clinical Outcomes Following an Initial Stereotactic Radiosurgery Course for Brain Metastases from MelanomaLocation: Hall B2Presenter: – Duke University
Jim Leng, MD – Duke University ### 535744###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University###Presenter: – Duke University
### 10:45 AM – 12:00 PM PT
2277 - Safety and Efficacy of Spatially Fractionated Radiation Therapy Using Lattice Radiation for Metastatic and/or Bulky DiseaseLocation: Hall B2Presenter: – Fujian Medical University Union Hospital
Anchuan Li, MD – Fujian Medical University Union Hospital ### 1972297###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fujian Medical University Union Hospital###Presenter: – Fujian Medical University Union Hospital
### 10:45 AM – 12:00 PM PT
2278 - Examining the Efficacy and Safety Profile of Palliative Radiotherapy Using 30 Gy in 5 FractionsLocation: Hall B2Presenter: – BC Cancer Agency
Zhang Hao (Jim) Li, MD – BC Cancer Agency ### 1972301###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###BC Cancer Agency###Presenter: – BC Cancer Agency
### 10:45 AM – 12:00 PM PT
2279 - Intensity-Modulated Radiotherapy (IMRT) for the Treatment of Cushings DiseaseLocation: Hall B2Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
Xin Lian, MD, PhD – Chinese Academy of Medical Sciences and Peking Union Medical College ### 1972339###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
### 10:45 AM – 12:00 PM PT
2280 - Optimizing Radiation Therapy for Brain Metastasis Patients: A Comparative Study of Knowledge-Based Treatment Planning with HyperArcLocation: Hall B2Presenter: – Kaohsiung Veterans General Hospital
Yu-Wei Lin, MD, PhD, MS – Kaohsiung Veterans General Hospital ### 525372###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaohsiung Veterans General Hospital###Presenter: – Kaohsiung Veterans General Hospital
### 10:45 AM – 12:00 PM PT
2281 - Safety Profile of Combination Treatment with Radiotherapy and Immune Checkpoint Blockades: A Multi-Institute Real World ExperienceLocation: Hall B2Presenter: – Taipei Medical University Hospital
Cheng Sheng Liu, MD – Taipei Medical University Hospital ### 747366###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Taipei Medical University Hospital###Presenter: – Taipei Medical University Hospital
### 10:45 AM – 12:00 PM PT
2282 - Adjuvant Chemoradiotherapy within One Year of Resection for Molecularly Defined AstrocytomaLocation: Hall B2
S. John Liu, MD, PhD – UCSF ### 747161###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSF###Presenter: – UCSF
### 10:45 AM – 12:00 PM PT
2283 - Comparison of Hippocampal Volume Change after Whole-Brain Radiotherapy with and without Hippocampal Avoidance: A Post-Hoc Analysis of a Phase II Randomized TrialLocation: Hall B2Presenter: – National Taiwan University Hospital
Ting-Fong Liu, MD – National Taiwan University Hospital ### 1972248###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Taiwan University Hospital###Presenter: – National Taiwan University Hospital
### 10:45 AM – 12:00 PM PT
2284 - Clinical Outcomes Following Postoperative Cavity Stereotactic Radiosurgery for Brain MetastasesLocation: Hall B2Presenter: – Kaiser Permanente - Pasadena
Kenneth Lodin, MD – Kaiser Permanente - Pasadena ### 2004072###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaiser Permanente - Pasadena###Presenter: – Kaiser Permanente - Pasadena
### 10:45 AM – 12:00 PM PT
2285 - Local Control after Re-Irradiation of Spinal Metastases with Stereotactic Body Radiation TherapyLocation: Hall B2Presenter: – Mayo Clinic Health System
John Lucido, PhD – Mayo Clinic Health System ### 1972318###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Health System###Presenter: – Mayo Clinic Health System
### 10:45 AM – 12:00 PM PT
2288 - Neurologic Events and Outcomes in Patients Receiving Proton and Photon Reirradiation for High Grade Non-Codeleted GliomasLocation: Hall B2Presenter: – University of Cincinnati Medical Center/College of Medicine
Taylor MacDonald, DO – University of Cincinnati Medical Center/College of Medicine ### 1972271###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Cincinnati Medical Center/College of Medicine###Presenter: – University of Cincinnati Medical Center/College of Medicine
### 10:45 AM – 12:00 PM PT
2289 - Early Bone Mineral Density Changes and Endocrinal Dysfunction in Childhood Brain Tumor Patients: A Prospective StudyLocation: Hall B2Presenter: – Post Graduate Institute of Medical Education and Research
Renu Madan, MD – Post Graduate Institute of Medical Education and Research ### 1972256###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Post Graduate Institute of Medical Education and Research###Presenter: – Post Graduate Institute of Medical Education and Research
### 10:45 AM – 12:00 PM PT
2290 - Efficacy of Protontherapy in Atypical MeningiomasLocation: Hall B2Presenter: – Institut Curie
Hamid Mammar, PhD, MD – Institut Curie ### 1972282###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Institut Curie###Presenter: – Institut Curie
### 10:45 AM – 12:00 PM PT
2292 - Outcomes of a Single Isocenter Brain Multi-Metastases Linear Accelerator Delivered Stereotactic Radiosurgery (SRS)Location: Hall B2Presenter: – The University of Arizona - Radiation Oncology
Jacob Mapp, BS – The University of Arizona - Radiation Oncology ### 1972272###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of Arizona - Radiation Oncology###Presenter: – The University of Arizona - Radiation Oncology
### 10:45 AM – 12:00 PM PT
2293 - Phase II Trial of Definitive Therapy for Osseous Oligometastases in Breast CancerLocation: Hall B2Presenter: – University of Texas MD Anderson Cancer Center
Kathryn Marqueen, MD – University of Texas MD Anderson Cancer Center ### 538149###Presenter###Disclosures: Employment: University of Texas MD Anderson Cancer Center:Resident:Other | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Texas MD Anderson Cancer Center###Presenter: – University of Texas MD Anderson Cancer Center
### 10:45 AM – 12:00 PM PT
2294 - Reirradiation vs. Systemic Therapy vs. Combination Therapy for Recurrent High-Grade Glioma: A Meta-Analysis of Survival and ToxicityLocation: Hall B2Presenter: – Townsville University Hospital
Ravi Marwah, MBBS – Townsville University Hospital ### 1972245###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Townsville University Hospital###Presenter: – Townsville University Hospital
### 10:45 AM – 12:00 PM PT
2295 - Development of an RPA for Prediction of Radiation Necrosis Following Single Fraction Gamma Knife Radiosurgery for Brain MetastasesLocation: Hall B2Presenter: – Cleveland Clinic Foundation
Zachary Mayo, MD – Cleveland Clinic Foundation ### 1972095###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 10:45 AM – 12:00 PM PT
2296 - WBRT is Associated with Higher Rates of Hematologic Toxicity than Stereotactic Radiosurgery in Brain Metastasis PatientsLocation: Hall B2Presenter: – Central Michigan University College of Medicine
Aliah McCalla, MD, BS – Central Michigan University College of Medicine ### 1972243###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Central Michigan University College of Medicine###Presenter: – Central Michigan University College of Medicine
### 10:45 AM – 12:00 PM PT
2297 - Pneumonitis after Palliative Thoracic Radiotherapy +/- Immunotherapy: A Retrospective Propensity-Matched Cohort StudyLocation: Hall B2Presenter: – Perelman School of Medicine at the University of Pennsylvania
David Miller, MD, MS – Perelman School of Medicine at the University of Pennsylvania ### 1972288###Presenter######Perelman School of Medicine at the University of Pennsylvania###Presenter: – Perelman School of Medicine at the University of Pennsylvania
### 10:45 AM – 12:00 PM PT
2297 - Pneumonitis after Palliative Thoracic Radiotherapy +/- Immunotherapy: A Retrospective Propensity-Matched Cohort StudyLocation: Hall B2Presenter: – University of Pennsylvania Perelman School of Medicine
Sylvia Rhodes, BA – University of Pennsylvania Perelman School of Medicine ### 2128191###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania Perelman School of Medicine###Presenter: – University of Pennsylvania Perelman School of Medicine
### 10:45 AM – 12:00 PM PT
2298 - Pulsed Reduced Dose Rate Re-Irradiation for Recurrent Grade 4 Gliomas: A Retrospective Analysis of Safety and EfficacyLocation: Hall B2Presenter: – University of Wisconsin
Brett Morris, MD, PhD – University of Wisconsin ### 525241###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin###Presenter: – University of Wisconsin
### 10:45 AM – 12:00 PM PT
2299 - What Do We Know about Grade 3 Intracranial Ependymoma in Adults?Location: Hall B2Presenter: – Maria Sklodowska-Curie National Research Institute of Oncology
Rafal Tarnawski, MD, PhD – Maria Sklodowska-Curie National Research Institute of Oncology ### 792542###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Maria Sklodowska-Curie National Research Institute of Oncology###Presenter: – Maria Sklodowska-Curie National Research Institute of Oncology
### 10:45 AM – 12:00 PM PT
2300 - Early Outcomes from Proton Craniospinal Irradiation (pCSI) for Leptomeningeal Disease from Solid TumorsLocation: Hall B2Presenter: – MD Anderson Cancer Center
Susan McGovern, MD, PhD – MD Anderson Cancer Center ### 535911###Presenter###Disclosures: Employment: MD Anderson:Associate Professor:Employee;Baylor College of Medicine:Assistant Professor:Employee | Compensation: Chimerix: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: To present | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:45 AM – 12:00 PM PT
2300 - Early Outcomes from Proton Craniospinal Irradiation (pCSI) for Leptomeningeal Disease from Solid TumorsLocation: Hall B2
Lewis Nasr, MD, MS ### 1972284###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:45 AM – 12:00 PM PT
2301 - Dosimetric Impact of Seed Segmentation in GammaTile Surgically Targeted Radiation Therapy for Gliomas and Brain Metastases CasesLocation: Hall B2Presenter: – Indiana University School of Medicine
Sook Kien Ng, PhD – Indiana University School of Medicine ### 1972266###Presenter###Disclosures: Employment: Indiana University School of Medicine:Assistant Professor of Radiation Oncology:Employee;Indiana University Health Physician:Faculty Medical Physicist:Employee | Compensation: Indiana University School of Medicine: Education Meeting Faculty, Salary Support-End Date: Present | Ownership: none | Leadership: none###Indiana University School of Medicine###Presenter: – Indiana University School of Medicine
### 10:45 AM – 12:00 PM PT
2302 - Dosimetric Impact of Radiolucent Carbon Fiber Hardware for Post-Operative Spine Stereotactic Body Radiation TherapyLocation: Hall B2Presenter: – University of Washington
Macklin Nguyen, MD – University of Washington ### 1972247###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 10:45 AM – 12:00 PM PT
2303 - RAPid SimPLE (RAPPLE) Targeted Radiation Treatment vs. Whole Brain Radiotherapy: A Retrospective Study of Matched Patients with Brain Metastases and Poor PrognosisLocation: Hall B2Presenter: – BC Cancer - Vancouver Centre
Alan Nichol, MD, FRCPC – BC Cancer - Vancouver Centre ### 746805###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###BC Cancer - Vancouver Centre###Presenter: – BC Cancer - Vancouver Centre
### 10:45 AM – 12:00 PM PT
2304 - Fracture Risk Following Lumbosacral Spine SBRT in Patients Having Received Previous Whole Pelvis Radiation TherapyLocation: Hall B2Presenter: – Cleveland Clinic Foundation
Elizabeth Obi, MD, BA – Cleveland Clinic Foundation ### 747116###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 10:45 AM – 12:00 PM PT
2305 - Predictors of Tumor Dynamics during a 6-Week Course of Chemoradiotherapy for GlioblastomaLocation: Hall B2Presenter: – Alfred Health Radiation Oncology
Wee Loon Ong, MBBS – Alfred Health Radiation Oncology ### 747114###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Alfred Health Radiation Oncology###Presenter: – Alfred Health Radiation Oncology
### 10:45 AM – 12:00 PM PT
2306 - Outcomes Specific to Spinal Metastases with Paraspinal Disease Extension Following Spine Stereotactic Body RadiotherapyLocation: Hall B2Presenter: – Alfred Health Radiation Oncology
Wee Loon Ong, MBBS – Alfred Health Radiation Oncology ### 747114###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Alfred Health Radiation Oncology###Presenter: – Alfred Health Radiation Oncology
### 10:45 AM – 12:00 PM PT
2307 - Quantitative Analysis of BrainAge using Neuroimaging Data to Estimate Radiation-Induced Brain Aging and Associations with Cognitive Changes in Brain Metastases PatientsLocation: Hall B2Presenter: – UC San Diego Health
Megan Orr, MD – UC San Diego Health ### 1972279###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UC San Diego Health###Presenter: – UC San Diego Health
### 10:45 AM – 12:00 PM PT
2308 - Stereotactic Body Radiotherapy (SBRT) for Sacral Metastases: Deviation from Recommended Target Volume Delineation Predicts Higher Risk of Local FailureLocation: Hall B2Presenter: – Sunnybrook Odette Cancer Centre
Daniel Palhares, MD, MSc – Sunnybrook Odette Cancer Centre ### 1972253###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sunnybrook Odette Cancer Centre###Presenter: – Sunnybrook Odette Cancer Centre
### 10:45 AM – 12:00 PM PT
2309 - Population Analysis of SABR/SRS for the Treatment of Metastatic Cancer in a Jurisdiction of 15 Million PeopleLocation: Hall B2Presenter: – Ontario Health - Cancer Care Ontario
Jason Pantarotto, MD, FRCPC – Ontario Health - Cancer Care Ontario ### 1972304###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ontario Health - Cancer Care Ontario###Presenter: – Ontario Health - Cancer Care Ontario
### 10:45 AM – 12:00 PM PT
2310 - Oncologic Outcomes and Safety After Spinal Re-Irradiation with Stereotactic Body Radiation TherapyLocation: Hall B2Presenter: – Johns Hopkins Medicine
Palak Patel, MD, BS – Johns Hopkins Medicine ### 1972244###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Medicine###Presenter: – Johns Hopkins Medicine
### 10:45 AM – 12:00 PM PT
2311 - Interobserver Variation in Tumor Delineation of Liver Metastases using Magnetic Resonance ImagingLocation: Hall B2Presenter: – Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL)
Julia Peltenburg, MD – Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) ### 1972254###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL)###Presenter: – Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL)
### 10:45 AM – 12:00 PM PT
2312 - Advancing beyond the Hippocampus to Preserve Cognition for Patients with Brain Metastases: Dosimetric Results from a Phase 2 Trial of Memory-Avoidance Whole Brain RadiotherapyLocation: Hall B2Presenter: – Ohio State University James Cancer Hospital
Haley Perlow, MD – Ohio State University James Cancer Hospital ### 537737###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ohio State University James Cancer Hospital###Presenter: – Ohio State University James Cancer Hospital
### 10:45 AM – 12:00 PM PT
2313 - Stereotactic Radiosurgery (SRS) vs. Hypofractionated Stereotactic Radiotherapy (SRT) in Brain Metastases: Kinetic ResponsesLocation: Hall B2Presenter: – Siriraj Hospital Mahidol University
Siwadol Pleanarom, MS – Siriraj Hospital Mahidol University ### 1972330###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Siriraj Hospital Mahidol University###Presenter: – Siriraj Hospital Mahidol University
### 10:45 AM – 12:00 PM PT
2314 - Multi-Institutional Outcomes Following Stereotactic Radiosurgery for Gastrointestinal Brain MetastasesLocation: Hall B2Presenter: – Duke University Medical Center
Jamiluddin Qazi, MD – Duke University Medical Center ### 1972316###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University Medical Center###Presenter: – Duke University Medical Center
### 10:45 AM – 12:00 PM PT
2315 - Impact of Prior Radiation Therapy on Bone Mineral Density Change Over Time: Secondary Analysis of the Control Arm of a Phase III Randomized TrialLocation: Hall B2Presenter: – Rush University Medical Center
Soumyajit Roy, MBBS – Rush University Medical Center ### 524773###Presenter###Disclosures: Employment: Rush University Medical Center:Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Rush University Medical Center###Presenter: – Rush University Medical Center
### 10:45 AM – 12:00 PM PT
2317 - Multi-Institutional Study of Stereotactic Radiosurgery for Recurrent WHO Grade 2/3 Meningiomas: An Interim AnalysisLocation: Hall B2Presenter: – NewYork-Presbyterian Hospital Columbia
Geoffrey Sedor, MD, MS, BS – NewYork-Presbyterian Hospital Columbia ### 747918###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NewYork-Presbyterian Hospital Columbia###Presenter: – NewYork-Presbyterian Hospital Columbia
### 10:45 AM – 12:00 PM PT
2318 - Dosimetric Analysis of Local Failure Outcomes and Vertebral Compression Fracture Risk in Single-Fraction Spine Stereotactic Radiosurgery for Metastatic SarcomaLocation: Hall B2Presenter: – Queensland Health
Mihir Shanker, MD – Queensland Health ### 1972242###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Queensland Health###Presenter: – Queensland Health
### 10:45 AM – 12:00 PM PT
2319 - Clinical Variables Impact Time to Inpatient Radiation Oncology Consultation for Spine Metastases: A Single Institution StudyLocation: Hall B2Presenter: – Case Western University Hospital
Saad Sheikh, MD – Case Western University Hospital ### 1972298###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Case Western University Hospital###Presenter: – Case Western University Hospital
### 10:45 AM – 12:00 PM PT
2320 - Fractionated Stereotactic Radiotherapy vs. Stereotactic Radiosurgery for Vestibular Schwannoma: Local Control, Hearing Preservation, and ToxicitiesLocation: Hall B2Presenter: – Thomas Jefferson University
Sanjna Shelukar, BS – Thomas Jefferson University ### 1972327###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 10:45 AM – 12:00 PM PT
2321 - Staged Stereotactic Radiosurgery as a Novel Adaptive Approach to Salvage Previously Irradiated Brain MetastasesLocation: Hall B2Presenter: – Sunnybrook Odette Cancer Centre
Dana Shor, MBBS – Sunnybrook Odette Cancer Centre ### 1972211###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sunnybrook Odette Cancer Centre###Presenter: – Sunnybrook Odette Cancer Centre
### 10:45 AM – 12:00 PM PT
2324 - Adrenal Stereotactic Body Radiation Therapy: Do Dosimetric Factors Predict for Grade 2+ Lymphopenia?Location: Hall B2Presenter: – USF Health Morsani College of Medicine
Pranit Singh, BS – USF Health Morsani College of Medicine ### 1972292###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###USF Health Morsani College of Medicine###Presenter: – USF Health Morsani College of Medicine
### 10:45 AM – 12:00 PM PT
2325 - Factors Associated with Short Interval from Treatment to Death in Patients Treated with Stereotactic Body Radiotherapy for Lung Metastases: Experience at a Large Academic FacilityLocation: Hall B2Presenter: – University of North Carolina at Chapel Hill
Ethan Steele, MD, MS – University of North Carolina at Chapel Hill ### 747493###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of North Carolina at Chapel Hill###Presenter: – University of North Carolina at Chapel Hill
### 10:45 AM – 12:00 PM PT
2326 - Incidence and Prognostic Factors of Painful Vertebral Compression Fracture Caused by Spine Stereotactic Body RadiotherapyLocation: Hall B2Presenter: – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Kentaro Taguchi, MD – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital ### 747825###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital###Presenter: – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
### 10:45 AM – 12:00 PM PT
2327 - Assessment of Local and Regional Control in Atypical (WHO Grade 2) Meningiomas Receiving Fractioned Stereotactic RadiotherapyLocation: Hall B2Presenter: – Heersink School of Medicine
Madyson Taylor, MS – Heersink School of Medicine ### 1972309###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Heersink School of Medicine###Presenter: – Heersink School of Medicine
### 10:45 AM – 12:00 PM PT
2328 - Stereotactic Body Radiotherapy (SBRT) for Breast Cancer Spinal Metastases is Associated with Low Rates of Long-Term Local Failure (LF) and Vertebral Compression Fracture (VCF) Independent of MolecularLocation: Hall B2Presenter: – University of Toronto
Bryce Thomsen, MD – University of Toronto ### 1972286###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Toronto###Presenter: – University of Toronto
### 10:45 AM – 12:00 PM PT
2329 - Patient-Reported Cognitive Outcomes and Survival after Stereotactic Radiosurgery for 15 or More Brain MetastasesLocation: Hall B2Presenter: – Ohio State University
Rituraj Upadhyay, MD, MBBS, DNB – Ohio State University ### 746809###Presenter###Disclosures: Employment: The Ohio State University Wexner Medical Center:Resident physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Ohio State University###Presenter: – Ohio State University
### 10:45 AM – 12:00 PM PT
2330 - Conformality Indices and Brain Dose Objective for Multi-Lesion Brain Single Isocenter Linac-Based Stereotactic RadiosurgeryLocation: Hall B2
Sarah Ashmeg, PhD – UPMC ### 2017343###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UPMC###Presenter: – UPMC
### 10:45 AM – 12:00 PM PT
2331 - Hypofractionated Stereotactic Radiotherapy vs. Single Fraction Stereotactic Radiosurgery to the Resection Cavity of Brain Metastases after Surgical Resection (SATURNUS trial): A Prospective, RandomizeLocation: Hall B2
Maria Waltenberger, MD – TU Muenchen ### 747187###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###TU Muenchen###Presenter: – TU Muenchen
### 10:45 AM – 12:00 PM PT
2332 - Radiation Necrosis following SRS or FSRT with Higher BED for Brain Metastases >20 mmLocation: Hall B2Presenter: – UKSH Campus Luebeck
Elisa Marie Werner, MD – UKSH Campus Luebeck ### 1972312###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UKSH Campus Luebeck###Presenter: – UKSH Campus Luebeck
### 10:45 AM – 12:00 PM PT
2333 - Outcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM StudyLocation: Hall B2Presenter: – The Royal Marsden Hospital
Rosalyne Westley – The Royal Marsden Hospital ### 1972261###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Royal Marsden Hospital###Presenter: – The Royal Marsden Hospital
### 10:45 AM – 12:00 PM PT
2334 - Clinical Outcomes and Patterns of Failure in Patients with High-Risk Atypical Meningioma Treated with Single Fraction vs. Hypofractionated Gamma Knife RadiosurgeryLocation: Hall B2Presenter: – Northwell Health
Yen-Ruh Wuu, MD – Northwell Health ### 1972280###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health###Presenter: – Northwell Health
### 10:45 AM – 12:00 PM PT
2335 - Prioritizing Radiation and Targeted Systemic Therapy in Patients with Resected Brain Metastases from Lung Cancer Primaries with Targetable Mutations: A Report from a Multi-Site Single InstitutionLocation: Hall B2Presenter: – Northwell Health
Yen-Ruh Wuu, MD – Northwell Health ### 1972280###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health###Presenter: – Northwell Health
### 10:45 AM – 12:00 PM PT
2336 - A Prospective Clinical Trial of Radiotherapy Combined with PD-1 Inhibitors and GM-CSF, Sequentially Followed by IL-2 (PRaG 2.0) Regimen in Advanced Refractory Solid TumorsLocation: Hall B2
Pengfei Xing, MD ### 1972290###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:45 AM – 12:00 PM PT
2337 - An Innovative Regimen Basing on HFRT/SBRT and RC48-ADC Coactivation for Salvage Therapy in Patients with HER2-Expressing Advanced Solid TumorsLocation: Hall B2Presenter: – The Second Affiliated Hospital of Soochow University
Meiling Xu, MD, PhD, RT – The Second Affiliated Hospital of Soochow University ### 1972291###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Second Affiliated Hospital of Soochow University###Presenter: – The Second Affiliated Hospital of Soochow University
### 10:45 AM – 12:00 PM PT
2338 - The Safety and Efficacy of SCART for Bulky Metastatic or Recurrent Cancer, a Phase I StudyLocation: Hall B2Presenter: – Golden Comprehensive Medicine
Weisi Yan, MD, PhD – Golden Comprehensive Medicine ### 1972239###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Golden Comprehensive Medicine###Presenter: – Golden Comprehensive Medicine
### 10:45 AM – 12:00 PM PT
2339 - Predicting Neurocognitive Decline in Multiple Brain Metastases Patients Undergoing Distributed Stereotactic RadiosurgeryLocation: Hall B2Presenter: – Stanford University
Zi Yang, PhD – Stanford University ### 1972255###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 10:45 AM – 12:00 PM PT
2340 - Overall Survival Prediction in Stereotactic Radiosurgery Patients with Glioblastoma Via a Deep-Learning ApproachLocation: Hall B2Presenter: – Stanford University
Zi Yang, PhD – Stanford University ### 1972255###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 10:45 AM – 12:00 PM PT
2341 - Stereotactic Radiosurgery for Small Intact Brain Metastasis: A Comparative Evaluation of 3 Different Single Fraction Prescription DosesLocation: Hall B2Presenter: – Miami Cancer Institute
Sreenija Yarlagadda, MD – Miami Cancer Institute ### 1972338###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 10:45 AM – 12:00 PM PT
2342 - MD Anderson Phase III Randomized Preoperative Stereotactic Radiosurgery (SRS) vs. Postoperative SRS for Brain Metastases TrialLocation: Hall B2Presenter: – MD Anderson Cancer Center
Debra Yeboa, MD – MD Anderson Cancer Center ### 747057###Presenter###Disclosures: Employment: Univ of Texas MD Anderson Cancer Center:Associate Professor:Employee | Compensation: Practical Radiation Oncology Journal: Other, Uncompensated-End Date: present ;Robert Wood Johnson: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Brockman Foundation/ Medical research Grant: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;MD Anderson Institutional Research Grant Funding: Grant Research Funding-End Date: to present | Ownership: none | Leadership: Society of Neuro-Oncology:Radiation Sciences Co-chair;Radiosurgery Society (RSS):Annual Planning Committee member & MD Anderson liason###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:45 AM – 12:00 PM PT
2343 - Dose Escalated Radiotherapy is Associated with Improved Outcomes for High Grade MeningiomaLocation: Hall B2Presenter: – Sunnybrook Odette Cancer Centre
K. Liang Zeng, MD – Sunnybrook Odette Cancer Centre ### 537830###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sunnybrook Odette Cancer Centre###Presenter: – Sunnybrook Odette Cancer Centre
### 10:45 AM – 12:00 PM PT
2344 - Efficacy and Safety of Multifraction Stereotactic Radiation Therapy with Volumetric Modulated Arc Therapy Technique for Multiple Brain MetastasesLocation: Hall B2
Mai Zhang, MS ### 1972258###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:45 AM – 12:00 PM PT
2345 - GlioPredictor: A Deep Learning Model for Identification of High-Risk Low Grade Glioma toward Adjuvant Treatment PlanningLocation: Hall B2Presenter: – Northwestern Feinberg School of Medicine
Shuhua Zheng, DO, PhD – Northwestern Feinberg School of Medicine ### 1972241###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwestern Feinberg School of Medicine###Presenter: – Northwestern Feinberg School of Medicine
### 3:00 PM – 4:00 PM PT
2346 - Predictors of Locoregional Recurrence and Distant Failure after Neoadjuvant Chemotherapy Among Patients Treated with Mastectomy Versus Breast-Conserving SurgeryLocation: Hall B2Presenter: – Massachusetts General Hospital
Hazim Ababneh, MD – Massachusetts General Hospital ### 1972391###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 3:00 PM – 4:00 PM PT
2347 - CANTO: Skin Toxicities Evaluation of a Multicenter Large Prospective Cohort of Irradiated Patients for Early-Stage Breast CancerLocation: Hall B2
Sofiane Allali, MD ### 1972362###Presenter#########Presenter:
### 3:00 PM – 4:00 PM PT
2348 - Timing of physical therapy to optimize shoulder range of motion among patients receiving breast radiotherapyLocation: Hall B2Presenter: – Massachusetts General Hospital
Carolyn Baek, DPT, CLT – Massachusetts General Hospital ### 1972374###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 3:00 PM – 4:00 PM PT
2349 - Interim Analysis of a Non-Randomized Prospective Trial Comparing Hypofractionated Post-Mastectomy Radiotherapy (HF-PMRT) to Conventional Post-Mastectomy Radiotherapy (CF-PMRT) for Breast Cancer (BC) PLocation: Hall B2Presenter: – Princess Margaret Cancer Centre
Marc Vincent Barcelona, MD – Princess Margaret Cancer Centre ### 1972413###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
### 3:00 PM – 4:00 PM PT
2350 - Decreasing Skin Toxicity in Whole Breast Irradiation with Helical Tomotherapy IMRTLocation: Hall B2Presenter: – Baptist Health
Awens Alphonse, MS – Baptist Health ### 2132648###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Baptist Health###Presenter: – Baptist Health
### 3:00 PM – 4:00 PM PT
2350 - Decreasing Skin Toxicity in Whole Breast Irradiation with Helical Tomotherapy IMRTLocation: Hall B2Presenter: – University of Maryland School of Medicine, Baltimore
Rashmi Benda, MD – University of Maryland School of Medicine, Baltimore ### 1972407###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland School of Medicine, Baltimore###Presenter: – University of Maryland School of Medicine, Baltimore
### 3:00 PM – 4:00 PM PT
2352 - Marginless 5-Fraction Robotic Radiosurgery for Unfavorable Nonfunctioning Pituitary Macroadenoma: 5-year Outcomes from a Single Institution ProtocolLocation: Hall B2
Akrita Bhatnagar, MD, PhD ### 1972357###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2353 - A Biosignature Integrating Immune and Metabolic Signaling Axes to Assess Limited Radiation Therapy Response in Early Stage Breast Cancer from a Low-Risk CohortLocation: Hall B2
Troy Bremer, PhD – PreludeDx ### 1972343###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###PreludeDx###Presenter: – PreludeDx
### 3:00 PM – 4:00 PM PT
2354 - Does Dual Anti-HER2 Therapy Increase Early Cardiac Toxicity in Comparison with Trastuzumab Alone in Breast Cancer Patients Receiving Adjuvant Radiotherapy? A Multicenter Retrospective StudyLocation: Hall B2Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Lu Cao, MD, PhD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine ### 535733###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ruijin Hospital, Shanghai Jiaotong University School of Medicine###Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
### 3:00 PM – 4:00 PM PT
2355 - Dosimetry Comparison of Incidental Irradiation to the Low Axilla in Whole Breast Irradiation Using IMRT and IMPT TherapyLocation: Hall B2Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Lu Cao, MD, PhD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine ### 535733###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ruijin Hospital, Shanghai Jiaotong University School of Medicine###Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
### 3:00 PM – 4:00 PM PT
2356 - Hyperfractionated and Accelerated Reirradiation for Angiosarcoma Following Breast-Conserving Therapy: Long-Term Clinical OutcomesLocation: Hall B2Presenter: – University of Florida Shands Cancer Center
Anthony Casper, DO – University of Florida Shands Cancer Center ### 1972345###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida Shands Cancer Center###Presenter: – University of Florida Shands Cancer Center
### 3:00 PM – 4:00 PM PT
2357 - Comparison of Early Outcomes of Stereotactic Accelerated Partial Breast Irradiation vs. Volumetric Modulated Arc Therapy-Based FAST-FORWARD Whole Breast Irradiation for Breast CancerLocation: Hall B2Presenter: – Yonsei University College of Medicine
Jeesuk Chang, MD – Yonsei University College of Medicine ### 524669###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yonsei University College of Medicine###Presenter: – Yonsei University College of Medicine
### 3:00 PM – 4:00 PM PT
2358 - Interpretable Deep Learning Identified the Significance of 1 Gy Volume on Lymphopenia After Radiotherapy in Breast CancerLocation: Hall B2Presenter: – The University of Hong Kong-Shenzhen Hospital
Fang Chen, MD, MS – The University of Hong Kong-Shenzhen Hospital ### 1972409###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of Hong Kong-Shenzhen Hospital###Presenter: – The University of Hong Kong-Shenzhen Hospital
### 3:00 PM – 4:00 PM PT
2359 - Quality Assurance of Protocol Compliance in a Multicenter Randomized Trial Investigating the Role of Hypofractionated Comprehensive Reginal Nodal Irradiation in Node-Positive Breast Cancer (HARVEST)Location: Hall B2Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Jiayi Chen, MD, PhD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine ### 1972403###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ruijin Hospital, Shanghai Jiaotong University School of Medicine###Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
### 3:00 PM – 4:00 PM PT
2360 - Early Cardiotoxicity in Patients Receiving Hypofractionated Radiotherapy after Breast Conserving Surgery: Analysis of a Prospective StudyLocation: Hall B2
Si-Ye Chen, MD ### 1972406###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2361 - Analysis of Skin Dose and Position Stability for a New Personalized Device for Breast RadiotherapyLocation: Hall B2Presenter: – Taipei Medical University Hospital
Tung-Ho Chen, MS – Taipei Medical University Hospital ### 1972384###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Taipei Medical University Hospital###Presenter: – Taipei Medical University Hospital
### 3:00 PM – 4:00 PM PT
2362 - Intensity-Modulated Proton Therapy (IMPT) Offered Advantageous Dosimetry Compared to Volumetric Arc Therapy (VMAT) or Helical Tomotherapy (HT) in Patients with Synchronous Bilateral Breast CancerLocation: Hall B2Presenter: – National Cancer Centre Singapore
Gail Chua, MD – National Cancer Centre Singapore ### 747200###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Centre Singapore###Presenter: – National Cancer Centre Singapore
### 3:00 PM – 4:00 PM PT
2363 - Managing RT Schedules of Early-Stage Breast Cancer Patients with a Genetic-Dosimetric Validated Model for Late FibrosisLocation: Hall B2Presenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
Tiziana Rancati, MS – Fondazione IRCCS - Istituto Nazionale dei Tumori ### 747410###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fondazione IRCCS - Istituto Nazionale dei Tumori###Presenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
### 3:00 PM – 4:00 PM PT
2364 - Dosimetry Predictors of Late Skin Reactions after Whole Breast Radiotherapy on a Large Mono-Institutional Cohort of PatientsLocation: Hall B2Presenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
Tiziana Rancati, MS – Fondazione IRCCS - Istituto Nazionale dei Tumori ### 747410###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fondazione IRCCS - Istituto Nazionale dei Tumori###Presenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
### 3:00 PM – 4:00 PM PT
2365 - Long Term Evaluation of Cardiac Events and Outcomes Following Breast Cancer IrradiationLocation: Hall B2Presenter: – University of Texas Health Science Center San Antonio
Colleen Conger, BS – University of Texas Health Science Center San Antonio ### 1972352###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas Health Science Center San Antonio###Presenter: – University of Texas Health Science Center San Antonio
### 3:00 PM – 4:00 PM PT
2366 - 3D Surface Imaging in Reducing Setup Error for Prone Whole Breast RadiotherapyLocation: Hall B2
Tyler Cordero, BS – UCLA ### 1972414###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA###Presenter: – UCLA
### 3:00 PM – 4:00 PM PT
2367 - Late Toxicity and Patient Satisfaction in Hypofractionated Post-Mastectomy Radiotherapy after Immediate-Autologous ReconstructionLocation: Hall B2
Alba Galatea Curbelo Artiles, MD ### 1972348###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2368 - Does Endocrine Therapy for DCIS Patients Treated with Breast-Conserving Surgery Followed by Postoperative Radiation Therapy is Needed? A Brazilian Retrospective Cohort StudyLocation: Hall B2Presenter: – Johns Hopkins School of Public Health
CecÃlia de Sousa, MD – Johns Hopkins School of Public Health ### 1972033###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins School of Public Health###Presenter: – Johns Hopkins School of Public Health
### 3:00 PM – 4:00 PM PT
2369 - Analysis of Institutional DIBH Coaching Program for Surface Guided-DIBH PatientsLocation: Hall B2
Sufen Deng, BS ### 1972369###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2370 - Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ (DCIS)Location: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Alexandra Dreyfuss, MD – Memorial Sloan Kettering Cancer Center ### 1972363###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 3:00 PM – 4:00 PM PT
2371 - Outcomes with Five Fraction Image-Guided Partial Breast Irradiation to Reduced Target VolumesLocation: Hall B2Presenter: – Cleveland Clinic Taussig Cancer Center
Ahmed Halima, MD – Cleveland Clinic Taussig Cancer Center ### 1972388###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 3:00 PM – 4:00 PM PT
2371 - Outcomes with Five Fraction Image-Guided Partial Breast Irradiation to Reduced Target VolumesLocation: Hall B1Presenter: – Case Western Reserve School of Medicine
Lauren Fane, BS – Case Western Reserve School of Medicine ### 1972378###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Case Western Reserve School of Medicine###Presenter: – Case Western Reserve School of Medicine
### 3:00 PM – 4:00 PM PT
2372 - Association of Left Anterior Descending Coronary Artery Calcium Progression and Radiation Dose with Major Adverse Cardiac Events in Breast CancerLocation: Hall B2Presenter: – Cedars-Sinai Medical Center
Jordan Gasho, BS – Cedars-Sinai Medical Center ### 1972346###Presenter######Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 3:00 PM – 4:00 PM PT
2373 - One Year Follow-up And Toxicity Review In a Series of 6 Patients Receiving Stereotactic Arrhythmia Radioablation For Ventricular TachycardiaLocation: Hall B2Presenter: – McGill University Health Centre
Ian Gerard, MD, PhD – McGill University Health Centre ### 1972136###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGill University Health Centre###Presenter: – McGill University Health Centre
### 3:00 PM – 4:00 PM PT
2374 - The Effect of Clinical (Anatomical) and Prognostic Stage Groups on Survival in Patients Diagnosed with Breast Cancer ? MULTI-Center Study Results ? TROD Breast Cancer Study GroupLocation: Hall B2
Ä°lknur Gorken, MD ### 1972342###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2375 - Post Mastectomy Radiation Therapy Impact on Clinical Outcomes of Male Breast Cancer: A Meta-Analysis of Comparative StudiesLocation: Hall B2Presenter: – LSU Health Sciences Center Shreveport
Philip Haddad, MD, MPH, MHA – LSU Health Sciences Center Shreveport ### 1972385###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###LSU Health Sciences Center Shreveport###Presenter: – LSU Health Sciences Center Shreveport
### 3:00 PM – 4:00 PM PT
2376 - Frameless Linear Accelerator (LINAC) Based Radiosurgery (SRS) vs. Framed Gamma Knife SRS for Idiopathic Trigeminal Neuralgia (TN)Location: Hall B2Presenter: – Thomas Jefferson University
Nilanjan Haldar, MD, BS – Thomas Jefferson University ### 1972358###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 3:00 PM – 4:00 PM PT
2377 - Five Fraction Accelerated Partial Breast Irradiation vs. Intraoperative Radiation Therapy for Early-Stage Breast CancerLocation: Hall B2Presenter: – Cleveland Clinic Taussig Cancer Center
Ahmed Halima, MD – Cleveland Clinic Taussig Cancer Center ### 1972388###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 3:00 PM – 4:00 PM PT
2378 - A Phase II, Randomized, Double Blind, Placebo Controlled Study of the Safety and Efficacy of a Caffeine-Based Antifibrosis Cream in Patients with Breast Cancer Undergoing Radiation TherapyLocation: Hall B2Presenter: – NYU Grossman School of Medicine
Camille Hardy Abeloos, MD – NYU Grossman School of Medicine ### 1972367###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Grossman School of Medicine###Presenter: – NYU Grossman School of Medicine
### 3:00 PM – 4:00 PM PT
2379 - Incidence, Radiologic and Dosimetric Parameters Associated with Radiation Induced Breast LymphedemaLocation: Hall B2Presenter: – Loyola University Stritch School of Medicine
Laila Hasnain, BS – Loyola University Stritch School of Medicine ### 1972379###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Loyola University Stritch School of Medicine###Presenter: – Loyola University Stritch School of Medicine
### 3:00 PM – 4:00 PM PT
2380 - The Impact of Tumor Location on Cardiac Toxicity in Patients Receiving Partial Breast IrradiationLocation: Hall B2Presenter: – Beaumont Health
Allison Hazy, MD – Beaumont Health ### 1972373###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health###Presenter: – Beaumont Health
### 3:00 PM – 4:00 PM PT
2381 - Combined Analysis of a Phase III Randomized Trial and Phase II Prospective Trial with Blind Control Matching of Patients Receiving Whole-Lung, Low-Dose Radiation for COVID-19: Full Results and ImmunolLocation: Hall B2Presenter: – Grass Valley Radiation Oncology
Clayton Hess, MD, MPH – Grass Valley Radiation Oncology ### 1972396###Presenter######Grass Valley Radiation Oncology###Presenter: – Grass Valley Radiation Oncology
### 3:00 PM – 4:00 PM PT
2382 - Prospective Clinical Trial of Premastectomy Radiotherapy Followed By Immediate Breast Reconstruction for Operable Breast CancerLocation: Hall B2Presenter: – MD Anderson Cancer Center
Karen Hoffman, MD, FASTRO – MD Anderson Cancer Center ### 536172###Presenter###Disclosures: Employment: MD Anderson Cancer Center:Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 3:00 PM – 4:00 PM PT
2383 - Effect of Dose to the Heart and Cardiac Substructures on Cardiac Toxicity after Breast Cancer RadiationLocation: Hall B2Presenter: – Washington University in St. Louis School of Medicine
Jacob Hogan, BS – Washington University in St. Louis School of Medicine ### 1972017###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University in St. Louis School of Medicine###Presenter: – Washington University in St. Louis School of Medicine
### 3:00 PM – 4:00 PM PT
2384 - Stereotactic Radiosurgery for Trigeminal Neuralgia: A Comparison of Proximal and Distal Isocenter OutcomesLocation: Hall B2Presenter: – Emory University
Benjamin Hopkins, MD – Emory University ### 1972356###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 3:00 PM – 4:00 PM PT
2385 - Early Clinical Experience of Utilizing Online Adaptive Radiotherapy for Accelerated Partial Breast Irradiation with Stereotactic Body Radiation Therapy for Early Stage Breast Cancer PatientsLocation: Hall B2Presenter: – University of Alabama at Birmingham
Whitney Hotsinpiller, MD – University of Alabama at Birmingham ### 1972353###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alabama at Birmingham###Presenter: – University of Alabama at Birmingham
### 3:00 PM – 4:00 PM PT
2386 - Patient-Specific Deep Learning Model for Clinical Target Volume Delineation on Daily CBCT of Breast Cancer Patients based on Intentional Deep Overfit Learning (IDOL) FrameworkLocation: Hall B2
Joonil Hwang – KAIST ### 1972390###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###KAIST###Presenter: – KAIST
### 3:00 PM – 4:00 PM PT
2387 - Target Volumes Comparison between Postoperative Simulation MRI and Preoperative Diagnostic MRI for Prone Breast Radiotherapy after Breast-Conserving SurgeryLocation: Hall B2
Ying Jin, BS ### 1972377###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2388 - A Retrospective Dosimetric Study in Breast Cancer Patients Who Received Conformal Radiation Therapy for Achievability of Recommended Dose Constraints of RTOG, DBCG, EORTC for Lung and HeartLocation: Hall B2Presenter: – Christian Medical College and Hospital
Rajendra Benny K, MD – Christian Medical College and Hospital ### 1972411###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Christian Medical College and Hospital###Presenter: – Christian Medical College and Hospital
### 3:00 PM – 4:00 PM PT
2389 - Clinical Trials of Carbon Ion Radiotherapy for Early Stage Breast CancerLocation: Hall B2Presenter: – Tokyo Women's Medical University
Kumiko Karasawa, MD, PhD – Tokyo Women's Medical University ### 538280###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tokyo Women's Medical University###Presenter: – Tokyo Women's Medical University
### 3:00 PM – 4:00 PM PT
2390 - A Comprehensive Deep Learning Framework for Automatic Target Volumes Segmentation in Post-Operative Stereotactic Partial Breast Irradiation (S-PBI)Location: Hall B2Presenter: – UT Southwestern Medical Center
Mahdieh Kazemimoghadam, PhD – UT Southwestern Medical Center ### 1972344###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 3:00 PM – 4:00 PM PT
2391 - Five-Fraction Stereotactic Radiation for Head-and-Neck ParagangliomasLocation: Hall B2Presenter: – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Dana Keilty, MD, MS, MDCM, MSc, BHSc – Princess Margaret Cancer Centre, University Health Network, University of Toronto ### 747108###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre, University Health Network, University of Toronto###Presenter: – Princess Margaret Cancer Centre, University Health Network, University of Toronto
### 3:00 PM – 4:00 PM PT
2392 - Observed and Predicted Toxicity in Daily Cone-Beam CT-Based Online Adaptive Stereotactic Partial Breast Irradiation with Decreased PTV MarginsLocation: Hall B2Presenter: – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Dana Keilty, MD, MS, MDCM, MSc, BHSc – Princess Margaret Cancer Centre, University Health Network, University of Toronto ### 747108###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre, University Health Network, University of Toronto###Presenter: – Princess Margaret Cancer Centre, University Health Network, University of Toronto
### 3:00 PM – 4:00 PM PT
2393 - Predicted Cardiac Toxicity in Daily Cone-Beam CT-Based Online Adaptive Stereotactic Partial Breast Irradiation with Decreased PTV MarginsLocation: Hall B2Presenter: – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Dana Keilty, MD, MS, MDCM, MSc, BHSc – Princess Margaret Cancer Centre, University Health Network, University of Toronto ### 747108###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre, University Health Network, University of Toronto###Presenter: – Princess Margaret Cancer Centre, University Health Network, University of Toronto
### 3:00 PM – 4:00 PM PT
2394 - Correlation between Thyroid Radiation Dose and Thyroid Function after Adjuvant Hypofractionated Locoregional Radiotherapy in Breast Cancer PatientsLocation: Hall B2Presenter: – University of Alexandria
Waleed Arafat, MD, PhD – University of Alexandria ### 525303###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alexandria###Presenter: – University of Alexandria
### 3:00 PM – 4:00 PM PT
2395 - The Number of Positive Lymph Nodes as Prognostic Factor in ypN1 Breast Cancer with Neoadjuvant ChemotherapyLocation: Hall B2
Aram Kim, MD ### 1972372###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2396 - Racial Difference in Outcomes in Breast Cancer Patients with Residual Nodal Disease after Neoadjuvant ChemotherapyLocation: Hall B2
Nathan Kim, MD, PhD ### 1972386###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2397 - Reappraisal of an Adequate Negative Margin Following Breast Conservation Therapy in Young Patients with Invasive Breast CancerLocation: Hall B2Presenter: – Konyang University College of Medicine
Sang-Won Kim, MD – Konyang University College of Medicine ### 2082524###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Konyang University College of Medicine###Presenter: – Konyang University College of Medicine
### 3:00 PM – 4:00 PM PT
2398 - Contact of the Tumor with the Internal Mammary Perforator Vessels as Risk Factor for Internal Mammary Lymph Node Involvement Based on Dynamic Contrast Enhancing MRI Imaging in Breast Cancer PatientsLocation: Hall B2
Sophie Klusen, MD – TU München ### 1972416###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###TU München###Presenter: – TU München
### 3:00 PM – 4:00 PM PT
2399 - Optimized Target Delineation Procedure for the Radiosurgery Treatment of Ventricular Tachycardia: Observer-Independent AccuracyLocation: Hall B2Presenter: – University Hospital Ostrava
LUKAS KNYBEL, PhD – University Hospital Ostrava ### 1972341###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospital Ostrava###Presenter: – University Hospital Ostrava
### 3:00 PM – 4:00 PM PT
2400 - Oncotype Recurrence Score (RS) at the Extremes of Tumor Size: Which Drives Clinical Outcomes?Location: Hall B2Presenter: – Philadelphia College of Osteopathic Medicine
Olufela Koleoso, MS, BS – Philadelphia College of Osteopathic Medicine ### 1972088###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Philadelphia College of Osteopathic Medicine###Presenter: – Philadelphia College of Osteopathic Medicine
### 3:00 PM – 4:00 PM PT
2401 - Neoadjuvant Radiation Therapy in the Treatment of Breast CancerLocation: Hall B2Presenter: – Instituto Nacional del Cancer
Hana Kristofovicova, MD – Instituto Nacional del Cancer ### 1972349###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Instituto Nacional del Cancer###Presenter: – Instituto Nacional del Cancer
### 3:00 PM – 4:00 PM PT
2402 - Dose DIBH Really Reduce the Subclinical Cardiac Acute Injury? Analysis of Clinical Real World from Our InstituteLocation: Hall B2Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
Zhang Kun, BS – Chinese Academy of Medical Sciences and Peking Union Medical College ### 1972393###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
### 3:00 PM – 4:00 PM PT
2403 - Autologous Stem Cell Transplantation with Intensity Modulated Total Body Irradiation Conditioning for Systemic SclerosisLocation: Hall B2Presenter: – City of Hope National Medical Center
Colton Ladbury, MD, BS – City of Hope National Medical Center ### 747995###Presenter###Disclosures: Employment: City of Hope National Medical Center:Resident Physician:Employee | Compensation: RefleXion Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 3:00 PM – 4:00 PM PT
2404 - The Early and Late Effects of High-Dose Irradiation on Cardiac Injury in a Rat ModelLocation: Hall B2Presenter: – Seoul National University Hospital
Hye In Lee, MD – Seoul National University Hospital ### 1972037###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University Hospital###Presenter: – Seoul National University Hospital
### 3:00 PM – 4:00 PM PT
2405 - Proton Re-Irradiation with Concurrent Hyperthermia in Patients with Recurrent Breast CancerLocation: Hall B2Presenter: – Beaumont Health
Joseph Lee, MD, PhD – Beaumont Health ### 1972387###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health###Presenter: – Beaumont Health
### 3:00 PM – 4:00 PM PT
2406 - The Effect of Age on Health-Related Quality of Life in Patients Treated for Early Stage, Estrogen Receptor Positive Breast CancerLocation: Hall B2Presenter: – Icahn School of Medicine at Mount Sinai
Keva Li, BS – Icahn School of Medicine at Mount Sinai ### 1972412###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Icahn School of Medicine at Mount Sinai###Presenter: – Icahn School of Medicine at Mount Sinai
### 3:00 PM – 4:00 PM PT
2407 - Nodal Response to Neo-Adjuvant Systemic Therapy Predicts Prognosis of cN3c Breast Cancer Patients Receiving Multidisciplinary TherapyLocation: Hall B2
Shuyan Li, PhD ### 1972382###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2408 - Stereotactic Cardiac Ablative Radiotherapy (SCAR) for Refractory Ventricular Tachycardia: Western Australia ExperienceLocation: Hall B2Presenter: – Genesis Cancer Care
Tee Lim, MD, MBBS, FRANZCR – Genesis Cancer Care ### 1972361###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Genesis Cancer Care###Presenter: – Genesis Cancer Care
### 3:00 PM – 4:00 PM PT
2409 - Radiosurgical Thalamotomy for Essential Tremor: A Prospective Study with Blinded Assessment By a Movement Disorder NeurologistLocation: Hall B2Presenter: – Tumor Institute Radiation Oncology Group
Chris Loiselle, MD – Tumor Institute Radiation Oncology Group ### 1972359###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tumor Institute Radiation Oncology Group###Presenter: – Tumor Institute Radiation Oncology Group
### 3:00 PM – 4:00 PM PT
2410 - Impact of Post-Mastectomy Radiotherapy on Cosmesis and Quality of Life after Deep Inferior Epigastric Perforator Flap Breast Reconstruction: A Single Institution ExperienceLocation: Hall B2
Mathilde Mahé ### 1972376###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2411 - Complication Avoidance of Reconstruction Implant Radiation Therapy (CARIT): A Retrospective Case-Cohort AnalysisLocation: Hall B2Presenter: – Schulich School of Medicine and Dentistry, Western University
Kimya Manouchehri, BS – Schulich School of Medicine and Dentistry, Western University ### 1972375###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Schulich School of Medicine and Dentistry, Western University###Presenter: – Schulich School of Medicine and Dentistry, Western University
### 3:00 PM – 4:00 PM PT
2412 - The New Quantum Image by Dynamic Nuclear Polarized MRI for the Assessment of Cardiac Radioablation to the Cavotricuspid IsthmusLocation: Hall B2Presenter: – Gifu University
Masayuki Matsuo, MD, PhD – Gifu University ### 525380###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Gifu University###Presenter: – Gifu University
### 3:00 PM – 4:00 PM PT
2413 - Impact of Breast Volume on Achieving a Conservative Heart and Target Coverage Metric for Patients Receiving Whole Breast Radiotherapy in a Statewide ConsortiumLocation: Hall B2Presenter: – Michigan Medicine
Alexander Moncion, PhD – Michigan Medicine ### 1972380###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Michigan Medicine###Presenter: – Michigan Medicine
### 3:00 PM – 4:00 PM PT
2414 - Practice Patterns and Disparities of Fractionation Schemes for Post-Mastectomy Comprehensive Nodal IrradiationLocation: Hall B2Presenter: – New York Proton Center
Julia Muallem, BS – New York Proton Center ### 1972415###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###New York Proton Center###Presenter: – New York Proton Center
### 3:00 PM – 4:00 PM PT
2415 - Near-Surface Dose Avoidance in Patients with Implant-Based Reconstruction Receiving Post-Mastectomy Proton IrradiationLocation: Hall B2Presenter: – Beaumont Health
Derek Mumaw, MD – Beaumont Health ### 1972350###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health###Presenter: – Beaumont Health
### 3:00 PM – 4:00 PM PT
2416 - Uncovering the Armpit of Axillary SBRTLocation: Hall B2Presenter: – London Health Sciences Centre
Adam Mutsaers, MD – London Health Sciences Centre ### 747781###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###London Health Sciences Centre###Presenter: – London Health Sciences Centre
### 3:00 PM – 4:00 PM PT
2417 - Omission of Chest Wall/Scar Boost and Skin Bolus Does Not Increase Risk of Local Recurrence for Breast Cancer PatientsLocation: Hall B2Presenter: – Massachusetts General Hospital
George Naoum, MD, MS – Massachusetts General Hospital ### 535714###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 3:00 PM – 4:00 PM PT
2418 - Long Term Patient Reported Quality of Life Outcomes and Patient Satisfaction of 1-Week Hypofractionated Whole Breast Radiation Therapy Using IMRT for Early-Stage Breast CancerLocation: Hall B2Presenter: – Baylor Scott and White
Ashley Arms, MD, MS – Baylor Scott and White ### 2031691###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Baylor Scott and White###Presenter: – Baylor Scott and White
### 3:00 PM – 4:00 PM PT
2418 - Long Term Patient Reported Quality of Life Outcomes and Patient Satisfaction of 1-Week Hypofractionated Whole Breast Radiation Therapy Using IMRT for Early-Stage Breast CancerLocation: Hall B2Presenter: – Baylor Scott & White Health
Jason Naziri, MD – Baylor Scott & White Health ### 805736###Presenter######Baylor Scott & White Health###Presenter: – Baylor Scott & White Health
### 3:00 PM – 4:00 PM PT
2419 - Posterior Neck Coverage in Patients Receiving Regional Nodal Irradiation for Breast CancerLocation: Hall B2Presenter: – Corewell Health William Beaumont University Hospital
Jacob Oyeniyi, MD – Corewell Health William Beaumont University Hospital ### 1972202###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Corewell Health William Beaumont University Hospital###Presenter: – Corewell Health William Beaumont University Hospital
### 3:00 PM – 4:00 PM PT
2420 - A Novel Strategy to Enhance Radiotherapy Efficacy: Results from the Prospective Phase I Clinical Trial of MR-Guided Focused Ultrasound-Stimulated Microbubbles (MRgFUS+MB) Treatment for Breast CancerLocation: Hall B2Presenter: – Sunnybrook Odette Cancer Centre
Daniel Palhares, MD, MSc – Sunnybrook Odette Cancer Centre ### 1972253###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sunnybrook Odette Cancer Centre###Presenter: – Sunnybrook Odette Cancer Centre
### 3:00 PM – 4:00 PM PT
2421 - Patterns and longitudinal changes in the practice of breast cancer radiotherapy in Korea: Korean Radiation Oncology Group 22-01Location: Hall B2Presenter: – Hanyang University
Hae Jin Park, MD, PhD – Hanyang University ### 1972360###Presenter######Hanyang University###Presenter: – Hanyang University
### 3:00 PM – 4:00 PM PT
2422 - Impact of the New ESTRO-ACROP Target Volume Delineation Guideline on Breast-Related Complications after Implant-Based Reconstruction and Postmastectomy RadiotherapyLocation: Hall B2
Jung Bin Park, MD ### 1972417###Presenter#########Presenter:
### 3:00 PM – 4:00 PM PT
2423 - Disparities in Breast-Conserving Therapy vs. Mastectomy among Asian American and Pacific Islander WomenLocation: Hall B2Presenter: – University of Pennsylvania
Tej Patel, BS – University of Pennsylvania ### 1972408###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 3:00 PM – 4:00 PM PT
2424 - Dosimetric Analysis Using Automated Tools of Trigeminal Neuralgia Treatment with Stereotactic RadiosurgeryLocation: Hall B2Presenter: – UCSF Dept Radiation Oncology
Christina Phuong, MD – UCSF Dept Radiation Oncology ### 1972383###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSF Dept Radiation Oncology###Presenter: – UCSF Dept Radiation Oncology
### 3:00 PM – 4:00 PM PT
2425 - Utility of Stereotactic Body Radiation Therapy (SBRT) in Establishing Local Control for Invasive Breast Cancer Patients not Undergoing Definitive SurgeryLocation: Hall B2Presenter: – Northwell Health
Simran Polce, MD, BS – Northwell Health ### 747543###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health###Presenter: – Northwell Health
### 3:00 PM – 4:00 PM PT
2426 - Characterization of Objective Skin Color Changes during and after Breast and Chest Wall Radiotherapy and Correlation with Radiation-Induced Skin Toxicity in Breast Cancer Patients, Including Patients Location: Hall B2Presenter: – New York University School of Medicine
Juhi Purswani, MD – New York University School of Medicine ### 538356###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###New York University School of Medicine###Presenter: – New York University School of Medicine
### 3:00 PM – 4:00 PM PT
2427 - A Radiation Therapy Contouring Atlas for Delineation of the Level I-II Axilla in the Prone PositionLocation: Hall B2Presenter: – New York University School of Medicine
Juhi Purswani, MD – New York University School of Medicine ### 538356###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###New York University School of Medicine###Presenter: – New York University School of Medicine
### 3:00 PM – 4:00 PM PT
2428 - Phase I-II Study of Prone Hypofractionated Accelerated Breast and Nodal Intensity Modulated Radiation TherapyLocation: Hall B2Presenter: – New York University School of Medicine
Juhi Purswani, MD – New York University School of Medicine ### 538356###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###New York University School of Medicine###Presenter: – New York University School of Medicine
### 3:00 PM – 4:00 PM PT
2429 - Establishing a Risk Stratification Model to Identify Clinically High-Risk N0 Breast Cancer Who Could Benefit from Regional Nodal Irradiation: A Single Institute AnalysisLocation: Hall B2Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Wei-Xiang Qi, MD, RT – Ruijin Hospital, Shanghai Jiaotong University School of Medicine ### 747303###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ruijin Hospital, Shanghai Jiaotong University School of Medicine###Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
### 3:00 PM – 4:00 PM PT
2430 - A Nomogram to Predict Pathological Axillary Status in Breast Cancer Patients Treated with Neoadjuvant ChemotherapyLocation: Hall B2
Zihan Qiu ### 1972395###Presenter#########Presenter:
### 3:00 PM – 4:00 PM PT
2431 - The Impact of Cardiac Sparing Techniques on Major Cardiac Events for Patients Undergoing Breast RadiotherapyLocation: Hall B2Presenter: – Dana-Farber/Brigham and Women's Cancer Center
Sarah Quirk, PhD – Dana-Farber/Brigham and Women's Cancer Center ### 1972418###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Dana-Farber/Brigham and Women's Cancer Center###Presenter: – Dana-Farber/Brigham and Women's Cancer Center
### 3:00 PM – 4:00 PM PT
2432 - Multi-Institutional Phase II Trial Using Dose Escalated Five Fraction Stereotactic Partial Breast Irradiation (S-PBI) with GammaPodTM for Early-Stage Breast CancerLocation: Hall B2Presenter: – University of Texas Southwestern Medical Center
Asal Rahimi, MD, MS – University of Texas Southwestern Medical Center ### 524517###Presenter###Disclosures: Employment: University Texas Southwestern Medical School:Associate Professor:Employee | Compensation: Accuray: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Education Meeting Faculty, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria, Travel Expenses-End Date: present ;GE Health: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 2022 ;Hologic: Consultant, Education Meeting Faculty, Honoraria, Compensation Payment-End Date: 2022 | Ownership: none | Leadership: NCCN:Breast Cancer Risk Reduction Panel###University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 3:00 PM – 4:00 PM PT
2433 - The Role of Tumor Bed Boost in Breast Cancer Patients with HER2-Positive Disease Treated with Breast Conservation TherapyLocation: Hall B2Presenter: – University of Utah
Eric Roach, BS – University of Utah ### 2127940###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Utah###Presenter: – University of Utah
### 3:00 PM – 4:00 PM PT
2434 - Radiotherapy Dose as a Predictor of Outcomes Following Cardiac Radioablation for High-risk Refractory VTLocation: Hall B2Presenter: – Washington University School of Medicine in St. Louis
Clifford Robinson, MD – Washington University School of Medicine in St. Louis ### 524480###Presenter###Disclosures: Employment: Washington University School of Medicine in St. Louis:Professor:Employee | Compensation: Varian: Consultant, Research Grants, Research Funding, Research Salary Support,Grant Research Funding, Honoraria-End Date: to present ;AstraZeneca: Consultant, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria-End Date: to present ;Merck: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;EMD Serono: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: to present ;Quantaras: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Remuneration Other-End Date: to present ;Radialogica: Consultant, Honoraria, Remuneration Other-End Date: to present ;EmpNia: Consultant, Compensation Payment-End Date: to present | Ownership: Varian:Copyright;Radialogica:Stock Options;Quantaras:Stock Options | Leadership: Radialogica:Chief Medical Officer###Washington University School of Medicine in St. Louis###Presenter: – Washington University School of Medicine in St. Louis
### 3:00 PM – 4:00 PM PT
2435 - Accelerated Partial Breast Irradiation (APBI) For HER2+ Early-Stage Breast CancerLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Diana Roth O'Brien, MD – Memorial Sloan Kettering Cancer Center ### 1972401###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 3:00 PM – 4:00 PM PT
2436 - Prospective Cohort Study to Evaluate Toxicity and Cosmesis between Interstitial APBI and Ultra-Hypo-Fractionated Whole Breast Irradiation in Patients with Early Breast CancerLocation: Hall B2Presenter: – AIIMS New Delhi
Daya Nand Sharma, MD, PhD – AIIMS New Delhi ### 2143441###Presenter######AIIMS New Delhi###Presenter: – AIIMS New Delhi
### 3:00 PM – 4:00 PM PT
2436 - Prospective Cohort Study to Evaluate Toxicity and Cosmesis between Interstitial APBI and Ultra-Hypo-Fractionated Whole Breast Irradiation in Patients with Early Breast CancerLocation: Hall B2Presenter: – AIIMS New Delhi
Soham Sanyal, MD, MBBS – AIIMS New Delhi ### 1972394###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###AIIMS New Delhi###Presenter: – AIIMS New Delhi
### 3:00 PM – 4:00 PM PT
2437 - Delayed Nipple-Areola Complex Radiotherapy after Nipple Sparing Mastectomy and Immediate Reconstruction for Invasive Breast Cancer or DCIS: Long-Term Results of a Phase I StudyLocation: Hall B2Presenter: – University of Miami School of Medicine
Crystal Seldon Taswell, MD, BS – University of Miami School of Medicine ### 1972354###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami School of Medicine###Presenter: – University of Miami School of Medicine
### 3:00 PM – 4:00 PM PT
2438 - Clinical Outcomes and Setup Reproducibility in Patients Receiving Synchronous Bilateral Breast Radiation in the Prone PositionLocation: Hall B2Presenter: – NYU Langone Health
Aishwarya Shah, MD – NYU Langone Health ### 747755###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Langone Health###Presenter: – NYU Langone Health
### 3:00 PM – 4:00 PM PT
2439 - Impact on Radiation Therapy Recommendation and Treatment Modality for Patients With Ductal Carcinoma In Situ Using the 7Gene Biosignature: Analysis of the PREDICT StudyLocation: Hall B2Presenter: – Cleveland Clinic
Chirag Shah, MD – Cleveland Clinic ### 537991###Presenter###Disclosures: Employment: Cleveland Clinic:Physician:Employee | Compensation: Impedimed: Consultant, Compensation Payment-End Date: To Present ;Videra Surgical: Consultant, Compensation Payment-End Date: To present ;PreludeDX: Consultant, Compensation Payment-End Date: To Present | Ownership: none | Leadership: none###Cleveland Clinic###Presenter: – Cleveland Clinic
### 3:00 PM – 4:00 PM PT
2440 - Surface Dose and Skin Toxicity Analysis in Breast Cancer Radiotherapy after Conserving Surgery with Five Treatment ModalitiesLocation: Hall B2
Shucan Shan, MS ### 1972371###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2441 - Skin Microbiome Composition is Associated with Radiation Dermatitis in Breast Cancer Patients Undergoing Radiation after Reconstructive Surgery: A Prospective, Longitudinal StudyLocation: Hall B2Presenter: – Fudan University Shanghai Cancer Center
Wei Shi, MD, PhD – Fudan University Shanghai Cancer Center ### 1972364###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 3:00 PM – 4:00 PM PT
2442 - Heart Dose Uncertainty Caused by Heartbeat during Adjuvant Breast RadiotherapyLocation: Hall B2
Litsun Shieh ### 1972400###Presenter#########Presenter:
### 3:00 PM – 4:00 PM PT
2443 - Mutations of the BRCA1/2 Genes in Patients with Breast Cancer do Not Alter Treatment Outcomes Following Radiation Therapy (RT)Location: Hall B2Presenter: – Fox Chase Cancer Center
Zachary Kiss, DO – Fox Chase Cancer Center ### 2037794###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
### 3:00 PM – 4:00 PM PT
2443 - Mutations of the BRCA1/2 Genes in Patients with Breast Cancer do Not Alter Treatment Outcomes Following Radiation Therapy (RT)Location: Hall B1Presenter: – Fox Chase Cancer Center
Rebecca Shulman, MD – Fox Chase Cancer Center ### 1972410###Presenter######Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
### 3:00 PM – 4:00 PM PT
2444 - Comparison of Supraclavicular Surgery plus Radiotherapy vs. Radiotherapy Alone in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis: A Multicenter RetrospectiveLocation: Hall B2Presenter: – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Yuchun Song, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ### 1972028###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
### 3:00 PM – 4:00 PM PT
2445 - Toxicity and Efficacy of Hypofractionated Regional Nodal IrradiationLocation: Hall B2Presenter: – Beth Israel Deaconess Medical Center
Daphna Spiegel, MD, MS – Beth Israel Deaconess Medical Center ### 524714###Presenter###Disclosures: Employment: Beth Israel Deaconess Medical Center:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Beth Israel Deaconess Medical Center###Presenter: – Beth Israel Deaconess Medical Center
### 3:00 PM – 4:00 PM PT
2446 - Intra-Operative Radiotherapy (IORT) in Breast Conserving Therapy in Early-Stage Breast Cancer and DCISLocation: Hall B2Presenter: – Virginia Mason Medical Center
Andrew Suen, MD – Virginia Mason Medical Center ### 1972392###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Virginia Mason Medical Center###Presenter: – Virginia Mason Medical Center
### 3:00 PM – 4:00 PM PT
2447 - A Population-Based Assessment of Long-Term Sexual Well-Being and Patient Satisfaction after Breast Reconstruction and Post-Mastectomy RadiationLocation: Hall B2Presenter: – University of Michigan
Jamie Takayesu, MD – University of Michigan ### 1972368###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 3:00 PM – 4:00 PM PT
2448 - Standardizing Breast Adjuvant Radiation Therapy Practices in a Diverse Health System through Development of a Delphi Consensus Supported Clinical AlgorithmLocation: Hall B2Presenter: – Northern Westchester Hospital
Leila Tchelebi, MD – Northern Westchester Hospital ### 747304###Presenter###Disclosures: Employment: Northwell Health:Attending Physician:Employee | Compensation: American College of Radiation Oncology: Other, Compensation Payment-End Date: present | Ownership: none | Leadership: none###Northern Westchester Hospital###Presenter: – Northern Westchester Hospital
### 3:00 PM – 4:00 PM PT
2449 - Omission of Adjuvant Radiotherapy in Low-Risk Elderly Males With Breast CancerLocation: Hall B2Presenter: – Western University of Health Sciences, College of Osteopathic Medicine of the Pacific
Kim Vo, MS, BS – Western University of Health Sciences, College of Osteopathic Medicine of the Pacific ### 1972389###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Western University of Health Sciences, College of Osteopathic Medicine of the Pacific###Presenter: – Western University of Health Sciences, College of Osteopathic Medicine of the Pacific
### 3:00 PM – 4:00 PM PT
2450 - Recurrence Risk Score Model for Evaluating the Impact of Postmastectomy Radiotherapy in Breast Cancer Patients with Pathologic Nodal Negative after Neoadjuvant Chemotherapy and MastectomyLocation: Hall B2Presenter: – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
Dan-Qiong Wang, MD – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade ### 1972399###Presenter######National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade###Presenter: – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
### 3:00 PM – 4:00 PM PT
2451 - Dose-Volume Predictors for Radiation Esophagitis in Breast Cancer Patients Undergoing Hypofractionated Regional Nodal RadiotherapyLocation: Hall B2Presenter: – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
Dan-Qiong Wang, MD – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade ### 1972399###Presenter######National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade###Presenter: – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
### 3:00 PM – 4:00 PM PT
2452 - Methodological and Reporting Quality of Non-Inferiority or Equivalence Designs: A Systematic Review of Trial Characteristics, Design Consideration and Interpretation in Breast Cancer Radiotherapy TriaLocation: Hall B2
Shijia Wang, MD ### 1972404###Presenter#########Presenter:
### 3:00 PM – 4:00 PM PT
2453 - Total Lymphoid Irradiation in the Treatment of Heart Transplant Rejection: Single Institution Long-Term ResultsLocation: Hall B2Presenter: – Stanford Health Care
Zachary White, MD, MS – Stanford Health Care ### 746543###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Health Care###Presenter: – Stanford Health Care
### 3:00 PM – 4:00 PM PT
2454 - Health-Related Quality of Life Analysis in Patients with Non-Functioning Pituitary Macroadenomas Treated with Transsphenoidal Surgery with or without Radiation TherapyLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Amy Wisdom, MD, PhD – Harvard Radiation Oncology Program ### 1972370###Presenter###Disclosures: Employment: Massachusetts General Hospital/Brigham and Women's Hospital/Dana Farber Cancer Institute:Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 3:00 PM – 4:00 PM PT
2455 - Dosimetric Evaluation of a Novel Non-Metallic Dual Port Expander for Proton TherapyLocation: Hall B2Presenter: – Miami Cancer Institute
Andrew Wroe, PhD – Miami Cancer Institute ### 1996705###Presenter###Disclosures: Employment: Miami Cancer Institute:Director of Proton Physics:Employee | Compensation: Ion Beam Applications: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: 12/31/2022 | Ownership: none | Leadership: none###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 3:00 PM – 4:00 PM PT
2456 - Adjuvant Breast Radiation Therapy for Early-Stage Breast Cancer or Ductal Carcinoma In-Situ in the Breast: A Systematic Review and Network Meta-Analysis of Randomized TrialsLocation: Hall B2Presenter: – National University Cancer Institute Singapore
Caryn Wujanto, MBBS – National University Cancer Institute Singapore ### 1972405###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National University Cancer Institute Singapore###Presenter: – National University Cancer Institute Singapore
### 3:00 PM – 4:00 PM PT
2457 - Texture Analysis Using Machine Learning-Based 3-T Magnetic Resonance Imaging for Predicting Pathological Response in Breast Cancer Patients Treated with Neoadjuvant ChemotherapyLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute
Feihong Xie – Shandong Cancer Hospital and Institute ### 1972398###Presenter######Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 3:00 PM – 4:00 PM PT
2458 - Convolution Neural Network-Based Automatic Scoring of Coronary Artery Calcification and Its Value to Identify the Risk of Radiation-Induced Cardiac Toxicity on Radiotherapy Planning CT Scans in BreastLocation: Hall B2
Jing Yang, MB ### 1972397###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:00 PM – 4:00 PM PT
2459 - Non-Animal Stabilized Hyaluronic Acid (NASHA) Gel Marker vs. Surgical Clips for Tumor Bed Delineation in Breast Cancer Using MR-SimulationLocation: Hall B2Presenter: – Peter MacCallum Cancer Centre
Janice Yeh, MBBS, FRANZCR – Peter MacCallum Cancer Centre ### 1972365###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peter MacCallum Cancer Centre###Presenter: – Peter MacCallum Cancer Centre
### 3:00 PM – 4:00 PM PT
2460 - Are All Prognostic Stage IB Breast Cancers Equivalent?Location: Hall B2Presenter: – City of Hope National Medical Center
Stephanie Yoon, MD – City of Hope National Medical Center ### 746643###Presenter###Disclosures: Employment: City of Hope Medical Center:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 3:00 PM – 4:00 PM PT
2461 - Postmastectomy Radiation in HER-2 Positive Breast Cancer after Neoadjuvant Therapy: Secondary Analysis of Two Randomized TrialsLocation: Hall B2Presenter: – Florida International University and Lynn Cancer Institute
Youssef Zeidan, MD, PhD – Florida International University and Lynn Cancer Institute ### 525019###Presenter###Disclosures: Employment: Baptist Health of South Florida, Lynn Cancer Institute, Boca Raton, Florida:Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Florida International University and Lynn Cancer Institute###Presenter: – Florida International University and Lynn Cancer Institute
### 3:00 PM – 4:00 PM PT
2462 - Lymphocyte Count Kinetics and the Effect of Different Radiotherapy Techniques on Radiation-Induced Lymphopenia in Patients with Breast Cancer Receiving Hypofractionated Postmastectomy RadiotherapyLocation: Hall B2Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
Xuran Zhao, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy ### 747104###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy###Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
### 3:00 PM – 4:00 PM PT
2463 - A Retrospective Analysis of Immediate Postoperative Electron Radiotherapy for KeloidsLocation: Hall B2Presenter: – Xijing Hospital Air Force Medical University
Wei Zhou, MD, DVM – Xijing Hospital Air Force Medical University ### 1972355###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Xijing Hospital Air Force Medical University###Presenter: – Xijing Hospital Air Force Medical University
### 3:00 PM – 4:00 PM PT
2464 - Does Epigallocatechin Gallate as a Radiation Protective Agent Reduce the Anti-Tumor Effect of Radiotherapy in Postoperative Breast Cancer Radiotherapy?Location: Hall B2
Wanqi Zhu, MD, PhD ### 1972402###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2048 - Clinical Outcomes with Triple Tandem Brachytherapy for Medically Inoperable Endometrial Cancer in a Predominantly Black Patient PopulationLocation: Hall B2Presenter: – University of Chicago
Michael Gutman, MD – University of Chicago ### 1972194###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago###Presenter: – University of Chicago
### 5:00 PM – 6:00 PM PT
2465 - Patient Reported Outcomes Following Palliative Whole Brain Radiation Therapy in Patients with Brain MetastasisLocation: Hall B2Presenter: – Lagos University Teaching Hospital
Boalnle Adegboyega, MBBS, FMCR – Lagos University Teaching Hospital ### 1972446###Presenter######Lagos University Teaching Hospital###Presenter: – Lagos University Teaching Hospital
### 5:00 PM – 6:00 PM PT
2466 - Role of ATP Binding Cassette Subfamily A Member 1 (ABCA1) in Chemoradiotherapy-induced Renal InjuryLocation: Hall B2Presenter: – University of Miami
Anis Ahmad, PhD – University of Miami ### 1972440###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami###Presenter: – University of Miami
### 5:00 PM – 6:00 PM PT
2467 - Improving Patient Compliance with Vaginal Dilator Therapy by Implementation of Sexual Health Consult in Gynecologic Malignancies after Radiation TherapyLocation: Hall B2Presenter: – Baptist MD Anderson
Heather Augustyniak, DNP – Baptist MD Anderson ### 1972429###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Baptist MD Anderson###Presenter: – Baptist MD Anderson
### 5:00 PM – 6:00 PM PT
2468 - Characterization of Radiographic and Molecular Changes in Mouse Brain after FLASH IrradiationLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Khaled Aziz, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 747096###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 5:00 PM – 6:00 PM PT
2469 - Ginsenoside Rg5 Enhances Radiosensitivity of Lung Adenocarcinoma via Reducing HSP90 CDC37 Interaction and Promoting Client Protein DegradationLocation: Hall B2Presenter: – Sichuan Provincial People's Hospital
Han-song Bai, MD, PhD – Sichuan Provincial People's Hospital ### 1972466###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Provincial People's Hospital###Presenter: – Sichuan Provincial People's Hospital
### 5:00 PM – 6:00 PM PT
2470 - Engaging Ambulatory Cancer Patients to Develop and Validate a Comprehensive New Patient-Reported Outcomes MeasureLocation: Hall B2Presenter: – Tom Baker Cancer Centre
Lisa Barbera, MD – Tom Baker Cancer Centre ### 1972449###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tom Baker Cancer Centre###Presenter: – Tom Baker Cancer Centre
### 5:00 PM – 6:00 PM PT
2471 - Dosimetric Parameters Correlate with Taste Alterations in Head and Neck RadiotherapyLocation: Hall B2Presenter: – University of Miami
Danielle Cerbon, MD – University of Miami ### 1972453###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami###Presenter: – University of Miami
### 5:00 PM – 6:00 PM PT
2472 - IL-1ß+ Tumor Associated Macrophages Induced by Type I Interferon Initiates Radiotherapy-Mediated Abscopal EffectLocation: Hall B2
Dawei Chen, MD, MB ### 2029570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2473 - Carm1 Inhibition Potentiates Irradiation-Induced Antitumor Immunity via Tumor Intrinsic STING Pathway ActivationLocation: Hall B2
Dawei Chen, MD, MB ### 2029570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2474 - Remodeling Tumor Immune Microenvironment by Targeting XPO1 Combined with Radiotherapy Enhances Systemic Anti-tumor Effects in Non-Small Cell Lung CancerLocation: Hall B2
Dawei Chen, MD, MB ### 2029570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2475 - Spatial Proteome Analysis Identifies Lymphocyte CD44 as a Biomarker Associated with SBRT Resistance in Early-Stage Non-Small Cell Lung CancerLocation: Hall B2
Dawei Chen, MD, MB ### 2029570###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2476 - Brachytherapy-on-Chip: A Microfluidic Setup for In Vitro Interrogation of Hypoxic SpheroidsLocation: Hall B2Presenter: – Polytechnique Montreal/CRCHUM
Rodin Chermat, M.Sc, M.Eng – Polytechnique Montreal/CRCHUM ### 1972422###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Polytechnique Montreal/CRCHUM###Presenter: – Polytechnique Montreal/CRCHUM
### 5:00 PM – 6:00 PM PT
2477 - Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition Induces DNA Damage and Radiosensitization in Glioblastoma Cell LinesLocation: Hall B2Presenter: – UPMC Department of Radiation Oncology
Serah Choi, MD, PhD (she/her/hers) – UPMC Department of Radiation Oncology ### 525324###Presenter###Associate Professor###UPMC Department of Radiation Oncology###Presenter: – UPMC Department of Radiation Oncology
### she/her/hers5:00 PM – 6:00 PM PT
2478 - Differential Oxidative Stress Responses in Type II Airway Epithelial Cells Impact Premature Senescence and Lung Fibrosis SusceptibilityLocation: Hall B2Presenter: – National Institute of Health
Eun Chung, PhD – National Institute of Health ### 535962###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Institute of Health###Presenter: – National Institute of Health
### 5:00 PM – 6:00 PM PT
2479 - The Effects of Glypican-3 Deficiency on Radiosensitivity in Liver Cancer CellsLocation: Hall B2Presenter: – National Cancer Institute
Joon-Yong Chung, PhD – National Cancer Institute ### 1972502###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Institute###Presenter: – National Cancer Institute
### 5:00 PM – 6:00 PM PT
2480 - Disabling Tumor Cell-Intrinsic PD-L1 Reprograms Radiation-Induced Locoregional Antitumor ImmunityLocation: Hall B2Presenter: – UAB Hazelrig Salter Radiation Oncology Center
Curtis Clark, MD, PhD – UAB Hazelrig Salter Radiation Oncology Center ### 1972423###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UAB Hazelrig Salter Radiation Oncology Center###Presenter: – UAB Hazelrig Salter Radiation Oncology Center
### 5:00 PM – 6:00 PM PT
2481 - Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-Based SABR-5 Phase II TrialLocation: Hall B2Presenter: – West Metro Cancer Center
Ella Mae Cruz-Lim, MD – West Metro Cancer Center ### 1972434###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West Metro Cancer Center###Presenter: – West Metro Cancer Center
### 5:00 PM – 6:00 PM PT
2482 - ePRO Use in Men Receiving Radiotherapy for Localized Prostate CancerLocation: Hall B2Presenter: – Varian Medical Systems, A Siemens Healthineers Company
Heather Curry, MD – Varian Medical Systems, A Siemens Healthineers Company ### 1972452###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Varian Medical Systems, A Siemens Healthineers Company###Presenter: – Varian Medical Systems, A Siemens Healthineers Company
### 5:00 PM – 6:00 PM PT
2483 - Reshaping Macrophage Polarization Potential Enhances Antitumor Immune Response to Radiation TherapyLocation: Hall B2Presenter: – Cedars-Sinai Medical Center
Tahir Dar, PhD – Cedars-Sinai Medical Center ### 2037984###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 5:00 PM – 6:00 PM PT
2484 - Proof-of-Concept and Characterization of Photosynthetic Bacteria as Radiation EnhancersLocation: Hall B2Presenter: – Stanford University
Neeladrisingha Das, PhD – Stanford University ### 1972464###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 5:00 PM – 6:00 PM PT
2485 - Radiosensitization of Glioblastoma Using Targeted Inhibition of N-MyristoylationLocation: Hall B2Presenter: – National Institute of Health
Deepak Dinakaran, MD, PhD – National Institute of Health ### 537530###Presenter######National Institute of Health###Presenter: – National Institute of Health
### 5:00 PM – 6:00 PM PT
2486 - Radiobiological Characterization of Pancreatic Cancer Patient-Derived OrganoidsLocation: Hall B2Presenter: – Technical University Munich
Sophie Dobiasch, MD – Technical University Munich ### 747882###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Technical University Munich###Presenter: – Technical University Munich
### 5:00 PM – 6:00 PM PT
2487 - Esophageal Cancer-Derived Organoids to Predict Patients Treatment ResponseLocation: Hall B2Presenter: – Chongqing University Cancer Hospital
Liang Du, PhD – Chongqing University Cancer Hospital ### 1972494###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###Presenter: – Chongqing University Cancer Hospital
### 5:00 PM – 6:00 PM PT
2488 - MTA3 Enhances Radiosensitivity of Patients with Esophageal Cancer by Inhibiting Glutamine Synthetase-Mediated GlutaminolysisLocation: Hall B2Presenter: – Chongqing University Cancer Hospital
Liang Du, PhD – Chongqing University Cancer Hospital ### 1972494###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###Presenter: – Chongqing University Cancer Hospital
### 5:00 PM – 6:00 PM PT
2489 - Non-Canonical p16-SP1 Signaling in Head and Neck Cancer Potentially Affects Cell PlasticityLocation: Hall B2Presenter: – University of Pittsburgh, UPMC Hillman Cancer Center
Mohamed Elfayoumi, BS – University of Pittsburgh, UPMC Hillman Cancer Center ### 1972509###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pittsburgh, UPMC Hillman Cancer Center###Presenter: – University of Pittsburgh, UPMC Hillman Cancer Center
### 5:00 PM – 6:00 PM PT
2490 - Sexual Function and Dosimetric Relationships to Erectile Structures among Patients Treated Definitively with Pd-103 LDR Prostate BrachytherapyLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Keara English, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 747292###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 5:00 PM – 6:00 PM PT
2491 - Dual Immune Checkpoint Therapy Combined with Radiotherapy Treats Castration-Resistant Prostate CancerLocation: Hall B2
Matthew Eximond, BS – N/A ### 1972419###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###N/A###Presenter: – N/A
### 5:00 PM – 6:00 PM PT
2492 - Influence of Bacterial Metabolites on the Systemic Antitumor Immune Response after Radiation Therapy in Combination with Immune Checkpoint InhibitorsLocation: Hall B2
Julius Fischer, MD – TU München ### 1972501###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###TU München###Presenter: – TU München
### 5:00 PM – 6:00 PM PT
2493 - Predictors of Low Anterior Resection Syndrome after Long-Course Chemoradiation for Locally Advanced Rectal CancerLocation: Hall B2Presenter: – McGovern Medical School
Ty Forbes, BS – McGovern Medical School ### 1972448###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGovern Medical School###Presenter: – McGovern Medical School
### 5:00 PM – 6:00 PM PT
2494 - Comparing Acute Oral Mucosa Toxicity Associated with Minibeam and Conventional RadiotherapyLocation: Hall B2Presenter: – Mayo Clinic College of Medicine and Science Rochester
Darwin Garcia, BA – Mayo Clinic College of Medicine and Science Rochester ### 1972474###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic College of Medicine and Science Rochester###Presenter: – Mayo Clinic College of Medicine and Science Rochester
### 5:00 PM – 6:00 PM PT
2495 - Enhanced Peroxide Fluxes and Radiosensitization in Colorectal Tumors but Not Normal Enterocytes from the Combination of Superoxide Disumutase Mimetics and Pharmacological AscorbateLocation: Hall B2Presenter: – University of Iowa
Benjamin George, BA – University of Iowa ### 1972508###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Iowa###Presenter: – University of Iowa
### 5:00 PM – 6:00 PM PT
2496 - Assessing the Sexual Health of Female Survivors of Pelvic Malignancies after RadiotherapyLocation: Hall B2Presenter: – Wilmot Cancer Center
Kimberly Gergelis, MD – Wilmot Cancer Center ### 1972451###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Wilmot Cancer Center###Presenter: – Wilmot Cancer Center
### 5:00 PM – 6:00 PM PT
2497 - HPV Infection Causes Dependence on Alternative DNA Damage Response Pathways Providing Cancer Specific Targets for RadiosensitizationLocation: Hall B2Presenter: – Johns Hopkins School of Medicine
Michael Goldstein, MD, PhD – Johns Hopkins School of Medicine ### 538073###Presenter###Disclosures: Employment: Johns Hopkins School of Medicine:Instructor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Johns Hopkins School of Medicine###Presenter: – Johns Hopkins School of Medicine
### 5:00 PM – 6:00 PM PT
2498 - The Effects of Adjuvant Chemoradiotherapy (CRT) on Myeloid-Derived Suppressor Cell (MDSC) Subsets in Glioblastoma (GBM)Location: Hall B2Presenter: – University of Minnesota
Matt Berkseth, PhD – University of Minnesota ### 2083694###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Minnesota###Presenter: – University of Minnesota
### 5:00 PM – 6:00 PM PT
2498 - The Effects of Adjuvant Chemoradiotherapy (CRT) on Myeloid-Derived Suppressor Cell (MDSC) Subsets in Glioblastoma (GBM)Location: Hall B1Presenter: – University of Minnesota Medical School
Lindsey Greenlund, BS – University of Minnesota Medical School ### 1972459###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Minnesota Medical School###Presenter: – University of Minnesota Medical School
### 5:00 PM – 6:00 PM PT
2499 - Sensitivity of the PROMIS-10 for Capturing Radiation-Related Quality of Life ChangesLocation: Hall B2
Heather Gunn, PhD – Mayo Clinic ### 1972455###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 5:00 PM – 6:00 PM PT
2500 - Tumor-Myeloid Cell Crosstalk Pathways Associated with Abscopal Responses in Breast CancerLocation: Hall B2Presenter: – University of North Carolina
Gaorav Gupta, MD, PhD – University of North Carolina ### 525025###Presenter###Disclosures: Employment: University of North Carolina at Chapel Hill:Associate Professor:Employee | Compensation: Naveris: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: present ;Merck: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present | Ownership: Naveris:Copyright, Ownership Equity | Leadership: none###University of North Carolina###Presenter: – University of North Carolina
### 5:00 PM – 6:00 PM PT
2501 - Targeted Pubic Neoantigen Immunotherapy Using Encapsulated Nanoparticles, Directed by RadiationLocation: Hall B2Presenter: – Iwate Medical University School of Medicine
Satoshi Harada, MD, PhD – Iwate Medical University School of Medicine ### 525163###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Iwate Medical University School of Medicine###Presenter: – Iwate Medical University School of Medicine
### 5:00 PM – 6:00 PM PT
2502 - Prospective Evaluation of Patient-Reported Outcomes of Invisible Ink Tattoos for the Delivery of External Beam Radiation Therapy: The PREFER TrialLocation: Hall B2Presenter: – NYU Grossman School of Medicine
Camille Hardy Abeloos, MD – NYU Grossman School of Medicine ### 1972367###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Grossman School of Medicine###Presenter: – NYU Grossman School of Medicine
### 5:00 PM – 6:00 PM PT
2503 - Severity of Financial Toxicity for Patients Receiving Palliative Radiation TherapyLocation: Hall B2Presenter: – Stanford Radiation Oncology
Jeremy Harris, MD, MPhil – Stanford Radiation Oncology ### 538217###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Radiation Oncology###Presenter: – Stanford Radiation Oncology
### 5:00 PM – 6:00 PM PT
2504 - Patterns of Independence in Adolescent/ Young Adult (AYA) Survivors of Childhood Cancer Having Received Radiotherapy (RT)Location: Hall B2Presenter: – University of Pennsylvania
Christine Hill-Kayser, MD – University of Pennsylvania ### 538144###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 5:00 PM – 6:00 PM PT
2505 - Hyperbaric Oxygen Therapy Attenuates the Whole Brain Radiotherapy-Induced Progressive Cognitive Dysfunction via Promoting Hippocampal Neurogenesis in RatsLocation: Hall B2Presenter: – Chi Mei Medical Center
Sheng-Yow Ho, MD, MS – Chi Mei Medical Center ### 1972457###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chi Mei Medical Center###Presenter: – Chi Mei Medical Center
### 5:00 PM – 6:00 PM PT
2506 - WEE1 Inhibition Promotes Radiotherapy-Induced Myeloid Suppressor Cells through cGAS/STING-STAT3-IRF3 PathwayLocation: Hall B2Presenter: – Xijing Hospital
Jing Hu, MD – Xijing Hospital ### 1972495###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Xijing Hospital###Presenter: – Xijing Hospital
### 5:00 PM – 6:00 PM PT
2507 - Carbon Ion Radiotherapy Exerts Anti-Tumor Activity by Inducing cGAS-STING Activation and Immune Response in Prostate Cancer-Bearing MiceLocation: Hall B2Presenter: – Shanghai Proton and Heavy Ion Center
Wei Hu – Shanghai Proton and Heavy Ion Center ### 1972424###Presenter######Shanghai Proton and Heavy Ion Center###Presenter: – Shanghai Proton and Heavy Ion Center
### 5:00 PM – 6:00 PM PT
2509 - Single-Cell Analysis Reveals the Alteration of Immune Checkpoint Molecules Induced by Radiochemotherapy in Cervical Cancer MicroenvironmentLocation: Hall B2
Qingyu Huang, MD ### 1972506###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2510 - Voice Handicap Following Curative Therapy for Locally Advanced Head and Neck CancerLocation: Hall B2Presenter: – University of Alabama at Birmingham
Adam Hubler, MD – University of Alabama at Birmingham ### 2065901###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alabama at Birmingham###Presenter: – University of Alabama at Birmingham
### 5:00 PM – 6:00 PM PT
2511 - Impact of Employment and Insurance Status on Hope Among Patients Treated within Radiation OncologyLocation: Hall B2
Caressa Hui, MD, BS – Stanford ### 525476###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford###Presenter: – Stanford
### 5:00 PM – 6:00 PM PT
2512 - Early Assessment of Radiation Treatment at Clinical Field Strength by D2O Administration and Deuterium MRILocation: Hall B2Presenter: – Gifu University
Fuminori Hyodo, PhD – Gifu University ### 537446###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Gifu University###Presenter: – Gifu University
### 5:00 PM – 6:00 PM PT
2513 - Bothersome Gynecomastia Following Neoadjuvant GnRH Agonists and Stereotactic Body Radiotherapy for Localized Prostate CancerLocation: Hall B2Presenter: – Georgetown University School of Medicine
Simran Jatar, MPH – Georgetown University School of Medicine ### 1972437###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Georgetown University School of Medicine###Presenter: – Georgetown University School of Medicine
### 5:00 PM – 6:00 PM PT
2514 - A Bidirectional Mendelian Randomization Analysis of Circulating Inflammatory Cytokines with Colon and Rectum CancersLocation: Hall B2Presenter: – Nanjing Medical University Affiliated Suzhou Hospital
Shengjun Ji, MD – Nanjing Medical University Affiliated Suzhou Hospital ### 525357###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Nanjing Medical University Affiliated Suzhou Hospital###Presenter: – Nanjing Medical University Affiliated Suzhou Hospital
### 5:00 PM – 6:00 PM PT
2515 - Shoulder Muscle Dosimetry and Post-Treatment Rehabilitation Utilization for Early-Stage Breast Cancer PatientsLocation: Hall B2Presenter: – Washington University/B-JH/SLCH Consortium
Shannon Jiang, MD – Washington University/B-JH/SLCH Consortium ### 1972427###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University/B-JH/SLCH Consortium###Presenter: – Washington University/B-JH/SLCH Consortium
### 5:00 PM – 6:00 PM PT
2516 - Trends in Racial and Ethnicity Disparities in the Health-Related Quality of Life in Older Adults with Breast Cancer: A SEER-MHOS National Database StudyLocation: Hall B2
Nicki Karimi-Mostowfi, BS ### 1972438###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2517 - Refining Surveillance Guidelines after SBRT for Early-Stage Lung CancerLocation: Hall B2Presenter: – University of Cincinnati - Barrett Cancer Center
Samuel Keltner, MD, BS – University of Cincinnati - Barrett Cancer Center ### 1972443###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Cincinnati - Barrett Cancer Center###Presenter: – University of Cincinnati - Barrett Cancer Center
### 5:00 PM – 6:00 PM PT
2518 - The Landscape of Genetic Alterations Associated with Metachronous Metastasis in Patients with Pancreatic Ductal Adenocarcinoma and Its Prognostic SignificanceLocation: Hall B2Presenter: – Rutgers Cancer Institute of New Jersey
Jongmyung Kim, MD, PhD – Rutgers Cancer Institute of New Jersey ### 1971978###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rutgers Cancer Institute of New Jersey###Presenter: – Rutgers Cancer Institute of New Jersey
### 5:00 PM – 6:00 PM PT
2519 - Combination Immunotherapy with Partial or Whole Tumor Radiotherapy in Preclinical Melanoma Tumor ModelLocation: Hall B2Presenter: – UPMC Hillman Cancer Center, Department of Radiation Oncology
Sean Koerner, MD, MS – UPMC Hillman Cancer Center, Department of Radiation Oncology ### 1972458###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UPMC Hillman Cancer Center, Department of Radiation Oncology###Presenter: – UPMC Hillman Cancer Center, Department of Radiation Oncology
### 5:00 PM – 6:00 PM PT
2520 - Pre- and Post-Treatment Patient-Reported Financial Toxicity in Head and Neck Cancer: Identifying Influential Factors and Clinical SignificanceLocation: Hall B2
Eric Ku, MD – UC Irvine ### 1972431###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UC Irvine###Presenter: – UC Irvine
### 5:00 PM – 6:00 PM PT
2521 - The Ferroptosis Induced by Palmitic Acid via CD36 Activating ER Stress to Break Calcium-Iron Balance in Colon Cancer CellsLocation: Hall B2
Hao Kuang, MD ### 1972496###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2522 - Comprehensive Use of a Multifunction Software Tool to Facilitate Education and Communication of Treatment-Related Distress in Patients with Cancer Receiving Radiation TherapyLocation: Hall B2Presenter: – Varian Medical Systems
Ian Kudel, PhD – Varian Medical Systems ### 1972454###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Varian Medical Systems###Presenter: – Varian Medical Systems
### 5:00 PM – 6:00 PM PT
2523 - Targeting VEGF/Neuropilin-2 as a Novel Approach to Induce Radiosensitivity in Triple Negative Breast CancerLocation: Hall B2Presenter: – UMass Chan Medical School / QARC
Ayush Kumar, BS – UMass Chan Medical School / QARC ### 1972450###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UMass Chan Medical School / QARC###Presenter: – UMass Chan Medical School / QARC
### 5:00 PM – 6:00 PM PT
2524 - Long-Term Quality of Life Following Head and Neck Radiation: A Study Using the Vanderbilt Head and Neck Symptom SurveyLocation: Hall B2Presenter: – City of Hope National Medical Center
Colton Ladbury, MD, BS – City of Hope National Medical Center ### 747995###Presenter###Disclosures: Employment: City of Hope National Medical Center:Resident Physician:Employee | Compensation: RefleXion Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 5:00 PM – 6:00 PM PT
2525 - Experimental Investigation of Lung Toxicity after Radiation Therapy Combined with Immune Checkpoint InhibitorsLocation: Hall B2Presenter: – Klinikum rechts der Isar TUM
Laura Lansink Rotgerink – Klinikum rechts der Isar TUM ### 1972487###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Klinikum rechts der Isar TUM###Presenter: – Klinikum rechts der Isar TUM
### 5:00 PM – 6:00 PM PT
2526 - Src Kinase Activates Signal Transducer and Activator of Transcription 3 to Enhance Radioresistance in Triple Negative Breast Cancer CellsLocation: Hall B2Presenter: – Chung Shan Medical University Hospital
Yueh Chun Lee, MD, PhD – Chung Shan Medical University Hospital ### 1972420###Presenter######Chung Shan Medical University Hospital###Presenter: – Chung Shan Medical University Hospital
### 5:00 PM – 6:00 PM PT
2527 - Dynamic Effects of Thoracic Irradiation on Immune Status of Organs in and out of Radiation Field in MiceLocation: Hall B2
Yaqi Li, MD ### 1972467###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2528 - Study of DNA Damage-Induced MSI1 Serine-347 Phosphorylation in Regulation of Radiosensitivity in Glioblastoma MultiformeLocation: Hall B2Presenter: – Hong Kong Polytechnic University
Liang-Ting Lin, PhD – Hong Kong Polytechnic University ### 747851###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hong Kong Polytechnic University###Presenter: – Hong Kong Polytechnic University
### 5:00 PM – 6:00 PM PT
2529 - Robust Radiosensitization by Combined Treatment of Cancer Cells with Talazoparib and Pol? InhibitorsLocation: Hall B2Presenter: – University Hospital Essen
Xixi Lin, MS – University Hospital Essen ### 1972473###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospital Essen###Presenter: – University Hospital Essen
### 5:00 PM – 6:00 PM PT
2530 - Hepatoma Derived Growth Factor (HDGF) Targeting as a Therapeutic Approach for Radio-Naive and Radioresistant Hepatocellular CarcinomaLocation: Hall B2Presenter: – Kaohsiung Veterans General Hospital
Yu-Wei Lin, MD, PhD, MS – Kaohsiung Veterans General Hospital ### 525372###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaohsiung Veterans General Hospital###Presenter: – Kaohsiung Veterans General Hospital
### 5:00 PM – 6:00 PM PT
2531 - Single-Cell Dissection of Concurrent Chemoradiotherapy-Induced Immunosenescence in Cervical CancerLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute, First Medical University
Chao Liu, MD, PhD – Shandong Cancer Hospital and Institute, First Medical University ### 746674###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute, First Medical University###Presenter: – Shandong Cancer Hospital and Institute, First Medical University
### 5:00 PM – 6:00 PM PT
2532 - Dissecting Systemic T Cell Responses after Stereotactic Ablative Radiotherapy in NSCLC by Single-Cell RNA and T Cell Receptor SequencingLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute, First Medical University
Chao Liu, MD, PhD – Shandong Cancer Hospital and Institute, First Medical University ### 746674###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute, First Medical University###Presenter: – Shandong Cancer Hospital and Institute, First Medical University
### 5:00 PM – 6:00 PM PT
2533 - Understanding Treatment Anxiety and Utility of Mixed Media Educational Tools in Radiation Oncology Consultation: A Qualitative StudyLocation: Hall B2Presenter: – NYU School of Medicine
Elisa Liu, MD, BS – NYU School of Medicine ### 1972447###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU School of Medicine###Presenter: – NYU School of Medicine
### 5:00 PM – 6:00 PM PT
2534 - Evaluation of Antitumor Immunity by a Combination Treatment of Radiation, Anti-PD1, and Anti-Angiogenic Therapy in Esophageal Squamous Cell CarcinomaLocation: Hall B2
Yudi Liu – No ### 1972484###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###No###Presenter: – No
### 5:00 PM – 6:00 PM PT
2535 - Identification of Hepatocellular Carcinoma-specific Targets for Imaging and TherapyLocation: Hall B2Presenter: – Georgetown University School of Medicine
Valeria Londono, BS – Georgetown University School of Medicine ### 1972463###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Georgetown University School of Medicine###Presenter: – Georgetown University School of Medicine
### 5:00 PM – 6:00 PM PT
2536 - m6A Reader YTHDC1 Inhibits Ferroptosis and Radiosensitivity by Promoting SREBF1 mRNA Nuclear Export in Nasopharyngeal CarcinomaLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Zhi-Qing Long, PhD – Sun Yat-Sen University Cancer Center ### 1972469###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 5:00 PM – 6:00 PM PT
2537 - AKR1C3 Induces Resistance to Radiotherapy in Prostate Cancer Cells by Inhibiting Ubiquitinated Degradation of Nrf2 through Interacting with KEAP1Location: Hall B2Presenter: – Peking University First Hospital
Feng Lyu, MD, PhD – Peking University First Hospital ### 1972512###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking University First Hospital###Presenter: – Peking University First Hospital
### 5:00 PM – 6:00 PM PT
2538 - The Role and Mechanism of Ferroptosis Mediated by METTL3-m6A Modification in Regulating Radioresistance of Esophageal CancerLocation: Hall B2Presenter: – Xijing Hospital, Air Force Medical University
Rui Ma, MS – Xijing Hospital, Air Force Medical University ### 1972493###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Xijing Hospital, Air Force Medical University###Presenter: – Xijing Hospital, Air Force Medical University
### 5:00 PM – 6:00 PM PT
2539 - Longitudinal Profiling of Tumor RNA Expression Signatures Reveal Key Biological Features Associated with Response to Neoadjuvant Stereotactic Body Radiation Therapy in High-Risk Prostate CancerLocation: Hall B2Presenter: – Massachusetts General Hospital
Ariel Marciscano, MD – Massachusetts General Hospital ### 525167###Presenter###Disclosures: Employment: Weill Cornell:Radiation Oncologist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 5:00 PM – 6:00 PM PT
2540 - Safety and Feasibility of the Addition of a Radiosensitizing Methionine-Restricted Diet to Radiation TherapyLocation: Hall B2Presenter: – Rutgers Cancer Institute of New Jersey
Malcolm Mattes, MD – Rutgers Cancer Institute of New Jersey ### 585101###Presenter###Disclosures: Employment: Rutgers Cancer Institute of New Jersey:Associate Professor:Employee | Compensation: Bristol Myers Squibb Foundation: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present ;New Jersey Health Foundation: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present ;Radiation Oncology Institute: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present | Ownership: none | Leadership: University Hospital Cancer Center:ACOS CoC Cancer Liaison Physician;ASTRO:Vice Chair###Rutgers Cancer Institute of New Jersey###Presenter: – Rutgers Cancer Institute of New Jersey
### 5:00 PM – 6:00 PM PT
2541 - Mechanisms of Intrinsic Radioresistance in Breast Cancer Identify Potential Therapeutic VulnerabilitiesLocation: Hall B2Presenter: – University of Michigan
Breanna McBean, BA – University of Michigan ### 1972475###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 5:00 PM – 6:00 PM PT
2542 - Fear of Cancer Recurrence (FCR) in Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC) Patients 12 months (12m) after (Chemo)Radiation (RT/CRT)Location: Hall B2Presenter: – Princess Alexandra Hospital
Lachlan Joseph McDowell, MB, BS, MBBS, FRANZCR – Princess Alexandra Hospital ### 2010635###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Alexandra Hospital###Presenter: – Princess Alexandra Hospital
### 5:00 PM – 6:00 PM PT
2543 - Evaluation of 68Ga-Fibroblast Activation Protein Inhibitor vs. 18F-FDG as a Novel Radiotracer for Biologically-Guided RadiotherapyLocation: Hall B2Presenter: – City of Hope Comprehensive Cancer Center
Heather McGee, MD, PhD – City of Hope Comprehensive Cancer Center ### 525015###Presenter###Disclosures: Employment: City of Hope:Assistant Professor:Employee | Compensation: RefleXion: Consultant, Honoraria-End Date: 2021 | Ownership: none | Leadership: none###City of Hope Comprehensive Cancer Center###Presenter: – City of Hope Comprehensive Cancer Center
### 5:00 PM – 6:00 PM PT
2544 - Comparison of Tumor Control between FLASH and CONV in an Orthotopic Breast Cancer ModelLocation: Hall B2Presenter: – Stanford University
Stavros Melemenidis, PhD – Stanford University ### 1972478###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 5:00 PM – 6:00 PM PT
2545 - Patient Reported Financial Distress and its Association with Quality of Life and Symptom Burden in Cancer Patients Reporting to a Public Facility in LMICLocation: Hall B2Presenter: – Sanjay Gandhi Postgraduate Institute of Medical Sciences
Shagun Misra, MD – Sanjay Gandhi Postgraduate Institute of Medical Sciences ### 570896###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sanjay Gandhi Postgraduate Institute of Medical Sciences###Presenter: – Sanjay Gandhi Postgraduate Institute of Medical Sciences
### 5:00 PM – 6:00 PM PT
2546 - Tracking Changes in Global Longitudinal Strain in Lung Cancer Patients Receiving Thoracic RadiationLocation: Hall B2Presenter: – UT Southwestern Medical Center
Steven Montalvo, MD – UT Southwestern Medical Center ### 1972233###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 5:00 PM – 6:00 PM PT
2547 - Differential Response to Radiation Fractionation in Head and Neck Cancer Patient-Derived XenograftsLocation: Hall B2Presenter: – Medical College of Wisconsin
Musaddiq Awan, MD – Medical College of Wisconsin ### 524804###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 5:00 PM – 6:00 PM PT
2548 - Macrophage Mediated Abscopal Effects of Radiation TherapyLocation: Hall B2Presenter: – Stanford University
Yoko Nishiga, MD – Stanford University ### 1972477###Presenter######Stanford University###Presenter: – Stanford University
### 5:00 PM – 6:00 PM PT
2549 - Dose Volume Thresholds Associated with Acute Skin Toxicities in Proton Beam TherapyLocation: Hall B2
Kenneth Oguejiofor, MD ### 1972442###Presenter#########Presenter:
### 5:00 PM – 6:00 PM PT
2550 - Pathway Analysis of Transcriptional Alterations in the Salivary Gland Following Radiation ExposureLocation: Hall B2Presenter: – University of Wisconsin
Cristina Paz, MS – University of Wisconsin ### 1972497###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin###Presenter: – University of Wisconsin
### 5:00 PM – 6:00 PM PT
2551 - Impact of PRaG Therapy on Peripheral Immune Cells of Subcutaneous Tumor Peritoneal Metastasis Model of Colon CancerLocation: Hall B2Presenter: – The Second Affiliated Hospital of Soochow University
Yong Peng – The Second Affiliated Hospital of Soochow University ### 1972488###Presenter######The Second Affiliated Hospital of Soochow University###Presenter: – The Second Affiliated Hospital of Soochow University
### 5:00 PM – 6:00 PM PT
2552 - Transcriptomic Analysis to Uncover the Mechanism of Radiosensitization of AR-Positive Triple Negative Breast Cancers with AR InhibitionLocation: Hall B2Presenter: – UH Seidman Cancer Center Case Western Reserve University
Courtney Pisano, DO, MS, MPH – UH Seidman Cancer Center Case Western Reserve University ### 1972465###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UH Seidman Cancer Center Case Western Reserve University###Presenter: – UH Seidman Cancer Center Case Western Reserve University
### 5:00 PM – 6:00 PM PT
2553 - Hyperthermic Enhancement of Immunotherapy: Findings of In Vitro ModelingLocation: Hall B2
Danielle Quaranto, MS ### 1972462###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2554 - Comparison of Two Triple Therapy Regimens for Enhancing the Abscopal Effect in MiceLocation: Hall B2
XI Rao, MD ### 1972472###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2555 - A Molecular Approach to Characterize the Effects of Fluence, Fluence Rate and LET on Radiation DamageLocation: Hall B2Presenter: – Johns Hopkins University School of Medicine
Mohammad Rezaee, PhD, MS – Johns Hopkins University School of Medicine ### 1972421###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University School of Medicine###Presenter: – Johns Hopkins University School of Medicine
### 5:00 PM – 6:00 PM PT
2556 - Psychiatric or Drug Hospitalizations in Older Cancer Survivors on Long-Term OpioidsLocation: Hall B2Presenter: – UCSD Radiation Medicine and Applied Sciences
Paul Riviere, MD – UCSD Radiation Medicine and Applied Sciences ### 746744###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSD Radiation Medicine and Applied Sciences###Presenter: – UCSD Radiation Medicine and Applied Sciences
### 5:00 PM – 6:00 PM PT
2559 - Preclinical Intraoperative FLASH RadiotherapyLocation: Hall B2Presenter: – Johns Hopkins University
Daniel Sforza, PhD – Johns Hopkins University ### 1972510###Presenter######Johns Hopkins University###Presenter: – Johns Hopkins University
### 5:00 PM – 6:00 PM PT
2560 - Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate CancerLocation: Hall B2Presenter: – GW Medical School
Sarthak Shah, BS – GW Medical School ### 1972436###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GW Medical School###Presenter: – GW Medical School
### 5:00 PM – 6:00 PM PT
2561 - Pancreatic Cancer Derived 3-D Organoids as Clinical Tool to Predict Response to Radiation and Chemo-Radiation TherapyLocation: Hall B2Presenter: – University of Maryland School of Medicine
Hem Shukla, PhD – University of Maryland School of Medicine ### 1972476###Presenter###Disclosures: Employment: University of Maryland, School of Medicine:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Maryland School of Medicine###Presenter: – University of Maryland School of Medicine
### 5:00 PM – 6:00 PM PT
2562 - Financial Toxicity and Patient Experience Outcomes on a Multi-Institutional Phase I Single Fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast CancerLocation: Hall B2Presenter: – UT Southwestern Medical Center
Ambrosia Simmons, MD, PhD – UT Southwestern Medical Center ### 1972444###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 5:00 PM – 6:00 PM PT
2563 - Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer: An Australian PerspectiveLocation: Hall B2Presenter: – Queensland Health Radiation Oncology Princess Alexandra Hospital
Justin Smith, MBBS – Queensland Health Radiation Oncology Princess Alexandra Hospital ### 1972430###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Queensland Health Radiation Oncology Princess Alexandra Hospital###Presenter: – Queensland Health Radiation Oncology Princess Alexandra Hospital
### 5:00 PM – 6:00 PM PT
2564 - Stroke Risk in Survivors of Head and Neck Cancer: A Descriptive Epidemiologic Cohort StudyLocation: Hall B2Presenter: – National University Hospital
Shing Fung Lee, MBBS – National University Hospital ### 2011573###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National University Hospital###Presenter: – National University Hospital
### 5:00 PM – 6:00 PM PT
2565 - Loss of ADAR1 Enhances Radiosensitivity of Esophagus Cancer by Causing Cell Apoptosis via NF-kB Signaling PathwayLocation: Hall B2
Liangchao Sun ### 747363###Presenter#########Presenter:
### 5:00 PM – 6:00 PM PT
2566 - The Effect of MDSC-Derived Exosomes Played in Esophageal Squamous Carcinoma Cells after Ionising RadiationLocation: Hall B2
Sun Rui, MD ### 1972499###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2567 - Transcriptomic Heterogeneity of Metastatic Disease Timing within Metastatic Castration-Sensitive Prostate CancerLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Philip Sutera, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 525073###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 5:00 PM – 6:00 PM PT
2568 - Analyzing the Predictive Effects of PD-L1 Expression, Early Changes of bTMB and Circulated CD8+T Cells during Treatment for Responses of RT Combined with ICI in NSCLCLocation: Hall B2Presenter: – Shandong Anti-Cancer Association
Feifei Teng, MD, PhD – Shandong Anti-Cancer Association ### 746759###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 5:00 PM – 6:00 PM PT
2569 - Radiation Therapy Generates Release of Microvesicle Particles in KeratinocytesLocation: Hall B2Presenter: – Wright State University Boonshoft School of Medicine
Ericson John Torralba – Wright State University Boonshoft School of Medicine ### 1972481###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Wright State University Boonshoft School of Medicine###Presenter: – Wright State University Boonshoft School of Medicine
### 5:00 PM – 6:00 PM PT
2570 - Adverse Events Relating to Radiation Therapy in Patients with Collagen Vascular DisordersLocation: Hall B2Presenter: – University of Oklahoma Health Sciences Center
Emily Tran, BS – University of Oklahoma Health Sciences Center ### 1972492###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Oklahoma Health Sciences Center###Presenter: – University of Oklahoma Health Sciences Center
### 5:00 PM – 6:00 PM PT
2571 - Comparative Analysis of Tumor Microbiome, Molecular Profile and Immune Cell Abundance by HPV Status in Head and Neck Cancers and Their Impact on SurvivalLocation: Hall B2Presenter: – Ohio State University
Rituraj Upadhyay, MD, MBBS, DNB – Ohio State University ### 746809###Presenter###Disclosures: Employment: The Ohio State University Wexner Medical Center:Resident physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Ohio State University###Presenter: – Ohio State University
### 5:00 PM – 6:00 PM PT
2572 - Improving Cancer Care by Incorporating the Patients Voice in Symptom Management (IMPROVE): A Multicenter-Prospective Pilot StudyLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Khinh Ranh Voong, MD, MPH – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 829220###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 5:00 PM – 6:00 PM PT
2574 - High Salt Diet Exacerbates Intestinal Radiotoxicity by Promoting Intestinal Epithelial Barrier Dysfunction after RTLocation: Hall B2Presenter: – Technische Universitat Munchen
Caroline Walther – Technische Universitat Munchen ### 1972490###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Technische Universitat Munchen###Presenter: – Technische Universitat Munchen
### 5:00 PM – 6:00 PM PT
2575 - Single-Cell and Bulk RNA Sequencing Reveal the Potential Immune Suppressive Role of PODXL in Cervical Cancer Treated with RadiochemotherapyLocation: Hall B2
Fuhao Wang, MD ### 1972507###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2576 - Study on the Dynamic Changes of Myocardial Injury Markers in Radiotherapy for Esophageal Carcinoma and Its Correlation with Cardiac DosimetryLocation: Hall B2Presenter: – Shandong Anti-Cancer Association
Jin Zhi Wang, MD – Shandong Anti-Cancer Association ### 1972505###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 5:00 PM – 6:00 PM PT
2577 - Ubiquitinated H2A.X-Induced RNF168 Condensation Promotes DNA Double-Strand Break Repair and Tumor RadioresistanceLocation: Hall B2Presenter: – Sixth Affiliated Hospital, Sun Yat-sen University
Yun-Long Wang, PhD – Sixth Affiliated Hospital, Sun Yat-sen University ### 747862###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sixth Affiliated Hospital, Sun Yat-sen University###Presenter: – Sixth Affiliated Hospital, Sun Yat-sen University
### 5:00 PM – 6:00 PM PT
2578 - Spatiotemporal Optimization of Pelvic Radiation TherapyLocation: Hall B2Presenter: – City of Hope National Medical Center
William Watkins, PhD – City of Hope National Medical Center ### 525120###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 5:00 PM – 6:00 PM PT
2579 - The Impact of Supervised, Individualized Exercise on Fatigue and Quality of Life during Adjuvant Radiotherapy for Breast CancerLocation: Hall B2
Karen Wonders, PhD ### 1972441###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2580 - Metformin Antagonizes Radiotherapy-Induced Anti-Tumor Effects via Inhibition of cGAS-STING Pathway Mediated Immune ResponsesLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute
Meng Wu, PhD – Shandong Cancer Hospital and Institute ### 1972479###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 5:00 PM – 6:00 PM PT
2581 - RUNX1 is a Potential Target for Combined Radioimmunotherapy of Lung AdenocarcinomaLocation: Hall B2
Changyan Xiao ### 1972482###Presenter#########Presenter:
### 5:00 PM – 6:00 PM PT
2582 - Modified Ketogenic Diet can Promote the Anti-Tumor Activity of Radiotherapy for Lung Cancer through AMPK Signaling PathwayLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Ling Xiao, PhD – Sichuan Cancer Hospital and Institute ### 1972461###Presenter######Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 5:00 PM – 6:00 PM PT
2583 - Probiotic Consortia and their Metabolites Protect Intestine Against Radiation Injury by Improving Intestinal Epithelial HomeostasisLocation: Hall B2Presenter: – The Second Affiliated Hospital of Soochow University
Liwei Xie, PhD – The Second Affiliated Hospital of Soochow University ### 1972468###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Second Affiliated Hospital of Soochow University###Presenter: – The Second Affiliated Hospital of Soochow University
### 5:00 PM – 6:00 PM PT
2584 - Prognostic and Predictive Significance of Tumor Immune Microenvironment in Breast Ductal Carcinoma In SituLocation: Hall B2
Fei-Fei Xu, MD ### 1972486###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2585 - Impact of PRaG Therapy on Immune Microenvironment of Bilateral Subcutaneous Tumor Model of Colon CancerLocation: Hall B2Presenter: – The Second Affiliated Hospital of Soochow University
Meiling Xu – The Second Affiliated Hospital of Soochow University ### 525427###Presenter######The Second Affiliated Hospital of Soochow University###Presenter: – The Second Affiliated Hospital of Soochow University
### 5:00 PM – 6:00 PM PT
2586 - Tumor Regression with 5-Aminolevulinic Acid (5-ALA)-Mediated Radiodynamic Therapy (RDT) Using Different Megavoltage EnergiesLocation: Hall B2Presenter: – Fox Chase Cancer Center
Dae-Myoung Yang, PhD – Fox Chase Cancer Center ### 1972425###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
### 5:00 PM – 6:00 PM PT
2587 - Investigation of Hydrogen Peroxide for 45MV 5-Aminolevulinic Acid-Mediated Radiodynamic TherapyLocation: Hall B2Presenter: – Fox Chase Cancer Center
Dae-Myoung Yang, PhD – Fox Chase Cancer Center ### 1972425###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
### 5:00 PM – 6:00 PM PT
2588 - Single-Cell Analyses Reveal SBRT-Induced Ccl8+ Mrc1+Macrophage Associated with NK Cells Exhaustion in Lung CancerLocation: Hall B2
Haonan Yang, MD – None ### 1972498###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###None###Presenter: – None
### 5:00 PM – 6:00 PM PT
2589 - Investigation of ATR inhibitor VX970 as radiosensitizer in colorectal cancer cellsLocation: Hall B2Presenter: – City of Hope Comprehensive Cancer Center
Linlin Yang, MD, PhD – City of Hope Comprehensive Cancer Center ### 2063796###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope Comprehensive Cancer Center###Presenter: – City of Hope Comprehensive Cancer Center
### 5:00 PM – 6:00 PM PT
2590 - Radiosensitizing Effects of CDK4/6 Inhibitors in Hormone Receptor-Positive and HER2-Negative Breast Cancer are through Downregulating DNA Repair Mechanism and NF-?B-Signaling PathwayLocation: Hall B2Presenter: – National Taiwan University Hospital
Wen-Chi Yang, MD – National Taiwan University Hospital ### 538402###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Taiwan University Hospital###Presenter: – National Taiwan University Hospital
### 5:00 PM – 6:00 PM PT
2591 - Equivalent Dose Estimation in FLASH Irradiation with a Deep Learning ApproachLocation: Hall B2Presenter: – Stanford University
Zi Yang, PhD – Stanford University ### 1972255###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 5:00 PM – 6:00 PM PT
2592 - Incidence of Major Depression, Suicidal Ideation, and Mental Health Treatment Amongst Cancer SurvivorsLocation: Hall B2Presenter: – City of Hope National Medical Center
Colton Ladbury, MD, BS – City of Hope National Medical Center ### 747995###Presenter###Disclosures: Employment: City of Hope National Medical Center:Resident Physician:Employee | Compensation: RefleXion Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 5:00 PM – 6:00 PM PT
2592 - Incidence of Major Depression, Suicidal Ideation, and Mental Health Treatment Amongst Cancer SurvivorsLocation: Hall B2Presenter: – Touro College of Osteopathic Medicine
Linda Ye, MD – Touro College of Osteopathic Medicine ### 1972432###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Touro College of Osteopathic Medicine###Presenter: – Touro College of Osteopathic Medicine
### 5:00 PM – 6:00 PM PT
2593 - The Effect of Dose Rate on Tumor Microenvironment in External Beam RadiotherapyLocation: Hall B2
Melek Tugce Yilmaz, MD ### 1972485###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2594 - Radiotherapy Combined with PD-L1 Antibody Exerts a Synergistic Anti-tumor Effect in a Mouse Model of Esophageal Squamous Cell CarcinomaLocation: Hall B2Presenter: – Hangzhou Cancer Hospital
Hao Yin, MD, PhD – Hangzhou Cancer Hospital ### 1972483###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hangzhou Cancer Hospital###Presenter: – Hangzhou Cancer Hospital
### 5:00 PM – 6:00 PM PT
2595 - The Role of Esophagography in the Diagnosis of Orthotopic Esophageal Squamous Cell Carcinoma in a Mouse ModeLocation: Hall B2Presenter: – Hangzhou Cancer Hospital
Hao Yin, MD, PhD – Hangzhou Cancer Hospital ### 1972483###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hangzhou Cancer Hospital###Presenter: – Hangzhou Cancer Hospital
### 5:00 PM – 6:00 PM PT
2596 - Effects of the PARP Inhibitor Niraparib on the Radiosensitivity of Human Lung and Cervical Cancer CellsLocation: Hall B2
Jingping Yu ### 1972433###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2597 - Dynamic Exosome Analysis to Predict Response to the Combination of SABR and Immunotherapy in Oligoprogressive DiseaseLocation: Hall B2Presenter: – Hospital Universitario Virgen de la Victoria
Juan Zafra Martin, MD – Hospital Universitario Virgen de la Victoria ### 1972470###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Universitario Virgen de la Victoria###Presenter: – Hospital Universitario Virgen de la Victoria
### 5:00 PM – 6:00 PM PT
2598 - Development and Validation of CT-Based Dose-Volume-Radiomics Nomogram for Radiation Induced Hypothyroidism in Nasopharyngeal CarcinomaLocation: Hall B2
Jian Zang, PhD ### 1972439###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:00 PM – 6:00 PM PT
2599 - Determining the Minimal Clinically Important Difference of the FACT-E to Evaluate the Change in the Quality of Life of Patients with Esophageal Cancer Treated with Curative RadiotherapyLocation: Hall B2Presenter: – City of Hope Comprehensive Cancer Center
Todd DeWees, PhD – City of Hope Comprehensive Cancer Center ### 747624###Presenter###Disclosures: Employment: City Of Hope:Research Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###City of Hope Comprehensive Cancer Center###Presenter: – City of Hope Comprehensive Cancer Center
### 5:00 PM – 6:00 PM PT
2601 - CDC73 Promotes Breast Cancer through Impairing MAPK1 Ubiquitination and Activating mTOR Signaling PathwayLocation: Hall B2Presenter: – The First Affiliated Hospital of Henan University of Science and Technology
Haige Zhang, PhD – The First Affiliated Hospital of Henan University of Science and Technology ### 1972480###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The First Affiliated Hospital of Henan University of Science and Technology###Presenter: – The First Affiliated Hospital of Henan University of Science and Technology
### 5:00 PM – 6:00 PM PT
2602 - The Effect of Dose-Fractionation Mode on the Immune Response and Therapeutic Effect of Lewis Lung Cancer Mice Model Based on Tumor MicroenvironmentLocation: Hall B2Presenter: – Sichuan Cancer Hospital
Hangyue Zhang, MS – Sichuan Cancer Hospital ### 1972489###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital###Presenter: – Sichuan Cancer Hospital
### 5:00 PM – 6:00 PM PT
2603 - Up-Regulation of TCF21 Expression Reverses the Malignant Phenotype of Cancer-Associated Fibroblasts in Esophageal Squamous Cell CarcinomaLocation: Hall B2Presenter: – Hangzhou Cancer Hospital
Hongfang Zhang, PhD – Hangzhou Cancer Hospital ### 525432###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hangzhou Cancer Hospital###Presenter: – Hangzhou Cancer Hospital
### 5:00 PM – 6:00 PM PT
2604 - Hyperthermia Enhances the Radiosensitivity of Pancreatic Cancer Cells by Inhibiting Wnt2B SignalingLocation: Hall B2Presenter: – Hangzhou Cancer Hospital
Hongfang Zhang, PhD – Hangzhou Cancer Hospital ### 525432###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hangzhou Cancer Hospital###Presenter: – Hangzhou Cancer Hospital
### 5:00 PM – 6:00 PM PT
2605 - LINC00921 Diminishes Lung Cancer Radiosensitivity by Bestabilizing NUDT21 and Driving Aberrant MED23 Alternative PolyadenylationLocation: Hall B2
Nasha Zhang ### 747682###Presenter#########Presenter:
### 5:00 PM – 6:00 PM PT
2606 - Impacts of Combining Pulsed Low Dose Rate Radiotherapy (PLDR) and Anti-PD-1 Antibody on Tumor Growth and Its Mechanism for Lung Cancer in MiceLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Peng Zhang, MD – Sichuan Cancer Hospital and Institute ### 537747###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 5:00 PM – 6:00 PM PT
2607 - Hypofractionated Radiotherapy with Prolonged Inter-Fraction Interval (Hypo-Slow RT) to Facilitate Immune Priming of TumorLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Shichuan Zhang, MD, PhD – Sichuan Cancer Hospital and Institute ### 537900###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 5:00 PM – 6:00 PM PT
2608 - Targeting Immunosuppressive Myeloid Cells and Exhausted CD8+ T Cells Overcomes Radioresistance in NSCLCLocation: Hall B2Presenter: – Tianjin Medical University Cancer Institute and Hospital
Yuhan Zhang, PhD – Tianjin Medical University Cancer Institute and Hospital ### 1972504###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tianjin Medical University Cancer Institute and Hospital###Presenter: – Tianjin Medical University Cancer Institute and Hospital
### 5:00 PM – 6:00 PM PT
2609 - Exploring the Efficacy and Molecular Mechanism of Systemic Therapy-Based Split-Course Stereotactic Body Radiation Therapy for Solid TumorsLocation: Hall B2Presenter: – Fujian Medical University Union Hospital
Rong Zheng, MD, PhD – Fujian Medical University Union Hospital ### 747290###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fujian Medical University Union Hospital###Presenter: – Fujian Medical University Union Hospital
### 5:00 PM – 6:00 PM PT
2610 - Radiation Induced Lung Injury in Rats after Pre-Oxygenation RadiotherapyLocation: Hall B2Presenter: – Zhejiang University The First Affiliated Hospital College of Medicine
Ziyang Zhou, MD – Zhejiang University The First Affiliated Hospital College of Medicine ### 1972500###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Zhejiang University The First Affiliated Hospital College of Medicine###Presenter: – Zhejiang University The First Affiliated Hospital College of Medicine
### 5:00 PM – 6:00 PM PT
2611 - A Ferroptosis Microneedle Integrated Wireless Implanted Photodynamic Therapy Pellet for Cancer TreatmentLocation: Hall B2Presenter: – University of Electronic Science and Technology of China
Pingjin Zou, PhD – University of Electronic Science and Technology of China ### 1972471###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Electronic Science and Technology of China###Presenter: – University of Electronic Science and Technology of China
### - Tuesday, October 3, 2023
12:45 PM – 2:00 PM PT
2612 - Long-Term Outcomes and Toxicity in Esophageal Cancer Patients after Neoadjuvant or Definitive Concurrent Chemotherapy with Proton Beam TherapyLocation: Hall B2Presenter: – The University of Texas M.D. Anderson Cancer Center
Chike Abana, MD, PhD – The University of Texas M.D. Anderson Cancer Center ### 1971969###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of Texas M.D. Anderson Cancer Center###Presenter: – The University of Texas M.D. Anderson Cancer Center
### 12:45 PM – 2:00 PM PT
2613 - Treatment Outcomes and Toxicity Profile of MRI-Guided Gated-Real Time Online Adaptive Stereotactic Body Radiotherapy to Patients with Pancreatic TumorsLocation: Hall B2Presenter: – Loyola University Medical Center
Lamiaa Abdallah, MD, MS – Loyola University Medical Center ### 1972592###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Loyola University Medical Center###Presenter: – Loyola University Medical Center
### 12:45 PM – 2:00 PM PT
2614 - Borderline Resectable Pancreatic Cancer: Impact on Neoadjuvant Response Post Integration of MRI Guided Adaptive Radiation TherapyLocation: Hall B2Presenter: – Lake Erie College of Osteopathic Medicine
Matthew Adams, BS – Lake Erie College of Osteopathic Medicine ### 1972623###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Lake Erie College of Osteopathic Medicine###Presenter: – Lake Erie College of Osteopathic Medicine
### 12:45 PM – 2:00 PM PT
2616 - Clinical Outcomes and Immunotoxicity in People with HIV (PWH) after Definitive Chemoradiation (CRT) for Anal Squamous Cell CarcinomaLocation: Hall B2Presenter: – University of Washington
August Anderson, MD – University of Washington ### 2027548###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 12:45 PM – 2:00 PM PT
2617 - Hypofractionated Preoperative Radiotherapy 30Gy in Five Fractions for Soft Tissue Sarcoma of the ExtremityLocation: Hall B2Presenter: – McGill University Health Centre
Constanza Martinez, MD, PhD – McGill University Health Centre ### 1972566###Presenter######McGill University Health Centre###Presenter: – McGill University Health Centre
### 12:45 PM – 2:00 PM PT
2617 - Hypofractionated Preoperative Radiotherapy 30Gy in Five Fractions for Soft Tissue Sarcoma of the ExtremityLocation: Hall B2Presenter: – Sirio Libanes Hospital
Rie Asso, MD – Sirio Libanes Hospital ### 1972120###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sirio Libanes Hospital###Presenter: – Sirio Libanes Hospital
### 12:45 PM – 2:00 PM PT
2618 - HPV Infection and Immunohistochemical Analysis of P16, P53, and PD-L1 Expression as Prognostic Biomarkers in Squamous Cell Anal Cancer Patients Receiving Definitive Radiotherapy/ChemoradiotherapyLocation: Hall B2
Beril Balci Topuz ### 1972584###Presenter#########Presenter:
### 12:45 PM – 2:00 PM PT
2619 - Quality of Life Before and After Radiotherapy for Early-Stage Keratinocyte Carcinoma: A Longitudinal AnalysisLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Christopher Barker, MD – Memorial Sloan Kettering Cancer Center ### 516066###Presenter###Disclosures: Employment: Memorial Sloan Kettering Cancer Center:Associate Member:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: Memorial Sloan Kettering Cancer Center:Vice Chair for Clinical Research;National Comprehensive Cancer Network:Panel member###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 12:45 PM – 2:00 PM PT
2620 - Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment VolumesLocation: Hall B2Presenter: – Medical College of Wisconsin
Sara Beltran Ponce, MD – Medical College of Wisconsin ### 538557###Presenter###Disclosures: Employment: Medical College of Wisconsin Affiliated Hospitals:Resident Physician:Employee | Compensation: American College of Radiation Oncology: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 11/2023 | Ownership: none | Leadership: Society for Women in Radiation Oncology:Vice Chair###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 12:45 PM – 2:00 PM PT
2621 - Pancreatic Cancer Outcome: Local Treatment with Radiation Using MRI-LinacLocation: Hall B2Presenter: – Assuta Medical Center
Merav Ben-David, MD – Assuta Medical Center ### 1972518###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Assuta Medical Center###Presenter: – Assuta Medical Center
### 12:45 PM – 2:00 PM PT
2622 - The Predictive Value of Changes in Basal Myocardial F-18 Fluorodeoxyglucose Uptake for Cardiotoxicity in Locally Advanced Esophageal Cancer Patients Receiving Definitive RadiotherapyLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute
Guoxin Cai, MD – Shandong Cancer Hospital and Institute ### 747344###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 12:45 PM – 2:00 PM PT
2623 - Gastric Radiotherapy in the UK - Current Practice and Opinion on Future DirectionsLocation: Hall B2Presenter: – South West Wales Cancer Centre
Amy Case, MBBCh – South West Wales Cancer Centre ### 1972605###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###South West Wales Cancer Centre###Presenter: – South West Wales Cancer Centre
### 12:45 PM – 2:00 PM PT
2624 - Inaugural Experience with Real-time Gated Liver Proton SBRT and Treatment Plan Quality ImprovementLocation: Hall B2Presenter: – Johns Hopkins University
Hao Chen, PhD – Johns Hopkins University ### 1972528###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 12:45 PM – 2:00 PM PT
2625 - Primary Small Cell Carcinoma of the Esophagus in a Large Multicenter Cohort: Prognostic Factors and Treatment Strategies in the Modern EraLocation: Hall B2Presenter: – National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academ
Silin Chen, MD – National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academ ### 746642###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academ###Presenter: – National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academ
### 12:45 PM – 2:00 PM PT
2626 - Grade 4 Lymphopenia Might Associate with Pericardial Irradiation Dose and Worse Prognosis in Patients with Locally Advanced Esophageal Cancer Receiving Concurrent Chemo-RadiotherapyLocation: Hall B2Presenter: – West China Hospital of Sichuan University
Xianyan Chen, MD – West China Hospital of Sichuan University ### 1972586###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West China Hospital of Sichuan University###Presenter: – West China Hospital of Sichuan University
### 12:45 PM – 2:00 PM PT
2627 - The Effect of Three Different Positioning Approaches for Prone Rectum Radiotherapy on Positioning Accuracy and Treatment MarginsLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
xuemei chen – Sun Yat-Sen University Cancer Center ### 1972580###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 12:45 PM – 2:00 PM PT
2629 - The Role of Postoperative Radiotherapy in T4 Rectal Cancer with Synchronous Distant MetastasisLocation: Hall B2Presenter: – Seoul St. Mary's Hospital
Kyu Hye Choi, MD, PhD – Seoul St. Mary's Hospital ### 1972564###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul St. Mary's Hospital###Presenter: – Seoul St. Mary's Hospital
### 12:45 PM – 2:00 PM PT
2630 - MRI Guided Adaptive Radiotherapy (MRgART) in Primary and Metastatic Liver LesionsLocation: Hall B2Presenter: – Genesis Cancer Care
Tee Lim, MD, MBBS, FRANZCR – Genesis Cancer Care ### 1972361###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Genesis Cancer Care###Presenter: – Genesis Cancer Care
### 12:45 PM – 2:00 PM PT
2630 - MRI Guided Adaptive Radiotherapy (MRgART) in Primary and Metastatic Liver LesionsLocation: Hall B1Presenter: – Fiona Stanley Hospital (Genesis Care)
Caris Chong, MBBS – Fiona Stanley Hospital (Genesis Care) ### 1972599###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fiona Stanley Hospital (Genesis Care)###Presenter: – Fiona Stanley Hospital (Genesis Care)
### 12:45 PM – 2:00 PM PT
2632 - Ablative 5-Fraction CT vs. MR-Guided Pancreatic SBRT: Evaluation of Interfraction Anatomic Changes on Dosimetric ConstraintsLocation: Hall B2Presenter: – Miami Cancer Institute
Michael Chuong, MD – Miami Cancer Institute ### 525437###Presenter###Disclosures: Employment: Baptist Health South Florida:physician:Employee | Compensation: ViewRay: Consultant, Research Grants, Research Funding, Research Salary Support, Speaker's Bureau, Grant Research Funding, Honoraria, Travel Expenses, In-kind Donations, Compensation Payment-End Date: to present ;Novocure: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;StratPharma: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Sirtex: Speaker's Bureau, Honoraria-End Date: to present | Ownership: none | Leadership: Proton Collaborative Group:Board of Directors member###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 12:45 PM – 2:00 PM PT
2633 - Fungating Soft Tissue Sarcoma: A Complex Treatment DilemmaLocation: Hall B2Presenter: – Naval Medical Center San Diego
Bailey Corson, MD, MS – Naval Medical Center San Diego ### 1972524###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Naval Medical Center San Diego###Presenter: – Naval Medical Center San Diego
### 12:45 PM – 2:00 PM PT
2633 - Fungating Soft Tissue Sarcoma: A Complex Treatment DilemmaLocation: Hall B2
Jonathan Bear, MD – U.S. Navy ### 2143444###Presenter######U.S. Navy###Presenter: – U.S. Navy
### 12:45 PM – 2:00 PM PT
2634 - CT-Based Radiomics Combined with Genomics may Predict Survival in Esophageal Cancer Patients Receiving Definitive ChemoradiotherapyLocation: Hall B2
Jinfeng Cui, MD ### 1972525###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2635 - Development and Validation of a Radiomics-Based Model to Predict Overall Survival after Definitive Chemoradiotherapy in Patients With Esophageal CancerLocation: Hall B2
Jinfeng Cui, MD ### 1972525###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2636 - Patient-Reported Outcomes of Rectal Cancer Patients Treated on a 1.5T MR-Linac within the MOMENTUM StudyLocation: Hall B2
Lois Daamen, MD, PhD – UMC Utrecht ### 1972550###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UMC Utrecht###Presenter: – UMC Utrecht
### 12:45 PM – 2:00 PM PT
2637 - Efficacy and Safety of High-Dose Vitamin C Combined with Total Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer (HCCSC R02 Study)Location: Hall B2Presenter: – Zhongnan Hospital of Wuhan University
Jing Dai, MD, PhD – Zhongnan Hospital of Wuhan University ### 1972603###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Zhongnan Hospital of Wuhan University###Presenter: – Zhongnan Hospital of Wuhan University
### 12:45 PM – 2:00 PM PT
2638 - Salvage Abdominoperineal Resection for Locally Recurrent or Persistent Anal Squamous Cell Carcinoma after Definitive ChemoradiationLocation: Hall B2Presenter: – McGovern Medical School
Ethan Damron, BS – McGovern Medical School ### 1972252###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGovern Medical School###Presenter: – McGovern Medical School
### 12:45 PM – 2:00 PM PT
2639 - Scalp Volumetric Modulated Arc Therapy Using 3D Milled Bolus: Dosimetry, Toxicity and OutcomeLocation: Hall B2Presenter: – The James Cancer Hospital & Solove Research Institute
Khaled Dibs, MD – The James Cancer Hospital & Solove Research Institute ### 1972058###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The James Cancer Hospital & Solove Research Institute###Presenter: – The James Cancer Hospital & Solove Research Institute
### 12:45 PM – 2:00 PM PT
2640 - Multicenter Retrospective Study of Stereotactic Body Radiotherapy for Patients with Previously Untreated Initial Small Hepatocellular CarcinomaLocation: Hall B2Presenter: – Hiroshima Prefectual Hospital
Yoshiko Doi, MD, PhD – Hiroshima Prefectual Hospital ### 747119###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hiroshima Prefectual Hospital###Presenter: – Hiroshima Prefectual Hospital
### 12:45 PM – 2:00 PM PT
2641 - Prospective Evaluation of MRI-Based Endoluminal Brachytherapy with Novel Applicator for Anorectal CancerLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Alexandra Dreyfuss, MD – Memorial Sloan Kettering Cancer Center ### 1972363###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 12:45 PM – 2:00 PM PT
2642 - Racial Disparties in the Utilization of Stereotactic Body Radiation Therapy (SBRT) in Patients with Hepatocellular CarcinomaLocation: Hall B2Presenter: – Yale School of Medicine
Kevin Du, MD, PhD, MS – Yale School of Medicine ### 1972610###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yale School of Medicine###Presenter: – Yale School of Medicine
### 12:45 PM – 2:00 PM PT
2643 - PD-1 Inhibitors and Chemotherapy Combined with or without Radiotherapy for Patients with Oligometastatic Esophageal CancerLocation: Hall B2
Yanan Duan ### 1972579###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2644 - Post-Progression Survival in Patients with Oligometastatic or Polymetastatic Pancreatic AdenocarcinomaLocation: Hall B2Presenter: – UT Southwestern Medical Center
Ahmed Elamir, MD, MS – UT Southwestern Medical Center ### 1972556###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 12:45 PM – 2:00 PM PT
2645 - Dose Escalation Using Magnetic Resonance Guided High-Dose-Rate Endorectal Brachytherapy to Enhance Clinical Response after Neoadjuvant Radiotherapy in Rectal AdenocarcinomaLocation: Hall B2Presenter: – Tata Memorial Hospital
Reena Engineer, MD – Tata Memorial Hospital ### 602237###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tata Memorial Hospital###Presenter: – Tata Memorial Hospital
### 12:45 PM – 2:00 PM PT
2646 - Racial and Ethnic Disparities in Health-Related Quality of Life for Patients with Colorectal Cancer: Analysis of the SEER-MHOS Linked Data SetLocation: Hall B2Presenter: – UCLA Radiation Oncology
Matthew Farrell, MD, MFA – UCLA Radiation Oncology ### 1971524###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 12:45 PM – 2:00 PM PT
2647 - Intratumoral Dose Escalation Using Lattice Radiotherapy for Hepatocellular Carcinoma with Unfavorable Size and LocationLocation: Hall B2Presenter: – University of Cincinnati
Andrew Frankart, MD – University of Cincinnati ### 747309###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Cincinnati###Presenter: – University of Cincinnati
### 12:45 PM – 2:00 PM PT
2648 - Advanced Hepatocellular Carcinoma Patients with Poor Access to Systemic Therapy Treated with Definitive Stereotactic Body Radiation Therapy: A Single-Institution Experience in Latin AmericaLocation: Hall B2Presenter: – Clinica IRAM
Maximiliano Fuentealba, MD – Clinica IRAM ### 1972546###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Clinica IRAM###Presenter: – Clinica IRAM
### 12:45 PM – 2:00 PM PT
2649 - Sarcopenia Predicts Poor Tolerance to Chemotherapy during Definitive Treatment of Primary Anal Squamous Cell CarcinomaLocation: Hall B2Presenter: – University of Kansas Medical Center
Ramesh Gadam, MD, MBBS – University of Kansas Medical Center ### 1972555###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 12:45 PM – 2:00 PM PT
2650 - Anal Canal Adenocarcinomas: Prognostic Factors and Outcomes at a Single InstitutionLocation: Hall B2Presenter: – Kaiser Permanente Los Angeles Medical Center
Derek Go, MD, MS – Kaiser Permanente Los Angeles Medical Center ### 1972598###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaiser Permanente Los Angeles Medical Center###Presenter: – Kaiser Permanente Los Angeles Medical Center
### 12:45 PM – 2:00 PM PT
2651 - Efficacy of Single-Fraction Postoperative Radiotherapy in Resected, Early-Stage Merkel Cell Carcinoma with High-Risk FeaturesLocation: Hall B2Presenter: – University of Washington
Peter Goff, MD, PhD – University of Washington ### 747867###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 12:45 PM – 2:00 PM PT
2652 - Comparison of Estimated Late Toxicities between IMRT and IMPT when Treating Retroperitoneal Sarcoma Preoperatively with Ultra-HypofractionationLocation: Hall B2Presenter: – The Ohio State University Wexner Medical Center
Emile Gogineni, DO – The Ohio State University Wexner Medical Center ### 538415###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ohio State University Wexner Medical Center###Presenter: – The Ohio State University Wexner Medical Center
### 12:45 PM – 2:00 PM PT
2653 - Spine Stereotactic Radiosurgery for Primary and Metastatic OsteosarcomaLocation: Hall B2Presenter: – MD Anderson Cancer Center
Adam Grippin, MD, PhD – MD Anderson Cancer Center ### 1972545###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:45 PM – 2:00 PM PT
2654 - The Association of Chemoradiation Induced Lymphopenia with Racial Disparity and Its Prognostic Impact on Survival for Anal CancerLocation: Hall B2Presenter: – Northwell Health
Bin Gui, MD – Northwell Health ### 1972616###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health###Presenter: – Northwell Health
### 12:45 PM – 2:00 PM PT
2655 - Safety of Radiation Therapy for Treatment of Malignancy in Patients with Inflammatory Bowel DiseaseLocation: Hall B2Presenter: – Stanford University School of Medicine
Jennifer Hall, BS – Stanford University School of Medicine ### 1972529###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 12:45 PM – 2:00 PM PT
2656 - Correlation between Lymph Node Regression Grading and Tumor Regression Grading after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerLocation: Hall B2
Lei He ### 1972515###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2657 - Effect of Anemia on Tumor Response to Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerLocation: Hall B2
Lei He ### 1972515###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2658 - Neoadjuvant Chemoradiotherapy Combined with Nimotuzumab and Camrelizumab in Initially Inoperable Patients with Locally Advanced Esophageal Cancer: A Prospective, One-Arm, Phase II StudyLocation: Hall B2
Yuan He ### 1972526###Presenter#########Presenter:
### 12:45 PM – 2:00 PM PT
2659 - Dose Escalation in Oesophageal Cancer: Comparing Pre-Accrual and On-Trial Target Volume Delineation in the UK SCOPE2 TrialPresenter: – South West Wales Cancer Centre
Jonathan Helbrow – South West Wales Cancer Centre ### 1972606###Presenter######South West Wales Cancer Centre###Presenter: – South West Wales Cancer Centre
### 12:45 PM – 2:00 PM PT
2659 - Dose Escalation in Oesophageal Cancer: Comparing Pre-Accrual and On-Trial Target Volume Delineation in the UK SCOPE2 TrialLocation: Hall B2Presenter: – South West Wales Cancer Centre
Sarah Gwynne, MD, MB, ChB – South West Wales Cancer Centre ### 2017344###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###South West Wales Cancer Centre###Presenter: – South West Wales Cancer Centre
### 12:45 PM – 2:00 PM PT
2660 - The Role of Coronary Artery Calcium Score to Assess Risk of Cardiovascular Disease in Irradiated Esophageal Cancer PatientsLocation: Hall B2Presenter: – Icahn School of Medicine at Mount Sinai
Alexandra Hotca-Cho, MD – Icahn School of Medicine at Mount Sinai ### 575288###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Icahn School of Medicine at Mount Sinai###Presenter: – Icahn School of Medicine at Mount Sinai
### 12:45 PM – 2:00 PM PT
2661 - Adding Bevacizumab to Neoadjuvant Concurrent Chemoradiation Causes a Paradoxical Increase in Circulating Vascular Endothelial Growth Factor-A and an Inferior Outcome in Locally Advanced Esophageal SquLocation: Hall B2Presenter: – National Taiwan University Hospital
Feng-Ming Hsu, MD, PhD – National Taiwan University Hospital ### 583361###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Taiwan University Hospital###Presenter: – National Taiwan University Hospital
### 12:45 PM – 2:00 PM PT
2662 - Salvage Radiotherapy Improves Survival in Patients with Metastatic Liver Cancer after Immunotherapy OligoprogressionLocation: Hall B2Presenter: – Zhongshan Hospital Fudan University
Shu Jung Hsu, MD – Zhongshan Hospital Fudan University ### 1972514###Presenter######Zhongshan Hospital Fudan University###Presenter: – Zhongshan Hospital Fudan University
### 12:45 PM – 2:00 PM PT
2663 - Effect of Histopathological Regression of Tumor and Lymph Node on the Progression of Esophageal Squamous Cell Carcinoma after Neoadjuvant ChemoradiotherapyLocation: Hall B2Presenter: – Shandong First Medical University and Shandong Academy of Medical Sciences
Bing Hu, MD, MS – Shandong First Medical University and Shandong Academy of Medical Sciences ### 1972523###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong First Medical University and Shandong Academy of Medical Sciences###Presenter: – Shandong First Medical University and Shandong Academy of Medical Sciences
### 12:45 PM – 2:00 PM PT
2664 - Predicting Radiation Esophagitis using 18F-FAPI-04 PET/CT in Patients with LA-ESCC Treated with Concurrent ChemoradiotherapyLocation: Hall B2
Xinying Hu, MD ### 1972600###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2665 - Patterns of Failure for Poor Response to Neoadjuvant Chemotherapy in Gastric CancerLocation: Hall B2
Caressa Hui, MD, BS – Stanford ### 525476###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford###Presenter: – Stanford
### 12:45 PM – 2:00 PM PT
2666 - Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot StudyLocation: Hall B2
Youn Ji Hur, MD ### 1972575###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2667 - Towards Global Consensus for MR-Guided Treatment Planning for Pancreatic Tumors on a 1.5 T MR-LinacLocation: Hall B2Presenter: – University Medical Center Utrecht
Martijn Intven, MD, PhD – University Medical Center Utrecht ### 1972299###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Medical Center Utrecht###Presenter: – University Medical Center Utrecht
### 12:45 PM – 2:00 PM PT
2668 - How the Underlying Etiology of Cirrhosis Impacts Response to SBRTLocation: Hall B2Presenter: – Virginia Commonwealth University Health System
Evrosina Isaac, MD – Virginia Commonwealth University Health System ### 1972554###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Virginia Commonwealth University Health System###Presenter: – Virginia Commonwealth University Health System
### 12:45 PM – 2:00 PM PT
2669 - The Outcomes of Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity Modulated Radiotherapy for Borderline Resectable Pancreatic CancerLocation: Hall B2Presenter: – Kyoto University Graduate School of Medicine
Takahiro Iwai, MD – Kyoto University Graduate School of Medicine ### 1972581###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kyoto University Graduate School of Medicine###Presenter: – Kyoto University Graduate School of Medicine
### 12:45 PM – 2:00 PM PT
2670 - Molecular Subtypes and Outcomes in a Multi-Institutional Review of Rectal Cancer PatientsLocation: Hall B2Presenter: – University of Virginia
Einsley-Marie Janowski, MD, PhD – University of Virginia ### 556353###Presenter######University of Virginia###Presenter: – University of Virginia
### 12:45 PM – 2:00 PM PT
2671 - Evaluation of the Possibility of Dose Realignment Adaptation by Shifting the Isocenter in Proton Beam Therapy for Pancreatic CancerLocation: Hall B2Presenter: – Hokkaido University Faculty of Medicine
Norio Katoh, MD, PhD – Hokkaido University Faculty of Medicine ### 747311###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hokkaido University Faculty of Medicine###Presenter: – Hokkaido University Faculty of Medicine
### 12:45 PM – 2:00 PM PT
2672 - Experience with 177Lu-Dotatate in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors at a Single Urban Cancer CenterLocation: Hall B2Presenter: – Detroit Medical Center
Aria Kieft, MD – Detroit Medical Center ### 1972607###Presenter###Disclosures: Employment: Detroit Medical Center - Wayne State University:Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Detroit Medical Center###Presenter: – Detroit Medical Center
### 12:45 PM – 2:00 PM PT
2673 - Liver-Directed Combined Radiotherapy for Downstaging of the Milan Advanced Hepatocellular Carcinoma Converting to Liver TransplantationLocation: Hall B2Presenter: – Yonsei Cancer Center, Yonsei University College of Medicine
Yong Tae Kim, MD – Yonsei Cancer Center, Yonsei University College of Medicine ### 1972527###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yonsei Cancer Center, Yonsei University College of Medicine###Presenter: – Yonsei Cancer Center, Yonsei University College of Medicine
### 12:45 PM – 2:00 PM PT
2674 - Association between Liver Metastases and Treatment Response in Patients with Metastatic, Microsatellite Stable Colorectal Cancer Treated with Radiation Therapy and Dual Immune Checkpoint BlockadeLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Julie Koenig, MD – Harvard Radiation Oncology Program ### 537787###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 12:45 PM – 2:00 PM PT
2675 - A Risk Prediction Model for Severe Radiation Induced Lymphopenia in Patients with Pancreatic Cancer Treated with Concurrent ChemoradiotherapyLocation: Hall B2Presenter: – Hokkaido University Hospital
Fuki Koizumi, MD – Hokkaido University Hospital ### 1972571###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hokkaido University Hospital###Presenter: – Hokkaido University Hospital
### 12:45 PM – 2:00 PM PT
2676 - Radiotherapy for Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy Combined with ChemotherapyLocation: Hall B2
Yue Kong ### 1972519###Presenter#########Presenter:
### 12:45 PM – 2:00 PM PT
2678 - Predictive Value of Tumor Volume on Local Control in Hepatocellular Carcinoma Treated with Image Guided Hypofractionated Radiation TreatmentLocation: Hall B2Presenter: – Rutgers Cancer Institute of New Jersey
Ritesh Kumar, MD, MBBS – Rutgers Cancer Institute of New Jersey ### 747093###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rutgers Cancer Institute of New Jersey###Presenter: – Rutgers Cancer Institute of New Jersey
### 12:45 PM – 2:00 PM PT
2679 - Study of a Geometric Score to Identify the Increased Risk of Local Failure after SBRT for Locally Advanced Pancreatic Cancer (LAPC)Location: Hall B2Presenter: – Azienda Ospedaliera universitaria Integrata di Verona
Eliana La Rocca, MD – Azienda Ospedaliera universitaria Integrata di Verona ### 1972530###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Azienda Ospedaliera universitaria Integrata di Verona###Presenter: – Azienda Ospedaliera universitaria Integrata di Verona
### 12:45 PM – 2:00 PM PT
2680 - Patient Selection is Critical When Evaluating Candidates for 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy (SMART) for Locally Advanced Pancreatic CancerLocation: Hall B2Presenter: – Washington University in St. Louis
David Lakomy, MD – Washington University in St. Louis ### 1972531###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University in St. Louis###Presenter: – Washington University in St. Louis
### 12:45 PM – 2:00 PM PT
2681 - CT-Guided Online Adaptive Stereotactic Body Radiotherapy for Pancreas Ductal Adenocarcinoma: Dosimetric and Initial Clinical ExperienceLocation: Hall B2Presenter: – Columbia University Irving Medical Center
Albert Lee, MD – Columbia University Irving Medical Center ### 1972548###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Columbia University Irving Medical Center###Presenter: – Columbia University Irving Medical Center
### 12:45 PM – 2:00 PM PT
2682 - A Single-Institution Experience of Acute Neuropathic Lumbosacral Pain in Patients Treated with Short Course Hypofractionated Radiotherapy in Locally Advanced Rectal CancerLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Katie Lee, MD, PhD – Harvard Radiation Oncology Program ### 1972295###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 12:45 PM – 2:00 PM PT
2683 - Pre-Treatment Trends in Child-Pugh Score as an Indicator of Post-Treatment Survival in Patients Receiving Liver SBRT for HCCLocation: Hall B2Presenter: – Fox Chase Cancer Center
Peter Lee, MD, PhD – Fox Chase Cancer Center ### 535760###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
### 12:45 PM – 2:00 PM PT
2684 - Efficacy and Safety of Image-Guided Hypofractionated Radiotherapy for Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisLocation: Hall B2Presenter: – Seoul National University College of Medicine
Sang Min Lee – Seoul National University College of Medicine ### 1972536###Presenter######Seoul National University College of Medicine###Presenter: – Seoul National University College of Medicine
### 12:45 PM – 2:00 PM PT
2685 - Treatment Outcomes of Stereotactic Body Radiation Therapy for Pulmonary Metastasis from Sarcoma: A Multicenter, Retrospective StudyLocation: Hall B2Presenter: – Samsung Medical Center
Tae Hoon Lee, MD – Samsung Medical Center ### 747592###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Samsung Medical Center###Presenter: – Samsung Medical Center
### 12:45 PM – 2:00 PM PT
2686 - Outcomes and Failure Patterns after Chemoradiotherapy for Locally Advanced Rectal Cancer with Positive Lateral Pelvic Lymph Nodes: A Propensity Score-Matched AnalysisLocation: Hall B2Presenter: – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
Shuai Li, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences ### 1972522###Presenter######Cancer Institute and Hospital Chinese Acedemy of Medical Sciences###Presenter: – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
### 12:45 PM – 2:00 PM PT
2687 - Sintilimab Injection Combination with Concurrent Chemoradiotherapy (cCRT) in Patients with Localized Esophageal Squamous Cell Carcinoma: A Prospective, Multi-Center, Single-Arm Trial in ProgressLocation: Hall B2Presenter: – School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
Tao Li, MD, PhD – School of Medicine, University of Electronic Science and Technology of China, Chengdu, China ### 537656###Presenter######School of Medicine, University of Electronic Science and Technology of China, Chengdu, China###Presenter: – School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
### 12:45 PM – 2:00 PM PT
2688 - Exploration of Multiomic Profiles and Biomarkers as Predictors of Neoadjuvant Chemoradiotherapy Responsiveness in Esophageal Squamous Cell CarcinomaLocation: Hall B2Presenter: – Shanghai Jiao Tong University
Yue Li, MD – Shanghai Jiao Tong University ### 1972596###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shanghai Jiao Tong University###Presenter: – Shanghai Jiao Tong University
### 12:45 PM – 2:00 PM PT
2689 - Clinical-Radiomics Nomogram for Risk Prediction of Esophageal Fistula in Patients with Esophageal Squamous Cell Carcinoma Treated by IMRT or VMATLocation: Hall B2Presenter: – Xijing Hospital
Zhaohui Li, BS – Xijing Hospital ### 1972576###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Xijing Hospital###Presenter: – Xijing Hospital
### 12:45 PM – 2:00 PM PT
2690 - The Association of Time Interval between Surgery and Neoadjuvant Chemoradiation Therapy with pCR and Overall Survival for Locally Advanced Rectal AdenocarcinomaLocation: Hall B2
Chi Lin, MD, PhD, MS – UNMC ### 535758###Presenter###Disclosures: Employment: NMC Radiation/Oncology/UNMC:Professor and Vice chair of research:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: NMC Radiation/Oncology/UNMC:Vice Chair of Research, Department of Radiation Oncology###UNMC###Presenter: – UNMC
### 12:45 PM – 2:00 PM PT
2691 - Impact of Local Therapy on Outcomes in Patients with Recurrent Hepatocellular Carcinoma after Liver TransplantationLocation: Hall B2Presenter: – Johns Hopkins University
Timothy Lin, MD, MBA – Johns Hopkins University ### 535807###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 12:45 PM – 2:00 PM PT
2692 - Local Time-to-Event Endpoint Under-Reporting and Variability in Pancreatic Cancer Trials Involving RadiotherapyLocation: Hall B2Presenter: – Johns Hopkins University
Timothy Lin, MD, MBA – Johns Hopkins University ### 535807###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 12:45 PM – 2:00 PM PT
2693 - Visceral Artery Pseudoaneurysm Rates after Pancreatoduodenectomy in Patients Who Received Pre-Operative Radiation for Pancreatic CancerLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
I-Chia Liu, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 1972587###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 12:45 PM – 2:00 PM PT
2694 - Patterns of Care for Patients with Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy between 2016-2020: An NCDB AnalysisLocation: Hall B2Presenter: – City of Hope National Medical Center
Jason Liu, MD – City of Hope National Medical Center ### 1972569###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:45 PM – 2:00 PM PT
2695 - Role of Radiation Therapy in Liver-Only Oligometastatic Disease: A SEER AnalysisLocation: Hall B2Presenter: – Northwestern Memorial Hospital
Yirong Liu, MD, PhD – Northwestern Memorial Hospital ### 1972617###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwestern Memorial Hospital###Presenter: – Northwestern Memorial Hospital
### 12:45 PM – 2:00 PM PT
2696 - A Machine Learning Method to Predict Pathological Complete Response of Esophageal Cancer after Neoadjuvant Chemoradiotherapy with Clinicohematological Markers and MR Radiomics: A Multi-Center StudyLocation: Hall B2Presenter: – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
Yunsong Liu, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC ### 1972614###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC###Presenter: – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
### 12:45 PM – 2:00 PM PT
2697 - Association between Tumor Volume Change on MRI with Surgical Margin Status, Pathological Response, and Local Control Following Pre-Operative Radiation Therapy for Soft Tissue SarcomaLocation: Hall B2Presenter: – H. Lee Moffitt Cancer Center and Research Institute
Casey Liveringhouse, MD, BA – H. Lee Moffitt Cancer Center and Research Institute ### 525374###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###H. Lee Moffitt Cancer Center and Research Institute###Presenter: – H. Lee Moffitt Cancer Center and Research Institute
### 12:45 PM – 2:00 PM PT
2698 - Treatment Modalities to Manage Hepatocellular Carcinoma Patients with Portal Vein Thrombus: A Systematic Review and Meta-AnalysisLocation: Hall B2Presenter: – London Health Sciences Centre
Michael Lock, MD – London Health Sciences Centre ### 1972621###Presenter###Disclosures: Employment: London Health Sciences Centre:Oncologist:Independent Contractor | Compensation: Knight Therapeutics: Speaker's Bureau, Honoraria-End Date: January 2023 ;Abbvie: Education Meeting Faculty, Honoraria-End Date: December 2022 ;Tersera: Consultant, Education Meeting Faculty, Honoraria-End Date: November 2022 ;Eisai: Education Meeting Faculty, Honoraria-End Date: July 2022 | Ownership: Myovant:Stock | Leadership: none###London Health Sciences Centre###Presenter: – London Health Sciences Centre
### 12:45 PM – 2:00 PM PT
2699 - Radiotherapy for Liver Cancer: An International Multi-Centre Pooled Analysis of 925 CasesLocation: Hall B2Presenter: – London Health Sciences Centre
Michael Lock, MD – London Health Sciences Centre ### 1972621###Presenter###Disclosures: Employment: London Health Sciences Centre:Oncologist:Independent Contractor | Compensation: Knight Therapeutics: Speaker's Bureau, Honoraria-End Date: January 2023 ;Abbvie: Education Meeting Faculty, Honoraria-End Date: December 2022 ;Tersera: Consultant, Education Meeting Faculty, Honoraria-End Date: November 2022 ;Eisai: Education Meeting Faculty, Honoraria-End Date: July 2022 | Ownership: Myovant:Stock | Leadership: none###London Health Sciences Centre###Presenter: – London Health Sciences Centre
### 12:45 PM – 2:00 PM PT
2700 - Preoperative Radiotherapy of Soft Tissue Sarcoma with Simultaneous Integrated Boost: A Phase II StudyLocation: Hall B2Presenter: – Azienda Ospedaliera Universitaria Careggi
Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi ### 1972601###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Azienda Ospedaliera Universitaria Careggi###Presenter: – Azienda Ospedaliera Universitaria Careggi
### 12:45 PM – 2:00 PM PT
2701 - Evaluation of Metastatic Potential in Esophageal and Gastroesophageal Junction (GEJ) Cancer with Adherence to Elective Nodal Volume Guidelines: A Retrospective Analysis of Elective Nodal IrradiationLocation: Hall B2Presenter: – University of California, Irvine School of Medicine
Jared Lyons, MS – University of California, Irvine School of Medicine ### 1972612###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, Irvine School of Medicine###Presenter: – University of California, Irvine School of Medicine
### 12:45 PM – 2:00 PM PT
2702 - Characterization of DNA Damage Response-Associated Somatic Mutations in Borderline Resectable and Locally Advanced Pancreatic CancerLocation: Hall B2Presenter: – Johns Hopkins University School of Medicine
Vrinda Madan, BA – Johns Hopkins University School of Medicine ### 1972577###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University School of Medicine###Presenter: – Johns Hopkins University School of Medicine
### 12:45 PM – 2:00 PM PT
2703 - Timing of Surgery and Pathologic Complete Response (pCR) after Completing Total Neoadjuvant Therapy for Rectal Adenocarcinoma: A Retrospective Study of the National Cancer DatabaseLocation: Hall B2Presenter: – Texas Tech University Health Science Center
Megan Mai, MPH – Texas Tech University Health Science Center ### 1972583###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Texas Tech University Health Science Center###Presenter: – Texas Tech University Health Science Center
### 12:45 PM – 2:00 PM PT
2704 - Multi-Institutional Experience of Proton Therapy for Osteosarcoma in the Proton Collaborative Group (PCG) Prospective RegistryLocation: Hall B2Presenter: – Miami Cancer Institute: Baptist Health South Florida
Keitrina Mair, MS, BS – Miami Cancer Institute: Baptist Health South Florida ### 1972609###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Miami Cancer Institute: Baptist Health South Florida###Presenter: – Miami Cancer Institute: Baptist Health South Florida
### 12:45 PM – 2:00 PM PT
2705 - Proton Beam Therapy for HCC Exceeding up-to-Seven CriteriaLocation: Hall B2Presenter: – University of Tsukuba
Hirokazu Makishima, MD, PhD – University of Tsukuba ### 1972535###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Tsukuba###Presenter: – University of Tsukuba
### 12:45 PM – 2:00 PM PT
2706 - Post-Hypofractionated Radiotherapy Neutrophil-to-Lymphocyte Ratio in Soft Tissue Sarcomas is a Prognostic Biomarker of Recurrence and Distant MetastasesLocation: Hall B2Presenter: – McGill University Health Centre
Constanza Martinez, MD, PhD – McGill University Health Centre ### 1972566###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGill University Health Centre###Presenter: – McGill University Health Centre
### 12:45 PM – 2:00 PM PT
2708 - Image-Guided Superficial Radiation Therapy Has Superior 2-Year Recurrence Rates to Mohs Micrographic SurgeryLocation: Hall B2
Erin McClure, BS ### 1972568###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2709 - Outcomes and after Hyperfractionated, Accelerated Reirradiation for Recurrent Anal Squamous Cell CarcinomaLocation: Hall B2Presenter: – MD Anderson Cancer Center
Jordan McDonald, MD – MD Anderson Cancer Center ### 1972551###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:45 PM – 2:00 PM PT
2710 - Short Course Radiotherapy (SCRT) with Simultaneous Integrated Boost (SIB) in the Treatment of Rectal Cancer: Feasibility and Early toxicitiesLocation: Hall B2Presenter: – University of Alabama Birmingham Hospital
Michael Melton, MD – University of Alabama Birmingham Hospital ### 1972597###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alabama Birmingham Hospital###Presenter: – University of Alabama Birmingham Hospital
### 12:45 PM – 2:00 PM PT
2711 - Neoadjuvant Stereotactic MR-Guided Ablative Radiation Therapy (SMART) and Surgical Outcomes in Patients with Pancreatic CancerLocation: Hall B2Presenter: – University of Wisconsin Radiation Oncology
Hari Menon, MD, BS – University of Wisconsin Radiation Oncology ### 747683###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin Radiation Oncology###Presenter: – University of Wisconsin Radiation Oncology
### 12:45 PM – 2:00 PM PT
2712 - Adjuvant Radiation Therapy Improves Local Control in the Treatment of Adnexal CarcinomaLocation: Hall B2Presenter: – MD Anderson Cancer Center
Devarati Mitra, MD, PhD – MD Anderson Cancer Center ### 537482###Presenter###Disclosures: Employment: University of Texas MD Anderson Cancer Center:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:45 PM – 2:00 PM PT
2713 - Predictive Value of Day of Treatment SPECT/CT Radiomics in Lobar Y90 Radioembolization of Hepatocellular Carcinoma: A Pilot StudyLocation: Hall B2Presenter: – Sylvester Comprehensive Cancer Center
Chris Montoya, MD – Sylvester Comprehensive Cancer Center ### 537477###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sylvester Comprehensive Cancer Center###Presenter: – Sylvester Comprehensive Cancer Center
### 12:45 PM – 2:00 PM PT
2714 - Long-Term Clinical Outcome of Carbon Ion Radio Therapy for Hepatocellular Carcinoma in the Caudate LobeLocation: Hall B2Presenter: – QST Hospital, National Institutes for Quantum and Radiological Science and Technology
Yasumasa Mori, MD, DVM, PhD – QST Hospital, National Institutes for Quantum and Radiological Science and Technology ### 1972574###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###QST Hospital, National Institutes for Quantum and Radiological Science and Technology###Presenter: – QST Hospital, National Institutes for Quantum and Radiological Science and Technology
### 12:45 PM – 2:00 PM PT
2715 - Laryngo-Esophageal Dysfunction Free Survival of Chemoradiation for Cervical Esophageal CancerLocation: Hall B2Presenter: – Hiroshima University
Yuji Murakami, MD, PhD – Hiroshima University ### 747044###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hiroshima University###Presenter: – Hiroshima University
### 12:45 PM – 2:00 PM PT
2716 - Long-Term Outcomes in a Phase II Study of Hypofractionated IGRT 60Gy/ 20F in Patients with Isolated Lymph Node Recurrence after Surgery for Esophageal CarcinomaLocation: Hall B2Presenter: – Keiyukai Sapporo
Miyako Myojin, MD, PhD – Keiyukai Sapporo ### 538589###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Keiyukai Sapporo###Presenter: – Keiyukai Sapporo
### 12:45 PM – 2:00 PM PT
2717 - Outcomes of Moderately Dose Escalated Hypofractionated Chemoradiation for Pancreatic CancerLocation: Hall B2Presenter: – UT Health Science Center at Houston
Ansel Nalin, MD, PhD – UT Health Science Center at Houston ### 1972595###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Health Science Center at Houston###Presenter: – UT Health Science Center at Houston
### 12:45 PM – 2:00 PM PT
2718 - Outcome of Proton Beam Therapy for Primary Hepatocellular Carcinoma with "Unfavorable" Macroscopic ClassificationLocation: Hall B2Presenter: – University of Tsukuba
Hikaru Niitsu, MD – University of Tsukuba ### 1972521###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Tsukuba###Presenter: – University of Tsukuba
### 12:45 PM – 2:00 PM PT
2719 - Impact of the G8 Score on Treatment Strategies and Outcome in Definitive Radiotherapy for the Elderly Esophageal Cancer PatientsLocation: Hall B2Presenter: – Hiroshima University
Ikuno Nishibuchi, MD, PhD – Hiroshima University ### 537537###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hiroshima University###Presenter: – Hiroshima University
### 12:45 PM – 2:00 PM PT
2720 - A Phase 1 Trial of the Safety, Tolerability, and Biological Effects of Intravenous Enadenotucirev (EnAd), a Novel Oncolytic Virus, in Combination with Chemoradiotherapy in Locally Advanced Rectal CancLocation: Hall B2Presenter: – University of Glasgow
Sean O'Cathail, MD, PhD – University of Glasgow ### 1972611###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Glasgow###Presenter: – University of Glasgow
### 12:45 PM – 2:00 PM PT
2721 - Machine Learning Based Prediction of Distant Metastasis in Rectal Cancer Patients with Complete Response following Neoadjuvant ChemoradiotherapyLocation: Hall B2Presenter: – Marmara University
Gulsah Ozden, MD – Marmara University ### 1972620###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Marmara University###Presenter: – Marmara University
### 12:45 PM – 2:00 PM PT
2722 - Role of Stereotactic Body Radiation Therapy in Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma: A Prospective Single Institute ExperienceLocation: Hall B2Presenter: – All India Institute of Medical Sciences
Suyash Pandey, MD – All India Institute of Medical Sciences ### 1972533###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###All India Institute of Medical Sciences###Presenter: – All India Institute of Medical Sciences
### 12:45 PM – 2:00 PM PT
2723 - Biological Response Assessment in Hepatocellular Carcinoma Post Stereotactic Body RadiotherapyLocation: Hall B2Presenter: – All India Institute of Medical Sciences
Haresh Kunhiparambath, MD – All India Institute of Medical Sciences ### 2087165###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###All India Institute of Medical Sciences###Presenter: – All India Institute of Medical Sciences
### 12:45 PM – 2:00 PM PT
2724 - Dosimetric Analysis of Major Wound Complications Following Preoperative Ultra-Hypofractionated Radiation Therapy for Soft Tissue SarcomaLocation: Hall B2Presenter: – Cleveland Clinic Health System
Sean Parker, MD – Cleveland Clinic Health System ### 538450###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Health System###Presenter: – Cleveland Clinic Health System
### 12:45 PM – 2:00 PM PT
2725 - Liver Stereotactic Body Radiation Therapy (SBRT) to Downstage Patients with Hepatocellular Carcinoma prior to Liver TransplantLocation: Hall B2Presenter: – Cleveland Clinic Health System
Sean Parker, MD – Cleveland Clinic Health System ### 538450###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Health System###Presenter: – Cleveland Clinic Health System
### 12:45 PM – 2:00 PM PT
2726 - Assessment of the Spatial Bio-Distribution of NBTXR3 for Locally Advanced or Borderline-Resectable Pancreatic Ductal Adenocarcinoma (LAPC or BRPC) Patients Undergoing Radiation TherapyLocation: Hall B2Presenter: – MD Anderson Cancer Center
Luis Perles, PhD – MD Anderson Cancer Center ### 1972544###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:45 PM – 2:00 PM PT
2727 - Surgical Outcomes in Patients Treated with 5-Day Preoperative Radiotherapy for Soft Tissue SarcomaLocation: Hall B2Presenter: – UCI Radiation Oncology
Nicholas Peterson, MD – UCI Radiation Oncology ### 1972538###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCI Radiation Oncology###Presenter: – UCI Radiation Oncology
### 12:45 PM – 2:00 PM PT
2728 - Early Outcomes of MR-Guided SBRT for Patients with Recurrent Pancreatic AdenocarcinomaLocation: Hall B2Presenter: – Thomas Jefferson University
Spencer Poiset, MD, BS – Thomas Jefferson University ### 1972557###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 12:45 PM – 2:00 PM PT
2729 - Single Institutional Experience Using Radiation Therapy in the Treatment of Neuroendocrine Tumor Primary and Metastatic LesionsLocation: Hall B2Presenter: – Mayo Clinic College of Medicine and Science Rochester
Kaitlin Qualls, MD – Mayo Clinic College of Medicine and Science Rochester ### 747183###Presenter######Mayo Clinic College of Medicine and Science Rochester###Presenter: – Mayo Clinic College of Medicine and Science Rochester
### 12:45 PM – 2:00 PM PT
2730 - Clinical Characteristics, Patterns of Care, and Treatment Outcomes of Radiation-Associated SarcomasLocation: Hall B2Presenter: – The Ohio State University Wexner Medical Center
Rohit Raj, MD – The Ohio State University Wexner Medical Center ### 1972559###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ohio State University Wexner Medical Center###Presenter: – The Ohio State University Wexner Medical Center
### 12:45 PM – 2:00 PM PT
2731 - Favorable Survival after Definitive Ablative RT in Surgically Resectable Pancreatic Cancer PatientsLocation: Hall B2
Marsha Reyngold, MD, PhD – MSKCC ### 746772###Presenter######MSKCC###Presenter: – MSKCC
### 12:45 PM – 2:00 PM PT
2732 - Alliance A022101: A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer -Â Evaluating Radiation, Ablation and Surgery (ERASur)Location: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Paul Romesser, MD – Memorial Sloan Kettering Cancer Center ### 525224###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 12:45 PM – 2:00 PM PT
2733 - Non-Operative Management of Rectal or Anal Canal Adenocarcinoma: National Cancer Database Analysis of the Impact of Disease, Treatment, and Social Determinants of Health on Overall SurvivalLocation: Hall B2Presenter: – University of Tennessee Medical Center
Keaton Rummel, MD – University of Tennessee Medical Center ### 2070867###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Tennessee Medical Center###Presenter: – University of Tennessee Medical Center
### 12:45 PM – 2:00 PM PT
2734 - Patterns of Recurrence for Lymph Node Positive Cutaneous Melanoma in the Era of ImmunotherapyLocation: Hall B2Presenter: – Beaumont Health
Kamran Salari, MD, BS – Beaumont Health ### 1972165###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health###Presenter: – Beaumont Health
### 12:45 PM – 2:00 PM PT
2735 - Five-Fraction Proton Therapy for Chordomas and Condrosarcomas of the Skull Base: Preliminary Results of a Prospective SeriesLocation: Hall B2
Morena Sallabanda, MD, PhD – Quironsalud ### 2004073###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Quironsalud###Presenter: – Quironsalud
### 12:45 PM – 2:00 PM PT
2736 - Longer Interval between Neoadjuvant Chemotherapy and Radiation Therapy Associated with Higher Metastasis Risk for Inoperable Non-Metastatic Pancreatic AdenocarcinomaLocation: Hall B2Presenter: – UC Irvine School of Medicine
Steven Seyedin, MD – UC Irvine School of Medicine ### 538254###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UC Irvine School of Medicine###Presenter: – UC Irvine School of Medicine
### 12:45 PM – 2:00 PM PT
2737 - Patient-Reported Adverse Effects in 15-Fraction Pancreatic Cancer Radiation TherapyLocation: Hall B2Presenter: – Mayo Clinic Rochester
Yasamin Sharifzadeh, MD – Mayo Clinic Rochester ### 828621###Presenter###Disclosures: Employment: Mayo Clinic:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: American College of Radiation Oncology (ACRO):ACRO Resident Communications Subcommittee Chair###Mayo Clinic Rochester###Presenter: – Mayo Clinic Rochester
### 12:45 PM – 2:00 PM PT
2739 - The Prevalence and Management of Synchronous Prostate and Rectal CancerLocation: Hall B2Presenter: – Northwell Health Cancer Institute
Baho Sidiqi, MD, MPH – Northwell Health Cancer Institute ### 538087###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health Cancer Institute###Presenter: – Northwell Health Cancer Institute
### 12:45 PM – 2:00 PM PT
2740 - Association of Radiation and Neutrophil to Lymphocyte Ratio with Survival in Hepatocellular Carcinoma Patients with Portal Vein ThrombusLocation: Hall B2Presenter: – Montefiore Medical Center/Albert Einstein College of Medicine
Karin Skalina, MD, PhD – Montefiore Medical Center/Albert Einstein College of Medicine ### 525398###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Montefiore Medical Center/Albert Einstein College of Medicine###Presenter: – Montefiore Medical Center/Albert Einstein College of Medicine
### 12:45 PM – 2:00 PM PT
2741 - Definitive Radiotherapy in Patients with Clinical T1N0M0 Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective StudyLocation: Hall B2Presenter: – Seoul National University Hospital
Jun Yeong Song, BS – Seoul National University Hospital ### 1972541###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University Hospital###Presenter: – Seoul National University Hospital
### 12:45 PM – 2:00 PM PT
2742 - Outcomes of Watch and Wait Following Total Neoadjuvant Therapy for Rectal CancerLocation: Hall B2Presenter: – University of Minnesota
Susan Sun, MD – University of Minnesota ### 1972619###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Minnesota###Presenter: – University of Minnesota
### 12:45 PM – 2:00 PM PT
2743 - "Moderately Hypofractionated" Radiotherapy with a Simultaneously Integrated Boost for Synchronous Treatment of Prostate and Anorectal CancerLocation: Hall B2
Elsa Sutton, MD – Mayo Clinic ### 1972608###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 12:45 PM – 2:00 PM PT
2744 - Enhancement Patterns of Metastatic Intrahepatic Cholangiocarcinoma and Outcomes after Chemotherapy and RadiationLocation: Hall B2Presenter: – MD Anderson Cancer Center
Fikir Tadesse, BS – MD Anderson Cancer Center ### 1972593###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:45 PM – 2:00 PM PT
2745 - Real-World Experience of Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Anal Cancer with Long-Term Follow up and Clinical OutcomesLocation: Hall B2Presenter: – Sunnybrook Odette Cancer Centre
Amandeep Taggar, MD, MS, BS – Sunnybrook Odette Cancer Centre ### 1972540###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sunnybrook Odette Cancer Centre###Presenter: – Sunnybrook Odette Cancer Centre
### 12:45 PM – 2:00 PM PT
2746 - Synergistic Effect of TVEC and Radiotherapy in the Treatment of Advanced MelanomaLocation: Hall B2Presenter: – City of Hope National Medical Center
Andrew Tam, MD – City of Hope National Medical Center ### 1972573###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:45 PM – 2:00 PM PT
2747 - Dosimetric Evaluation of Cardiac Substructures in Irradiation of EsophagusLocation: Hall B2Presenter: – City of Hope National Medical Center
Andrew Tam, MD – City of Hope National Medical Center ### 1972573###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:45 PM – 2:00 PM PT
2748 - Evaluation of Liver Functionality after Liver Stereotactic Body Radiation Therapy (SBRT) Using Blood Tests and Imaging ExaminationsLocation: Hall B2Presenter: – Asahi Univeristy Hospital
Osamu Tanaka, MD, PhD – Asahi Univeristy Hospital ### 1972565###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Asahi Univeristy Hospital###Presenter: – Asahi Univeristy Hospital
### 12:45 PM – 2:00 PM PT
2749 - Pancreas Cancer Learning Health Network Established to Share Best Practice Across 14 Centers and Improve Patient OutcomesLocation: Hall B2Presenter: – Northern Westchester Hospital
Leila Tchelebi, MD – Northern Westchester Hospital ### 747304###Presenter###Disclosures: Employment: Northwell Health:Attending Physician:Employee | Compensation: American College of Radiation Oncology: Other, Compensation Payment-End Date: present | Ownership: none | Leadership: none###Northern Westchester Hospital###Presenter: – Northern Westchester Hospital
### 12:45 PM – 2:00 PM PT
2750 - Carbon-Ion Radiotherapy for Postoperative Locoregional Recurrence of Pancreatic CancerLocation: Hall B2Presenter: – Ion Beam Therapy Center, SAGA-HIMAT Foundation
Kotaro Terashima, MD, PhD – Ion Beam Therapy Center, SAGA-HIMAT Foundation ### 525408###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ion Beam Therapy Center, SAGA-HIMAT Foundation###Presenter: – Ion Beam Therapy Center, SAGA-HIMAT Foundation
### 12:45 PM – 2:00 PM PT
2751 - Conventionally Fractionated vs. Hypofractionated Radiotherapy for Treatment of Unresectable Pancreatic Cancer: Local Control and Survival Outcomes in a Retrospective Single-Institutional AnalysisLocation: Hall B2Presenter: – The Ottawa Hospital and University of Ottawa
Daniel Tesolin, MS, BS – The Ottawa Hospital and University of Ottawa ### 1972563###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ottawa Hospital and University of Ottawa###Presenter: – The Ottawa Hospital and University of Ottawa
### 12:45 PM – 2:00 PM PT
2752 - Long-Term Outcome of Rectal Cancer Patients Treated by High-Dose Radiotherapy and Concurrent ChemotherapyLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Xue Tian, MD, MS – Sun Yat-Sen University Cancer Center ### 1972578###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 12:45 PM – 2:00 PM PT
2753 - A Comparison of Clinicopathologic Outcomes and Patterns of Lymphatic Spread across Neoadjuvant Chemotherapy, Neoadjuvant Chemoradiotherapy and Neoadjuvant Immunochemotherapy in Locally Advanced EsophaLocation: Hall B2
Yuanyuan Tian, MD ### 1972585###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2754 - Longitudinal Analysis of Circulating Tumor DNA and Detection of Tumor Genomic Alterations Using Liquid Biopsy in Patients with Locally Advanced Esophagogastric CarcinomaLocation: Hall B2Presenter: – University of Washington
Hao To, MD – University of Washington ### 1972547###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 12:45 PM – 2:00 PM PT
2755 - Compensatory Enlargement of the Liver after Proton Beam Therapy for Hepatocellular CarcinomaLocation: Hall B2Presenter: – National Cancer Center Hospital East
Kento Tomizawa, MD, PhD – National Cancer Center Hospital East ### 1972613###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center Hospital East###Presenter: – National Cancer Center Hospital East
### 12:45 PM – 2:00 PM PT
2756 - Comparing 90-Day Post-Operative Mortality after Neoadjuvant Proton-Based vs. Photon-Based Chemoradiotherapy for Esophageal CancerLocation: Hall B2Presenter: – Amsterdam UMC
Peter van Rossum, MD, PhD – Amsterdam UMC ### 746610###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Amsterdam UMC###Presenter: – Amsterdam UMC
### 12:45 PM – 2:00 PM PT
2757 - A Novel CT-Based Radiomic Analysis for the Prediction of Overall Survival in Rectal Cancer Patients Treated with Short Course RT Total Neoadjuvant TherapyLocation: Hall B2Presenter: – Hospital Carlos Van Buren
Gabriel Lazcano Alvarez, MD – Hospital Carlos Van Buren ### 2130796###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Carlos Van Buren###Presenter: – Hospital Carlos Van Buren
### 12:45 PM – 2:00 PM PT
2757 - A Novel CT-Based Radiomic Analysis for the Prediction of Overall Survival in Rectal Cancer Patients Treated with Short Course RT Total Neoadjuvant TherapyLocation: Hall B2
Gabriel Veillon Contreras, MD – HCVB ### 1972549###Presenter######HCVB###Presenter: – HCVB
### 12:45 PM – 2:00 PM PT
2758 - Preoperative Carbon Ion Radiotherapy (CIRT) with Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma (PCa): A Multicenter Prospective Phase II Clinical Study (Pioppo study NLocation: Hall B2
Viviana Vitolo ### 1972542###Presenter#########Presenter:
### 12:45 PM – 2:00 PM PT
2759 - Clinical Outcomes of Carbon-Ion Radiotherapy for Large-Sized (=4cm) Hepatocellular CarcinomaLocation: Hall B2Presenter: – University of Tsukuba
Hirokazu Makishima, MD, PhD – University of Tsukuba ### 1972535###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Tsukuba###Presenter: – University of Tsukuba
### 12:45 PM – 2:00 PM PT
2759 - Clinical Outcomes of Carbon-Ion Radiotherapy for Large-Sized (=4cm) Hepatocellular CarcinomaLocation: Hall B2Presenter: – QST Hospital
Masaru Wakatsuki, MD, PhD – QST Hospital ### 747507###Presenter######QST Hospital###Presenter: – QST Hospital
### 12:45 PM – 2:00 PM PT
2760 - Pathway Mutations are Associated with Clinical Outcomes in Localized Pancreatic Cancer Treated with Neoadjuvant Chemoradiation Followed By SurgeryLocation: Hall B2
Jarey Wang, MD, PhD ### 1972553###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2761 - Elective Nodal Irradiation vs. Involved-Field Irradiation for Stage ?-? Cervical Esophageal Squamous Cell Carcinoma Patients Undergoing Definitive Concurrent Chemoradiotherapy: A Retrospective PropensLocation: Hall B2Presenter: – Fourth Hospital of Hebei Medical University
Jun Wang, MD, PhD – Fourth Hospital of Hebei Medical University ### 537549###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fourth Hospital of Hebei Medical University###Presenter: – Fourth Hospital of Hebei Medical University
### 12:45 PM – 2:00 PM PT
2762 - Endoscopic Ultrasonography-Derived Maximum Tumor Thickness and Tumor Shrinkage Rate as Independent Prognostic Factors in Locally Advanced Esophageal Squamous Cell Carcinoma after Neoadjuvant ChemoradiLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute ### 2094333###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 12:45 PM – 2:00 PM PT
2763 - An Immune-Related Gene Prognostic Prediction Risk Model for Neoadjuvant Chemoradiotherapy in Rectal Cancer Using Artificial IntelligenceLocation: Hall B2Presenter: – West China Hospital of Sichuan University
Xin Wang, MD – West China Hospital of Sichuan University ### 747325###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West China Hospital of Sichuan University###Presenter: – West China Hospital of Sichuan University
### 12:45 PM – 2:00 PM PT
2764 - Comparison of Pathologic Response and Survival Outcomes between Neoadjuvant Immunochemotherapy (nICT) and Neoadjuvant Chemoradiotherapy (nCRT) in Patients with Locally Advanced Esophageal Squamous CelLocation: Hall B2
Yi Wang, MD ### 1972591###Presenter#########Presenter:
### 12:45 PM – 2:00 PM PT
2765 - The Role of CT-Based Radiomics Nomogram in Differential Diagnosis of Immune Checkpoint Inhibitor-Related Pneumonitis from Radiation Pneumonitis for Patients with ESCCLocation: Hall B2
Qiang Wen ### 1972552###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2766 - Long-Term Results of Induction Chemotherapy for Esophageal Squamous Cell Carcinoma Receiving Concurrent ChemoradiotherapyLocation: Hall B2
Geng Xiang ### 1972561###Presenter#########Presenter:
### 12:45 PM – 2:00 PM PT
2767 - Re-Irradiation for Locally Primary Recurrence in Esophageal Squamous Cell Carcinoma Treated with IMRT/VMATLocation: Hall B2
Geng Xiang ### 1972561###Presenter#########Presenter:
### 12:45 PM – 2:00 PM PT
2768 - The Japanese Nationwide Cohort Data of Particle Beam Therapy for Liver Oligometastasis in Esophagogastric Cancer PatientsLocation: Hall B2Presenter: – Fukushima Medical University
Hisashi Yamaguchi, MD – Fukushima Medical University ### 1972615###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fukushima Medical University###Presenter: – Fukushima Medical University
### 12:45 PM – 2:00 PM PT
2769 - The Japanese Nationwide Cohort Data of Proton Beam Therapy for Liver Oligometastasis in Breast Cancer PatientsLocation: Hall B2Presenter: – Fukushima Medical University
Hisashi Yamaguchi, MD – Fukushima Medical University ### 1972615###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fukushima Medical University###Presenter: – Fukushima Medical University
### 12:45 PM – 2:00 PM PT
2770 - Influence of Contrast Materials on Dose Accuracy ofMR-Linac in Patients with SBRT Liver CancerLocation: Hall B2
Feng Yang, PhD, MS ### 1972560###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2771 - Prevalence and Predictors of Sexual Dysfunction (SD) after Treatment of Localized Rectal and Anal Cancer (LRAC)Location: Hall B2Presenter: – Fox Chase Cancer Center
Hilario Yankey, MD, MBA – Fox Chase Cancer Center ### 1972622###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
### 12:45 PM – 2:00 PM PT
2772 - Evaluating the Utility of Traditional Bowel Dose Constraints when Treating Abdominal and Pelvic Sarcomas with Preoperative Radiation TherapyLocation: Hall B2Presenter: – MD Anderson Cancer Center
Alison Yoder, MD, MPH – MD Anderson Cancer Center ### 535882###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:45 PM – 2:00 PM PT
2773 - Efficacy of Nimotuzumab plus Concurrent Chemo-Radiotherapy for Unresectable Esophageal Cancer: A Real-World StudyLocation: Hall B2
Jingping Yu ### 1972433###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2774 - Chemoradiotherapy Combined with Nab-Paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase ?/? StudyLocation: Hall B2
Nuo Yu, BS ### 1972516###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2775 - Camrelizumab with Chemoradiotherapy is Tolerable and Effective for Locally Advanced Biliary Tract Cancer: Peliminary Results from A Phase II StudyLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute
Jinbo Yue, MD, PhD – Shandong Cancer Hospital and Institute ### 1972543###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 12:45 PM – 2:00 PM PT
2776 - Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Advanced Biliary Tract Cancer: Compared with MRI/CTLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute
Jinbo Yue, MD, PhD – Shandong Cancer Hospital and Institute ### 1972543###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 12:45 PM – 2:00 PM PT
2777 - Dosimetric Predictors of Acute Diarrhea in Locally Advanced Rectal Cancer Patients Treated with Neoadjuvant Chemoradiation with Capecitabine and Irinotecan: A Discovery and Validation StudyLocation: Hall B2Presenter: – Fudan University Shanghai Cancer Center
Jing Zhang, MD – Fudan University Shanghai Cancer Center ### 537448###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 12:45 PM – 2:00 PM PT
2778 - Treatment Response Prediction Using a Combination of Hematological Biomarkers and CT Deep Learning Radiomics in Locally Advanced Esophageal Squamous Cell CarcinomaLocation: Hall B2
Zhenjiang Li, PhD ### 747368###Presenter#########Presenter:
### 12:45 PM – 2:00 PM PT
2778 - Treatment Response Prediction Using a Combination of Hematological Biomarkers and CT Deep Learning Radiomics in Locally Advanced Esophageal Squamous Cell CarcinomaLocation: Hall B1Presenter: – Shandong University
Meng Zhang – Shandong University ### 1972582###Presenter######Shandong University###Presenter: – Shandong University
### 12:45 PM – 2:00 PM PT
2779 - The Applicability of the AJCC TNM Staging 8th Edition to Esophageal Small-Cell Carcinoma: A Multicenter Retrospective Trial from ChinaLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute
Qi Zhang, MD, MS – Shandong Cancer Hospital and Institute ### 1972520###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 12:45 PM – 2:00 PM PT
2780 - Cost-Effectiveness of Short-Course Radiotherapy Based Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer in ChinaLocation: Hall B2Presenter: – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
Wenjue Zhang, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences ### 1972534###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Institute and Hospital Chinese Acedemy of Medical Sciences###Presenter: – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
### 12:45 PM – 2:00 PM PT
2781 - Perturbation of Gut Microbiota Modulated the Abscopal Effects of Immunoradiotherapy in Rectal CancerLocation: Hall B2Presenter: – Shandong Cancer Hospital and Institute
Xiang Zhang, MD, PhD – Shandong Cancer Hospital and Institute ### 1972562###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 12:45 PM – 2:00 PM PT
2783 - Multiomics Analysis Revealed the Close Connection between Intratumoral Microbiota and Immune Cell Infiltration in Colorectal CancerLocation: Hall B2
Mengyu Zhao, MS ### 1972558###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2784 - Prediction of Response to Neoadjuvant Chemoradiotherapy Combined with Pembrolizumab in Esophageal Squamous Cell Carcinoma with CT/FDG PET Radiomic Signatures Based on Machine Learning ClassificationLocation: Hall B2Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shengguang Zhao, MD, PhD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine ### 1972604###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ruijin Hospital, Shanghai Jiaotong University School of Medicine###Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
### 12:45 PM – 2:00 PM PT
2785 - Sarcopenia as a Predictor of Neoadjuvant Therapy-Related Toxicity in Esophageal Squamous Cell Carcinoma PatientsLocation: Hall B2
Siyue Zheng, MD ### 1972532###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2786 - 4D-MRI guided stereotactic body radiation therapy for unresectable colorectal liver metastasesLocation: Hall B2Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
xuan zheng, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy ### 1972589###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy###Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
### 12:45 PM – 2:00 PM PT
2787 - Radical Chemoradiotherapy vs. Radical Surgery plus Adjuvant Chemotherapy or Chemoradiotherapy in Locally Advanced Primary Small Cell Carcinoma of the Esophagus: A Multicenter Retrospective Study in ChLocation: Hall B2
Jie Zhu, MD ### 1972588###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:45 PM – 2:00 PM PT
2788 - 18F-AlF-NOTA-FAPI-04 PET/CT can Predict Treatment Response and Survival in Patients with Inoperable Pancreatic AdenocarcinomaLocation: Hall B2Presenter: – Weifang Medical University
Ziyuan Zhu, MD – Weifang Medical University ### 1972517###Presenter######Weifang Medical University###Presenter: – Weifang Medical University
### 12:45 PM – 2:00 PM PT
2789 - Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular CarcinomaLocation: Hall B2Presenter: – Zhongshan Hospital, Fudan University
Yuan Zhuang, MD, PhD – Zhongshan Hospital, Fudan University ### 1972572###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Zhongshan Hospital, Fudan University###Presenter: – Zhongshan Hospital, Fudan University
### 12:45 PM – 2:00 PM PT
2790 - Comparison of Survival Outcomes between Adults and Pediatrics with Non-Metastatic Head and Neck Rhabdomyosarcoma: A SEER Database Analysis of 550 PatientsLocation: Hall B2
Teng Zou, MD ### 1972618###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
Trial in Progress: Adaptive RADiation therapy with concurrent Sacituzumab Govitecan (SG) for bladder preservation in patients with MIBC (RAD-SG)Presenter: – Cleveland Clinic Taussig Cancer Center
Omar Mian, MD, PhD – Cleveland Clinic Taussig Cancer Center ### 525239###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 2:30 PM – 3:45 PM PT
2791 - Long-Term Urinary Toxicity Follow-Up of Combined External Beam Radiation and Cs-131 LDR Brachytherapy Boost for Prostate CancerLocation: Hall B2Presenter: – UPMC Hillman Cancer Center
Mohamed Abdelhakiem, MD – UPMC Hillman Cancer Center ### 538141###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UPMC Hillman Cancer Center###Presenter: – UPMC Hillman Cancer Center
### 2:30 PM – 3:45 PM PT
2792 - A Checklist for Radiation Therapy Planning: Update 2023Location: Hall B2Presenter: – Shenandoah Medical Center
Mohamed Abdi, MD – Shenandoah Medical Center ### 1972712###Presenter###Disclosures: Employment: MercyOne North Iowa:Radiation Oncologist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Shenandoah Medical Center###Presenter: – Shenandoah Medical Center
### 2:30 PM – 3:45 PM PT
2793 - Stereotactic Body Radiation Therapy and High-Dose Rate Brachytherapy Boost in Combination with Intensity Modulated Radiation Therapy for Localized Prostate Cancer: A Single-Institution Cohort StudyLocation: Hall B2Presenter: – The Ohio State University College of Medicine
Jessica Aduwo, BS – The Ohio State University College of Medicine ### 1972637###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ohio State University College of Medicine###Presenter: – The Ohio State University College of Medicine
### 2:30 PM – 3:45 PM PT
2794 - Transient Radiographic Pseudoprogression Following Fractionated SBRT for Primary Renal Cell CarcinomaLocation: Hall B2Presenter: – Beth Israel Deaconess Medical Center
Nima Aghdam, MD, MS – Beth Israel Deaconess Medical Center ### 525425###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beth Israel Deaconess Medical Center###Presenter: – Beth Israel Deaconess Medical Center
### 2:30 PM – 3:45 PM PT
2795 - Virtual Reality Changes the Concept of Patients Education, Patient Experience Report StudyLocation: Hall B2
Abdulrahman Aldakheel, MBBS – KFSH&RC ### 1972678###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###KFSH&RC###Presenter: – KFSH&RC
### 2:30 PM – 3:45 PM PT
2796 - Change in Therapeutic Approach after PET/TC PSMA-18F DCFPyL in Occult Biochemical Recurrence of Prostate Carcinoma with Low PSA ValuesLocation: Hall B2Presenter: – Hospital Del Mar - Parc de Salut Mar
Francesco Amorelli, MD – Hospital Del Mar - Parc de Salut Mar ### 1972157###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Del Mar - Parc de Salut Mar###Presenter: – Hospital Del Mar - Parc de Salut Mar
### 2:30 PM – 3:45 PM PT
2797 - Diagnostic Utility of PSMA 18F-DCFPyL PET/TC in Occult Biochemical Recurrence of Prostate Carcinoma with PSA Values <2ng/ml More than Two Years of ExperienceLocation: Hall B2Presenter: – Hospital Del Mar - Parc de Salut Mar
Francesco Amorelli, MD – Hospital Del Mar - Parc de Salut Mar ### 1972157###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Del Mar - Parc de Salut Mar###Presenter: – Hospital Del Mar - Parc de Salut Mar
### 2:30 PM – 3:45 PM PT
2798 - A SEER Database Cohort of 547 Patients with Non-Squamous Cell Carcinoma of the Penis: Clinical Characteristics and OutcomesLocation: Hall B2
Lucas Ashley, MS ### 1972677###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2798 - A SEER Database Cohort of 547 Patients with Non-Squamous Cell Carcinoma of the Penis: Clinical Characteristics and OutcomesLocation: Hall B2Presenter: – Vidant Heart and Vascular Care
Arjun Bhatt, BA – Vidant Heart and Vascular Care ### 2143446###Presenter######Vidant Heart and Vascular Care###Presenter: – Vidant Heart and Vascular Care
### 2:30 PM – 3:45 PM PT
2799 - Conditional Prostate Cancer-Specific Survival Probabilities in Recurrent Prostate Cancer Patients Receiving Radiation ± Antiandrogen Therapy: Secondary Analysis of a Randomized Clinical TrialLocation: Hall B2Presenter: – University of Maryland Radiation Oncology
James Assif, MD – University of Maryland Radiation Oncology ### 1972738###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Radiation Oncology###Presenter: – University of Maryland Radiation Oncology
### 2:30 PM – 3:45 PM PT
2800 - Patterns of recurrence following radiation and ADT for pathologic lymph node positive prostate cancer: A multi-institutional studyLocation: Hall B2Presenter: – Cedars Sinai
Leslie Ballas, MD – Cedars Sinai ### 524742###Presenter###Disclosures: Employment: Cedars Sinai Medical Center:Physician:Employee | Compensation: Pfizer: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 11/11/22 ;Blue Earth: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 12/7/22 | Ownership: none | Leadership: none###Cedars Sinai###Presenter: – Cedars Sinai
### 2:30 PM – 3:45 PM PT
2801 - Clinicopathologic Features of Prostate Cancer with Mesorectal Lymph Node Involvement on PSMA or Fluciclovine PET/CTLocation: Hall B2Presenter: – University of Washington
Andrew Barbour, MD, PhD – University of Washington ### 1972685###Presenter###Disclosures: Employment: University of Washington:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: GSK plc:Stock;Haleon plc:Stock;3M:Stock;Pfizer:Stock;Procter & Gamble:Stock | Leadership: none###University of Washington###Presenter: – University of Washington
### 2:30 PM – 3:45 PM PT
2802 - ARTIA-Bladder: Daily Online Adaptive Short-Course Radiation Therapy (RT) and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer (MIBC): A Prospective Trial of an Individualized Approach for ReLocation: Hall B2Presenter: – Springfield Clinic
Brian Baumann, MD – Springfield Clinic ### 524741###Presenter###Disclosures: Employment: none | Compensation: Varian: Consultant, Research Grants, Research Funding, Research Salary Support,Grant Research Funding, Compensation Payment-End Date: Present ;Boston Scientific: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Travel Expenses, Compensation Payment-End Date: Present ;Myovant: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 09/01/22 ;Galera Therapeutics: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 09/01/21 ;Regeneron: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 10/01/21 ;Mevion: Consultant, Compensation Payment-End Date: 10/01/21 | Ownership: none | Leadership: none###Springfield Clinic###Presenter: – Springfield Clinic
### 2:30 PM – 3:45 PM PT
2803 - Erectile Dysfunction Pharmacotherapy Utilization after 60Gy in 20 Fractions Volumetric Modulated Arc Therapy to the ProstateLocation: Hall B2Presenter: – University of Calgary
Conrad Bayley, MD, BS – University of Calgary ### 1972680###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Calgary###Presenter: – University of Calgary
### 2:30 PM – 3:45 PM PT
2804 - Prospective Characterization of Circulating Tumor Cells in Hormone Sensitive Oligometastatic Prostate Cancer Patients on a Metastasis-Directed Therapy TrialLocation: Hall B2Presenter: – University of Maryland
Soha Bazyar, MD, PhD – University of Maryland ### 1972734###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland###Presenter: – University of Maryland
### 2:30 PM – 3:45 PM PT
2805 - F18-DCFPyL PSMA-PET/CT vs. mpMRI for Localizing the Gross Target Volume for Radiotherapy in Prostate CancerLocation: Hall B2Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
Colin Belliveau, MD – Centre Hospitalier de l'Universite de Montreal (CHUM) ### 1972728###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Centre Hospitalier de l'Universite de Montreal (CHUM)###Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
### 2:30 PM – 3:45 PM PT
2806 - DCE-MRI-Based Atlas for Prostate Bed Recurrence after Radical Prostatectomy: Consistency of CTV Delineation with the Available Contouring GuidelinesLocation: Hall B2Presenter: – Regina Elena National Cancer Institute
Marta Bottero, MD – Regina Elena National Cancer Institute ### 1972646###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Regina Elena National Cancer Institute###Presenter: – Regina Elena National Cancer Institute
### 2:30 PM – 3:45 PM PT
2807 - Disease and Toxicity Outcomes after Salvage Radiotherapy (SRT) for Biochemically Recurrent Prostate Cancer (PC) for Patients Enrolled in a Phase II, Open Label Trial Investigating Neoadjuvant ChemohorLocation: Hall B2Presenter: – University of Wisconsin Hospitals and Clinics
Graham Campbell, MD, BS – University of Wisconsin Hospitals and Clinics ### 1972683###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin Hospitals and Clinics###Presenter: – University of Wisconsin Hospitals and Clinics
### 2:30 PM – 3:45 PM PT
2808 - Health-Related Quality of Life after Combined External Beam and Either High Dose Rate (HDR) or Low Dose Rate (LDR) Brachytherapy: Does the Rectal Dose from the LDR Brachytherapy Make a Difference?Location: Hall B2Presenter: – Instituto Nacional de Enfermedades Neoplásicas
Felipe Castro, MD, DRCPSC – Instituto Nacional de Enfermedades Neoplásicas ### 1972653###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Instituto Nacional de Enfermedades Neoplásicas###Presenter: – Instituto Nacional de Enfermedades Neoplásicas
### 2:30 PM – 3:45 PM PT
2809 - Quantifying Value in an Iterative Disease-Site Specific Peer Review SystemLocation: Hall B2Presenter: – Johns Hopkins University
Leslie Chang, MD – Johns Hopkins University ### 1972059###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 2:30 PM – 3:45 PM PT
2810 - Does Stereotactic Online Adaptive MRgRT to the Prostate Preclude the Need for Rectal SpacerLocation: Hall B2Presenter: – Henry Ford Hospital-Henry Ford Cancer Institute
Daniel Chapman, MD – Henry Ford Hospital-Henry Ford Cancer Institute ### 1972730###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Henry Ford Hospital-Henry Ford Cancer Institute###Presenter: – Henry Ford Hospital-Henry Ford Cancer Institute
### 2:30 PM – 3:45 PM PT
2811 - Partial Stereotactic Ablative Radiotherapy In Bulky Urinary Tract Malignancy: An Update Clinical Outcomes and Dosimetric AnalysisLocation: Hall B2Presenter: – Peking University First Hospital
Jiayan Chen, MD – Peking University First Hospital ### 537633###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking University First Hospital###Presenter: – Peking University First Hospital
### 2:30 PM – 3:45 PM PT
2812 - Patient Education Practices and Preferences of Interprofessional Radiation Oncology ProvidersLocation: Hall B2Presenter: – University of California, San Francisco
Jie Jane Chen, MD – University of California, San Francisco ### 746941###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, San Francisco###Presenter: – University of California, San Francisco
### 2:30 PM – 3:45 PM PT
2813 - Complexity Metrics and Planning Dose-Based Pretreatment Patient-Specific Quality Assurance Prediction: Classification, Gamma Passing Rates, and DVH DeviationLocation: Hall B2Presenter: – Chongqing University Cancer Hospital
Liyuan Chen, MS – Chongqing University Cancer Hospital ### 1972703###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###Presenter: – Chongqing University Cancer Hospital
### 2:30 PM – 3:45 PM PT
2814 - Utility of PSMA PET Guided Metastasis-Directed RadiotherapyLocation: Hall B2
William Chen, MD – UCSF ### 1972723###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSF###Presenter: – UCSF
### 2:30 PM – 3:45 PM PT
2815 - The Efficacy of Silver Sulfadiazine (SSD) Dressing Combined with Recombinant Human Epidermal Growth Factor in the Treatment of Third-Grade Radiation Dermatitis: A Randomized Controlled StudyLocation: Hall B2Presenter: – First Affiliated Hospital of Air Force Medical University
Ming Cheng, BS – First Affiliated Hospital of Air Force Medical University ### 1972650###Presenter######First Affiliated Hospital of Air Force Medical University###Presenter: – First Affiliated Hospital of Air Force Medical University
### 2:30 PM – 3:45 PM PT
2816 - Mapping the Anatomical Distribution of MRI-Identified Locoregional Recurrence following Robotic-Assisted Laparoscopic Prostatectomy for Prostate AdenocarcinomaLocation: Hall B2Presenter: – Yonsei Cancer Center
Hyeok Choi, MD – Yonsei Cancer Center ### 1972657###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yonsei Cancer Center###Presenter: – Yonsei Cancer Center
### 2:30 PM – 3:45 PM PT
2818 - Navigating the Global IV Contrast Shortage: The Experience of a Comprehensive Cancer CenterLocation: Hall B2Presenter: – Roswell Park Comprehensive Cancer Center
Varun Chowdhry, MD, MBA – Roswell Park Comprehensive Cancer Center ### 1972691###Presenter###Disclosures: Employment: Roswell Park Comprehensive Cancer Center:Physician (Radiation-Oncologist):Employee;Department of Veterans Affairs:Staff Geriatrician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Roswell Park Comprehensive Cancer Center###Presenter: – Roswell Park Comprehensive Cancer Center
### 2:30 PM – 3:45 PM PT
2819 - Utilization of Radical Prostatectomy vs. Radiation Therapy for Gleason Grade Group 5 Prostate Cancer before and after USPSTF Grade D Recommendation against Prostate-Specific Antigen Screening in 2012Location: Hall B2Presenter: – Emory University School of Medicine
Taylor Corriher, MD, MBA – Emory University School of Medicine ### 1972725###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University School of Medicine###Presenter: – Emory University School of Medicine
### 2:30 PM – 3:45 PM PT
2820 - Does a Dominant Intraprostatic Lesion Boost Require Daily Adaptation when Treated with Stereotactic Online Adaptive MR-Guided Therapy?Location: Hall B2Presenter: – Henry Ford Hospital
Elliott Czarnecki, MD – Henry Ford Hospital ### 1972674###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Henry Ford Hospital###Presenter: – Henry Ford Hospital
### 2:30 PM – 3:45 PM PT
2821 - Customizable Health Literacy Appropriate Patient Education Materials: The Impact on Patient SatisfactionLocation: Hall B2Presenter: – Rush University Medical Center
Leah D'Souza, MD, MS – Rush University Medical Center ### 1972639###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rush University Medical Center###Presenter: – Rush University Medical Center
### 2:30 PM – 3:45 PM PT
2822 - Determinants of Widespread Metastases and of Metastatic Tropism in Patients with Prostate Cancer: A Genomic Analysis of Primary and Metastatic TumorsLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Alexander Goglia, MD, PhD – Memorial Sloan Kettering Cancer Center ### 2123549###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 2:30 PM – 3:45 PM PT
2823 - Biochemical Relapse-Free Survival in Post-Prostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed Only Radiation: Post-Hoc Analysis of a Prospective Randomized TrialLocation: Hall B2Presenter: – Emory University
Vishal Dhere, MD – Emory University ### 747180###Presenter###Disclosures: Employment: Emory University:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 2:30 PM – 3:45 PM PT
2824 - Rapid Reinstatement of Cancer Care after Hurricane IanLocation: Hall B2Presenter: – GenesisCare USA
Eric Dick, MS, DABR – GenesisCare USA ### 1972715###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GenesisCare USA###Presenter: – GenesisCare USA
### 2:30 PM – 3:45 PM PT
2825 - Dynamic Changes of Molecular Subtype Classification and Genomic Classifier Scores in High-Risk Prostate Cancer Patients Undergoing Pre-Operative Stereotactic Body Radiation TherapyLocation: Hall B2
Marshall Diven, MD – NYP/BMH ### 1972636###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYP/BMH###Presenter: – NYP/BMH
### 2:30 PM – 3:45 PM PT
2826 - Radiation Therapy and Irreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)Location: Hall B2
Marshall Diven, MD – NYP/BMH ### 1972636###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYP/BMH###Presenter: – NYP/BMH
### 2:30 PM – 3:45 PM PT
2827 - Randomized Trial of Five or Two MRI-guided Adaptive Radiotherapy Treatments for Prostate Cancer (FORT)Location: Hall B2
Marshall Diven, MD – NYP/BMH ### 1972636###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYP/BMH###Presenter: – NYP/BMH
### 2:30 PM – 3:45 PM PT
2828 - Advantages of Implementing Sliding Window Gamma Thresholding to Traditional QA MethodsLocation: Hall B2Presenter: – Akron General Medical Center
Jeremy Donaghue, MS – Akron General Medical Center ### 1972711###Presenter######Akron General Medical Center###Presenter: – Akron General Medical Center
### 2:30 PM – 3:45 PM PT
2829 - Liver Fat and Its Association with Time to Biochemical Failure (TTBCF) after Definitive Treatment to the ProstateLocation: Hall B2Presenter: – Fox Chase Cancer Center
Timothy Dougherty, MD – Fox Chase Cancer Center ### 1972626###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
### 2:30 PM – 3:45 PM PT
2830 - Standardization of Stereotactic MR-Guided Adaptive Radiation Therapy Planning for Prostate CancerLocation: Hall B2
Joeseph Drabble, RT – GenesisCare ### 1972702###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GenesisCare###Presenter: – GenesisCare
### 2:30 PM – 3:45 PM PT
2831 - Association between National Area Deprivation Index Rank on Disease Characteristics in Prostate CancerLocation: Hall B2
Elizabeth Duran, MS – UCSD Health ### 1972679###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSD Health###Presenter: – UCSD Health
### 2:30 PM – 3:45 PM PT
2832 - Androgen Deprivation Therapy Use among Intermediate Risk Prostate Cancer Patients Undergoing Radiation Therapy across a Statewide Radiation Oncology Quality ConsortiumLocation: Hall B2Presenter: – University of Michigan
Michael Dykstra, MD – University of Michigan ### 1972638###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 2:30 PM – 3:45 PM PT
2833 - Impact of Prostate Cancer Treatment with Low Dose Rate Brachytherapy on Testosterone: A Retrospective AnalysisLocation: Hall B2
Daniel Ebner, MD, MPH – Mayo Clinic ### 524730###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 2:30 PM – 3:45 PM PT
2834 - Increasing Use of Conservative Management of Low-Risk Prostate Cancer in the Veterans Affairs System from 2012 to 2021Location: Hall B2Presenter: – University of Michigan
Ameer Elaimy, MD, PhD, BS – University of Michigan ### 1972340###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 2:30 PM – 3:45 PM PT
2835 - Impact of Severe Weather on Operations of a Radiation Oncology DepartmentLocation: Hall B2Presenter: – Roswell Park Comprehensive Cancer Center
Fatemeh Fekrmandi, MD, MS – Roswell Park Comprehensive Cancer Center ### 1972250###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Roswell Park Comprehensive Cancer Center###Presenter: – Roswell Park Comprehensive Cancer Center
### 2:30 PM – 3:45 PM PT
2836 - Hypofractionated Radiotherapy for Prostate Cancer (HRT20) Trial: ResultsLocation: Hall B2
Nicolas Feltes, RT ### 1972656###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2837 - Prehabilitation in Radiation Therapy: A Scoping ReviewLocation: Hall B2Presenter: – University of Nebraska Medical Center
Laura Flores, PhD – University of Nebraska Medical Center ### 1972689###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Nebraska Medical Center###Presenter: – University of Nebraska Medical Center
### 2:30 PM – 3:45 PM PT
2838 - Evaluating the Reliability of Chat-GPT Model Responses for Radiation Oncology Patient InquiriesLocation: Hall B2Presenter: – MD Anderson Cancer Center
Warren Floyd, MD, PhD, BS – MD Anderson Cancer Center ### 1972690###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 2:30 PM – 3:45 PM PT
2839 - Radiotherapy vs. Cystectomy for Treatment of Muscle Invasive Bladder Cancer in Very Elderly PatientsLocation: Hall B2Presenter: – University of Pennsylvania Lancaster General Health
Melissa Frick, MD – University of Pennsylvania Lancaster General Health ### 524992###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania Lancaster General Health###Presenter: – University of Pennsylvania Lancaster General Health
### 2:30 PM – 3:45 PM PT
2840 - Daikenchuto Therapy Reduces the Rate of Rectal Bleeding after IMRT for Prostate CancerLocation: Hall B2
Masateru Fujiwara, MD, PhD – Japan ### 1972640###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Japan###Presenter: – Japan
### 2:30 PM – 3:45 PM PT
2841 - Adaptive Ultra-Hypofractionated Whole-Pelvic Radiotherapy in High-Risk and Very High-Risk Prostate Cancer on 1.5-Tesla MR Linac: The Estimated Delivered Dose and Early Toxicity ResultsLocation: Hall B2Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
Lin-rui Gao, MD – Chinese Academy of Medical Sciences and Peking Union Medical College ### 1972643###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
### 2:30 PM – 3:45 PM PT
2842 - Are Psychiatric Comorbidities in the Radiation Oncology Patient Population Under-Recognized by Providers?Location: Hall B2Presenter: – National Cancer Institute
Nancy Garren, MSN, RN, CRNP, PMHN-BC, GC-C – National Cancer Institute ### 1972625###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Institute###Presenter: – National Cancer Institute
### 2:30 PM – 3:45 PM PT
2843 - Long-Term Patient-Reported Bowel and Urinary Quality of Life in Patients Treated with Intensity-Modulated Radiotherapy and Intensity-Modulated Proton Therapy for Localized Prostate CancerLocation: Hall B2Presenter: – Wilmot Cancer Center
Kimberly Gergelis, MD – Wilmot Cancer Center ### 1972451###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Wilmot Cancer Center###Presenter: – Wilmot Cancer Center
### 2:30 PM – 3:45 PM PT
2844 - Splenic Irradiation and Late Volume Changes Following Stereotactic Ablative Radiotherapy (SABR) for Adrenal TumorsLocation: Hall B2Presenter: – Amsterdam UMC
Nicolas Giraud, MD – Amsterdam UMC ### 1972155###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Amsterdam UMC###Presenter: – Amsterdam UMC
### 2:30 PM – 3:45 PM PT
2845 - Volumes Changes in Adrenal Metastases during Delivery of 5-Fraction Stereotactic Magnetic Resonance-Guided Adaptive RadiotherapyLocation: Hall B2Presenter: – Amsterdam UMC
Nicolas Giraud, MD – Amsterdam UMC ### 1972155###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Amsterdam UMC###Presenter: – Amsterdam UMC
### 2:30 PM – 3:45 PM PT
2846 - Evaluation of Peer Review Practice in Radiation Oncology Treatment Planning: Single Institution ExperienceLocation: Hall B2Presenter: – King Abdullah Medical City
Heba Gomaa, MD, PhD – King Abdullah Medical City ### 747139###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###King Abdullah Medical City###Presenter: – King Abdullah Medical City
### 2:30 PM – 3:45 PM PT
2847 - Clinical Usefulness of PSMA PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer after Primary RT with PSA below the Phoenix Criteria Threshold: Systematic Review and Meta-AnalysisLocation: Hall B2
ELIAS GOMIS SELLES, MD, PhD ### 1972719###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2848 - Implementing an Additional Weekly Treatment Visit with an Advance Practice Provider to Reduce Hospitalizations and Improve Quality of Care in Patients Undergoing Radiation TherapyLocation: Hall B2Presenter: – Baptist MD Anderson
Julie Greenwalt, MD – Baptist MD Anderson ### 1972696###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Baptist MD Anderson###Presenter: – Baptist MD Anderson
### 2:30 PM – 3:45 PM PT
2849 - The Effect of Nursing Intervention Based on HFMEA Model on the Prevention of Radiation Dermatitis: A Randomized Controlled StudyLocation: Hall B2Presenter: – Xijing Hospital Air Force Medical University
Jing Guo, BS – Xijing Hospital Air Force Medical University ### 1972663###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Xijing Hospital Air Force Medical University###Presenter: – Xijing Hospital Air Force Medical University
### 2:30 PM – 3:45 PM PT
2850 - Focal Brachytherapy for Localized Prostate Cancer: Systematic Review and Meta-AnalysisLocation: Hall B2Presenter: – Princess Margaret Cancer Center
Enrique Gutierrez, MD – Princess Margaret Cancer Center ### 1972675###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Center###Presenter: – Princess Margaret Cancer Center
### 2:30 PM – 3:45 PM PT
2851 - Patterns of Adaptive Replanning in Proton Therapy for Thoracic MalignanciesLocation: Hall B2Presenter: – University of Maryland Radiation Oncology
Muhammad Hamza, MD, BS – University of Maryland Radiation Oncology ### 1972642###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Radiation Oncology###Presenter: – University of Maryland Radiation Oncology
### 2:30 PM – 3:45 PM PT
2852 - Concurrent Radiation and Deep Hyperthermia Therapy for the Treatment of Recurrent Prostate CancerLocation: Hall B2Presenter: – University of Maryland Radiation Oncology
Muhammad Hamza, MD, BS – University of Maryland Radiation Oncology ### 1972642###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Radiation Oncology###Presenter: – University of Maryland Radiation Oncology
### 2:30 PM – 3:45 PM PT
2853 - Timely Initiation of Radiation Treatment for Primary Head and Neck Squamous Cell Carcinoma in an Urban Safety Net Hospital during the COVID-19 PandemicLocation: Hall B2Presenter: – University of Southern California/LAC+ USC Medical Center
Hye Ri Han, MD, MS – University of Southern California/LAC+ USC Medical Center ### 1972717###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Southern California/LAC+ USC Medical Center###Presenter: – University of Southern California/LAC+ USC Medical Center
### 2:30 PM – 3:45 PM PT
2854 - Focal Boosted IMRT Treatment of Prostate Cancer to 84 Gy in 28 Fractions: Preliminary Clinical Outcomes and DosimetryLocation: Hall B2
Jacob Hands ### 1972729###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2855 - Development of a Screening Nomogram for Regional Lymph Node Metastasis Development in Muscle Invasive Bladder Cancer after Multiagent Systemic TherapyLocation: Hall B2
Garrett Harada, MD – UCI Health ### 1972652###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCI Health###Presenter: – UCI Health
### 2:30 PM – 3:45 PM PT
2856 - Empowering the Role of Nurse Triage in Radiation Oncology - A Single Center AnalysisLocation: Hall B2Presenter: – University of Wisconsin Carbone Cancer Center
Colin Harari, MD – University of Wisconsin Carbone Cancer Center ### 1972630###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin Carbone Cancer Center###Presenter: – University of Wisconsin Carbone Cancer Center
### 2:30 PM – 3:45 PM PT
2857 - Evaluation of kV Triggered Fiducial Tracking for Prostate SBRT Intrafraction Motion ManagementLocation: Hall B2Presenter: – University of Wisconsin Carbone Cancer Center
Colin Harari, MD – University of Wisconsin Carbone Cancer Center ### 1972630###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin Carbone Cancer Center###Presenter: – University of Wisconsin Carbone Cancer Center
### 2:30 PM – 3:45 PM PT
2858 - Improving Patient Compliance for More Efficient Deep Inspiration Breath Hold Treatment through Innovation and EducationLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Wendy Harris, PhD – Memorial Sloan Kettering Cancer Center ### 2099969###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 2:30 PM – 3:45 PM PT
2860 - A Needs Assessment Exploring Radiation Oncology Nursing Confidence in Caring for Patients with Acute and Late Radiation Therapy EffectsLocation: Hall B2Presenter: – Duke University Medical Center
John Hillson, OCN, BSN, RN, dnp – Duke University Medical Center ### 1972681###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University Medical Center###Presenter: – Duke University Medical Center
### 2:30 PM – 3:45 PM PT
2861 - A Phase I/II Dose-Escalation Study Evaluating the Safety of 21 Gy, 23 Gy, and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy: An Interim Toxicity ReportLocation: Hall B2Presenter: – Washington University in St. Louis
Daniel Hong, MD – Washington University in St. Louis ### 1972631###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University in St. Louis###Presenter: – Washington University in St. Louis
### 2:30 PM – 3:45 PM PT
2862 - Development and Validation of MRI Imaging Biomarkers for Prostate Cancer Using Deep LearningLocation: Hall B2Presenter: – Yale School of Medicine
Sajid Hossain, MS, BS – Yale School of Medicine ### 1972664###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yale School of Medicine###Presenter: – Yale School of Medicine
### 2:30 PM – 3:45 PM PT
2863 - Early Experience with CBCT-Guided Online Adaptive Radiotherapy for Muscle Invasive Bladder CancerLocation: Hall B2Presenter: – University of Alabama at Birmingham
Whitney Hotsinpiller, MD – University of Alabama at Birmingham ### 1972353###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alabama at Birmingham###Presenter: – University of Alabama at Birmingham
### 2:30 PM – 3:45 PM PT
2864 - Initial Clinical Outcomes of a Phase II Trial of Focal Salvage LDR Brachytherapy for Local Recurrence of Prostate Cancer After External Beam Radiation TherapyLocation: Hall B2Presenter: – University of Washington-Fred Hutchinson Cancer Center
R. Hsi, MD – University of Washington-Fred Hutchinson Cancer Center ### 587653###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington-Fred Hutchinson Cancer Center###Presenter: – University of Washington-Fred Hutchinson Cancer Center
### 2:30 PM – 3:45 PM PT
2865 - Changes and Relationship in Nutrition Impact Symptoms, Malnutrition during Esophageal Cancer TreatmentLocation: Hall B2
Guiyu Huang ### 1972647###Presenter#########Presenter:
### 2:30 PM – 3:45 PM PT
2866 - Multifocal MRI-Directed Simultaneous Integrated Boost (SIB) in the Treatment of Prostate Cancer with Stereotactic Body Radiation Therapy (SBRT)Location: Hall B2Presenter: – New York University Long Island School of Medicine
Joshua Hurwitz, BA – New York University Long Island School of Medicine ### 1972627###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###New York University Long Island School of Medicine###Presenter: – New York University Long Island School of Medicine
### 2:30 PM – 3:45 PM PT
2867 - Phase II Clinical Trial of Hypofractionated Image-Guided Proton Therapy with 12 Fractions for Prostate CancerLocation: Hall B2Presenter: – Nagoya Proton Therapy Center
Hiromitsu Iwata, MD, PhD – Nagoya Proton Therapy Center ### 525353###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Nagoya Proton Therapy Center###Presenter: – Nagoya Proton Therapy Center
### 2:30 PM – 3:45 PM PT
2868 - Dosimetric Implications of Prostate Bed Deformability: An Analysis of the SCIMITAR Clinical TrialLocation: Hall B2
Tommy Jiang, BA – UCLA ### 1972670###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA###Presenter: – UCLA
### 2:30 PM – 3:45 PM PT
2869 - One Year Radiographic Response Following Prostrate SBRT: An Exploratory Analysis of a Phase III Randomized TrialLocation: Hall B2
Tommy Jiang, BA – UCLA ### 1972670###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA###Presenter: – UCLA
### 2:30 PM – 3:45 PM PT
2870 - MR-Guided HDR Brachytherapy Boost in Localized Prostate Cancer - Results of a Phase II TrialLocation: Hall B2Presenter: – Princess Margaret Cancer Center, University Health Network
Carlton Johnny, MD – Princess Margaret Cancer Center, University Health Network ### 1972687###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Center, University Health Network###Presenter: – Princess Margaret Cancer Center, University Health Network
### 2:30 PM – 3:45 PM PT
2871 - Prostate Cancer Screening Uptake in Transgender FemalesLocation: Hall B2Presenter: – University of California San Diego
Sandhya Kalavacherla, BS – University of California San Diego ### 1972667###Presenter######University of California San Diego###Presenter: – University of California San Diego
### 2:30 PM – 3:45 PM PT
2872 - Prophylactic ?-Blockers for Radiotherapy-Induced LUTS in Men with Prostate Cancer: A Phase III Randomized Trial AnalysisLocation: Hall B2Presenter: – McGill University
Tamim Niazi, MD – McGill University ### 524755###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGill University###Presenter: – McGill University
### 2:30 PM – 3:45 PM PT
2873 - Prospective Validation of Single Nucleotide Polymorphisms As Predictors of Gastrointestinal, Genitourinary, and Sexual Patient-Reported Outcomes Following Radiotherapy for Prostate CancerLocation: Hall B2Presenter: – Massachusetts General Hospital
Sophia Kamran, MD – Massachusetts General Hospital ### 524914###Presenter###Disclosures: Employment: MGH:Assistant Professor of Radiation Oncology:Employee;Sanofi:Global Market Access:Employee | Compensation: Varian: Other, Honoraria-End Date: 7/25/2022 ;DAVA Oncology: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: 11/13/2022 ;Prostate Cancer Foundation: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 12/30/2024 ;NRG Oncology: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Travel Expenses-End Date: present | Ownership: none | Leadership: ASCO:Chair- Renal and Rare Tumors Track;MGH:Director of Diversity, Equity & Inclusion;American Board of Radiology:American Board of Radiology Radiation Oncology Certifying Exam Genitourinary Committee###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 2:30 PM – 3:45 PM PT
2875 - Long-Term Safety and Efficacy of SAbR for Metastatic RCCLocation: Hall B2Presenter: – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Dana Keilty, MD, MS, MDCM, MSc, BHSc – Princess Margaret Cancer Centre, University Health Network, University of Toronto ### 747108###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre, University Health Network, University of Toronto###Presenter: – Princess Margaret Cancer Centre, University Health Network, University of Toronto
### 2:30 PM – 3:45 PM PT
2876 - Location of Local Recurrences Post-Prostatectomy Detected by 18F-DCPFyL and Implications for Salvage Radiotherapy Target VolumesLocation: Hall B2Presenter: – Genesis Care (Australia)
Fiona Kelly – Genesis Care (Australia) ### 1972641###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Genesis Care (Australia)###Presenter: – Genesis Care (Australia)
### 2:30 PM – 3:45 PM PT
2877 - Low Incidence of Late Lymphopenia Following Stereotactic Body Radiotherapy for Localized Prostate CancerLocation: Hall B2Presenter: – Georgetown University School of Medicine
Irfan Khan, PhD – Georgetown University School of Medicine ### 1972654###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Georgetown University School of Medicine###Presenter: – Georgetown University School of Medicine
### 2:30 PM – 3:45 PM PT
2878 - Multidisciplinary Institutional Guidelines for Workflow Efficiency in Optimizing Patient Start TimeLocation: Hall B2Presenter: – West Virginia University School of Medicine
Cody Kilar, DO, PhD – West Virginia University School of Medicine ### 1972699###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West Virginia University School of Medicine###Presenter: – West Virginia University School of Medicine
### 2:30 PM – 3:45 PM PT
2879 - Optimal Planning Target Margin for Prostate Radiotherapy Based on Interfractional and Intrafractional Variability Assessment during 1.5T MR-Guided RadiotherapyLocation: Hall B2Presenter: – Yonsei Cancer Center
Jina Kim, MD – Yonsei Cancer Center ### 746814###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yonsei Cancer Center###Presenter: – Yonsei Cancer Center
### 2:30 PM – 3:45 PM PT
2880 - Association of Apical Spacing with Bowel Quality-of-Life: A Secondary Analysis of the Hyaluronic Acid Randomized TrialLocation: Hall B2Presenter: – Brigham and Womens Hopsital
Martin King, MD, PhD – Brigham and Womens Hopsital ### 525487###Presenter###Disclosures: Employment: Brigham and Women's Physician's Organization:Physician:Employee | Compensation: Bayer Healthcare: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Ongoing ;Palette Life Sciences: Grant Research Funding, Salary Support-End Date: To present | Ownership: none | Leadership: none###Brigham and Womens Hopsital###Presenter: – Brigham and Womens Hopsital
### 2:30 PM – 3:45 PM PT
2882 - Real-World Toxicity of Conventional Versus Hypofractionated Definitive Prostate Radiotherapy across a Large, Diverse, Academic and Community-Based EnterpriseLocation: Hall B2Presenter: – City of Hope National Medical Center
Colton Ladbury, MD, BS – City of Hope National Medical Center ### 747995###Presenter###Disclosures: Employment: City of Hope National Medical Center:Resident Physician:Employee | Compensation: RefleXion Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 2:30 PM – 3:45 PM PT
2883 - Implementation of a Systematic, Digital Oncology Workflow for Patient Distress Screening in a National, Multi-site Radiotherapy Outpatient SettingLocation: Hall B2
Kieu Lai, RT – GenesisCare ### 1972672###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GenesisCare###Presenter: – GenesisCare
### 2:30 PM – 3:45 PM PT
2883 - Implementation of a Systematic, Digital Oncology Workflow for Patient Distress Screening in a National, Multi-site Radiotherapy Outpatient SettingLocation: Hall B2
Timothy Fox, PhD – GenesisCare ### 2134199###Presenter######GenesisCare###Presenter: – GenesisCare
### 2:30 PM – 3:45 PM PT
2884 - Squamous Cell Carcinoma of the Bladder: Analysis of Treatments and OutcomesLocation: Hall B2Presenter: – East Carolina University Brody School of Medicine
Michael Larkins, BS – East Carolina University Brody School of Medicine ### 1972722###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###East Carolina University Brody School of Medicine###Presenter: – East Carolina University Brody School of Medicine
### 2:30 PM – 3:45 PM PT
2885 - Association between Gut Microbial Change and Acute Gastrointestinal Toxicity in Patients with Prostate Cancer Receiving Definitive Radiation Therapy: A Prospective Pilot AnalysisLocation: Hall B2
Dong Soo Lee, MD, PhD ### 1972726###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2886 - Immunohistochemistry-Based Biomarkers and Impact on Outcomes Following Salvage Radiotherapy for Prostate CancerLocation: Hall B2Presenter: – Johns Hopkins University
Emerson Lee, MD, BS – Johns Hopkins University ### 1972733###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 2:30 PM – 3:45 PM PT
2887 - Implementation Science in Radiation Oncology: Case Study for Liver SBRTLocation: Hall B2Presenter: – Creighton University School of Medicine
Jacob Lee, BS – Creighton University School of Medicine ### 1972714###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Creighton University School of Medicine###Presenter: – Creighton University School of Medicine
### 2:30 PM – 3:45 PM PT
2888 - Individual Patient Data Analysis of 17 Randomized Trials vs. Real-World Data for Men with Localized Prostate Cancer Receiving RadiotherapyLocation: Hall B2
Joan Lee, MD ### 1972645###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2889 - Artificial Intelligence-Derived Dominant Intraprostatic Lesion Volume Predicts Indications for Adjuvant Radiation after Radical ProstatectomyLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Katie Lee, MD, PhD – Harvard Radiation Oncology Program ### 1972295###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 2:30 PM – 3:45 PM PT
2890 - A Modified Robust Nomogram for Predicting the Probability of Pelvic Lymph Node Invasion in Localized Prostate CancerLocation: Hall B2Presenter: – Shanghai Jiao Tong University
Huan Li, MD – Shanghai Jiao Tong University ### 747864###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shanghai Jiao Tong University###Presenter: – Shanghai Jiao Tong University
### 2:30 PM – 3:45 PM PT
2891 - The Potential Ability of Plan Complexity Metrics on the Dose Calculation and Plans Delivery in Intensity Modulated RadiotherapyLocation: Hall B2Presenter: – Chongqing University Cancer Hospital
Shi Li, MS – Chongqing University Cancer Hospital ### 1972704###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###Presenter: – Chongqing University Cancer Hospital
### 2:30 PM – 3:45 PM PT
2892 - Real-World Evaluation of Adjuvant Radiotherapy in Upper Tract Urothelial Carcinoma Patients: A Prospective Cohort StudyLocation: Hall B2Presenter: – Peking University First Hospital
Xiaoying Li, MD – Peking University First Hospital ### 538536###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking University First Hospital###Presenter: – Peking University First Hospital
### 2:30 PM – 3:45 PM PT
2893 - Characterizing Hospital Admissions after Proton Beam Therapy Using the National Inpatient Sample DatabaseLocation: Hall B2Presenter: – Mayo Clinic Alix School of Medicine Scottsdale
Keldon Lin, BA – Mayo Clinic Alix School of Medicine Scottsdale ### 1972716###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Alix School of Medicine Scottsdale###Presenter: – Mayo Clinic Alix School of Medicine Scottsdale
### 2:30 PM – 3:45 PM PT
2894 - Designing Patient-Centered Health Education Materials for Radiation Dermatitis in Breast Cancer Patients: A Pilot Study and Single-Center Clinical TrialLocation: Hall B2Presenter: – China Medical University Hospital
Ting-Chun Lin, MD – China Medical University Hospital ### 747612###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###China Medical University Hospital###Presenter: – China Medical University Hospital
### 2:30 PM – 3:45 PM PT
2895 - Incidence of Radiotherapy Induced Cardiac Implantable Electronic Devices Malfunction: Australian-Based Observation StudyLocation: Hall B2Presenter: – Alfred Health
Yuan-Hong Lin, MD – Alfred Health ### 1972708###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Alfred Health###Presenter: – Alfred Health
### 2:30 PM – 3:45 PM PT
2896 - High-Dose Rate Brachytherapy Alone for Treatment of Unfavorable Intermediate Risk Prostate Cancer: A Propensity-Score Matched AnalysisLocation: Hall B2Presenter: – UCLA Radiation Oncology
Eulanca Liu, MD, PhD – UCLA Radiation Oncology ### 1972732###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 2:30 PM – 3:45 PM PT
2897 - Safety and Efficacy of Radiotherapy Combined with Chemotherapy for Recurrent Metastatic Renal Pelvic and Ureteral CarcinomaLocation: Hall B2Presenter: – Peking University First Hospital
Ming-Zhu Liu, MD – Peking University First Hospital ### 1972633###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking University First Hospital###Presenter: – Peking University First Hospital
### 2:30 PM – 3:45 PM PT
2898 - Radiation Therapy Knowledge and Health Literacy among Culturally Diverse Patients with Prostate Cancer Treated at a Safety-Net HospitalLocation: Hall B2Presenter: – University of Southern California/LAC+ USC Medical Center
Derrick Lock, MD – University of Southern California/LAC+ USC Medical Center ### 537420###Presenter###Disclosures: Employment: University of Southern California (USC)/LA General Medical Center:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Southern California/LAC+ USC Medical Center###Presenter: – University of Southern California/LAC+ USC Medical Center
### 2:30 PM – 3:45 PM PT
2899 - Real World Multi-Institutional Outcomes of Bladder Carbogen and Nicotinamide (BCON) in Muscle-Invasive Bladder Cancer (MIBC)Location: Hall B2Presenter: – The Christie NHS Foundation Trust
Ananya Choudhury, PhD, MA MRCP FRCR – The Christie NHS Foundation Trust ### 524736###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Christie NHS Foundation Trust###Presenter: – The Christie NHS Foundation Trust
### 2:30 PM – 3:45 PM PT
2900 - Three Months PSA Response after PSMA-Guided Approach for Biochemical Relapse after Prostatectomy (PSICHE Trial)Location: Hall B2Presenter: – Azienda Ospedaliera Universitaria Careggi
Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi ### 1972601###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Azienda Ospedaliera Universitaria Careggi###Presenter: – Azienda Ospedaliera Universitaria Careggi
### 2:30 PM – 3:45 PM PT
2901 - Proton Radiation Therapy for Stage IIA/IIB Testicular SeminomaLocation: Hall B2Presenter: – University of Washington
Andrew Lui, BS – University of Washington ### 537919###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 2:30 PM – 3:45 PM PT
2902 - Identification and Validation of a Ferroptosis Prognostic Model for Prostate Cancer Patients through Screening the TCGA and scRNA-seq DatasetsLocation: Hall B2Presenter: – Peking University First Hospital
Feng Lyu, MD, PhD – Peking University First Hospital ### 1972512###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking University First Hospital###Presenter: – Peking University First Hospital
### 2:30 PM – 3:45 PM PT
2903 - Outcomes of Targeted Therapy Plus Immunotherapy and High-Dose Stereotactic Ablative Body Radiotherapy (SABR) for Metastatic Renal Cell Cancer PatientsLocation: Hall B2
Ming-Wei Ma, MD ### 1972634###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2904 - Effect of Adjuvant Chemotherapy in Highly Malignant Non-Metastatic Prostate Cancer: An Interim Analysis of Non-Randomized Comparative TrialsLocation: Hall B2
Ming-Wei Ma, MD ### 1972634###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2905 - Integration of Multiparameter MRI Into Conventional Pretreatment Risk Factors to Predict Adverse Features After Radical ProstatectomyLocation: Hall B2
Ming-Wei Ma, MD ### 1972634###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2906 - Outcomes in Locally Advanced Non-Metastatic Prostate Cancer Presenting with Low PSA at DiagnosisLocation: Hall B2Presenter: – The Christie NHS Foundation Trust
Priyamvada Maitre, MD – The Christie NHS Foundation Trust ### 1972024###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Christie NHS Foundation Trust###Presenter: – The Christie NHS Foundation Trust
### 2:30 PM – 3:45 PM PT
2907 - Association of Prostate Specific Antigen Kinetics after Testosterone Recovery with Subsequent Recurrence: Secondary Analysis of a Phase III Randomized Controlled TrialLocation: Hall B2Presenter: – The Ottawa Hospital
Shawn Malone, MD – The Ottawa Hospital ### 536098###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ottawa Hospital###Presenter: – The Ottawa Hospital
### 2:30 PM – 3:45 PM PT
2909 - The Anatomy and Evolution of a Quality Proton Therapy Plan Check Process: An Institutional ReviewLocation: Hall B2Presenter: – Miami Cancer Institute
Andrew Wroe, PhD – Miami Cancer Institute ### 1996705###Presenter###Disclosures: Employment: Miami Cancer Institute:Director of Proton Physics:Employee | Compensation: Ion Beam Applications: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: 12/31/2022 | Ownership: none | Leadership: none###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 2:30 PM – 3:45 PM PT
2910 - A Novel Brachytherapy Needle Design to Reduce Urethra Dose in HDR Prostate BrachytherapyLocation: Hall B2Presenter: – Emory University
Moeen Meftahi, PhD – Emory University ### 1972669###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 2:30 PM – 3:45 PM PT
2911 - A Single Institution Experience of a Biweekly Head and Neck Contouring Peer ReviewLocation: Hall B2Presenter: – UAMS Radiation Oncology
Romy Megahed, MD – UAMS Radiation Oncology ### 1972706###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UAMS Radiation Oncology###Presenter: – UAMS Radiation Oncology
### 2:30 PM – 3:45 PM PT
2912 - Risk Factors Predicting Relapse 10 Years Following Extreme Dose-escalated SBRT for Intermediate-risk Prostate Cancer: Is De-Intensification Feasible in Unfavorable Subgroups?Location: Hall B2Presenter: – Swedish Cancer Institute
Robert Meier, MD – Swedish Cancer Institute ### 1972655###Presenter######Swedish Cancer Institute###Presenter: – Swedish Cancer Institute
### 2:30 PM – 3:45 PM PT
2913 - Robotic SBRT in Prostate Cancer Patients Younger Than 50 Years Old-Updated ResultsLocation: Hall B2Presenter: – Perlmutter Cancer Center at NYU Langone Hospital - Long Island
Christopher Mendez, MA – Perlmutter Cancer Center at NYU Langone Hospital - Long Island ### 1972635###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Perlmutter Cancer Center at NYU Langone Hospital - Long Island###Presenter: – Perlmutter Cancer Center at NYU Langone Hospital - Long Island
### 2:30 PM – 3:45 PM PT
2914 - Implementing Standardized Patient Education in Radiation OncologyLocation: Hall B2Presenter: – Penn Medicine
Courtney Misher, RT, BS, MPH – Penn Medicine ### 1972727###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Penn Medicine###Presenter: – Penn Medicine
### 2:30 PM – 3:45 PM PT
2915 - Comparison of the Efficacy of Low Dose tadalafil with tamsulosin against Lower Urinary Tract Symptoms and Sexual Dysfunction after Low Dose Rate Prostate BrachytherapyLocation: Hall B2Presenter: – Keio University School of Medicine
Ryuichi Mizuno, MD – Keio University School of Medicine ### 1972658###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Keio University School of Medicine###Presenter: – Keio University School of Medicine
### 2:30 PM – 3:45 PM PT
2916 - Long Term Results of Prostate Cancer Patients Treated with Cs131 LDR Brachytherapy Compared with Recently Published SBRT DataLocation: Hall B2Presenter: – UPMC Hillman Cancer Center
Mohammed Mohammed, MD – UPMC Hillman Cancer Center ### 1972673###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UPMC Hillman Cancer Center###Presenter: – UPMC Hillman Cancer Center
### 2:30 PM – 3:45 PM PT
2917 - Toxicity Analysis of a Modified Prostate Bed CTV Based on PSMA-PET Patterns of FailureLocation: Hall B2Presenter: – Sylvester Comprehensive Cancer Center
Chris Montoya, MD – Sylvester Comprehensive Cancer Center ### 537477###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sylvester Comprehensive Cancer Center###Presenter: – Sylvester Comprehensive Cancer Center
### 2:30 PM – 3:45 PM PT
2918 - Radiation-Associated Lymphopenia in Advanced Prostate Cancer Treated with Contemporary Radiation TechniquesLocation: Hall B2Presenter: – Aurora Health Care
Javier Mora, MD – Aurora Health Care ### 1972205###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Aurora Health Care###Presenter: – Aurora Health Care
### 2:30 PM – 3:45 PM PT
2919 - Hyaluronic Acid Rectal Spacer Stability during Radiation Therapy for Localized Prostate Cancer: An Intercontinental StudyLocation: Hall B2Presenter: – Genesiscare UK (Oxford)
Elena Moreno-Olmedo, MD – Genesiscare UK (Oxford) ### 1972040###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Genesiscare UK (Oxford)###Presenter: – Genesiscare UK (Oxford)
### 2:30 PM – 3:45 PM PT
2920 - Association of Transgender or Gender Non-Binary Identity on Disease Characteristics and Survival Outcomes in Prostate CancerLocation: Hall B2
Kylie Morgan, BS – UCSD Health ### 1972731###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSD Health###Presenter: – UCSD Health
### 2:30 PM – 3:45 PM PT
2921 - Biochemical Failure in Intermediate Risk Prostate Cancer: Then What? Long-Term Data from a Phase III TrialLocation: Hall B2
Abdenour Nabid, MD – CHUS ### 524757###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###CHUS###Presenter: – CHUS
### 2:30 PM – 3:45 PM PT
2922 - Compatibility of Topical Products to Manage Skin Irritation Associated with TTFieldsLocation: Hall B2
Narasimha Karanam, PhD ### 537632###Poster Presenter#########Poster Presenter:
### 2:30 PM – 3:45 PM PT
2923 - A Prospective Phase II Dose Escalation Study using IMRT for High Risk N0M0 Prostate CancerLocation: Hall B2Presenter: – St. Luke's Radiation Oncology
Jill Nicholson, MBBS – St. Luke's Radiation Oncology ### 1972661###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###St. Luke's Radiation Oncology###Presenter: – St. Luke's Radiation Oncology
### 2:30 PM – 3:45 PM PT
2924 - Improving Complex Brachytherapy Efficiency in the Current Financial ClimateLocation: Hall B2Presenter: – University Hospitals Case Medical Center
Karina Nieto, MD – University Hospitals Case Medical Center ### 1972705###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospitals Case Medical Center###Presenter: – University Hospitals Case Medical Center
### 2:30 PM – 3:45 PM PT
2925 - Tolerability of Metastasis-Directed Stereotactic Body Radiotherapy with Short-Course Triple-Agent Androgen Annihilation Therapy in Recurrent Oligometastatic Prostate Cancer: Secondary Analysis of a PhLocation: Hall B2Presenter: – UCLA Radiation Oncology
John Nikitas, MD – UCLA Radiation Oncology ### 747729###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 2:30 PM – 3:45 PM PT
2926 - Predictive Value of Genomic Classifier Scores and Transcriptomic Data for Prostate Cancer Distant Metastasis Risk: A Multicenter Retrospective StudyLocation: Hall B2Presenter: – UCLA Radiation Oncology
John Nikitas, MD – UCLA Radiation Oncology ### 747729###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 2:30 PM – 3:45 PM PT
2927 - Dose-Volume Parameters to the Urinary Tract Sub-Volumes and Predictors of Genitourinary Acute Toxicity in a Phase 2 Clinical Trial Assessing MRI-Guided Prostate Boost for Localized Prostate Cancer - TLocation: Hall B2Presenter: – Albany Medical College
Miguel Noy, BS – Albany Medical College ### 1972666###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Albany Medical College###Presenter: – Albany Medical College
### 2:30 PM – 3:45 PM PT
2928 - An Analysis of Patients Treated with Stereotactic Body Radiotherapy for Metastatic Urinary Tract Tumors to Identify Predictors of ResponseLocation: Hall B2
Nayeon Oh ### 1972662###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2929 - Treatment Outcomes of Simultaneous Integrated Boost to Intraprostatic Lesions with External Beam Radiotherapy in Localized Prostate Cancer PatientsLocation: Hall B2Presenter: – Baskent University Faculty of Medicine
Huseyin Cem Onal, MD, PhD – Baskent University Faculty of Medicine ### 536101###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Baskent University Faculty of Medicine###Presenter: – Baskent University Faculty of Medicine
### 2:30 PM – 3:45 PM PT
2930 - Dosimetric Predictors of Toxicities and Quality of Life Following Two-Fraction Stereotactic Body Radiotherapy for Prostate CancerLocation: Hall B2Presenter: – Alfred Health Radiation Oncology
Wee Loon Ong, MBBS – Alfred Health Radiation Oncology ### 747114###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Alfred Health Radiation Oncology###Presenter: – Alfred Health Radiation Oncology
### 2:30 PM – 3:45 PM PT
2931 - Improving Radiation Oncology Staff Engagement with Quality Improvement and Safety through a QI Committee Visiting Staff InitiativeLocation: Hall B2Presenter: – Brigham and Women's/Dana Farber Cancer Institute
Itai Pashtan, MD – Brigham and Women's/Dana Farber Cancer Institute ### 1972693###Presenter###Disclosures: Employment: Dana Farber Brigham Cancer Center:Radiation Oncologist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Brigham and Women's/Dana Farber Cancer Institute###Presenter: – Brigham and Women's/Dana Farber Cancer Institute
### 2:30 PM – 3:45 PM PT
2932 - A Phase I Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate CancerLocation: Hall B2Presenter: – National Institutes of Health
Krishnan Patel, MD – National Institutes of Health ### 1972721###Presenter###Disclosures: Employment: National Cancer Institute (NIH):Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###National Institutes of Health###Presenter: – National Institutes of Health
### 2:30 PM – 3:45 PM PT
2933 - Contouring — How Do We Manage This Pivotal but Time-Consuming Workload?Location: Hall B2Presenter: – Medical College of Wisconsin
Mira Patel, BS – Medical College of Wisconsin ### 1972692###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 2:30 PM – 3:45 PM PT
2934 - Factors Associated with Stereotactic Radiation Plan Revision in Prospective Peer ReviewLocation: Hall B2Presenter: – Brigham and Women's/Dana Farber Cancer Institute
Luke Peng, MD, MS – Brigham and Women's/Dana Farber Cancer Institute ### 535991###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brigham and Women's/Dana Farber Cancer Institute###Presenter: – Brigham and Women's/Dana Farber Cancer Institute
### 2:30 PM – 3:45 PM PT
2935 - Long-Term Effectiveness of a Nonsurgical BPH Treatment System in Prostate Radiation Patients with Medication-Refractory Lower Urinary Tract SymptomsLocation: Hall B2Presenter: – Fred Hutch Cancer Center - Peninsula
Anthony Pham, MD – Fred Hutch Cancer Center - Peninsula ### 574783###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fred Hutch Cancer Center - Peninsula###Presenter: – Fred Hutch Cancer Center - Peninsula
### 2:30 PM – 3:45 PM PT
2936 - Application of a Radiopaque Viscous Hydrogel Spacer for Prostate Cancer Radiotherapy - A Prospective Multi-Institutional Phase II StudyLocation: Hall B2Presenter: – MediClin Robert Janker Klinik
Michael Pinkawa, MD, PhD – MediClin Robert Janker Klinik ### 525080###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MediClin Robert Janker Klinik###Presenter: – MediClin Robert Janker Klinik
### 2:30 PM – 3:45 PM PT
2937 - Impact of Prophylactic Pelvic Lymph Node Irradiation in De-novo Oligometastatic Prostate CancerLocation: Hall B2Presenter: – Peking University First Hospital
Xin Qi, MD, MS – Peking University First Hospital ### 536086###Presenter######Peking University First Hospital###Presenter: – Peking University First Hospital
### 2:30 PM – 3:45 PM PT
2938 - Radiation Treatment Preparation Safety Risk PredictionLocation: Hall B2Presenter: – Dana-Farber/Brigham and Women's Cancer Center
Sarah Quirk, PhD – Dana-Farber/Brigham and Women's Cancer Center ### 1972418###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Dana-Farber/Brigham and Women's Cancer Center###Presenter: – Dana-Farber/Brigham and Women's Cancer Center
### 2:30 PM – 3:45 PM PT
2939 - Factors Associated with Grade 3-4 Late Toxicity after Hypofractionated Prostate Salvage RadiationLocation: Hall B2Presenter: – UW Health Radiation Oncology
Kaili Ranta, MD, PhD, BS – UW Health Radiation Oncology ### 1972736###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UW Health Radiation Oncology###Presenter: – UW Health Radiation Oncology
### 2:30 PM – 3:45 PM PT
2940 - Validating a Simple Urethra Surrogate Model to Facilitate Dosimetric Analysis to Predict Genitourinary ToxicityLocation: Hall B2Presenter: – Royal Marsden NHS Foundation Trust
Ragu Ratnakumaran, MBBS – Royal Marsden NHS Foundation Trust ### 1972022###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Royal Marsden NHS Foundation Trust###Presenter: – Royal Marsden NHS Foundation Trust
### 2:30 PM – 3:45 PM PT
2941 - ADT Use and Nodal Irradiation in Men Receiving Post-Prostatectomy Salvage Radiotherapy within a Statewide Radiation Oncology Quality ConsortiumLocation: Hall B2Presenter: – University of Michigan
Samuel Regan, MD – University of Michigan ### 538396###Presenter###Disclosures: Employment: University of Michigan:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 2:30 PM – 3:45 PM PT
2942 - Multidisciplinary Management of Primary Urethral Cancer with RadiotherapyLocation: Hall B2Presenter: – USF Health Morsani College of Medicine
Austin Retzloff – USF Health Morsani College of Medicine ### 1972629###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###USF Health Morsani College of Medicine###Presenter: – USF Health Morsani College of Medicine
### 2:30 PM – 3:45 PM PT
2943 - The Importance of Multi-Parametric MRI, PET/CT, and Biopsy for Identifying and Delineating the Extent of Locally Radiorecurrent Prostate Cancer: A Multi-institutional Analysis of the F-SHARP Clinical Location: Hall B2Presenter: – Loyola University Chicago Stritch School of Medicine
Dylan Ross, BS – Loyola University Chicago Stritch School of Medicine ### 1972651###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Loyola University Chicago Stritch School of Medicine###Presenter: – Loyola University Chicago Stritch School of Medicine
### 2:30 PM – 3:45 PM PT
2944 - Impact of Workflow and Educational Interventions on MR Safety in Radiation OncologyLocation: Hall B2
Rachel Sabol, MD, PhD – UCSF ### 525397###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSF###Presenter: – UCSF
### 2:30 PM – 3:45 PM PT
2945 - Long-Term Outcomes Associated with Different High-Dose-Rate Brachytherapy Dose Regimens for Favorable and Unfavorable Intermediate Risk Prostate CancerLocation: Hall B2Presenter: – Beaumont Health
Kamran Salari, MD, BS – Beaumont Health ### 1972165###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health###Presenter: – Beaumont Health
### 2:30 PM – 3:45 PM PT
2946 - Clinical Presentation and Management of Prostate Cancer in the Middle EastLocation: Hall B2Presenter: – Brigham and Women's Hospital/Dana Farber Cancer Institute
Mutlay Sayan, MD – Brigham and Women's Hospital/Dana Farber Cancer Institute ### 538368###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brigham and Women's Hospital/Dana Farber Cancer Institute###Presenter: – Brigham and Women's Hospital/Dana Farber Cancer Institute
### 2:30 PM – 3:45 PM PT
2947 - Prostate Cancer Awareness in the Middle EastLocation: Hall B2Presenter: – Brigham and Women's Hospital/Dana Farber Cancer Institute
Mutlay Sayan, MD – Brigham and Women's Hospital/Dana Farber Cancer Institute ### 538368###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brigham and Women's Hospital/Dana Farber Cancer Institute###Presenter: – Brigham and Women's Hospital/Dana Farber Cancer Institute
### 2:30 PM – 3:45 PM PT
2948 - Evaluation of Volumetric Response Assessment from Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma (RCC)Location: Hall B2Presenter: – Juravinski Cancer Centre
Daniel Schep, MD, MS – Juravinski Cancer Centre ### 1972720###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Juravinski Cancer Centre###Presenter: – Juravinski Cancer Centre
### 2:30 PM – 3:45 PM PT
2949 - Association of Radiation Facility Volume with Overall Survival in Patients with Very High Risk Prostate Cancer Treated with Radiation and Androgen Deprivation TherapyLocation: Hall B2Presenter: – Winship Cancer Institute of Emory University
Nikhil Sebastian, MD – Winship Cancer Institute of Emory University ### 538375###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Winship Cancer Institute of Emory University###Presenter: – Winship Cancer Institute of Emory University
### 2:30 PM – 3:45 PM PT
2950 - Machine Learning and Explainable Artificial Intelligence to Predict Occult Pelvic Nodal Metastases in Prostate CancerLocation: Hall B2Presenter: – City of Hope National Medical Center
Colton Ladbury, MD, BS – City of Hope National Medical Center ### 747995###Presenter###Disclosures: Employment: City of Hope National Medical Center:Resident Physician:Employee | Compensation: RefleXion Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 2:30 PM – 3:45 PM PT
2950 - Machine Learning and Explainable Artificial Intelligence to Predict Occult Pelvic Nodal Metastases in Prostate CancerLocation: Hall B2
Hemal Semwal, MS, BS ### 2134200###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2951 - Online Correction of Intrafraction Motion during Volumetric Modulated Arc Therapy for Prostate Radiotherapy: A Cohort Study Quantifying the Frequency of Shifts and Analysis of Men at Highest RiskLocation: Hall B2Presenter: – University of Chicago
Lucas Serra, MD, MS – University of Chicago ### 1972649###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago###Presenter: – University of Chicago
### 2:30 PM – 3:45 PM PT
2952 - Prophylaxis for Treatment-Induced Gynecomastia in Prostate Cancer Patients: A Network Meta-AnalysisLocation: Hall B2Presenter: – West Virginia University School of Medicine
Parvez Shaikh, MD, ScB MSHI – West Virginia University School of Medicine ### 524673###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West Virginia University School of Medicine###Presenter: – West Virginia University School of Medicine
### 2:30 PM – 3:45 PM PT
2953 - CT vs. MRI: Which is More Accurate in Grading Rectal Wall Infiltration after Hydrogel Spacer Placement for Prostate Cancer Patients?Location: Hall B2Presenter: – Allegheny General Hospital
Parisa Shamsesfandabadi, MD – Allegheny General Hospital ### 1972648###Presenter###Disclosures: Employment: Allegheny Health Network:Resident:Other | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Allegheny General Hospital###Presenter: – Allegheny General Hospital
### 2:30 PM – 3:45 PM PT
2954 - H2H Standardized Nutritional Support Management Mode Improves Nutritional Status of Patients with Head and Neck Cancer Receiving Radiotherapy: A Randomized Controlled StudyLocation: Hall B2Presenter: – Xijing Hospital Air Force Medical University
Juanli Shi – Xijing Hospital Air Force Medical University ### 1972735###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Xijing Hospital Air Force Medical University###Presenter: – Xijing Hospital Air Force Medical University
### 2:30 PM – 3:45 PM PT
2955 - Pilot Study of Peer Review in Low Middle Income Country (LMIC) through Cloud-Based PlatformLocation: Hall B2Presenter: – American Oncology Institute
Manjinder Sidhu, MD, MBBS – American Oncology Institute ### 1972695###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###American Oncology Institute###Presenter: – American Oncology Institute
### 2:30 PM – 3:45 PM PT
2956 - Comparison of Low Dose Rate and High Dose Rate Brachytherapy Boost Techniques in Prostate Cancer: Evaluation of ToxicityLocation: Hall B2Presenter: – University of Tennessee Medical Center
Andrew Skipper, MD – University of Tennessee Medical Center ### 1972682###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Tennessee Medical Center###Presenter: – University of Tennessee Medical Center
### 2:30 PM – 3:45 PM PT
2957 - PSMA PET Guided Salvage Radiotherapy Among Prostate Cancer Patients in the Post-Prostatectomy Setting: A Single Center Post-Hoc AnalysisLocation: Hall B2Presenter: – UCLA Radiation Oncology
Clayton Smith, MD – UCLA Radiation Oncology ### 537565###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 2:30 PM – 3:45 PM PT
2958 - Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate CancerLocation: Hall B2Presenter: – Virginia Mason Medical Center
Jiheon Song, MD, MS – Virginia Mason Medical Center ### 747954###Presenter######Virginia Mason Medical Center###Presenter: – Virginia Mason Medical Center
### 2:30 PM – 3:45 PM PT
2959 - Stereotactic Ablative Radiotherapy for the Treatment of Glandular Metastases from Renal Cell CarcinomaLocation: Hall B2Presenter: – UT Southwestern Medical Center
Tidie Song, BS – UT Southwestern Medical Center ### 1972686###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 2:30 PM – 3:45 PM PT
2960 - A Comparison of Treatment Plan Adaptation Methods on PTV Margin Coverage in MR-Linac Prostate SBRTLocation: Hall B2Presenter: – Allegheny Health Network
Fady Sourial, DO – Allegheny Health Network ### 1972671###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Allegheny Health Network###Presenter: – Allegheny Health Network
### 2:30 PM – 3:45 PM PT
2961 - Oncologic Outcomes of Conventionally Fractionated, Hypofractionated, and Stereotactic Body Spot-Scanned Proton Radiation Therapy for Prostate Cancer: The Mayo Clinic ExperienceLocation: Hall B2Presenter: – Mayo Clinic Arizona
Will Sperduto, MD – Mayo Clinic Arizona ### 1972688###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Arizona###Presenter: – Mayo Clinic Arizona
### 2:30 PM – 3:45 PM PT
2962 - Incident Learning in an Academic Radiation Oncology Practice During the COVID EraLocation: Hall B2
Matthew Whitmill, MD – UNC Health ### 2127941###Presenter######UNC Health###Presenter: – UNC Health
### 2:30 PM – 3:45 PM PT
2963 - Workflow Considerations for Biology-Guided Radiotherapy (BgRT) ImplementationLocation: Hall B2Presenter: – Stanford University School of Medicine
Murat Surucu, PhD – Stanford University School of Medicine ### 747898###Presenter###Disclosures: Employment: Stanford University:Chief of Clinical Physics and Clinical Assocaite Professor:Employee | Compensation: RefleXion Medical Inc.: Research Grants, Research Funding, Research Salary Support, Speaker's Bureau, Grant Research Funding, Honoraria-End Date: Present | Ownership: none | Leadership: none###Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 2:30 PM – 3:45 PM PT
2964 - Identification of a Predictive Genomic Biomarker for Prostate Directed Therapy in Synchronous Low-Volume Metastatic Castration Sensitive Prostate CancerLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Philip Sutera, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 525073###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 2:30 PM – 3:45 PM PT
2965 - Multi-Institutional Analysis of Metastasis Directed Therapy with or without Androgen Deprivation Therapy in Oligometastatic Castration Sensitive Prostate CancerLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Philip Sutera, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 525073###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 2:30 PM – 3:45 PM PT
2966 - The Impact of TP53 Mutations and Use of the TP53-Mutation-Reactivating Agent APR-246 on Metastatic Castrate-Sensitive Prostate CancerLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Philip Sutera, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 525073###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 2:30 PM – 3:45 PM PT
2967 - International Clinical Radiotherapy Audit in CCCN- iPAAC ProjectLocation: Hall B2Presenter: – Lower Silesian Oncology Center
Aleksandra Sztuder, MD – Lower Silesian Oncology Center ### 1972707###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Lower Silesian Oncology Center###Presenter: – Lower Silesian Oncology Center
### 2:30 PM – 3:45 PM PT
2968 - Effects of Radiation Doses on Clinical Recurrence in Patients with Biochemically Recurrent Prostate Cancer after ProstatectomyLocation: Hall B2Presenter: – Nagoya City University Graduate School of Medical Sciences
Seiya Takano, MD – Nagoya City University Graduate School of Medical Sciences ### 2043628###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Nagoya City University Graduate School of Medical Sciences###Presenter: – Nagoya City University Graduate School of Medical Sciences
### 2:30 PM – 3:45 PM PT
2969 - A Systematic Review and Network Meta-Analysis Assessing the Impact of Adding First Generation Non-Steroidal Anti-Androgens (NSAA) to LHRH Agonists (LHRHa) in Men Receiving Radiotherapy for Localized PLocation: Hall B2Presenter: – University of Michigan
Jamie Takayesu, MD – University of Michigan ### 1972368###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 2:30 PM – 3:45 PM PT
2970 - A Prospective, Multi-Institutional Study of Problematic Plan Detection during Physician Chart RoundsLocation: Hall B2Presenter: – Northwell Health Center for Advanced Medicine
Wesley Talcott, MD, MBA – Northwell Health Center for Advanced Medicine ### 746575###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Northwell Health Center for Advanced Medicine###Presenter: – Northwell Health Center for Advanced Medicine
### 2:30 PM – 3:45 PM PT
2971 - Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update from the FASTR/FASTR-2 TrialsLocation: Hall B2Presenter: – London Health Sciences Centre
Terence Tang, MD – London Health Sciences Centre ### 1972737###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###London Health Sciences Centre###Presenter: – London Health Sciences Centre
### 2:30 PM – 3:45 PM PT
2972 - Diagnostic Performance of 18F-rhPSMA-7.3 PET in Men with Newly Diagnosed High-Risk Prostate Cancer and Negative Conventional ImagingLocation: Hall B2
Phillip Kuo, MD, PhD ### 2032950###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2973 - Success of Liquid Tumor Biopsy in Men with Metastatic Prostate Cancer According to Self-Identified RaceLocation: Hall B2Presenter: – UCLA Radiation Oncology
Luca Valle, MD – UCLA Radiation Oncology ### 525273###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 2:30 PM – 3:45 PM PT
2974 - Did COVID-19 Have an Impact on Incident Leaning? Implications for Patient SafetyLocation: Hall B2
Matthew Volpini, MD ### 1972713###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2975 - Trial in Progress: Adaptive RADiation Therapy with Concurrent Sacituzumab Govitecan (SG) for Bladder Preservation in Patients with MIBC (RAD-SG)Location: Hall B2Presenter: – Cleveland Clinic Foundation
Winston Vuong, MD – Cleveland Clinic Foundation ### 1996706###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 2:30 PM – 3:45 PM PT
2976 - Gastrointestinal Toxicity Following Proton and Photon Radiation for Prostate Cancer in Patients with Inflammatory Bowel DiseaseLocation: Hall B2Presenter: – University of Washington
Loise Wairiri, MD – University of Washington ### 1972668###Presenter###Disclosures: Employment: University of Washington:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 2:30 PM – 3:45 PM PT
2977 - Investigating Incidence of Nausea and Vomiting in Patients Receiving Concurrent Chemoradiotherapy: A Real World Cohort StudyLocation: Hall B2
Lili Wang, BS ### 1972632###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2978 - The Need for Patience When Making Operational Changes to Address QualityLocation: Hall B2Presenter: – UNC School of Medicine
Ashley Weiner, MD, PhD – UNC School of Medicine ### 1972710###Presenter###Disclosures: Employment: University of North Carolina:Assistant Professor:Employee | Compensation: EmpNia: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: present ;Varian: Consultant-End Date: present | Ownership: none | Leadership: none###UNC School of Medicine###Presenter: – UNC School of Medicine
### 2:30 PM – 3:45 PM PT
2980 - Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate CancerLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Amy Wisdom, MD, PhD – Harvard Radiation Oncology Program ### 1972370###Presenter###Disclosures: Employment: Massachusetts General Hospital/Brigham and Women's Hospital/Dana Farber Cancer Institute:Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 2:30 PM – 3:45 PM PT
2981 - Pilot Study of a Novel Ring Gantry-Based PET/CT Linear Accelerator in Patients with Prostate Cancer Receiving [18F]-DCFPyL for PSMA PET ImagingLocation: Hall B2Presenter: – City of Hope National Medical Center
Jeffrey Wong, MD, FASTRO – City of Hope National Medical Center ### 535883###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 2:30 PM – 3:45 PM PT
2982 - A Pilot Study of an Interactive Virtual Tour Tool for Patient Education Prior to Undergoing High-Dose Rate Brachytherapy for Prostate CancerLocation: Hall B2Presenter: – Stanford University
Yufan (Fred) Wu, MD, BS – Stanford University ### 1972219###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 2:30 PM – 3:45 PM PT
2983 - Can SGRT be a Substitute for Plan Verification Procedure?Location: Hall B2
Geng Xu, BS ### 1972700###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 2:30 PM – 3:45 PM PT
2985 - Association between Artificial Intelligence-Derived Tumor Volume and Oncologic Outcomes for Localized Prostate Cancer Treated with Radiation TherapyLocation: Hall B2Presenter: – Brigham and Womens Hopsital
Martin King, MD, PhD – Brigham and Womens Hopsital ### 525487###Presenter###Disclosures: Employment: Brigham and Women's Physician's Organization:Physician:Employee | Compensation: Bayer Healthcare: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Ongoing ;Palette Life Sciences: Grant Research Funding, Salary Support-End Date: To present | Ownership: none | Leadership: none###Brigham and Womens Hopsital###Presenter: – Brigham and Womens Hopsital
### 2:30 PM – 3:45 PM PT
2985 - Association between Artificial Intelligence-Derived Tumor Volume and Oncologic Outcomes for Localized Prostate Cancer Treated with Radiation TherapyLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
David Yang, MD – Harvard Radiation Oncology Program ### 525288###Presenter######Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 2:30 PM – 3:45 PM PT
2986 - The Effectiveness of Music Interventions for Improving Anxiety Symptoms in Cancer Patients Undergoing Radiation TherapyLocation: Hall B2Presenter: – Chung Shan Medical University Hospital
Huei Fang Yang, BS, RN – Chung Shan Medical University Hospital ### 1972698###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chung Shan Medical University Hospital###Presenter: – Chung Shan Medical University Hospital
### 2:30 PM – 3:45 PM PT
2987 - Coping Strategies among Filipino Cancer Patients Undergoing Radiation Therapy in Two Tertiary Care Hospitals in the Philippines: An Analytical Cross-Sectional StudyLocation: Hall B2Presenter: – St. Luke's Medical Center
Jose Ma. Zaldarriaga, MD, MBA – St. Luke's Medical Center ### 1995807###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###St. Luke's Medical Center###Presenter: – St. Luke's Medical Center
### 2:30 PM – 3:45 PM PT
2988 - Use of Focal Radiotherapy Boost for Prostate Cancer and Perceived Barriers toward its Implementation: A SurveyLocation: Hall B2Presenter: – University of California, San Diego Health System
Allison Zhong, BA – University of California, San Diego Health System ### 1972665###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, San Diego Health System###Presenter: – University of California, San Diego Health System
### 2:30 PM – 3:45 PM PT
2989 - Clinical Impact of Contouring Variability for Prostate Cancer Tumor BoostLocation: Hall B2Presenter: – University of California, San Diego Health System
Allison Zhong, BA – University of California, San Diego Health System ### 1972665###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, San Diego Health System###Presenter: – University of California, San Diego Health System
### 2:30 PM – 3:45 PM PT
2990 - Ten-Year Outcomes of Hypofractionated (45 Gy in 9 Fractions) Intensity Modulated Radiotherapy for Localized Prostate CancerLocation: Hall B2
Sijin Zhong, MD ### 1972644###Presenter#########Presenter:
### 4:00 PM – 5:00 PM PT
2991 - Outcomes of Bridging and Salvage Radiotherapy in Relapsed or Refractory Mantle Cell Lymphoma Patients Undergoing CD19-Targeted CAR T-Cell TherapyLocation: Hall B2Presenter: – Massachusetts General Hospital
Hazim Ababneh, MD – Massachusetts General Hospital ### 1972391###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 4:00 PM – 5:00 PM PT
2992 - Development of Population-Based Pediatric Computational Phantoms for Radiotherapy ApplicationsLocation: Hall B2Presenter: – University College London
Catarina Veiga, PhD – University College London ### 524913###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University College London###Presenter: – University College London
### 4:00 PM – 5:00 PM PT
2993 - Racial and Ethnic Disparities in Health-Related Quality of Life in Older Adults with Non-Hodgkin LymphomaLocation: Hall B2Presenter: – Drexel University College of Medicine
Wisdom Akingbemi, BS – Drexel University College of Medicine ### 1972789###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Drexel University College of Medicine###Presenter: – Drexel University College of Medicine
### 4:00 PM – 5:00 PM PT
2994 - Hypofractionated Radiotherapy for Hematological Malignancies during COVID-19 Pandemic and BeyondLocation: Hall B2Presenter: – Cancercare Manitoba
Arbind Dubey, FRCPC – Cancercare Manitoba ### 2011576###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancercare Manitoba###Presenter: – Cancercare Manitoba
### 4:00 PM – 5:00 PM PT
2995 - Intelligent Interactive Deformable Image Registration for Online Adaptive RadiotherapyLocation: Hall B2
Ti Bai, PhD ### 1972803###Presenter#########Presenter:
### 4:00 PM – 5:00 PM PT
2995 - Intelligent Interactive Deformable Image Registration for Online Adaptive RadiotherapyLocation: Hall B2Presenter: – UT-Southwestern Medical Center
Weiguo Lu, PhD – UT-Southwestern Medical Center ### 524937###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT-Southwestern Medical Center###Presenter: – UT-Southwestern Medical Center
### 4:00 PM – 5:00 PM PT
2996 - Low Dose Splenic Radiotherapy for Myeloproliferative Neoplasms prior to Allogeneic Hematopoietic Stem Cell TransplantLocation: Hall B2Presenter: – Stanford University
Claire Baniel, MD – Stanford University ### 746677###Presenter###Disclosures: Employment: Stanford University:Resident physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: Society for Women in Radiation Oncology:Vice Chair;Stanford Resident Safety Council:Co-Chair###Stanford University###Presenter: – Stanford University
### 4:00 PM – 5:00 PM PT
2997 - Clinical Implementation and Evaluation of Automated Contouring for Breast MalignanciesLocation: Hall B2Presenter: – University of Alabama at Birmingham
Andrew Bonner, BS – University of Alabama at Birmingham ### 1972784###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alabama at Birmingham###Presenter: – University of Alabama at Birmingham
### 4:00 PM – 5:00 PM PT
2998 - Local Control after Low-Dose Radiation for Two Rare Forms of Indolent Non-Hodgkin LymphomaLocation: Hall B2Presenter: – Mayo Clinic College of Medicine and Science Rochester
Jessica Burlile, MD – Mayo Clinic College of Medicine and Science Rochester ### 854851###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic College of Medicine and Science Rochester###Presenter: – Mayo Clinic College of Medicine and Science Rochester
### 4:00 PM – 5:00 PM PT
2999 - Salvage Radiotherapy as a Bridge for Relapsed Secondary CNS LymphomaLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Gustav Cederquist, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1972756###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:00 PM – 5:00 PM PT
3000 - Outcomes and Toxicities in Patients with Diffuse Large B-Cell Lymphoma of the Gastrointestinal TractLocation: Hall B2Presenter: – MD Anderson Cancer Center
Elaine Cha, MD – MD Anderson Cancer Center ### 1972755###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:00 PM – 5:00 PM PT
3001 - Demystifying the Role of Radiation Dose Bath in Brain Injury Using Machine LearningLocation: Hall B2Presenter: – Massachusetts General Hospital
Annie Chan, MD – Massachusetts General Hospital ### 525096###Presenter###Disclosures: Employment: MGH:physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Massachusetts General Hospital###Presenter: – Massachusetts General Hospital
### 4:00 PM – 5:00 PM PT
3002 - Identifying Common Topics in Patient Portal Messages with Unsupervised Natural Language ProcessingLocation: Hall B2Presenter: – Seoul National University Hospital
Ji Hyun Chang, MD, PhD – Seoul National University Hospital ### 746721###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University Hospital###Presenter: – Seoul National University Hospital
### 4:00 PM – 5:00 PM PT
3003 - Homeostatic Balance of Gut Microbiota in Head and Neck Squamous Cell Carcinoma Patients during RadiotherapyLocation: Hall B2Presenter: – The First Affiliated Hospital of Zhejiang University Medical College
Ying Chen, MD – The First Affiliated Hospital of Zhejiang University Medical College ### 1972779###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The First Affiliated Hospital of Zhejiang University Medical College###Presenter: – The First Affiliated Hospital of Zhejiang University Medical College
### 4:00 PM – 5:00 PM PT
3004 - Whole Regional Lymph Node Area Delineation with Deep Learning Model for Total Marrow and Lymphoid IrradiationLocation: Hall B2Presenter: – Seoul National University College of Medicine
Hyeonseok Choi, BS – Seoul National University College of Medicine ### 1972744###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University College of Medicine###Presenter: – Seoul National University College of Medicine
### 4:00 PM – 5:00 PM PT
3005 - Novel Deep Learning Segmentation Models for Accurate GTV and OAR Segmentation in MR-Guided Adaptive Radiotherapy for Pancreatic Cancer PatientsLocation: Hall B2Presenter: – Thomas Jefferson University
Wookjin Choi, PhD – Thomas Jefferson University ### 525117###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 4:00 PM – 5:00 PM PT
3006 - Predicting Treatment Response of Esophageal Cancer Treated by Concurrent Chemoradiotherapy using Pre- and Posttreatment 18F-FDG PET Metabolic CharacteristicsLocation: Hall B2Presenter: – Chung Shan Medical University Hospital
Ying-Hsiang Chou, MD, PhD, MBA – Chung Shan Medical University Hospital ### 538305###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chung Shan Medical University Hospital###Presenter: – Chung Shan Medical University Hospital
### 4:00 PM – 5:00 PM PT
3007 - Feasibility and Acceptability of ChatGPT Generated Radiology Report Summaries for Cancer PatientsLocation: Hall B2Presenter: – Cedars-Sinai Medical Center
Eric Chung, MD, MS – Cedars-Sinai Medical Center ### 538475###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 4:00 PM – 5:00 PM PT
3009 - Prevalence of Non-Hodgkin Lymphoma Patients at High Risk of Failure after CAR T-Cell Therapy Eligible for Bridging Radiation TherapyLocation: Hall B2Presenter: – St. Josephs Health/RCCA Hackensack Division
Adnan Danish, MD – St. Josephs Health/RCCA Hackensack Division ### 1972752###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###St. Josephs Health/RCCA Hackensack Division###Presenter: – St. Josephs Health/RCCA Hackensack Division
### 4:00 PM – 5:00 PM PT
3010 - Interpretable Machine Learning for Predicting Symptomatic Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Immune Checkpoint Inhibitor Location: Hall B2Presenter: – University of Pennsylvania
Lian Duan, MS, BS – University of Pennsylvania ### 1972801###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 4:00 PM – 5:00 PM PT
3011 - Craniospinal Irradiation for CNS Leukemia: Rates of Response and Durability of CNS ControlLocation: Hall B2Presenter: – University of Washington
Maryam Ebadi, MD – University of Washington ### 1972743###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 4:00 PM – 5:00 PM PT
3012 - Significance of Radiomics in Predicting Local Control for Patients with Malignant Liver Tumors Treated Using Stereotactic Body RadiotherapyLocation: Hall B2Presenter: – Cross Cancer Institute
Arun Elangovan, MD – Cross Cancer Institute ### 2037839###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cross Cancer Institute###Presenter: – Cross Cancer Institute
### 4:00 PM – 5:00 PM PT
3013 - An MRI-Based Convolutional Neural Network to Predict Biochemical Recurrence Following Radiotherapy for Intermediate and High-Risk Localized Prostate CancerLocation: Hall B2Presenter: – The Ottawa Hospital, University of Ottawa
Scott Morgan, MD, MSc, FRCPC – The Ottawa Hospital, University of Ottawa ### 535627###Presenter###Disclosures: Employment: The Ottawa Hospital:Radiation Oncologist:Independent Contractor | Compensation: Bayer: Consultant, Honoraria-End Date: November 2021 ;Knight Therapeutics Inc.: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;NRG Oncology: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: none | Leadership: none###The Ottawa Hospital, University of Ottawa###Presenter: – The Ottawa Hospital, University of Ottawa
### 4:00 PM – 5:00 PM PT
3014 - Dosimetric Advantages of VMAT TBI Plans: A Direct Comparison to Conventional TBI PlansLocation: Hall B2Presenter: – Indiana University School of Medicine
Samantha Freije, MD – Indiana University School of Medicine ### 747731###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Indiana University School of Medicine###Presenter: – Indiana University School of Medicine
### 4:00 PM – 5:00 PM PT
3015 - Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic DiseaseLocation: Hall B2Presenter: – University Health Network
Caryn Geady, MS, BS – University Health Network ### 1972762###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Health Network###Presenter: – University Health Network
### 4:00 PM – 5:00 PM PT
3016 - CT Based Tumor Radiomics with Machine Learning Classifiers for Molecular Subtyping of Diffuse Large B Cell LymphomaLocation: Hall B2Presenter: – Tata Memorial Centre
Jayant Goda, MD – Tata Memorial Centre ### 1972793###Presenter######Tata Memorial Centre###Presenter: – Tata Memorial Centre
### 4:00 PM – 5:00 PM PT
3017 - Development of a Machine Learning Model to Evaluate Changes during Radiotherapy in Cervical Cancer Tumor CellsLocation: Hall B2Presenter: – University of Tsukuba
Masaaki Goto, MD – University of Tsukuba ### 1972764###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Tsukuba###Presenter: – University of Tsukuba
### 4:00 PM – 5:00 PM PT
3019 - Multimodality deep learning fusion methods for predicting mandibular osteoradionecrosis incidenceLocation: Hall B2Presenter: – MD Anderson Cancer Center
Laia Humbert-Vidan, PhD – MD Anderson Cancer Center ### 1972759###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:00 PM – 5:00 PM PT
3020 - Development of a Radiomic Signature from Pre-Treatment FDG-PET for Recurrence Prediction in Cervical CancerLocation: Hall B2Presenter: – Washington University
Matthew Inkman, MS – Washington University ### 1972772###Presenter###Disclosures: Employment: Washington University in St. Louis:Bioinformaticist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Washington University###Presenter: – Washington University
### 4:00 PM – 5:00 PM PT
3021 - Developing a Word Lexicon from Electronic Health Records for Natural Language Processing Analysis of Free-Text Reports for Patients with Venous ThromboembolismLocation: Hall B2
Sarisha Jagasia, BS ### 1972758###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3022 - Outcomes of Proton Therapy for Patients with Infradiaphragmatic LymphomaLocation: Hall B2Presenter: – University of Pennsylvania
Cecilia Jiang, MD – University of Pennsylvania ### 747351###Presenter###Disclosures: Employment: University of Pennsylvania:Resident physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 4:00 PM – 5:00 PM PT
3023 - AI Beam Angle Prediction in Proton Therapy for Brain PatientsLocation: Hall B2Presenter: – University of Miami Sylvester Comprehensive Cancer Center
Robert Kaderka, PhD – University of Miami Sylvester Comprehensive Cancer Center ### 525044###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami Sylvester Comprehensive Cancer Center###Presenter: – University of Miami Sylvester Comprehensive Cancer Center
### 4:00 PM – 5:00 PM PT
3024 - A Nomogram Based on Pretreatment Radiomics and Dosiomics Features for Predicting Overall Survival for Esophageal Squamous Cell Cancer: Multi-Institutional StudyLocation: Hall B2Presenter: – Hiroshima University
Daisuke Kawahara, PhD – Hiroshima University ### 746654###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hiroshima University###Presenter: – Hiroshima University
### 4:00 PM – 5:00 PM PT
3025 - Treatment of Mantle and Inverted Y Fields in Modern Era: A VMAT ApproachLocation: Hall B2Presenter: – Northwestern Memorial Hospital
Gocha Khelashvili, PhD – Northwestern Memorial Hospital ### 1972742###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwestern Memorial Hospital###Presenter: – Northwestern Memorial Hospital
### 4:00 PM – 5:00 PM PT
3026 - Impact of Salvage Versus Palliative Dose Bridging Radiation Therapy on Local Control and Overall Survival in Patients with DLBCL Receiving CD19 CAR T Cell TherapyLocation: Hall B2Presenter: – Washington University/B-JH/SLCH Consortium
Kendall Kiser, MD, MS – Washington University/B-JH/SLCH Consortium ### 747924###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University/B-JH/SLCH Consortium###Presenter: – Washington University/B-JH/SLCH Consortium
### 4:00 PM – 5:00 PM PT
3027 - A Generalized Deep Learning Method for Synthetic CT GenerationLocation: Hall B2
Lingke Kong, DO, MBBS ### 1972787###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3028 - Utility of the "All of Us" Database for Radiation Oncology ResearchLocation: Hall B2Presenter: – George Washington University School of Medicine
Jason Krastein, BS – George Washington University School of Medicine ### 1972775###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###George Washington University School of Medicine###Presenter: – George Washington University School of Medicine
### 4:00 PM – 5:00 PM PT
3029 - The Value of Equivalent Dose Calculation for Dosiomics and Radiomics-Based Prediction of Pneumonitis after Thoracic Radiotherapy with Immune Checkpoint InhibitionLocation: Hall B2Poster Presenter: – Technical University Munich
Jan Peeken, MD – Technical University Munich ### 791594###Poster Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Technical University Munich###Poster Presenter: – Technical University Munich
### 4:00 PM – 5:00 PM PT
3030 - Integration of an App-based Cognitive Evaluation Program into Radiosurgery Practice: Outcomes and Patient Survey Analysis from a Prospective Observational StudyLocation: Hall B2Presenter: – Baptist Health South Florida
Tugce Kutuk, MD – Baptist Health South Florida ### 537429###Presenter###Disclosures: Employment: Baptist Health South Florida:Research Associate:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Baptist Health South Florida###Presenter: – Baptist Health South Florida
### 4:00 PM – 5:00 PM PT
3031 - The Theoretical Role for Radiotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Secondary Analysis of a Prospective Randomized Controlled TrialLocation: Hall B2Presenter: – Wake Forest School of Medicine
Claire Lanier, MD – Wake Forest School of Medicine ### 535894###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Wake Forest School of Medicine###Presenter: – Wake Forest School of Medicine
### 4:00 PM – 5:00 PM PT
3032 - Early Prediction of Radiation Treatment Response via Longitudinal Analysis of CBCT Radiomic Features for Locally Advanced Rectal CancerLocation: Hall B2
Zi Rong Li, BS ### 1972786###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3033 - Deep Learning-Based Synthesis of Contrast-Enhanced MRI for Automated Delineation of Primary Gross Tumor Volume in Radiotherapy of Nasopharyngeal CarcinomaLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Li Lin, MD, PhD – Sun Yat-Sen University Cancer Center ### 535809###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 4:00 PM – 5:00 PM PT
3035 - Objective Boundary Generation for Gross Target Volume and Organs at Risk Using 3D Multi-Modal Medical ImagesLocation: Hall B2
Xiao Liu, MS ### 1972785###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3036 - Automated Detection, Segmentation, and Tracking of Brain Metastases in Repeated Courses of Stereotactic Radiosurgery Using Integrated Artificial IntelligenceLocation: Hall B2Presenter: – National Taiwan University Hospital
Wen-Chi Yang, MD – National Taiwan University Hospital ### 538402###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Taiwan University Hospital###Presenter: – National Taiwan University Hospital
### 4:00 PM – 5:00 PM PT
3037 - Optimizing the Combination of Cytotoxic Drugs Along with Radiotherapy as Effective Treatment for Extranodal NK/T-Cell LymphomaLocation: Hall B2
Fei Luo ### 1972749###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3038 - Thirty-Year Experience of Radiotherapy for Primary Intraocular Lymphoma with and without ChemotherapyLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Nikhil Mankuzhy, MD – Memorial Sloan Kettering Cancer Center ### 747670###Presenter###Disclosures: Employment: Memorial Sloan Kettering Cancer Center:Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:00 PM – 5:00 PM PT
3039 - Cardiac Sparing with Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (CS VMAT-TBI)Location: Hall B2Presenter: – UT Southwestern Medical Center
Steven Montalvo, MD – UT Southwestern Medical Center ### 1972233###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 4:00 PM – 5:00 PM PT
3040 - Combining obinutuzumab with Radiation for Treatment Refractory Diffuse Large B Cell Lymphoma: Retrospective Safety and Efficacy AnalysisLocation: Hall B2Presenter: – University of Wisconsin
Brett Morris, MD, PhD – University of Wisconsin ### 525241###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin###Presenter: – University of Wisconsin
### 4:00 PM – 5:00 PM PT
3041 - Webapp for Data Recollection and Presentation in a Head and Neck Tumor BoardLocation: Hall B2Presenter: – Hospital Universitario
Jose Felipe Munoz Lozano, MD – Hospital Universitario ### 1972042###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Universitario###Presenter: – Hospital Universitario
### 4:00 PM – 5:00 PM PT
3042 - Outcomes of Patients with Transformed Diffuse Large B-Cell Lymphoma (DLBCL)Location: Hall B2Presenter: – Moffitt Cancer Center
Justyn Nakashima, DO – Moffitt Cancer Center ### 2122125###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Moffitt Cancer Center###Presenter: – Moffitt Cancer Center
### 4:00 PM – 5:00 PM PT
3043 - Low Dose Involved Site Radiotherapy as Single Modality Treatment for Early Stage Nodular Lymphocyte Predominant Hodgkin LymphomaLocation: Hall B2Poster Presenter: – Mount Vernon Hospital
Peter Hoskin, MD – Mount Vernon Hospital ### 524448###Poster Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mount Vernon Hospital###Poster Presenter: – Mount Vernon Hospital
### 4:00 PM – 5:00 PM PT
3044 - Prediction of Radiomics-Based Machine Learning for Specific Dosimetric Verification of Pelvic Intensity Modulated RadiotherapyLocation: Hall B2
Qianxi Ni, PhD ### 1972757###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3045 - Investigating PET Responses to Treatment in Nodular Lymphocyte-Predominant Hodgkin LymphomaLocation: Hall B2Presenter: – Stanford University School of Medicine
Natalie Park, BA – Stanford University School of Medicine ### 1972753###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 4:00 PM – 5:00 PM PT
3046 - Deep Learning vs. Handcrafted Radiomics to Predict Chemoradiotherapy Response for Locally Advanced Cervical CancerLocation: Hall B2Presenter: – Korea, Republic of
Shin-Hyung Park, MD, PhD – Korea, Republic of ### 1972761###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Korea, Republic of###Presenter: – Korea, Republic of
### 4:00 PM – 5:00 PM PT
3047 - A Photograph-Based Visualization and Prediction Framework for Radiation-Induced DermatitisLocation: Hall B2
Ye-In Park, MS ### 1972788###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3048 - Predicting Complete Response after Chemoradiation in Patients with Localized Rectal CancerLocation: Hall B2Presenter: – Hospital Universitario Fundacion Jimenez Diaz
Ignacio Azinovic Gamo, PhD – Hospital Universitario Fundacion Jimenez Diaz ### 2117581###Presenter######Hospital Universitario Fundacion Jimenez Diaz###Presenter: – Hospital Universitario Fundacion Jimenez Diaz
### 4:00 PM – 5:00 PM PT
3049 - Clinical Evaluation of Deep Learning-Based Auto-Segmentation toward MRI-Only Prostate RadiotherapyLocation: Hall B2Presenter: – University of Florida
James Perez-Sanchez, MS – University of Florida ### 1972770###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida###Presenter: – University of Florida
### 4:00 PM – 5:00 PM PT
3049 - Clinical Evaluation of Deep Learning-Based Auto-Segmentation toward MRI-Only Prostate RadiotherapyLocation: Hall B2Presenter: – University of Florida
Chihray Liu, PhD – University of Florida ### 2131440###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida###Presenter: – University of Florida
### 4:00 PM – 5:00 PM PT
3050 - The Microvascular Network Density and Morphology Affect the Radiotherapy Outcome at the Microscale Level: A Computational AnalysisLocation: Hall B2Presenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
Tiziana Rancati, MS – Fondazione IRCCS - Istituto Nazionale dei Tumori ### 747410###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fondazione IRCCS - Istituto Nazionale dei Tumori###Presenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
### 4:00 PM – 5:00 PM PT
3051 - Interdigitation of Radiation Earlier in the Multimodal Treatment of Patients with Lymphoma: The Effect on Opiate Analgesic RequirementsLocation: Hall B2Presenter: – University of Chicago Medicine
Greeshma Rajeev-Kumar, MD – University of Chicago Medicine ### 575517###Presenter###Disclosures: Employment: University of Chicago:Radiation Oncology Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Chicago Medicine###Presenter: – University of Chicago Medicine
### 4:00 PM – 5:00 PM PT
3052 - Development and Validation of a Deep Learning-Based Auto-Delineation of Target Volume and Organs at Risk in Pancreatic Cancer RadiotherapyLocation: Hall B2Presenter: – Air Force Medical Center
Gang Ren, MD – Air Force Medical Center ### 1972776###Presenter######Air Force Medical Center###Presenter: – Air Force Medical Center
### 4:00 PM – 5:00 PM PT
3053 - Man vs. Machine (Learning): Comparing Speed and Cost-Effectiveness of Manual vs. Deep Learning Segmentation-Aided Volume Delineation for Head and Neck Lymph Node TargetsLocation: Hall B2Presenter: – University of Mississippi Medical Center
Paul Roberts, MD, BS – University of Mississippi Medical Center ### 1972795###Presenter######University of Mississippi Medical Center###Presenter: – University of Mississippi Medical Center
### 4:00 PM – 5:00 PM PT
3053 - Man vs. Machine (Learning): Comparing Speed and Cost-Effectiveness of Manual vs. Deep Learning Segmentation-Aided Volume Delineation for Head and Neck Lymph Node TargetsLocation: Hall B2Presenter: – University of MS Medical Center
William Duggar, PhD – University of MS Medical Center ### 2135674###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of MS Medical Center###Presenter: – University of MS Medical Center
### 4:00 PM – 5:00 PM PT
3054 - Outcomes with Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Pts with Aggressive B Cell LymphomasLocation: Hall B2Presenter: – MD Anderson Cancer Center
Michael Rooney, MD – MD Anderson Cancer Center ### 747053###Presenter###Disclosures: Employment: MD Anderson Cancer Center:Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:00 PM – 5:00 PM PT
3055 - Machine Learning for the Prediction of Adverse Pathological Outcomes in Patients Treated with Radical ProstatectomyLocation: Hall B2Presenter: – University of California San Francisco
Ali Sabbagh, MD – University of California San Francisco ### 1972800###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 4:00 PM – 5:00 PM PT
3056 - Machine Learning for the Prediction of Biochemical Recurrence in Patients Treated with Radical ProstatectomyLocation: Hall B2Presenter: – University of California San Francisco
Ali Sabbagh, MD – University of California San Francisco ### 1972800###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 4:00 PM – 5:00 PM PT
3057 - The Role of Radiation Therapy in the Management of Gray Zone LymphomaLocation: Hall B2Presenter: – Mayo Clinic Florida
Omran Saifi, MD – Mayo Clinic Florida ### 1971997###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Florida###Presenter: – Mayo Clinic Florida
### 4:00 PM – 5:00 PM PT
3058 - Automated Small Tumor Segmentation by a Template-Based Global Hierarchical Attention MethodLocation: Hall B2Presenter: – Stanford University
Shengtian Sang, PhD – Stanford University ### 1972781###Presenter######Stanford University###Presenter: – Stanford University
### 4:00 PM – 5:00 PM PT
3060 - Developing an Online Interactive Volumetric Surface Viewer for Visualizing Spatial Distribution of Intracranial LesionsLocation: Hall B2Presenter: – UCLA Radiation Oncology
Ricky Savjani, MD, PhD – UCLA Radiation Oncology ### 1972797###Presenter###Disclosures: Employment: UCLA:Resident Physician:Employee | Compensation: Varian - A Siemens Healthineers Company: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 06/30/2021 | Ownership: none | Leadership: none###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 4:00 PM – 5:00 PM PT
3061 - Dorsal Column Myelopathy Following Intrathecal Chemotherapy for LeukemiaLocation: Hall B2Presenter: – MD Anderson Cancer Center
Benjamin Schrank, MD, PhD – MD Anderson Cancer Center ### 1972198###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:00 PM – 5:00 PM PT
3062 - Radiation Oncology Practice Changes during the COVID-19 PandemicLocation: Hall B2Presenter: – MD Anderson Cancer Center
Aaron Seo, MD, PhD – MD Anderson Cancer Center ### 1972798###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:00 PM – 5:00 PM PT
3063 - Global Plan Check: A Software to Register and Analyze Dose Distribution Independent from Treatment Planning SystemsLocation: Hall B2Presenter: – Ege University School of Medicine
Fatma Sert – Ege University School of Medicine ### 1972792###Presenter######Ege University School of Medicine###Presenter: – Ege University School of Medicine
### 4:00 PM – 5:00 PM PT
3064 - Clinical prior Knowledge-Based One-Shot Learning for Automatic Delineation of Clinical Target Volumes in Adaptation Radiotherapy of Cervical CancerLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Shuai Sun, MD, PhD – Peking Union Medical College Hospital ### 1972778###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### 4:00 PM – 5:00 PM PT
3065 - A Multicenter Study on Deep Learning for Glioblastoma Auto-Segmentation with Prior Knowledge in Multimodal ImagingLocation: Hall B2Presenter: – Peking University Third Hospital
Suqing Tian, MD – Peking University Third Hospital ### 1972774###Presenter######Peking University Third Hospital###Presenter: – Peking University Third Hospital
### 4:00 PM – 5:00 PM PT
3066 - Risk of Cardiac-Specific Mortality in Patients with Lymphoma Treated with RadiotherapyLocation: Hall B2Presenter: – University of Utah
Eduardo Urias, MD, MBA – University of Utah ### 1972751###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Utah###Presenter: – University of Utah
### 4:00 PM – 5:00 PM PT
3067 - Evaluation of Observer Variation as Natural Experiment to Detect Sensitive Heart SubregionsLocation: Hall B2Presenter: – University of Manchester
Marcellinus van Herk, PhD – University of Manchester ### 2055985###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Manchester###Presenter: – University of Manchester
### 4:00 PM – 5:00 PM PT
3068 - Deep Learning-Based Quality Assurance for Auto-Segmentation Masks in RadiotherapyLocation: Hall B2Presenter: – UT Southwestern Medical Center
Mu-Han Lin, PhD – UT Southwestern Medical Center ### 746652###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 4:00 PM – 5:00 PM PT
3069 - Interpretable Machine Learning Models for Severe Esophagitis Prediction in LA-NSCLC Patients Treated with Chemoradiation TherapyLocation: Hall B2Presenter: – Hospital of the University of Pennsylvania
Du Wang, MS – Hospital of the University of Pennsylvania ### 1972804###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital of the University of Pennsylvania###Presenter: – Hospital of the University of Pennsylvania
### 4:00 PM – 5:00 PM PT
3070 - Prospective Clinical Adoption of Artificial Intelligence for Organ Contouring in Head and Neck Radiation Treatment PlanningLocation: Hall B2Presenter: – Stanford University School of Medicine
Jen-Yeu Wang, BS – Stanford University School of Medicine ### 1972791###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 4:00 PM – 5:00 PM PT
3071 - Develop a Deep Radiomics Model for Predicting the Response to Neoadjuvant Chemoradiotherapy (nCRT) in Patients with Locally Advanced Esophageal Cancer Using Three-Stage Longitudinal CT ImagesLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute ### 2094333###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 4:00 PM – 5:00 PM PT
3072 - Treatment Outcomes and Prognostic Factors of Chemotherapy Combined with Radiotherapy for Patients with Stage I-II Nasal-Type Natural Killer/T-Cell LymphomaLocation: Hall B2
Shubei Wang, MD ### 537642###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3073 - Radiotherapy Effect on Long-Term Net Survival Benefit for Early-Stage Diffuse Large B-Cell Lymphoma in the Rituximab EraLocation: Hall B2
Xin Wang, MD ### 1972747###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3074 - Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the LungLocation: Hall B2Presenter: – MD Anderson Cancer Center
Susan Wu, MD – MD Anderson Cancer Center ### 525285###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:00 PM – 5:00 PM PT
3075 - Association of Treatment Disparities and Primary Sites with the Survival of Non-Gastric Early-Stage MALT LymphomaLocation: Hall B2Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
Yunpeng Wu, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital ### 1972746###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital###Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
### 4:00 PM – 5:00 PM PT
3076 - Evaluating the Performance of ChatGPT at Breast Tumor BoardLocation: Hall B2Presenter: – Alberta Health Services
Yang Xu, MD – Alberta Health Services ### 1972790###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Alberta Health Services###Presenter: – Alberta Health Services
### 4:00 PM – 5:00 PM PT
3077 - Dosimetric Quality of Artificial Intelligence Based Organ at Risk SegmentationLocation: Hall B2Presenter: – Cleveland Clinic Taussig Cancer Center
Chenyu Yan, PhD – Cleveland Clinic Taussig Cancer Center ### 1972796###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 4:00 PM – 5:00 PM PT
3078 - A Cascaded Deep Learning-Based Cardiac Substructures Segmentation Frame and on Non-Gated Non-Enhanced Planning CT Scans in Breast Cancer PatientsLocation: Hall B2
Jing Yang, MB ### 1972397###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:00 PM – 5:00 PM PT
3079 - Feasibility of Using Pseudo-CT for Dosimetry, Radiomics, and Efficacy Assessment in IMRT/VMAT of Brain Tumors: A Multi-Omics AnalysisLocation: Hall B2Presenter: – Chongqing University Cancer Hospital
Xin Yang, MS – Chongqing University Cancer Hospital ### 1972773###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###Presenter: – Chongqing University Cancer Hospital
### 4:00 PM – 5:00 PM PT
3080 - CAU-Net: An Improved Attention U-Net for CT Head and Neck Organs at Risk ContouringLocation: Hall B2
Xin Yang, PhD ### 1972777###Presenter#########Presenter:
### 4:00 PM – 5:00 PM PT
3081 - Is a Deep Learning Based Segmentation Model Trained on planning CTs Transferable for Segmentation of Organs at Risk in Replanning CTs?Location: Hall B2
Xin Yang, PhD ### 1972777###Presenter#########Presenter:
### 4:00 PM – 5:00 PM PT
3082 - Proliferation Saturation Index to Simulate Adaptive Radiation Fractionation in HPV-Associated Oropharyngeal CancerLocation: Hall B2Presenter: – Moffitt Cancer Center
Mohammad Zahid, PhD – Moffitt Cancer Center ### 854852###Presenter######Moffitt Cancer Center###Presenter: – Moffitt Cancer Center
### 4:00 PM – 5:00 PM PT
3083 - Deep Learning for Automated Contouring of Primary Gross Tumor Volumes by MRI for Radiation Therapy of Brain MetastasisLocation: Hall B2
Rui-ping Zhang ### 1972763###Presenter#########Presenter:
### 4:00 PM – 5:00 PM PT
3084 - Real World Utilization of Cranial or Craniospinal Radiation in Adult Acute Lymphoid Leukemia Patients: Data from the Center for International Blood and Marrow Transplant ResearchLocation: Hall B2Presenter: – Cedars-Sinai Medical Center
Samuel Zhang, MD – Cedars-Sinai Medical Center ### 747678###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 4:00 PM – 5:00 PM PT
3085 - Unsupervised Domain Adaptation of Auto-Segmentation on Multi-Source MRIsLocation: Hall B2Presenter: – Manteia Technologies Co.,Ltd.
Wei Zhang, ME – Manteia Technologies Co.,Ltd. ### 1972782###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Manteia Technologies Co.,Ltd.###Presenter: – Manteia Technologies Co.,Ltd.
### 4:00 PM – 5:00 PM PT
3086 - Development and Assessment of a Multi-Purpose Knowledge-Based Planning Model (RapidPlan) for Prostate RadiationLocation: Hall B2Presenter: – Boston University Medical Center
Xin Zhang, PhD – Boston University Medical Center ### 746624###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Boston University Medical Center###Presenter: – Boston University Medical Center
### 4:00 PM – 5:00 PM PT
3088 - Deep Learning-Based Multi-Modality Segmentation of Primary Gross Tumor Volume in CT and MRI for Nasopharyngeal CarcinomaLocation: Hall B2Presenter: – Johns Hopkins University
Yixiao Zhang – Johns Hopkins University ### 1972794###Presenter######Johns Hopkins University###Presenter: – Johns Hopkins University
### 4:00 PM – 5:00 PM PT
3089 - Change in Blood Counts after Palliative Radiotherapy for Multiple MyelomaLocation: Hall B2Presenter: – Mayo Clinic Alix School of Medicine
Conan Zhao, PhD – Mayo Clinic Alix School of Medicine ### 1972754###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Alix School of Medicine###Presenter: – Mayo Clinic Alix School of Medicine
### 4:00 PM – 5:00 PM PT
3090 - The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint InhibitorsLocation: Hall B2Presenter: – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
RuiZhi Zhao, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences ### 537973###Presenter######Cancer Institute and Hospital Chinese Acedemy of Medical Sciences###Presenter: – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
### 4:00 PM – 5:00 PM PT
3091 - Deep Learning and GAN-Synthesis for Auto-Segmentation of Pancreatic Cancer by Non-Enhanced CT for Adaptive RadiotherapyLocation: Hall B2Presenter: – Zhongnan Hospital of Wuhan University
Shuai Sun, MD, PhD – Zhongnan Hospital of Wuhan University ### 1972765###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Zhongnan Hospital of Wuhan University###Presenter: – Zhongnan Hospital of Wuhan University
### 4:00 PM – 5:00 PM PT
3092 - Feasibility of Using Zero-Shot Learning in Transformer-Based Natural Language Processing Algorithm for Key Information Extraction from Head and Neck Tumor Board NotesLocation: Hall B2Presenter: – Ohio State University James Cancer Hospital
Simeng Zhu, MD – Ohio State University James Cancer Hospital ### 1972109###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ohio State University James Cancer Hospital###Presenter: – Ohio State University James Cancer Hospital
### 4:00 PM – 5:00 PM PT
3093 - Development and Validation of Clinical-Metabolic-Radiomics Model Based on Nomogram-Revised Risk Index for Prognosis Prediction in Patients with Extranodal Natural Kill/T Cell LymphomaLocation: Hall B2Presenter: – Shandong Anti-Cancer Association
Yingming Zhu, MD, PhD – Shandong Anti-Cancer Association ### 1972748###Presenter######Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 4:00 PM – 5:00 PM PT
3094 - Prognostic and treatment values of baseline metabolic tumor volume in extranodal nasal-type natural killer/T-cell lymphoma in the modern treatment eraLocation: Hall B2Presenter: – Shandong Anti-Cancer Association
Yingming Zhu, MD, PhD – Shandong Anti-Cancer Association ### 1972748###Presenter######Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 5:15 PM – 6:15 PM PT
3095 - Investigating the Relationship between the Dose to the Recto-Vaginal Reference Point and Vaginal Stenosis among Cervical Cancer Patients Treated at a North American Academic InstitutionLocation: Hall B2Presenter: – Yale New Haven Hospital
Bethel Adefres, MD, BS – Yale New Haven Hospital ### 1972868###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yale New Haven Hospital###Presenter: – Yale New Haven Hospital
### 5:15 PM – 6:15 PM PT
3096 - A Novel Method for Intracavitary Cervical HDR Brachytherapy: Express Finger-Guided Implant Insertion at Simulation Table without Speculum, Cervical Dilatation, Sleeve, Anesthesia, or SedationLocation: Hall B2Presenter: – King Abdullah Medical City
Nasser Al-Dhaibani, MD, FRCPC. – King Abdullah Medical City ### 1972851###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###King Abdullah Medical City###Presenter: – King Abdullah Medical City
### 5:15 PM – 6:15 PM PT
3097 - The Use of Problem-Based Learning Curriculum to Increase Medical Student Exposure to Radiation OncologyLocation: Hall B2Presenter: – Emory University
Naba Ali, MD, BS – Emory University ### 1972855###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 5:15 PM – 6:15 PM PT
3098 - Predictors of Poor Treatment Experience in Cervical Cancer Patients Receiving Definitive Chemoradiation and Brachytherapy Boost: A Prospective StudyLocation: Hall B2Presenter: – MD Anderson Cancer Center
Lauren Andring, MD – MD Anderson Cancer Center ### 747150###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 5:15 PM – 6:15 PM PT
3099 - Real-Time Precision Needle Tracking for Gynecological Interstitial Brachytherapy: A Phantom Feasibility StudyLocation: Hall B2Presenter: – Duke University Health System
Diandra Ayala-Peacock, MD – Duke University Health System ### 746455###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University Health System###Presenter: – Duke University Health System
### 5:15 PM – 6:15 PM PT
3100 - Characterizing Wellness Leadership in Academic Radiation Oncology Departments in the United StatesLocation: Hall B2Presenter: – Medical College of Wisconsin
Sara Beltran Ponce, MD – Medical College of Wisconsin ### 538557###Presenter###Disclosures: Employment: Medical College of Wisconsin Affiliated Hospitals:Resident Physician:Employee | Compensation: American College of Radiation Oncology: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 11/2023 | Ownership: none | Leadership: Society for Women in Radiation Oncology:Vice Chair###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 5:15 PM – 6:15 PM PT
3101 - Patterns of failure in pediatric and young adult rhabdomyosarcomaLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Rohini Bhatia, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 538056###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 5:15 PM – 6:15 PM PT
3102 - Radiation Treatment Plan Evaluation Education in Residency: A Needs AssessmentLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Graham Boyd, MD – Harvard Radiation Oncology Program ### 537518###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 5:15 PM – 6:15 PM PT
3103 - Outcomes Following Proton Therapy for Non-Metastatic Central Nervous System Germinoma in Children and AdolescentsLocation: Hall B2Presenter: – University of Florida
Ryan Brisson, MD – University of Florida ### 747428###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida###Presenter: – University of Florida
### 5:15 PM – 6:15 PM PT
3104 - Green Tea Derivative (-)-Epigallocatechin-3-Gallate (EGCG) Prevents against Acute Radiation-Induced Intestinal Injury: A Prospective Phase II Clinical Study in Pelvic Cancer PatientsLocation: Hall B2Presenter: – soochow university
Shang Cai, MD, PhD – soochow university ### 1972854###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###soochow university###Presenter: – soochow university
### 5:15 PM – 6:15 PM PT
3105 - Using Longitudinal MRI to Manage Proton Range Uncertainty for Pediatric Proton Craniospinal IrradiationLocation: Hall B2Presenter: – Emory University
Chih-Wei Chang, PhD – Emory University ### 1972840###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 5:15 PM – 6:15 PM PT
3106 - Clinical Significance of Arginine Signaling in Patients with Cervical Cancer Receiving Cisplatin Chemoradiation TherapyLocation: Hall B2Presenter: – Taiwan National Cheng Kung University Hospital
Helen Chen, MD, PhD – Taiwan National Cheng Kung University Hospital ### 525318###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Taiwan National Cheng Kung University Hospital###Presenter: – Taiwan National Cheng Kung University Hospital
### 5:15 PM – 6:15 PM PT
3107 - Automation of Dosimetric Data Collection Using C# ESAPI for Intracavitary and Hybrid Intracavitary/Interstitial Brachytherapy PlansLocation: Hall B2Presenter: – USC Norris Comprehensive Cancer Center
Karen Cheng, MD – USC Norris Comprehensive Cancer Center ### 2057792###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###USC Norris Comprehensive Cancer Center###Presenter: – USC Norris Comprehensive Cancer Center
### 5:15 PM – 6:15 PM PT
3108 - Toward Burnout Prevention: Can One Short Virtual Reality Relaxation and Mindfulness Training Session for Staff and Patients Decrease Stress and Improve Subjective Sense of Wellbeing?Location: Hall B2Presenter: – University of South Florida College of Medicine
Sylvia Choo, BA – University of South Florida College of Medicine ### 1972829###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of South Florida College of Medicine###Presenter: – University of South Florida College of Medicine
### 5:15 PM – 6:15 PM PT
3109 - Cesium-131 Low-Dose Rate Interstitial Brachytherapy as a Salvage Re-Irradiation Technique in Treating Cervical and Uterine Cancer Pelvic Recurrence with Prior History of Pelvic RadiationLocation: Hall B2Presenter: – University of Kentucky
Zeta Chow, MD, MS – University of Kentucky ### 1972856###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kentucky###Presenter: – University of Kentucky
### 5:15 PM – 6:15 PM PT
3110 - Recursive Partitioning Analysis Predicts Survival in Uterine Cancer and Defines Oligometastatic State with Improved Survival: A National Cancer Database AnalysisLocation: Hall B2Presenter: – Baylor College of Medicine
Cheryl Claunch, MD, PhD – Baylor College of Medicine ### 1972811###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Baylor College of Medicine###Presenter: – Baylor College of Medicine
### 5:15 PM – 6:15 PM PT
3111 - Single Institute Experience with MRI-Guided Adaptive Brachytherapy for Locally Advanced Cervix Cancer: Long Term Outcomes and Toxicity AnalysisLocation: Hall B2Presenter: – Guy's and St. Thomas' NHS Foundation Trust
Sian Cooper, MBBS – Guy's and St. Thomas' NHS Foundation Trust ### 1972817###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Guy's and St. Thomas' NHS Foundation Trust###Presenter: – Guy's and St. Thomas' NHS Foundation Trust
### 5:15 PM – 6:15 PM PT
3111 - Single Institute Experience with MRI-Guided Adaptive Brachytherapy for Locally Advanced Cervix Cancer: Long Term Outcomes and Toxicity AnalysisLocation: Hall B2Presenter: – Guy's and St. Thomas' NHS Foundation Trust
Ingrid White, MD, PhD – Guy's and St. Thomas' NHS Foundation Trust ### 746648###Presenter######Guy's and St. Thomas' NHS Foundation Trust###Presenter: – Guy's and St. Thomas' NHS Foundation Trust
### 5:15 PM – 6:15 PM PT
3112 - Role of Brachytherapy in Adjuvant Radiation Practices for FIGO Stage II Endometrial CancerLocation: Hall B2Presenter: – Huntsman Cancer Institute at the University of Utah
Jessica Cruttenden, MD – Huntsman Cancer Institute at the University of Utah ### 1972810###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Huntsman Cancer Institute at the University of Utah###Presenter: – Huntsman Cancer Institute at the University of Utah
### 5:15 PM – 6:15 PM PT
3113 - Dosimetric Advantages of Online Adaptative Radiotherapy for Cervical Cancer on 1.5T MR-LinacLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Shouliang Ding, MS – Sun Yat-Sen University Cancer Center ### 1972317###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 5:15 PM – 6:15 PM PT
3114 - Pediatric Esthesioneuroblastoma Treated with Proton RadiotherapyLocation: Hall B2Presenter: – University of Florida Shands Cancer Center
Nicolette Drescher, MD – University of Florida Shands Cancer Center ### 1972841###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida Shands Cancer Center###Presenter: – University of Florida Shands Cancer Center
### 5:15 PM – 6:15 PM PT
3115 - Effect of Concurrent Chemoradiotherapy on Regulatory T Cells?CD8/Treg Ratio?PD1 and CTLA-4 in Patients with Cervical CancerLocation: Hall B2
Yanjun Du ### 1972864###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3116 - Prospective Feasibility Trial of Vertebral Body Sparing Pencil Beam Scanning Proton Craniospinal Irradiation in Growing ChildrenLocation: Hall B2Presenter: – Emory University
Bree Eaton, MD – Emory University ### 535897###Presenter###Disclosures: Employment: Emory University:Associate Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 5:15 PM – 6:15 PM PT
3117 - Is Programmed Death Ligand 1(PD-L1) Expression in Vulvar Cancer Prognostic for Locoregional Control?Location: Hall B2Presenter: – UPMC Hillman Cancer Center
Baher Elgohari, MD, MS, MBBS – UPMC Hillman Cancer Center ### 537845###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UPMC Hillman Cancer Center###Presenter: – UPMC Hillman Cancer Center
### 5:15 PM – 6:15 PM PT
3118 - Three Decade Single-Institution Experience of Safety and Efficacy of Radiotherapy and Adjuvant Chemotherapy for Young Adult Patients with MedulloblastomaLocation: Hall B2Presenter: – Brigham and Women's Hospital/Dana Farber Cancer Institute
Hesham Elhalawani, MD, MS – Brigham and Women's Hospital/Dana Farber Cancer Institute ### 537808###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brigham and Women's Hospital/Dana Farber Cancer Institute###Presenter: – Brigham and Women's Hospital/Dana Farber Cancer Institute
### 5:15 PM – 6:15 PM PT
3119 - Social Media as a Tool to Directly Address Misinformation in Health Care and Promote Patient EducationLocation: Hall B2Presenter: – Medical College of Wisconsin
Sarah Emma, BS – Medical College of Wisconsin ### 1972833###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 5:15 PM – 6:15 PM PT
3120 - Efficacy and Safety of Local Radiotherapy Combined with Chemotherapy ± Bevacizumab in the Treatment of Patients with Advanced and Recurrent Metastatic Cervical CancerLocation: Hall B2
LI Fenghu, PhD, MS ### 1972860###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3121 - Impact of Immune, Inflammatory, and Nutritional Indices on Outcome in Patients with Cervical Cancer Treated with Definitive (Chemo)radiotherapyLocation: Hall B2Presenter: – University of Calgary
Corinne Doll, MD, BS – University of Calgary ### 536160###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Calgary###Presenter: – University of Calgary
### 5:15 PM – 6:15 PM PT
3122 - Hypomagnesemia and Survival in Patients with Cervical Cancer Treated with Definitive ChemoradiotherapyLocation: Hall B2Presenter: – University of Calgary
Corinne Doll, MD, BS – University of Calgary ### 536160###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Calgary###Presenter: – University of Calgary
### 5:15 PM – 6:15 PM PT
3123 - A 3D Deep Convolutional Neural Network for Dose Distribution Prediction of Intracavitary HDR Brachytherapy of Cervical CancerLocation: Hall B2Presenter: – Virginia Commonwealth University
Suman Gautam, MS – Virginia Commonwealth University ### 1972881###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Virginia Commonwealth University###Presenter: – Virginia Commonwealth University
### 5:15 PM – 6:15 PM PT
3124 - Impact of Lymphopenia on Definitive Treatment of Locally Advanced Cervical CancerLocation: Hall B2Presenter: – University of Virginia
Emilee Hall – University of Virginia ### 1972816###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Virginia###Presenter: – University of Virginia
### 5:15 PM – 6:15 PM PT
3125 - Intraoral Gavage of Second Generation Probiotic Lactobacillus Reuteri Releasing IFN-ß (LR-IFN-ß) Mitigates Intestinal Irradiation Toxicity and Improves Survival During Whole Abdomen IrradiatiLocation: Hall B2Presenter: – University of Pittsburgh Medical Center
Diala Hamade, MD – University of Pittsburgh Medical Center ### 1972853###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pittsburgh Medical Center###Presenter: – University of Pittsburgh Medical Center
### 5:15 PM – 6:15 PM PT
3126 - A Multi-Institutional Analysis of MRI-Based Brachytherapy for Medically Inoperable Endometrial CancerLocation: Hall B2Presenter: – Loyola University Medical Center
Matthew Harkenrider, MD – Loyola University Medical Center ### 524776###Presenter###Disclosures: Employment: Loyola University Medical Center:Associate Professor of Radiation Oncology:Employee | Compensation: RTOG Foundation: Consultant, Compensation Payment-End Date: to present | Ownership: none | Leadership: Chicago Radiological Society:President###Loyola University Medical Center###Presenter: – Loyola University Medical Center
### 5:15 PM – 6:15 PM PT
3126 - A Multi-Institutional Analysis of MRI-Based Brachytherapy for Medically Inoperable Endometrial CancerLocation: Hall B2Presenter: – Duke University Medical Center
Junzo Chino, MD – Duke University Medical Center ### 516062###Presenter###Disclosures: Employment: Duke University Health System:Associate Professor:Employee | Compensation: KM Pharmaceutical Consulting LLC: Other, Honoraria-End Date: to present ;Stryker: Consultant, Honoraria-End Date: to present ;GOG Foundation: Other, Honoraria-End Date: 4/10/23 | Ownership: none | Leadership: American Brachytherapy Society:Board Member###Duke University Medical Center###Presenter: – Duke University Medical Center
### 5:15 PM – 6:15 PM PT
3127 - Patient-Reported Distress and Acute Care Utilization for Cervical Cancer Patients Undergoing Concurrent ChemoradiationLocation: Hall B1
Areeb Hassan ### 1972824###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3127 - Patient-Reported Distress and Acute Care Utilization for Cervical Cancer Patients Undergoing Concurrent ChemoradiationLocation: Hall B2Presenter: – Princess Margaret Cancer Centre
Jennifer Croke, MD, BS, MHPE – Princess Margaret Cancer Centre ### 524777###Presenter###Disclosures: Employment: Princes Margaret Cancer Centre:Radiation Oncologist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
### 5:15 PM – 6:15 PM PT
3128 - Comparison of Two Different Adjuvant High Dose Rate Vaginal Brachytherapy Fractionation Regimens in Early-Stage Endometrial CancerLocation: Hall B2Presenter: – Beaumont Health
Allison Hazy, MD – Beaumont Health ### 1972373###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health###Presenter: – Beaumont Health
### 5:15 PM – 6:15 PM PT
3129 - Survival and Local Recurrence Risk in Patients with High-Risk Neuroblastoma Treated with Proton Therapy over a 10 Year IntervalLocation: Hall B2Presenter: – University of Pennsylvania
Christine Hill-Kayser, MD – University of Pennsylvania ### 538144###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 5:15 PM – 6:15 PM PT
3130 - Medical Student Survey of ASCO Sponsored Oncology Interest Groups in the United States Demonstrates Lack of Education in Radiation Oncology and Negative Perceptions of Future Employment ProspectsLocation: Hall B2Presenter: – University of Kansas Medical Center
Andrew Hoover, MD – University of Kansas Medical Center ### 525232###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 5:15 PM – 6:15 PM PT
3131 - Correlation of Post-Treatment Biopsy and Fluorodeoxyglucose PET/CT Findings Following Definitive Chemotherapy and Radiation for Cervical CancerLocation: Hall B2Presenter: – University of Kansas Medical Center
Andrew Hoover, MD – University of Kansas Medical Center ### 525232###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 5:15 PM – 6:15 PM PT
3132 - Risk Stratification of Postoperative Adjuvant Therapy for Endometrial Cancera (POAT-ENDORISK) Based on Bayesian Network Model: A Development and Validation StudyLocation: Hall B2Presenter: – Pecking Union Medical College Hospital
Xiaorong Hou, MD – Pecking Union Medical College Hospital ### 538432###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Pecking Union Medical College Hospital###Presenter: – Pecking Union Medical College Hospital
### 5:15 PM – 6:15 PM PT
3133 - Academic U.S. Radiation Oncology Department Chairs: Who are They?Location: Hall B2Presenter: – Icahn School of Medicine at Mount Sinai
Kristin Hsieh, MD – Icahn School of Medicine at Mount Sinai ### 537692###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Icahn School of Medicine at Mount Sinai###Presenter: – Icahn School of Medicine at Mount Sinai
### 5:15 PM – 6:15 PM PT
3134 - Clinical Outcomes of Sidewall/Parametrial Simultaneous Integrated Boost for Patients with Cervical CancerLocation: Hall B2Presenter: – Duke University School of Medicine
Christina Huang, MD, MS – Duke University School of Medicine ### 747699###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University School of Medicine###Presenter: – Duke University School of Medicine
### 5:15 PM – 6:15 PM PT
3135 - Uterine Body Invasion is a Significant Factor of Para-Aortic Lymph Node Recurrence in Patients with Cervical Carcinoma after Pelvic RadiotherapyLocation: Hall B2Presenter: – Kaohsiung Chang Gung Memorial Hospital
Kuan-Ching Huang, MD – Kaohsiung Chang Gung Memorial Hospital ### 1972857###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaohsiung Chang Gung Memorial Hospital###Presenter: – Kaohsiung Chang Gung Memorial Hospital
### 5:15 PM – 6:15 PM PT
3136 - Multi-Institutional Phase I Feasibility Trial of Vertebral Body Sparing CSI for Pediatric Brain TumorsLocation: Hall B2Presenter: – Massachusets General Hospital
Myrsini Ioakeim-Ioannidou, MD – Massachusets General Hospital ### 575546###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Massachusets General Hospital###Presenter: – Massachusets General Hospital
### 5:15 PM – 6:15 PM PT
3137 - Investigating the Potential Role of IKZF3 in HPV-Associated CarcinogenesisLocation: Hall B2Presenter: – Tufts University School of Medicine
Amira Ishag-Osman, MS, BS – Tufts University School of Medicine ### 1972850###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tufts University School of Medicine###Presenter: – Tufts University School of Medicine
### 5:15 PM – 6:15 PM PT
3138 - Treatment of Recurrent Orbital Rhabdomyosarcoma with Exenteration and HDR Brachytherapy in a Custom MoldLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Christopher Jackson, MD, MS – Memorial Sloan Kettering Cancer Center ### 537740###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 5:15 PM – 6:15 PM PT
3139 - Response-Adapted Omission of Radiotherapy in Pediatric Patients with Intermediate- and High-Risk Hodgkin Lymphoma Treated per EuroNet-PHL-C1: A Single Institution Analysis of Outcomes and Patterns of Location: Hall B2Presenter: – UT Southwestern Medical Center
Meredith Jackson, BS – UT Southwestern Medical Center ### 1972844###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 5:15 PM – 6:15 PM PT
3140 - Evaluation of National Conference-Associated Medical Student Research and Mentorship Award for Medical Students, Resident Mentors, and Radiation Oncologist SupervisorsLocation: Hall B2Presenter: – University of British Columbia
Ruijia Jin, MS4 – University of British Columbia ### 1972838###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of British Columbia###Presenter: – University of British Columbia
### 5:15 PM – 6:15 PM PT
3141 - Outcomes of Children Diagnosed with Unilateral Retinoblastoma: Retrospective AuditLocation: Hall B2Presenter: – S L Raheja Hospital
Nehal Khanna, MD, MBBS – S L Raheja Hospital ### 1972845###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###S L Raheja Hospital###Presenter: – S L Raheja Hospital
### 5:15 PM – 6:15 PM PT
3142 - Identification and Management of Radiation-Induced Premature Ovarian FailureLocation: Hall B2Presenter: – Virginia Commonwealth University
Anna Kikut – Virginia Commonwealth University ### 1972820###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Virginia Commonwealth University###Presenter: – Virginia Commonwealth University
### 5:15 PM – 6:15 PM PT
3143 - Quantifying Radiation Induced Vaginal Stenosis for the Development of a Novel Dilator Device: A Prospective Cohort Study of Patients with Cervical Cancer Treated with Definitive Chemoradiation TherapyLocation: Hall B2Presenter: – University of California, San Diego
Sangwoo Kim, MD – University of California, San Diego ### 525366###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, San Diego###Presenter: – University of California, San Diego
### 5:15 PM – 6:15 PM PT
3144 - ChatGPT is an Unreliable Tool for Reviewing Radiation Oncology LiteratureLocation: Hall B2Presenter: – MD Anderson Cancer Center
Troy Kleber, MD, MS – MD Anderson Cancer Center ### 1972837###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 5:15 PM – 6:15 PM PT
3145 - Focused Ultrasound for Blood-Brain Barrier Opening Enhances Delivery of Anti-PD1 in Diffuse Midline GliomasLocation: Hall B2Presenter: – Columbia University Irving Medical Center
Danae Kokossis, MD – Columbia University Irving Medical Center ### 1972847###Presenter######Columbia University Irving Medical Center###Presenter: – Columbia University Irving Medical Center
### 5:15 PM – 6:15 PM PT
3146 - The Changing Profile of Academic Radiation Oncology Leaders: Updates over the Past DecadeLocation: Hall B2Presenter: – University of Texas Southwestern Medical Center at Dallas
Young Suk Kwon, MD – University of Texas Southwestern Medical Center at Dallas ### 1972836###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas Southwestern Medical Center at Dallas###Presenter: – University of Texas Southwestern Medical Center at Dallas
### 5:15 PM – 6:15 PM PT
3147 - Sociotechnical Factors Contributing to Burnout among Radiation Oncology Medical Physicists: Survey and Focus Group Results from a Systems-Analysis ApproachLocation: Hall B2Presenter: – University of North Carolina at Chapel Hill
Elizabeth Kwong, BS – University of North Carolina at Chapel Hill ### 1972805###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of North Carolina at Chapel Hill###Presenter: – University of North Carolina at Chapel Hill
### 5:15 PM – 6:15 PM PT
3148 - Clinical Outcomes for Chest Wall Ewing Sarcoma: A Multi-Center Single Institution ExperienceLocation: Hall B2Presenter: – Mayo Clinic Arizona
Brady Laughlin, MD – Mayo Clinic Arizona ### 1971961###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Arizona###Presenter: – Mayo Clinic Arizona
### 5:15 PM – 6:15 PM PT
3149 - Improving the Efficacy and Safety of Concurrent Chemoradiotherapy by Neoadjuvant Chemotherapy: A Randomized Controlled Study of Locally Advanced Cervical Cancer with a Large TumorLocation: Hall B2Presenter: – Affiliated Hospital of Guizhou Medical University
Fenghu Li, PhD – Affiliated Hospital of Guizhou Medical University ### 1972866###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Affiliated Hospital of Guizhou Medical University###Presenter: – Affiliated Hospital of Guizhou Medical University
### 5:15 PM – 6:15 PM PT
3150 - Silva Classification System for HPV-Related EAC of Stage I ~ IIIc1p Cervical Adenocarcinoma and Its Effect on Prognosis and SurvivalLocation: Hall B2
jiehui Li, PhD ### 1972877###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3151 - Image-Guided High-Dose-Rate Brachytherapy for Definitive Management of Primary Vaginal Cancer: A Single Institutional ExperienceLocation: Hall B2Presenter: – University of California San Francisco
Katie Lichter, MD, MD MPH – University of California San Francisco ### 1971549###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 5:15 PM – 6:15 PM PT
3152 - Prognostic Value of Tumor Volume Reduction during Radiotherapy in Patients with Locally Advanced Cervical Cancer in Different Risk GroupsLocation: Hall B2
Canyang Lin, MD ### 1972807###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3154 - Newly Diagnosed Mental Health Disorders in Patients with Breast Cancer Receiving Radiation TherapyLocation: Hall B2Presenter: – Beaumont Health - Royal Oak
Bailey Loving, MD – Beaumont Health - Royal Oak ### 1972832###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health - Royal Oak###Presenter: – Beaumont Health - Royal Oak
### 5:15 PM – 6:15 PM PT
3155 - VMAT TBI Technique Using Autoplanning ScriptsLocation: Hall B2Presenter: – Stanford Cancer Institute Palo Alto
Yuliia Lozko, MD – Stanford Cancer Institute Palo Alto ### 1972032###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Cancer Institute Palo Alto###Presenter: – Stanford Cancer Institute Palo Alto
### 5:15 PM – 6:15 PM PT
3156 - A Survey of Submission and Review Standards across Clinical Radiation Oncology and Medical Physics Journals: Devising the Optimal Criteria for Reproducibility and Sustained ImpactLocation: Hall B2Presenter: – St. Jude Children's Research Hospital
John Lucas, MD, MS – St. Jude Children's Research Hospital ### 516031###Presenter###Disclosures: Employment: St. Jude Children's Research Hospital:Associate Member:Employee | Compensation: Philips: Speaker's Bureau, Uncompensated-End Date: 26 ;Children's Cancer and Leukaemia Group - CCLG: Education Meeting Faculty, Uncompensated-End Date: 9th ;Malaysian Society of Paediatric Haem & Onc: Education Meeting Faculty, Uncompensated-End Date: 7th ;International PPB/DICER1 Registry: Consultant, Uncompensated-End Date: present | Ownership: none | Leadership: ASTRO Scientific Committee - Pediatric section:Chair;St. Jude Children's Research Hospital Continuing Medical Education (CME) Committee:Member;Pediatric Cancer Data Commons - NODAL & REACH:Executive Committee member;Global Neuroblastoma Network:Radiation Oncology Panel Lead###St. Jude Children's Research Hospital###Presenter: – St. Jude Children's Research Hospital
### 5:15 PM – 6:15 PM PT
3158 - A Machine Learning Framework Integrating Electronic Health Records for Survival Prognostication in Cervix CancerLocation: Hall B2Presenter: – University of California San Francisco
Nauman Malik, MD, MS – University of California San Francisco ### 747576###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 5:15 PM – 6:15 PM PT
3159 - Direction Modulated Brachytherapy Tandem Model Applicators for Treatment Planning of Multi-Institutional Cervical Cancer Cases: Removing Needles in Intracavitary-Interstitial TechniquesLocation: Hall B2Presenter: – Virginia Commonwealth University
William Song, PhD – Virginia Commonwealth University ### 1972815###Presenter###Disclosures: Employment: Virginia Commonwealth University:Medical Physicist:Employee | Compensation: ViewRay: Speaker's Bureau, Honoraria-End Date: to present ;Varian: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 9/30/2023 | Ownership: ViewRay:Stock | Leadership: Korean American Medical Physicists in North Americ:President###Virginia Commonwealth University###Presenter: – Virginia Commonwealth University
### 5:15 PM – 6:15 PM PT
3160 - Re-Irradiation for Diffuse Intrinsic Pontine Glioma with 3 Gy per FractionLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Nikhil Mankuzhy, MD – Memorial Sloan Kettering Cancer Center ### 747670###Presenter###Disclosures: Employment: Memorial Sloan Kettering Cancer Center:Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 5:15 PM – 6:15 PM PT
3161 - Prophylactic Para-Aortic Extended Field Irradiation with Concurrent Chemotherapy for FIGO Stage IIIC1 Cervical Cancer Using Intensity Modulated Radiotherapy Technique: Acute Toxicity and Dosimetric AsLocation: Hall B2Presenter: – Dr Ram Manohar Lohia Institute of Medical Sciences
Akanksha Manral, MBBS – Dr Ram Manohar Lohia Institute of Medical Sciences ### 1972876###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Dr Ram Manohar Lohia Institute of Medical Sciences###Presenter: – Dr Ram Manohar Lohia Institute of Medical Sciences
### 5:15 PM – 6:15 PM PT
3162 - Defining the Transcriptional Landscapes of the Tumor Microenvironment of Cervical and Vaginal Cancers at Single-Cell ResolutionLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Serena Mao, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 1971975###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 5:15 PM – 6:15 PM PT
3163 - Brazilian Pediatric Patients with Gliomas: Treatment Characteristics and Survival OutcomesLocation: Hall B2Presenter: – Hospital Sirio-Libanes
Gustavo Marta, MD, PhD – Hospital Sirio-Libanes ### 1972842###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Sirio-Libanes###Presenter: – Hospital Sirio-Libanes
### 5:15 PM – 6:15 PM PT
3164 - Prognostic Factors for Pediatric, Adolescent, and Young Adult Patients with Non-DIPG Grade 4 Gliomas: A Contemporary Pooled Institutional ExperienceLocation: Hall B2Presenter: – The Ohio State
Jennifer Matsui, PhD – The Ohio State ### 1972849###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Ohio State###Presenter: – The Ohio State
### 5:15 PM – 6:15 PM PT
3165 - Pilot Study Assessing Student Interest in Combined Residency Training Pathways with Radiation OncologyLocation: Hall B2Presenter: – Rutgers Cancer Institute of New Jersey
Malcolm Mattes, MD – Rutgers Cancer Institute of New Jersey ### 585101###Presenter###Disclosures: Employment: Rutgers Cancer Institute of New Jersey:Associate Professor:Employee | Compensation: Bristol Myers Squibb Foundation: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present ;New Jersey Health Foundation: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present ;Radiation Oncology Institute: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present | Ownership: none | Leadership: University Hospital Cancer Center:ACOS CoC Cancer Liaison Physician;ASTRO:Vice Chair###Rutgers Cancer Institute of New Jersey###Presenter: – Rutgers Cancer Institute of New Jersey
### 5:15 PM – 6:15 PM PT
3166 - ARTIA-Cervix: A Prospective Clinical Trial to Assess Patient Reported Intestinal Toxicity with Adaptive External Beam Radiation Therapy in the Treatment of Cervical CancerLocation: Hall B2
Jyoti Mayadev, MD – UCSD ### 524876###Presenter###Disclosures: Employment: University of California San Diego:Professor:Employee | Compensation: Varian Medical Systems: Consultant, Honoraria-End Date: ongoing ;Merck: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Honoraria-End Date: ongoing ;KORTUC: Consultant, Honoraria-End Date: ongoing ;AstraZeneca: Consultant, Honoraria, Compensation Payment-End Date: ongoing ;Primmune: Consultant, Honoraria-End Date: ongoing | Ownership: none | Leadership: NRG Oncology:Co-Chair###UCSD###Presenter: – UCSD
### 5:15 PM – 6:15 PM PT
3167 - Burnout Rates in Clinical Radiation Oncology and Variations across Professional SubgroupsLocation: Hall B2Presenter: – University of Arizona College of Medicine - Phoenix
Sean McCauley, BS – University of Arizona College of Medicine - Phoenix ### 1972831###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Arizona College of Medicine - Phoenix###Presenter: – University of Arizona College of Medicine - Phoenix
### 5:15 PM – 6:15 PM PT
3168 - A Novel Multi-Channel Tandem Applicator for Direction Modulated BrachytherapyLocation: Hall B2Presenter: – Emory University
Moeen Meftahi, PhD – Emory University ### 1972669###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 5:15 PM – 6:15 PM PT
3169 - Pre-Brachytherapy Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) Response as Predictor of Local Control in the Definitive Treatment of Cervical CancerLocation: Hall B2Presenter: – Rabin Medical Center - Beilinson Hospital
Assaf Moore, MD – Rabin Medical Center - Beilinson Hospital ### 1972867###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rabin Medical Center - Beilinson Hospital###Presenter: – Rabin Medical Center - Beilinson Hospital
### 5:15 PM – 6:15 PM PT
3170 - Impact of Race and Socioeconomic Factors on Clinical Outcomes in Cervical and Endometrial Cancer Patients Treated with BrachytherapyLocation: Hall B2Presenter: – UPMC Cancer Center
Ria Mulherkar, MD – UPMC Cancer Center ### 1972808###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UPMC Cancer Center###Presenter: – UPMC Cancer Center
### 5:15 PM – 6:15 PM PT
3171 - Radiation Induced Lumbar Plexopathy (RILP) in Patients of Cancer Cervix Treated by IMRT Technique: A Study of Dosimetry and Clinical CorrelationLocation: Hall B2Presenter: – Bibi Cancer Hospitals
Sankalp Naidu, MD, MBBS – Bibi Cancer Hospitals ### 1972827###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Bibi Cancer Hospitals###Presenter: – Bibi Cancer Hospitals
### 5:15 PM – 6:15 PM PT
3172 - The Inpatient Consultation Experience in Radiation Oncology: A Contemporary Evaluation of a Single Academic InstitutionLocation: Hall B2Presenter: – University of California Los Angeles
Beth Neilsen, MD, PhD – University of California Los Angeles ### 1972875###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California Los Angeles###Presenter: – University of California Los Angeles
### 5:15 PM – 6:15 PM PT
3173 - Pharmacological Targeting of Interferon-Related DNA Damage Resistant Signature (IRDS) and XRCC4-Mediated DNA Repair Pathways as a Novel Therapeutic Approach to DIPG Radio-SensitizationLocation: Hall B2Presenter: – Cleveland Clinic Florida
Anatoly Nikolaev, MD, PhD – Cleveland Clinic Florida ### 535970###Presenter######Cleveland Clinic Florida###Presenter: – Cleveland Clinic Florida
### 5:15 PM – 6:15 PM PT
3174 - Results From a Multi-Institutional Pilot Study of iContour, an Interactive Online Platform with Real-Time Feedback to Improve Contouring Education for Radiation Oncology ResidentsLocation: Hall B2Presenter: – UC San Diego Health
Megan Orr, MD – UC San Diego Health ### 1972279###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UC San Diego Health###Presenter: – UC San Diego Health
### 5:15 PM – 6:15 PM PT
3175 - Feasibility and Workflow Efficiency in MRI-Based HDR Brachytherapy for Cervical Cancer at a Community-Based PracticeLocation: Hall B2Presenter: – NYP BMH Radiation Oncology
Ranjani Padmanabhan, MD – NYP BMH Radiation Oncology ### 1972826###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYP BMH Radiation Oncology###Presenter: – NYP BMH Radiation Oncology
### 5:15 PM – 6:15 PM PT
3176 - Maintenance Therapy for Recurrent or Metastatic Cervical Cancer: A Multicenter, Cohort StudyLocation: Hall B2
Chen Peng ### 1972879###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3177 - Fixed-Field IMRT for Cervix Carcinoma Patients on an MR-LINAC Platform: Dosimetric Feasibility and ChallengesLocation: Hall B2Presenter: – Stanford Health Care
Daniel Pham, PhD, CMD, RT – Stanford Health Care ### 1972819###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Health Care###Presenter: – Stanford Health Care
### 5:15 PM – 6:15 PM PT
3178 - Enhancing Specialist Training in Radiation Oncology through the Implementation of Structured Radiotherapy Contouring WorkshopsLocation: Hall B2Presenter: – St.Lukes Radiation Oncology Network
Guhan Rangaswamy, MD, MBBS – St.Lukes Radiation Oncology Network ### 1972830###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###St.Lukes Radiation Oncology Network###Presenter: – St.Lukes Radiation Oncology Network
### 5:15 PM – 6:15 PM PT
3179 - A Comparative Analysis of Effect of HIV Infection on Outcomes of Cervical Cancer Treated with RadiotherapyLocation: Hall B2Presenter: – Gujarat Cancer and Research Institute Ahmedabad
Krishna Ratanchandani, MD, MBBS – Gujarat Cancer and Research Institute Ahmedabad ### 1972813###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Gujarat Cancer and Research Institute Ahmedabad###Presenter: – Gujarat Cancer and Research Institute Ahmedabad
### 5:15 PM – 6:15 PM PT
3180 - Comparison of Molecular and Clinicopathologic-Based Classifications and the Transition of Adjuvant Treatment Mode for Early-Stage Endometrial CancerLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Kang Ren, PhD – Peking Union Medical College Hospital ### 1972821###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### 5:15 PM – 6:15 PM PT
3181 - Direction Modulated Brachytherapy Tandem Model Applicators for Treatment Planning of Multi-Institutional Cervical Cancer CasesLocation: Hall B2Presenter: – Virginia Commonwealth University
Dylan Richeson, MS – Virginia Commonwealth University ### 1972818###Presenter######Virginia Commonwealth University###Presenter: – Virginia Commonwealth University
### 5:15 PM – 6:15 PM PT
3182 - Prospective Application of an Artificial Intelligence Decision Support Tool for Applicator and Needle Selection in High-Dose-Rate Brachytherapy for Cervical Cancer PatientsLocation: Hall B2Presenter: – Johns Hopkins University
Michael Roumeliotis, PhD – Johns Hopkins University ### 1972812###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 5:15 PM – 6:15 PM PT
3183 - Impact of Changing ACGME Case Requirements on Radiation Oncology Resident Rotation StructureLocation: Hall B2Presenter: – UAB Hazelrig Salter Radiation Oncology Center
John Roveda, MD – UAB Hazelrig Salter Radiation Oncology Center ### 1972834###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UAB Hazelrig Salter Radiation Oncology Center###Presenter: – UAB Hazelrig Salter Radiation Oncology Center
### 5:15 PM – 6:15 PM PT
3184 - Prognostic Impact of a Negative Central Pelvic Biopsy after Definitive Chemoradiotherapy (CRT) for Locally Advanced Cervical Cancer (LACC)Location: Hall B2Presenter: – Baylor College of Medicine
Lucas Sapienza, MD, PhD – Baylor College of Medicine ### 747606###Presenter######Baylor College of Medicine###Presenter: – Baylor College of Medicine
### 5:15 PM – 6:15 PM PT
3185 - TEAMRO: TEAching Mentorship in Radiation Oncology, a Multicenter Prospective Phase 2 Intervention Study on Teaching Mentorship Skills to Residents Working with Medical StudentsLocation: Hall B2Presenter: – Brigham and Women's Hospital/Dana-Farber
Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber ### 537850###Presenter###Disclosures: Employment: Brigham Womens Hospital:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Brigham and Women's Hospital/Dana-Farber###Presenter: – Brigham and Women's Hospital/Dana-Farber
### 5:15 PM – 6:15 PM PT
3186 - Prevalence of Trauma History and Symptoms in Patients Who Have Received Vaginal Brachytherapy as Part of their Endometrial Cancer TreatmentLocation: Hall B2Presenter: – Loyola University Medical Center
Anjali Saripalli, MD, MSE – Loyola University Medical Center ### 1972822###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Loyola University Medical Center###Presenter: – Loyola University Medical Center
### 5:15 PM – 6:15 PM PT
3187 - Concurrent Chemoradiotherapy plus Programmed Death-1 (PD-1) Blockade for Locally Advanced Cervical Cancer: Preliminary Results of a Single-Arm, Open-Label, Phase II TrialLocation: Hall B2Presenter: – Suzhou Municipal Hospital
Runjun Shi, PhD – Suzhou Municipal Hospital ### 1972852###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Suzhou Municipal Hospital###Presenter: – Suzhou Municipal Hospital
### 5:15 PM – 6:15 PM PT
3188 - Favorable Toxicity and Local Control with Ultrahypofractionated Radiation Therapy (UH-RT) for Melanoma of the Lower Genital Tract (LGT)Location: Hall B2Presenter: – Rochester Regional Health System
Benjamin Silver, MD – Rochester Regional Health System ### 1972809###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rochester Regional Health System###Presenter: – Rochester Regional Health System
### 5:15 PM – 6:15 PM PT
3189 - Single Institute Experience Treating Uterine Carcinosarcoma: Outcome AnalysisLocation: Hall B2
Van-Ren Sim ### 1972880###Presenter#########Presenter:
### 5:15 PM – 6:15 PM PT
3190 - Can Volume-Based MRI-Guided Planning for Interstitial Gynecologic Brachytherapy Overcome Clinicopathologic Risk Factors for Fistula Formation?Location: Hall B2Presenter: – University of Chicago
Aranee Sivananthan, MD, MS, BS – University of Chicago ### 537423###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago###Presenter: – University of Chicago
### 5:15 PM – 6:15 PM PT
3191 - Understanding Burnout Among US Radiation Oncology ResidentsLocation: Hall B2Presenter: – Medical College of Wisconsin
Christina Small, MD – Medical College of Wisconsin ### 1972835###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 5:15 PM – 6:15 PM PT
3192 - Combining Novel Direction Modulated Brachytherapy Tandem-and-Ovoids Applicators for Treatment Planning of Multi-Institutional Cervical Cancer Cases: Removing Needles in Intracavitary-Interstitial TechLocation: Hall B2Presenter: – Virginia Commonwealth University
William Song, PhD – Virginia Commonwealth University ### 1972815###Presenter###Disclosures: Employment: Virginia Commonwealth University:Medical Physicist:Employee | Compensation: ViewRay: Speaker's Bureau, Honoraria-End Date: to present ;Varian: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 9/30/2023 | Ownership: ViewRay:Stock | Leadership: Korean American Medical Physicists in North Americ:President###Virginia Commonwealth University###Presenter: – Virginia Commonwealth University
### 5:15 PM – 6:15 PM PT
3193 - An On-the-Go Platform for Continuing Medical Education in Radiation Oncology in BrazilLocation: Hall B2Presenter: – Hospital Sirio Libanes
Maria Thereza Starling, MD – Hospital Sirio Libanes ### 1972806###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Sirio Libanes###Presenter: – Hospital Sirio Libanes
### 5:15 PM – 6:15 PM PT
3194 - Social Media as a Strategy for Continuing Education in BrazilLocation: Hall B2Presenter: – Hospital Sirio Libanes
Maria Thereza Starling, MD – Hospital Sirio Libanes ### 1972806###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hospital Sirio Libanes###Presenter: – Hospital Sirio Libanes
### 5:15 PM – 6:15 PM PT
3195 - Assessing Equity of Family Members Roles in Supporting Pediatric Patients Receiving Proton Radiation Therapy: A Retrospective Study of Parent/Guardian Attendance at Clinic VisitsLocation: Hall B2Presenter: – University of Washington
Emily Stiles, BA – University of Washington ### 1972848###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 5:15 PM – 6:15 PM PT
3196 - Genomic Characterization of Low and High Grade Cervical Intraepithelial Neoplasia in Comparison to Cervical CancerLocation: Hall B2Presenter: – The University of North Carolina at Chapel Hill
Shivani Sud, MD – The University of North Carolina at Chapel Hill ### 746709###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of North Carolina at Chapel Hill###Presenter: – The University of North Carolina at Chapel Hill
### 5:15 PM – 6:15 PM PT
3197 - Pseudo CT Images Synthesized from CBCT Based on Unsupervised DDPM in Cervical Cancer RadiotherapyLocation: Hall B2
Hongfei Sun ### 1972882###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3198 - Risk Factors and Clinical Features of Fistula after Concurrent Chemoradiation and Brachytherapy for Locally Advanced Cervical CancerLocation: Hall B2Presenter: – Winship Cancer Institute of Emory University
Katherine Sykes Martin, MD, MS – Winship Cancer Institute of Emory University ### 1983800###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Winship Cancer Institute of Emory University###Presenter: – Winship Cancer Institute of Emory University
### 5:15 PM – 6:15 PM PT
3199 - Impact of the COVID-19 Pandemic on Academic Productivity in Oncology: A Journal-, Conference- and Author-level AnalysisLocation: Hall B2Presenter: – London Health Sciences Centre
Vivian Tan, MD – London Health Sciences Centre ### 1972041###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###London Health Sciences Centre###Presenter: – London Health Sciences Centre
### 5:15 PM – 6:15 PM PT
3200 - Radiotherapy Can Influence the Expression of PD-L1 and Circulating Exosomal PD-L1 May Better Predict the Immunotherapy Efficiency in Cervical Cancer PatientsLocation: Hall B2
Wenjie Tang, PhD ### 747700###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3201 - Single Institution Experience of the Effect of Adjuvant Radiation on Outcomes for Patients with Uterine CarcinosarcomaLocation: Hall B2Presenter: – Emory University
Rachel Tobillo, MD – Emory University ### 1972865###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 5:15 PM – 6:15 PM PT
3202 - Advantage of Adding Non-Coplanar Arcs for Scalp-Avoidance Whole-Brain Irradiation with Volumetric-Modulated Arc Radiotherapy to Reduce Scalp Dose in Pediatric Patients with MedulloblastomasLocation: Hall B2Presenter: – Kyoto University
Daichi Torizuka, MD – Kyoto University ### 1972839###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kyoto University###Presenter: – Kyoto University
### 5:15 PM – 6:15 PM PT
3203 - The Impact of Updated ACGME Program Requirements for Radiation Oncology ResidenciesLocation: Hall B2Presenter: – University of Florida College of Medicine
Olivia Trumble, BS – University of Florida College of Medicine ### 1972870###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida College of Medicine###Presenter: – University of Florida College of Medicine
### 5:15 PM – 6:15 PM PT
3204 - Can an In-Person Hands-On Applicator-Based Teaching Session Improve Trainee Knowledge and Comfort with Complex Gynecologic Brachytherapy?Location: Hall B2Presenter: – University of Pittsburgh Medical Center
John Austin Vargo, MD, MBA – University of Pittsburgh Medical Center ### 524790###Presenter######University of Pittsburgh Medical Center###Presenter: – University of Pittsburgh Medical Center
### 5:15 PM – 6:15 PM PT
3205 - Evaluation of Sexual Side Effects in Patients after Chemoradiation and Brachytherapy for Gynecologic Cancers Involving the Lower Vagina and BulboclitorisLocation: Hall B2Presenter: – NYU Grossman School of Medicine
Pooja Venkatesh – NYU Grossman School of Medicine ### 1972861###Presenter######NYU Grossman School of Medicine###Presenter: – NYU Grossman School of Medicine
### 5:15 PM – 6:15 PM PT
3205 - Evaluation of Sexual Side Effects in Patients after Chemoradiation and Brachytherapy for Gynecologic Cancers Involving the Lower Vagina and BulboclitorisLocation: Hall B2Presenter: – New York University School of Medicine
Juhi Purswani, MD – New York University School of Medicine ### 538356###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###New York University School of Medicine###Presenter: – New York University School of Medicine
### 5:15 PM – 6:15 PM PT
3206 - Multi-Institutional Experience of Proton Therapy for Rhabdomyosarcoma and Ewing Sarcoma in the Proton Collaborative Group (PCG) Prospective RegistryLocation: Hall B2Presenter: – Miami Cancer Institute: Baptist Health South Florida
Katherine Von Werne, MSN – Miami Cancer Institute: Baptist Health South Florida ### 1972843###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Miami Cancer Institute: Baptist Health South Florida###Presenter: – Miami Cancer Institute: Baptist Health South Florida
### 5:15 PM – 6:15 PM PT
3207 - Reducing CTV to PTV Margins with Daily Adaptive Radiotherapy in the Postoperative Treatment of Endometrial and Cervical CancerLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Guangyu Wang, MD – Peking Union Medical College Hospital ### 1972862###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### 5:15 PM – 6:15 PM PT
3208 - Clinical Implementation of Optical Surface Imaging Systems in Vulvar Cancer to Reduce Setup ErrorLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Guangyu Wang, MD – Peking Union Medical College Hospital ### 1972862###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### 5:15 PM – 6:15 PM PT
3209 - Weekly Image Guidance in Patients with Cervical Cancer Treated with Intensity Modulated Radiation Therapy: Results of a Large Cohort StudyLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Weiping Wang, PhD – Peking Union Medical College Hospital ### 538508###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### 5:15 PM – 6:15 PM PT
3210 - Poor Survival Outcomes in Patients with Stage IIIC2 Cervical Cancer Receiving Concurrent ChemoradiotherapyLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Weiping Wang, PhD – Peking Union Medical College Hospital ### 538508###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### 5:15 PM – 6:15 PM PT
3211 - Mismatch Repair Status is an Effective Prognostic Factor for Early-Stage Endometrial CarcinomaLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Wenhui Wang, MD, PhD – Peking Union Medical College Hospital ### 538276###Presenter######Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### 5:15 PM – 6:15 PM PT
3212 - The Clinical Practice and Dosimetric Outcome of the Manual Adaptive Planning during Definitive Radiotherapy Treatment for Cervical CancerLocation: Hall B2
Yiwei Wang, MD, PhD ### 1972874###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3213 - Effect of External Beam Radiation Therapy (EBRT) and Brachytherapy (BT) on Circulating MDSC Populations in Patients Treated Definitively for Cervical CancerLocation: Hall B2Presenter: – University of Minnesota
Matt Berkseth, PhD – University of Minnesota ### 2083694###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Minnesota###Presenter: – University of Minnesota
### 5:15 PM – 6:15 PM PT
3214 - The Role of Radiation Therapy for Metastatic Cervical CancerLocation: Hall B2
Fang Wu, MD, PhD ### 1972873###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3215 - Performance Metric Analysis of a Radiation Oncology Educational PodcastLocation: Hall B2Presenter: – University of California Los Angeles
Trudy Wu, MD, BS – University of California Los Angeles ### 538334###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California Los Angeles###Presenter: – University of California Los Angeles
### 5:15 PM – 6:15 PM PT
3216 - Timing of Postoperative Radiation Therapy for Early Stage Endometrial Carcinoma: A 20-Year Single-Center Retrospective Cohort Experience in ChinaLocation: Hall B2
Zihan Yan, MB ### 1972871###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 5:15 PM – 6:15 PM PT
3217 - Pseudo CT Synthesis Using Cone-Beam CT of Cervical Cancer with GAN-Based Neural Network ModelLocation: Hall B2Presenter: – The First Affiliated Hospital of Air Force Medical University
Hua Yang, MD – The First Affiliated Hospital of Air Force Medical University ### 747518###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The First Affiliated Hospital of Air Force Medical University###Presenter: – The First Affiliated Hospital of Air Force Medical University
### 5:15 PM – 6:15 PM PT
3218 - The Value of Progression-Free Survival at Three Years as a Primary Endpoint for Studies on Radiotherapy in Patients with Locally Advanced Cervical Cancer: Individual Patient Data and Validation From 2Location: Hall B2Presenter: – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
Xi Yang, MD, PhD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences ### 1972858###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Institute and Hospital Chinese Acedemy of Medical Sciences###Presenter: – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
### 5:15 PM – 6:15 PM PT
3219 - Total Reference Air Kerma (TRAK) is Associated with Dosimetric Parameters in Template-Based High Dose-Rate (HDR) Interstitial Brachytherapy in Advanced Gynecologic CancersLocation: Hall B2Presenter: – Montefiore Medical Center
Ravindra Yaparpalvi, MS – Montefiore Medical Center ### 538181###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Montefiore Medical Center###Presenter: – Montefiore Medical Center
### 5:15 PM – 6:15 PM PT
3220 - Protocol in a Day: An Educational Institutional Workshop for Protocol DevelopmentLocation: Hall B2Presenter: – University of Texas MD Anderson Cancer Center
Adriana Cavazos, BS – University of Texas MD Anderson Cancer Center ### 2033577###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas MD Anderson Cancer Center###Presenter: – University of Texas MD Anderson Cancer Center
### 5:15 PM – 6:15 PM PT
3221 - Continuing Professional Development for Radiation Oncologists: Where are the Gaps and Barriers?Location: Hall B2Presenter: – London Regional Cancer Program
Sympascho Young, MD, BS – London Regional Cancer Program ### 1972828###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###London Regional Cancer Program###Presenter: – London Regional Cancer Program
### 5:15 PM – 6:15 PM PT
3222 - Development and Validation of CT-Based Clinical-Radiomics Nomogram for Early Stage Extranodal Nasal-Type NK/T Cell Lymphoma: A Multicenter StudyLocation: Hall B2Presenter: – Xijing Hospital
Jian Zang, MD – Xijing Hospital ### 1972846###Presenter######Xijing Hospital###Presenter: – Xijing Hospital
### 5:15 PM – 6:15 PM PT
3223 - Quantifying the Impact of Research Productivity on Salary in Academic Radiation OncologyLocation: Hall B2Presenter: – University Hospitals Case Medical Center
Nicholas Zaorsky, MD, MS – University Hospitals Case Medical Center ### 535741###Presenter###Disclosures: Employment: University Hospitals:Radiation Oncologist:Employee | Compensation: American Cancer Society: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;NIH: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 2022 ;American College of Radiation Oncology: Consultant, Compensation Payment-End Date: present ;Springer Nature: Remuneration Other-End Date: 2021 | Ownership: none | Leadership: none###University Hospitals Case Medical Center###Presenter: – University Hospitals Case Medical Center
### 5:15 PM – 6:15 PM PT
3224 - Optimal Cisplatin Cycles in Locally Advanced Cervical Carcinoma Patients Treated with Concurrent ChemoradiotherapyLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Zheng Zeng, MD – Peking Union Medical College Hospital ### 1972863###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### 5:15 PM – 6:15 PM PT
3225 - Radiotherapy for Postoperative Vaginal Recurrences of Cervical Cancer Patients: Analysis of Recurrent Causes and PrognosisLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Ziye Zheng, MD – Peking Union Medical College Hospital ### 1972859###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### 5:15 PM – 6:15 PM PT
3226 - Adjuvant Concurrent Chemoradiotherapy vs. Radiotherapy Alone in Cervical Cancer Patients with Intermediate-Risk Factors after Radical SurgeryLocation: Hall B2Presenter: – Peking Union Medical College Hospital
Yuncan Zhou, RT – Peking Union Medical College Hospital ### 1972878###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking Union Medical College Hospital###Presenter: – Peking Union Medical College Hospital
### - Wednesday, October 4, 2023
10:30 AM – 11:45 AM PT
2573 - Impact of Family Caregiver and Patient Related Factors on Quality of Life in Head Neck Cancer PatientsLocation: Hall B2Presenter: – DVVPPRH and DBVPRMC PIMS-DU LONI
Chaitali Waghmare, MD – DVVPPRH and DBVPRMC PIMS-DU LONI ### 1972435###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###DVVPPRH and DBVPRMC PIMS-DU LONI###Presenter: – DVVPPRH and DBVPRMC PIMS-DU LONI
### 10:30 AM – 11:45 AM PT
3227 - Which Criteria Should We use to Determine an Adequate Number of Linear Accelerators in Emerging Economy CountriesLocation: Hall B2
Zahid Al Mandhari, MD ### 1972933###Presenter#########Presenter:
### 10:30 AM – 11:45 AM PT
3228 - An Update of Stereotactic Body Radiotherapy (SBRT) for the Palliation of Unirradiated Mucosal Head and Neck Squamous Cell Carcinoma (SCC)Location: Hall B2Presenter: – McGill University Health Center
Mohammed AlDohan, MBBS – McGill University Health Center ### 1972912###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGill University Health Center###Presenter: – McGill University Health Center
### 10:30 AM – 11:45 AM PT
3229 - Positive Predictive Value of PET CT in HPV Associated Oropharyngeal Cancers Treated with Definitive Proton TherapyLocation: Hall B2Presenter: – Thomas Jefferson University
Gregory Alexander, MD – Thomas Jefferson University ### 1972023###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 10:30 AM – 11:45 AM PT
3230 - Intensity-Modulated Neutron Therapy (IMNT) for Head and Neck Cancer: Early Toxicity OutcomesLocation: Hall B2Presenter: – University of Washington
August Anderson, MD – University of Washington ### 2027548###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 10:30 AM – 11:45 AM PT
3231 - Photon vs. Proton Radiotherapy in the Definitive Treatment of Nasopharyngeal Cancer: Single Institution ExperienceLocation: Hall B2Presenter: – Emory University School of Medicine
Joshua Anderson, MD, BS – Emory University School of Medicine ### 746763###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University School of Medicine###Presenter: – Emory University School of Medicine
### 10:30 AM – 11:45 AM PT
3232 - Radiomics Based Assessment of Tumor Infiltrating CD8 T-Cells Predicts Induction Systemic Therapy Response in HPV+ Oropharyngeal Cancer: Exploratory Analysis of Prospective TrialsLocation: Hall B2Presenter: – University of Chicago
Muzamil Arshad, MD, PhD – University of Chicago ### 1972897###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago###Presenter: – University of Chicago
### 10:30 AM – 11:45 AM PT
3233 - Radiation Therapy in the Management of Cutaneous Squamous Cell Carcinoma Metastatic to the Parotid: A 50-Year Single Institution ExperienceLocation: Hall B2Presenter: – University of Florida College of Medicine
Frederick Ashby, PhD, MPH – University of Florida College of Medicine ### 1972914###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida College of Medicine###Presenter: – University of Florida College of Medicine
### 10:30 AM – 11:45 AM PT
3234 - Challenging the Role of Subtotal Resection Following Proton Radiotherapy for Adenoid Cystic Carcinoma of the Head and NeckLocation: Hall B2Presenter: – UF Health Radiation Oncology – Davis Cancer Pavilion
Etzer Augustin, MD, MS – UF Health Radiation Oncology – Davis Cancer Pavilion ### 1972915###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UF Health Radiation Oncology – Davis Cancer Pavilion###Presenter: – UF Health Radiation Oncology – Davis Cancer Pavilion
### 10:30 AM – 11:45 AM PT
3235 - VMAT-IGRT Hypofractionated Radiotherapy for Locally Advanced Thyroid Cancer in Resource-Limited Settings: A Retrospective Report from BoliviaLocation: Hall B2Presenter: – Lijia Aviles
Lijia Aviles, MD – Lijia Aviles ### 1972926###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Lijia Aviles###Presenter: – Lijia Aviles
### 10:30 AM – 11:45 AM PT
3236 - Evaluation of Sentinel Lymph Node Drainage Patterns in Early Stage Oral Cavity CancerLocation: Hall B2Presenter: – Rush University Medical Center
Omar Azem, MD – Rush University Medical Center ### 1972963###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rush University Medical Center###Presenter: – Rush University Medical Center
### 10:30 AM – 11:45 AM PT
3237 - Stereotactic Boost and Short-Course Radiotherapy for p16-Associated Oropharynx Cancer (SHORT-OPC): First Planned Interim Safety Analysis from a Randomized Phase II TrialLocation: Hall B2Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
Houda Bahig, MD, PhD – Centre Hospitalier de l'Universite de Montreal (CHUM) ### 525114###Presenter###Disclosures: Employment: Centre Hospitalier de l'Université de Montréal:Radiation Oncologist:Employee | Compensation: Astra Zeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: present ;Astra Zeneca: Education Meeting Faculty, Compensation Payment-End Date: present ;Varian Medical Systems: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Sanofi: Consultant, Honoraria-End Date: September 2022 ;Astra Zeneca: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 2022 | Ownership: none | Leadership: none###Centre Hospitalier de l'Universite de Montreal (CHUM)###Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
### 10:30 AM – 11:45 AM PT
3238 - Outcomes after Contemporary Definitive Radiotherapy Alone in Patients with TNM-7 Stage III/IV Head and Neck Squamous Cell CarcinomaLocation: Hall B2Presenter: – Princess Margaret Cancer Centre
Marc Vincent Barcelona, MD – Princess Margaret Cancer Centre ### 1972413###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
### 10:30 AM – 11:45 AM PT
3239 - Toxicity and Outcomes of Definitive Local Therapy in Elderly Patients with HPV-Associated Oropharyngeal CancerLocation: Hall B2Presenter: – Ohio State University James Cancer Hospital
Rahul Barve, MD – Ohio State University James Cancer Hospital ### 1972920###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ohio State University James Cancer Hospital###Presenter: – Ohio State University James Cancer Hospital
### 10:30 AM – 11:45 AM PT
3240 - Correlation of Dose Volume Parameters with Dysphagia and Pharyngeal Constrictor Muscle Thickness in Dysphagia Optimized IMRTLocation: Hall B2Presenter: – Gujarat Cancer and Research Institute Ahmedabad
Nikhil Bathija, MD, MBBS – Gujarat Cancer and Research Institute Ahmedabad ### 1972901###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Gujarat Cancer and Research Institute Ahmedabad###Presenter: – Gujarat Cancer and Research Institute Ahmedabad
### 10:30 AM – 11:45 AM PT
3241 - Differences in Radiotherapy-Treated Members with Cancer during COVID-19 Pandemic Using Nationwide Claim DataLocation: Hall B2
Abigail Berman, MD, MS, MSCE – CVS Health ### 536137###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###CVS Health###Presenter: – CVS Health
### 10:30 AM – 11:45 AM PT
3242 - Hypo-Fractionated Palliative QUADSHOT Radiotherapy and Concurrent CDDP in Patients with LAHNSCC: Toxicities and Clinical OutcomesLocation: Hall B2Presenter: – All India Institute of Medical Sciences
Suman Bhasker, MD – All India Institute of Medical Sciences ### 1972921###Presenter######All India Institute of Medical Sciences###Presenter: – All India Institute of Medical Sciences
### 10:30 AM – 11:45 AM PT
3243 - Trends in the Use of Hypofractionation in Treatment of Breast Cancer in BotswanaLocation: Hall B2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Rohini Bhatia, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 538056###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 10:30 AM – 11:45 AM PT
3244 - Definitive Radiotherapy is Effective Treatment for Gross Disease in Unresected Differentiated Thyroid CancerLocation: Hall B2Presenter: – Cleveland Clinic Foundation
David Buchberger, MD, MSc – Cleveland Clinic Foundation ### 1972183###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 10:30 AM – 11:45 AM PT
3246 - Partial Tongue Sparing without Marginal Failures: The Dosimetric Advantages for Oral Tongue Squamous Cell CarcinomaLocation: Hall B2Presenter: – Cleveland Clinic Taussig Cancer Center
Shauna Campbell, MD, DO – Cleveland Clinic Taussig Cancer Center ### 537504###Presenter###Disclosures: Employment: Cleveland Clinic Foundation:Radiation Oncologist:Employee | Compensation: Accuray: Education Meeting Faculty, Travel Expenses-End Date: 06/15/22 | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 10:30 AM – 11:45 AM PT
3247 - Outcomes of Patients with Oral Cavity Squamous Cell Carcinomas Treated with Adjuvant IMRT with Perineural InvasionLocation: Hall B2Presenter: – University of Pittsburgh School of Medicine
Kasey Cargill, PhD – University of Pittsburgh School of Medicine ### 1972973###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pittsburgh School of Medicine###Presenter: – University of Pittsburgh School of Medicine
### 10:30 AM – 11:45 AM PT
3248 - Voxel Based Analysis of Local Dose Patterns on Radiation Induced Xerostomia in Head and Neck Cancer with Machine Learning MethodsLocation: Hall B2
Ming Chao, PhD ### 746656###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3249 - Demographics, Medical Comorbidities, and Functional Factors Associated with Radiation Therapy Regimen Length in Older PatientsLocation: Hall B2Presenter: – Mount Sinai Hospital
Daniel Cherry, MD, MAS – Mount Sinai Hospital ### 1972943###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mount Sinai Hospital###Presenter: – Mount Sinai Hospital
### 10:30 AM – 11:45 AM PT
3251 - Insurance Request and Approval Process for Proton Beam Therapy in Patients With Esophageal CancerLocation: Hall B2Presenter: – Stanford Health Care
Jennifer Chiang, MD, MS – Stanford Health Care ### 1972938###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Health Care###Presenter: – Stanford Health Care
### 10:30 AM – 11:45 AM PT
3252 - Transoral Laser Microsurgery and Radiotherapy for Early Glottic Cancer: An Old Story with a New EndingLocation: Hall B2Presenter: – Kaohsiung Veterans General Hospital
Ju-chun Chien, MD – Kaohsiung Veterans General Hospital ### 1972893###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaohsiung Veterans General Hospital###Presenter: – Kaohsiung Veterans General Hospital
### 10:30 AM – 11:45 AM PT
3253 - Impact of Dosimetric Parameters on Local Control and Toxicity of Head and Neck SBRTLocation: Hall B2Presenter: – Northwell Health Center for Advanced Medicine
Bhargava Chitti, MD – Northwell Health Center for Advanced Medicine ### 747403###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health Center for Advanced Medicine###Presenter: – Northwell Health Center for Advanced Medicine
### 10:30 AM – 11:45 AM PT
3254 - External Validation of 8 Normal Tissue Complication Probability Models for Radiation-Associated Primary Hypothyroidism Using Long-Term Thyroid Function OutcomesLocation: Hall B2Presenter: – Queen Elizabeth Hospital
James Chow, MBChB – Queen Elizabeth Hospital ### 537959###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Queen Elizabeth Hospital###Presenter: – Queen Elizabeth Hospital
### 10:30 AM – 11:45 AM PT
3255 - Oral Cavity Squamous Cell Carcinomas in Patients with a History of Oral Lichen Planus: Frequency and OutcomesLocation: Hall B2
Samantha Cook, BS ### 1972972###Presenter#########Presenter:
### 10:30 AM – 11:45 AM PT
3256 - Characteristics of Premature Radiotherapy Terminations in Patients with Oral Cavity and Laryngeal CarcinomasLocation: Hall B2Presenter: – Zucker School of Medicine at Hofstra/Northwell
Dylan Cooper, BA – Zucker School of Medicine at Hofstra/Northwell ### 1972975###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Zucker School of Medicine at Hofstra/Northwell###Presenter: – Zucker School of Medicine at Hofstra/Northwell
### 10:30 AM – 11:45 AM PT
3257 - Assessing the Compliance and Accuracy of a National Australian Head and Neck Cancer (HNC) DatabaseLocation: Hall B2
June Corry, MD – GenesisCare ### 535674###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GenesisCare###Presenter: – GenesisCare
### 10:30 AM – 11:45 AM PT
3258 - Racial Disparities in Survival of Patients with High-Risk LA SCCHN in the U.S.Location: Hall B2
David Fox, MS, PharmD – Genentech ### 2010638###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Genentech###Presenter: – Genentech
### 10:30 AM – 11:45 AM PT
3259 - Use of Postoperative PET/CT in Altering Management in Adjuvant Head and Neck Radiation TherapyLocation: Hall B2Presenter: – UCLA David Geffen School of Medicine/UCLA Medical Center
Patrick Courtney, MD, MAS – UCLA David Geffen School of Medicine/UCLA Medical Center ### 1972187###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA David Geffen School of Medicine/UCLA Medical Center###Presenter: – UCLA David Geffen School of Medicine/UCLA Medical Center
### 10:30 AM – 11:45 AM PT
3260 - Financial Implications of Evolving Breast Cancer Radiotherapy Treatment ProtocolsLocation: Hall B2Presenter: – Beaumont Hospital Dublin
Daniel Coyle, MB, ChB, BAO – Beaumont Hospital Dublin ### 1972955###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Hospital Dublin###Presenter: – Beaumont Hospital Dublin
### 10:30 AM – 11:45 AM PT
3261 - Evolution of the MOMENTUM Study for Evidence-Based Implementation of MR-Guided Radiotherapy Using the 1.5 Tesla MR-LinacLocation: Hall B2
Lois Daamen, MD, PhD – UMC Utrecht ### 1972550###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UMC Utrecht###Presenter: – UMC Utrecht
### 10:30 AM – 11:45 AM PT
3262 - Definitive Chemoradiation with Concurrent Carboplatin and Paclitaxel for HPV-Mediated Oropharyngeal Cancer (p16+ OPSCC): Survival and Local ControlLocation: Hall B2Presenter: – Vanderbilt University Medical Center
Kaleb Darrow, MD – Vanderbilt University Medical Center ### 1972961###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Vanderbilt University Medical Center###Presenter: – Vanderbilt University Medical Center
### 10:30 AM – 11:45 AM PT
3263 - Stereotactic Body Radiotherapy in Latin America: Real-World Evidence of Health OutcomesLocation: Hall B2Presenter: – Centro Medico ABC
M. Dolores De La Mata Moya, MD, PhD, MBA – Centro Medico ABC ### 524433###Presenter###Disclosures: Employment: CENTRO MEDICO ABC:HEAD OF RADIOTHERAPY:Employee;TEC MONTERREY MEDICINE FACULTY:PROFESSOR:Employee | Compensation: ELEKTA: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Education Meeting Faculty, Speaker's Bureau, Honoraria, Travel Expenses-End Date: to present ;ASTRA ZENECA: Speaker's Bureau, Honoraria, Travel Expenses-End Date: to present ;C-RAD: Education Meeting Faculty, Uncompensated-End Date: to present | Ownership: none | Leadership: LATIN AMERICA RADIOTHERAPY SOCIETY:secretary;CENTRO MEDICO ABC:HEAD OF RADIOTHERAPY, Tumor Comittees director###Centro Medico ABC###Presenter: – Centro Medico ABC
### 10:30 AM – 11:45 AM PT
3264 - Is 80 the New 70? Octogenarians with Oropharyngeal Squamous Cell CarcinomaLocation: Hall B2Presenter: – Icahn School of Medicine at Mount Sinai
Daniel Dickstein, MD – Icahn School of Medicine at Mount Sinai ### 747609###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Icahn School of Medicine at Mount Sinai###Presenter: – Icahn School of Medicine at Mount Sinai
### 10:30 AM – 11:45 AM PT
3265 - Cost-Effectiveness of Prophylactic Radiation in Patients with Asymptomatic Bone MetastasesLocation: Hall B2Presenter: – UC San Diego
Anna Dornisch, MD – UC San Diego ### 1972916###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UC San Diego###Presenter: – UC San Diego
### 10:30 AM – 11:45 AM PT
3266 - Radiotherapy Quality Indicators in the Pilot Program of the NON in Poland in 2019-2021Location: Hall B2Presenter: – Lower Silesian Oncology Center
Arkadiusz Drapiewski, MD – Lower Silesian Oncology Center ### 1972940###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Lower Silesian Oncology Center###Presenter: – Lower Silesian Oncology Center
### 10:30 AM – 11:45 AM PT
3267 - Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid CancerLocation: Hall B2Presenter: – MD Anderson Cancer Center
Stephanie Dudzinski, MD, PhD – MD Anderson Cancer Center ### 1972977###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:30 AM – 11:45 AM PT
3268 - Carbon Footprint of Photon TherapyLocation: Hall B2Presenter: – Orlando Health
Tomas Dvorak, MD – Orlando Health ### 1972928###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Orlando Health###Presenter: – Orlando Health
### 10:30 AM – 11:45 AM PT
3269 - Unique T-cell Sub-Population Shifts after SBPT and Nivolumab in Platinum Refractory HNC: Biomarker Correlates from ROR1771Location: Hall B2
Daniel Ebner, MD, MPH – Mayo Clinic ### 524730###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 10:30 AM – 11:45 AM PT
3270 - Low-Dose Fractionated Radiotherapy Combined with Neoadjuvant Chemotherapy for T3-4 Nasopharyngeal Carcinoma Patients: The Preliminary Results of a Phase II Randomized Controlled TrialLocation: Hall B2Presenter: – Si Chuan Cancer Hospital
Mei Feng, MD, PhD – Si Chuan Cancer Hospital ### 525161###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Si Chuan Cancer Hospital###Presenter: – Si Chuan Cancer Hospital
### 10:30 AM – 11:45 AM PT
3271 - Long-Term Survival Outcome for Metastatic Nasopharyngeal Carcinoma Patients Receiving Radiation to Primary and Metastatic Sites with Palliative ChemotherapyLocation: Hall B2Presenter: – Si Chuan Cancer Hospital
Mei Feng, MD, PhD – Si Chuan Cancer Hospital ### 525161###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Si Chuan Cancer Hospital###Presenter: – Si Chuan Cancer Hospital
### 10:30 AM – 11:45 AM PT
3272 - Cervical Cancer Progression in Patients Waiting for Radiotherapy Treatment at A Referral Center in Ethiopia: A Longitudinal StudyLocation: Hall B2Presenter: – Dartmouth-Hitchcock Medical Center
Jilcha Feyisa, MD, MPH – Dartmouth-Hitchcock Medical Center ### 1972925###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Dartmouth-Hitchcock Medical Center###Presenter: – Dartmouth-Hitchcock Medical Center
### 10:30 AM – 11:45 AM PT
3273 - Evaluation of Radiotherapy Dose and Survival Outcomes for Teenagers, and Young Adults with Nasopharyngeal Carcinoma in UK and IrelandLocation: Hall B2Presenter: – The Christie NHS Foundation Trust
John Gaffney, MD – The Christie NHS Foundation Trust ### 1972906###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Christie NHS Foundation Trust###Presenter: – The Christie NHS Foundation Trust
### 10:30 AM – 11:45 AM PT
3274 - Temporal Incidence and Patterns of Distant Failure for Human Papillomavirus (HPV) Related Oropharyngeal CancerLocation: Hall B2Presenter: – The Christie NHS Foundation Trust
John Gaffney, MD – The Christie NHS Foundation Trust ### 1972906###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Christie NHS Foundation Trust###Presenter: – The Christie NHS Foundation Trust
### 10:30 AM – 11:45 AM PT
3275 - Definitive and Salvage Radiotherapy Compared to Other Modalities for Laryngeal Carcinoma in SituLocation: Hall B2Presenter: – Henry Ford Cancer Institute/Alexandria University
Ahmed Ghanem, MD, PhD – Henry Ford Cancer Institute/Alexandria University ### 535783###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Henry Ford Cancer Institute/Alexandria University###Presenter: – Henry Ford Cancer Institute/Alexandria University
### 10:30 AM – 11:45 AM PT
3276 - Disease Characteristics, Treatment and Survival for Oropharyngeal Squamous Cell Carcinoma of ElderlyLocation: Hall B2Presenter: – Henry Ford Cancer Institute/Alexandria University
Ahmed Ghanem, MD, PhD – Henry Ford Cancer Institute/Alexandria University ### 535783###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Henry Ford Cancer Institute/Alexandria University###Presenter: – Henry Ford Cancer Institute/Alexandria University
### 10:30 AM – 11:45 AM PT
3277 - Treatment Tolerance and Toxicity in Elderly Oropharyngeal Cancer Patients and Implication on OutcomesLocation: Hall B2Presenter: – Henry Ford Cancer Institute/Alexandria University
Ahmed Ghanem, MD, PhD – Henry Ford Cancer Institute/Alexandria University ### 535783###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Henry Ford Cancer Institute/Alexandria University###Presenter: – Henry Ford Cancer Institute/Alexandria University
### 10:30 AM – 11:45 AM PT
3278 - Quantifying the Travel Undertaken by Cancer Patients Receiving Radiotherapy in Victoria, AustraliaLocation: Hall B2Presenter: – Austin Health
Richard Khor, MBBS – Austin Health ### 763899###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Austin Health###Presenter: – Austin Health
### 10:30 AM – 11:45 AM PT
3278 - Quantifying the Travel Undertaken By Cancer Patients Receiving Radiotherapy in Victoria, AustraliaLocation: Hall B2Presenter: – University of Melbourne
Piers Gillett – University of Melbourne ### 1972942###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Melbourne###Presenter: – University of Melbourne
### 10:30 AM – 11:45 AM PT
3279 - Radiation Toxicity Profile Difference in p16+ vs. p16- Oropharyngeal Cancer PatientsLocation: Hall B2Presenter: – Baylor College of Medicine
Ronald Goldsberry, BS – Baylor College of Medicine ### 1972917###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Baylor College of Medicine###Presenter: – Baylor College of Medicine
### 10:30 AM – 11:45 AM PT
3280 - Fractionated Stereotactic Radiotherapy in the Management of Dural Recurrence of Olfactory NeuroblastomaLocation: Hall B2Presenter: – University of Western Ontario
Christopher Goodman, MD – University of Western Ontario ### 536047###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Western Ontario###Presenter: – University of Western Ontario
### 10:30 AM – 11:45 AM PT
3281 - Delay in Time to Oncologic Therapies for Patients with Positive COVID-19 TestLocation: Hall B2Presenter: – University of Utah Huntsman Cancer Institute
Nicholas Gravbrot, MD – University of Utah Huntsman Cancer Institute ### 1972931###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Utah Huntsman Cancer Institute###Presenter: – University of Utah Huntsman Cancer Institute
### 10:30 AM – 11:45 AM PT
3282 - Hippocampal-Sparing Radiotherapy in Primary Sinonasal and Cutaneous Head and Neck Malignancies: A Feasibility StudyLocation: Hall B2
Jacob Hall, MD – UNC Health ### 1972273###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UNC Health###Presenter: – UNC Health
### 10:30 AM – 11:45 AM PT
3283 - The Lyman Normal Tissue Complication Probability Model and Risk Prediction for Temporal Lobe Injury after Re-Irradiation in Patients with Recurrent Nasopharyngeal CarcinomaLocation: Hall B2
Fei Han ### 1972887###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3284 - Long-Term Outcomes of Stereotactic Body Radiation Therapy with or without PD-1 Inhibitors in Metastatic Nasopharyngeal CarcinomaLocation: Hall B2Presenter: – MD Anderson Cancer Center
Jinlan He, MD, MS – MD Anderson Cancer Center ### 1972962###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:30 AM – 11:45 AM PT
3285 - Impact of Head and Neck Cancer Treatment on CD4 T Cell Decline and Recovery in People with HIVLocation: Hall B2Presenter: – Yale New Haven Hospital
Daniel Hicks, MD – Yale New Haven Hospital ### 537948###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yale New Haven Hospital###Presenter: – Yale New Haven Hospital
### 10:30 AM – 11:45 AM PT
3286 - Adjuvant External Beam Radiotherapy and Histopathologic Prognostic Factors in Tall Cell Papillary Thyroid CarcinomaLocation: Hall B2Presenter: – Washington University in St. Louis
Daniel Hong, MD – Washington University in St. Louis ### 1972631###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University in St. Louis###Presenter: – Washington University in St. Louis
### 10:30 AM – 11:45 AM PT
3287 - Prognostic Significance of the Novel Nutrition-Inflammation Marker of Lymphocyte-C-Reactive Protein Ratio in Patients with Nasopharyngeal Carcinoma Receiving Concurrent ChemoradiotherapyLocation: Hall B2
Xin Hua, MD ### 1972968###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3288 - Standard Therapy vs. Individualized Therapy in Elderly Locally Advanced Nasopharyngeal Carcinoma: A Real-World StudyLocation: Hall B2
Jing Huang, MD ### 1972982###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3289 - Radiation-Induced Nasopharyngeal Necrosis in Locally-Recurrent Nasopharyngeal Carcinoma Patients after Re-RadiotherapyLocation: Hall B2Presenter: – Koo Foundation Sun Yat-Sen Cancer Center
Runda Huang, PhD, MS, Master of Medicine – Koo Foundation Sun Yat-Sen Cancer Center ### 1972900###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Koo Foundation Sun Yat-Sen Cancer Center###Presenter: – Koo Foundation Sun Yat-Sen Cancer Center
### 10:30 AM – 11:45 AM PT
3290 - Feasibility of a Keratin-Based Topical Cream for Radiation Dermatitis in Patients with Head and Neck Cancer: Results of a Randomized Pilot StudyLocation: Hall B2Presenter: – Wake Forest University Baptist Medical Center
Ryan Hughes, MD – Wake Forest University Baptist Medical Center ### 525171###Presenter###Disclosures: Employment: Wake Forest University School of Medicine:Assistant Professor, Radiation Oncology:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Wake Forest University Baptist Medical Center###Presenter: – Wake Forest University Baptist Medical Center
### 10:30 AM – 11:45 AM PT
3291 - Surgeon, Pathologist and Pathology Technician Effects on Nodal Yield after a Neck DissectionLocation: Hall B2Presenter: – Southern California Permanente Medical Group
Zain Husain, MD – Southern California Permanente Medical Group ### 524807###Presenter###Disclosures: Employment: Southern California Permanente Medical Group:Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Southern California Permanente Medical Group###Presenter: – Southern California Permanente Medical Group
### 10:30 AM – 11:45 AM PT
3292 - Bridging the Gap of Radiotherapy Treatment Planning Quality between High-Income, and Low- and Middle-Income Countries Using Knowledge-Based PlanningLocation: Hall B2Presenter: – Liga Nacional Contra el Cancer
Milton Ixquiac, MS – Liga Nacional Contra el Cancer ### 1972919###Presenter######Liga Nacional Contra el Cancer###Presenter: – Liga Nacional Contra el Cancer
### 10:30 AM – 11:45 AM PT
3293 - The Prognostic and Predictive Value of Pre-Treatment Total Lymphocyte Count in HPV+ Oropharyngeal Carcinoma Receiving Definitive (Chemo-) RadiationLocation: Hall B2Presenter: – Princess Margaret Cancer Center, University Health Network
Carlton Johnny, MD – Princess Margaret Cancer Center, University Health Network ### 1972687###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Center, University Health Network###Presenter: – Princess Margaret Cancer Center, University Health Network
### 10:30 AM – 11:45 AM PT
3294 - Identifying Key Barriers for Radiation Oncology Financial Advocacy ProgramsLocation: Hall B2Presenter: – Association of Community Cancer Centers
Elana Plotkin, BS – Association of Community Cancer Centers ### 2065904###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Association of Community Cancer Centers###Presenter: – Association of Community Cancer Centers
### 10:30 AM – 11:45 AM PT
3295 - Disease Control and Toxicity Outcomes after Intraoperative HDR Brachytherapy for Neck Recurrences in Patients Previously Irradiated Head and Neck CancerLocation: Hall B2Presenter: – MD Anderson Cancer Center
Julia Khriguian, MD – MD Anderson Cancer Center ### 747465###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:30 AM – 11:45 AM PT
3296 - Characterization of Antibody Repertoires in Patients with HPV-Related HNSCC Undergoing Definitive Radiation with ImmunotherapyLocation: Hall B2Presenter: – University of California, San Diego
Sangwoo Kim, MD – University of California, San Diego ### 525366###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, San Diego###Presenter: – University of California, San Diego
### 10:30 AM – 11:45 AM PT
3297 - Stereotactic Body Radiation Therapy (SBRT) for Head and Neck Cancer Re-Irradiation: Should >180° Carotid Encasement or Dermal Involvement Remain an Exclusion Criteria?Location: Hall B2Presenter: – Cleveland Clinic Taussig Cancer Center
Jenna Kocsis, MD – Cleveland Clinic Taussig Cancer Center ### 747813###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 10:30 AM – 11:45 AM PT
3298 - Radiotherapy Alone vs. Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein-Barr Virus DNA Post-Induction ChemotherapyLocation: Hall B2Presenter: – Fudan University Shanghai Cancer Center
Fang Kong, MD – Fudan University Shanghai Cancer Center ### 537961###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 10:30 AM – 11:45 AM PT
3299 - Prognostic Value of Lymph Node-to-Primary Tumor Ratio of PET Standardized Uptake Value for Nasopharyngeal Carcinoma: A Recursive Partitioning Risk Stratification AnalysisLocation: Hall B2Presenter: – Fudan University Shanghai Cancer Center
Fang Kong, MD – Fudan University Shanghai Cancer Center ### 537961###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 10:30 AM – 11:45 AM PT
3300 - Outcomes of Patients Treated with Re-Irradiation for Recurrent Head and Neck Cancer Using Pencil Beam Scanning Proton TherapyLocation: Hall B2Presenter: – University of Maryland Radiation Oncology
Rebecca Krc, DO – University of Maryland Radiation Oncology ### 1972232###Presenter###Disclosures: Employment: University of Maryland Medical Center:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: Society for Women in Radiation Oncology:Membership Chair###University of Maryland Radiation Oncology###Presenter: – University of Maryland Radiation Oncology
### 10:30 AM – 11:45 AM PT
3301 - Using Life Cycle Assessment as a Tool to Evaluate the Environmental Impact of Radiation Oncology and Inform Treatment Decision-Making in Early-Stage Breast CancerLocation: Hall B2Presenter: – Harvard Radiation Oncology Program
Dalia Larios, MD – Harvard Radiation Oncology Program ### 1972898###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 10:30 AM – 11:45 AM PT
3302 - Prophylactic vs. Reactive Gastrostomy Tube Placement in Patients Treated with Radiotherapy for Head and Neck CancerLocation: Hall B2
Ji Hyae Lee, MD ### 1972909###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3303 - Eosinophil Dynamics during Chemo-Radiation Correlate to Clinical Outcome in Stage II-IVA Nasopharyngeal Carcinoma Patients: Results from a Large Cohort StudyLocation: Hall B2
Dan Li, DSc ### 1972890###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3304 - Exploring the Clinical Characteristics and Survival of Early-Onset and Late-Onset Nasopharyngeal CarcinomaLocation: Hall B2
Pian Li, MD ### 1972891###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3305 - Study on Lattice Radiotherapy Treatments (LRT) for Head and Neck Bulky TumorsLocation: Hall B2Presenter: – Sichuan Cancer Hospital
Xiongfei Liao, PhD, MS – Sichuan Cancer Hospital ### 1972894###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital###Presenter: – Sichuan Cancer Hospital
### 10:30 AM – 11:45 AM PT
3306 - Impacts of Wildfire Events on California Radiation Oncology Clinics and PatientsLocation: Hall B2Presenter: – University of California San Francisco
Katie Lichter, MD, MD MPH – University of California San Francisco ### 1971549###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 10:30 AM – 11:45 AM PT
3307 - The Environmental Impact of Radiation Oncology: The "Footprint" of External Beam Radiation TherapyLocation: Hall B2Presenter: – University of California San Francisco
Katie Lichter, MD, MD MPH – University of California San Francisco ### 1971549###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 10:30 AM – 11:45 AM PT
3308 - Automated Contouring of Cervical Lymph Nodes and Clinical Target Volumes for Nasopharyngeal Carcinoma Based on Deep Learning and Experience ConstraintsLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Li Lin, MD, PhD – Sun Yat-Sen University Cancer Center ### 535809###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 10:30 AM – 11:45 AM PT
3309 - Identification and Automated Delineation of Radioresistant Biological Tumor Volume in Nasopharyngeal Carcinoma Based on Magnetic Resonance Imaging RadiomicsLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Li Lin, MD, PhD – Sun Yat-Sen University Cancer Center ### 535809###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 10:30 AM – 11:45 AM PT
3310 - Selectively Irradiation of the Supraclavicular Area in Nasopharyngeal Carcinoma Treated with Intensity Modulated RadiotherapyLocation: Hall B2Presenter: – Fujian Provincial Cancer Hospital
Shaojun Lin, MD, PhD – Fujian Provincial Cancer Hospital ### 537774###Presenter######Fujian Provincial Cancer Hospital###Presenter: – Fujian Provincial Cancer Hospital
### 10:30 AM – 11:45 AM PT
3311 - Radiopharmaceutical Therapy Practice Patterns Across Medicare Providers: An Opportunity for Growth in Radiation OncologyLocation: Hall B2Presenter: – UCLA Radiation Oncology
Eulanca Liu, MD, PhD – UCLA Radiation Oncology ### 1972732###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 10:30 AM – 11:45 AM PT
3312 - Feasibility of Omitting Contralateral Neck Irradiation in Patients with Node-Negative Sinonasal Squamous Cell Carcinoma Crossing the MidlineLocation: Hall B2Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
Qian Liu, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy ### 1972957###Presenter######National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy###Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
### 10:30 AM – 11:45 AM PT
3313 - A Phase 2 Trial of Efficacy and Safety of Intraoperative Radiation Therapy for Locally Advanced LaryngocarcinomaLocation: Hall B2Presenter: – National Cancer Center CAMS & PUMC
qingfeng liu, MD – National Cancer Center CAMS & PUMC ### 1972899###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center CAMS & PUMC###Presenter: – National Cancer Center CAMS & PUMC
### 10:30 AM – 11:45 AM PT
3314 - Proposals for the Delineation of Neck Clinical Target Volume Specific to Oral Squamous Cell Cancer Based on Lymph Node DistributionLocation: Hall B2
Yun-Chang Liu, MD ### 1972889###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3315 - Irradiation Dose to the Swallowing Muscles Impacts Nutritional Status in Head and Neck Cancer Patients: The Prospective Randomized HEADNUT TrialLocation: Hall B2Presenter: – University Medical-Center Schleswig-Holstein
Anastassia Loeser, MD – University Medical-Center Schleswig-Holstein ### 1972956###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Medical-Center Schleswig-Holstein###Presenter: – University Medical-Center Schleswig-Holstein
### 10:30 AM – 11:45 AM PT
3316 - Long Term Clinical Outcomes of a Cohort of Lung-Only Oligometastatic HNSCC Patients Treated with SBRTLocation: Hall B2Presenter: – Azienda Ospedaliera Universitaria Careggi
Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi ### 1972601###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Azienda Ospedaliera Universitaria Careggi###Presenter: – Azienda Ospedaliera Universitaria Careggi
### 10:30 AM – 11:45 AM PT
3317 - All that Glitters is Not Gold: Examining Cost Effectiveness Analyses in Radiation OncologyLocation: Hall B2Presenter: – Sunnybrook Health Sciences Centre
Alexander Louie, MD, PhD, MSc, FRCPC – Sunnybrook Health Sciences Centre ### 524452###Presenter###Disclosures: Employment: Sunnybrook Health Science Centre:Radiation Oncologist:Employee | Compensation: AstraZeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Speaker's Bureau, Honoraria-End Date: ongoing | Ownership: none | Leadership: none###Sunnybrook Health Sciences Centre###Presenter: – Sunnybrook Health Sciences Centre
### 10:30 AM – 11:45 AM PT
3318 - Palliative Care as a Component of High Value and Cost-Saving Care During Hospitalization for Metastatic CancerLocation: Hall B2Presenter: – SUNY Downstate Health Sciences University
Sifan Lu, BA – SUNY Downstate Health Sciences University ### 1972927###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###SUNY Downstate Health Sciences University###Presenter: – SUNY Downstate Health Sciences University
### 10:30 AM – 11:45 AM PT
3319 - Refining the TNM M1 Subcategory for De Novo Metastatic Nasopharyngeal CarcinomaLocation: Hall B2
Tianzhu Lu, MD ### 747530###Presenter#########Presenter:
### 10:30 AM – 11:45 AM PT
3320 - Patient-Family Caregiver Concordance in Assessment of Psychological Distress of Chinese Patients with Head and Neck Cancer during ChemoradiotherapyLocation: Hall B2
Jianxia Lyu, MS ### 1972980###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3321 - Combining Radiotherapy with Chemotherapy and Immunotherapy as First-Line Treatment for De Novo Metastatic Nasopharyngeal Carcinoma: A Dual-Center Retrospective AnalysisLocation: Hall B2
Li Ma, MD ### 1972954###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3322 - Optimum Radiation Dose for Palliation in Head and Neck SCC: A Phase III Randomized Controlled Trial (OPRAH)Location: Hall B2Presenter: – All India Institute of Medical Sciences
Supriya Mallick, MD, MB – All India Institute of Medical Sciences ### 1972978###Presenter######All India Institute of Medical Sciences###Presenter: – All India Institute of Medical Sciences
### 10:30 AM – 11:45 AM PT
3323 - Can Advanced Radiotherapy Clinical Trials be Conducted in Resources Limited Countries?Location: Hall B2
Wilfred Ngwa, PhD, MS ### 2149152###Presenter#########Presenter:
### 10:30 AM – 11:45 AM PT
3324 - Stereotactic Radiotherapy Deserts are Under-Represented among Radiation Oncology Alternative Payment Model SitesLocation: Hall B2Presenter: – University of Minnesota
Erin McCammack, MD, MBA – University of Minnesota ### 1972934###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Minnesota###Presenter: – University of Minnesota
### 10:30 AM – 11:45 AM PT
3325 - Tailoring Radiation to the Contralateral Neck for Midline HPV-Mediated Oropharyngeal Squamous Cell Carcinoma (p16+ OPSCC)Location: Hall B2Presenter: – Vanderbilt University Medical Center
Kyra McComas, MD – Vanderbilt University Medical Center ### 1972910###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Vanderbilt University Medical Center###Presenter: – Vanderbilt University Medical Center
### 10:30 AM – 11:45 AM PT
3326 - Are Different Modes of Weight Loss Associated with Survival in Oropharyngeal Cancer?Location: Hall B2Presenter: – The University of Manchester
Donal McSweeney, PhD, MS – The University of Manchester ### 1972907###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of Manchester###Presenter: – The University of Manchester
### 10:30 AM – 11:45 AM PT
3327 - The Feasibility of Level Ib Sparing Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma Patients with High-Risk Factors: Based on International GuidelineLocation: Hall B2
Zhen Meng ### 1972964###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3328 - Prospective Evaluation of Locoregional Control In Oral Cavity Squamous Cell Carcinoma With Infratemporal Fossa Involvement Treated With Surgery And Adjuvant Concurrent ChemoradiotherapyLocation: Hall B2Presenter: – Dr Ram Manohar Lohia Institute of Medical Sciences
Prasoon Mishra, MBBS – Dr Ram Manohar Lohia Institute of Medical Sciences ### 1972902###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Dr Ram Manohar Lohia Institute of Medical Sciences###Presenter: – Dr Ram Manohar Lohia Institute of Medical Sciences
### 10:30 AM – 11:45 AM PT
3329 - Radiotherapy (RT) for Cutaneous Adnexal Carcinoma (CAC): 49 Patients Treated at a Single Institution Over 2 DecadesLocation: Hall B2Presenter: – SUNY Downstate College of Medicine
Nader Mohamed – SUNY Downstate College of Medicine ### 2027550###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###SUNY Downstate College of Medicine###Presenter: – SUNY Downstate College of Medicine
### 10:30 AM – 11:45 AM PT
3330 - Comparison of Standard vs. Relative Risk Models to Define Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal CancerLocation: Hall B2Presenter: – University of North Carolina at Chapel Hill
Ryan Morse, MD – University of North Carolina at Chapel Hill ### 537838###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of North Carolina at Chapel Hill###Presenter: – University of North Carolina at Chapel Hill
### 10:30 AM – 11:45 AM PT
3331 - Effects of Comprehensive Geriatric Assessment (CGA) Guided Care vs. Usual Care on Overall Survival (OS) and Health-Related Quality of Life (HRQL) for Older Adults with Cancer: A Systematic Review of RLocation: Hall B2Presenter: – National University Cancer Institute Singapore
Zhi Xuan Ng, MBBS – National University Cancer Institute Singapore ### 1972884###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National University Cancer Institute Singapore###Presenter: – National University Cancer Institute Singapore
### 10:30 AM – 11:45 AM PT
3332 - Impact of Outside Referral and Dental Extractions on Package Time With Postoperative Radiation Therapy for Head and Neck CancerLocation: Hall B2Presenter: – University of Virginia School of Medicine
Joseph Nguyen, BS – University of Virginia School of Medicine ### 1972945###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Virginia School of Medicine###Presenter: – University of Virginia School of Medicine
### 10:30 AM – 11:45 AM PT
3333 - Acute and Late Toxicities in Patients with Collagen Vascular Disease Receiving Curative-Intent Intensity-Modulated Radiotherapy to the Head and Neck RegionLocation: Hall B2Presenter: – University of California San Francisco
Lisa Ni, MD – University of California San Francisco ### 538130###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 10:30 AM – 11:45 AM PT
3334 - Treatment Outcomes of Concurrent Nimotuzumab with Intensity Modulated Radiotherapy in Advanced Nasopharyngeal Carcinoma Patients Unfit for Concurrent Chemoradiotherapy: A Single Institute ExperienceLocation: Hall B2
Weiqiong Ni, MD, MS ### 1972953###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3335 - An Analysis of Delays in Treatment Time for Prostate Cancer Patients in Sub-Saharan AfricaLocation: Hall B2Presenter: – Johns Hopkins Medicine
Elizabeth Olatunji, BS, MPhil – Johns Hopkins Medicine ### 1995710###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Medicine###Presenter: – Johns Hopkins Medicine
### 10:30 AM – 11:45 AM PT
3336 - A Novel Multi-Objective Based Feature Selection Method for Response PredictionLocation: Hall B2
Xiaoying Pan, PhD ### 1972950###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3337 - An Adaptive Multi-Feature Fusion Network for Predicting Overall Survival of Patients with Head and Neck CancerLocation: Hall B2
Xiaoying Pan, PhD ### 1972950###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3338 - Impact of the COVID-19 Pandemic on Brachytherapy and Cancer Patient Outcomes: A Systematic ReviewLocation: Hall B2
Shreel Parikh, DO, MS – CINJ/RWJ ### 1972892###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###CINJ/RWJ###Presenter: – CINJ/RWJ
### 10:30 AM – 11:45 AM PT
3339 - Health Equity Achievement in Radiation Therapy (HEART) Score: A Social PrognosisLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Akshat Patel, MD, BA – Memorial Sloan Kettering Cancer Center ### 1972932###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 10:30 AM – 11:45 AM PT
3340 - Expanding Radiotherapy Access in Sub-Saharan Africa: An Analysis of Travel Burdens and Patient-Related Benefits of HypofractionationLocation: Hall B2Presenter: – Johns Hopkins Medicine
Saloni Patel, BS – Johns Hopkins Medicine ### 1972883###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Medicine###Presenter: – Johns Hopkins Medicine
### 10:30 AM – 11:45 AM PT
3341 - Trends in Utilization and Medicare Spending on Shorter vs. Longer Radiotherapy Courses for Breast and Prostate CancerLocation: Hall B2Presenter: – University of Pennsylvania
Tej Patel, BS – University of Pennsylvania ### 1972408###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 10:30 AM – 11:45 AM PT
3342 - Evaluating Childcare Support in NCI Designated Cancer Centers for Patients with Young Children Undergoing TreatmentLocation: Hall B2Presenter: – University of Florida Proton Therapy Institute
Sonile Peck, BS – University of Florida Proton Therapy Institute ### 1972941###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida Proton Therapy Institute###Presenter: – University of Florida Proton Therapy Institute
### 10:30 AM – 11:45 AM PT
3343 - Mitigation of Dosimetric Uncertainty in MRI-Based Proton Planning Using Spot-Scanning Proton Arc (SPArc) TechniqueLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Yinglin Peng, PhD – Sun Yat-Sen University Cancer Center ### 1972951###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 10:30 AM – 11:45 AM PT
3344 - Predicting Acute Radio-Induced Toxicity for Head and Neck Cancer Patients: Combining Dosimetry with Biomarker Data, Disclosing a Synergistic EffectLocation: Hall B2Presenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
Tiziana Rancati, MS – Fondazione IRCCS - Istituto Nazionale dei Tumori ### 747410###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fondazione IRCCS - Istituto Nazionale dei Tumori###Presenter: – Fondazione IRCCS - Istituto Nazionale dei Tumori
### 10:30 AM – 11:45 AM PT
3345 - The Effect of Package Time on Locally Advanced Oral Cavity Cancer OutcomesLocation: Hall B2Presenter: – University of Cincinnati College of Medicine
Taylor Petery, BS, BA – University of Cincinnati College of Medicine ### 1972960###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Cincinnati College of Medicine###Presenter: – University of Cincinnati College of Medicine
### 10:30 AM – 11:45 AM PT
3346 - Toxicity and Dosimetric Analysis of Reirradiation of Head and Neck Cancers with High Dose Rate BrachytherapyLocation: Hall B2Presenter: – UCSF Dept Radiation Oncology
Christina Phuong, MD – UCSF Dept Radiation Oncology ### 1972383###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSF Dept Radiation Oncology###Presenter: – UCSF Dept Radiation Oncology
### 10:30 AM – 11:45 AM PT
3347 - Beneficial Role of Multi-Disciplinary Treatment for Anaplastic Thyroid Cancer with Initial Distant MetastasisLocation: Hall B2Presenter: – Yonsei Cancer Center Yonsei College of Medicine
Ji Hoon Pyo, MD – Yonsei Cancer Center Yonsei College of Medicine ### 1972885###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Yonsei Cancer Center Yonsei College of Medicine###Presenter: – Yonsei Cancer Center Yonsei College of Medicine
### 10:30 AM – 11:45 AM PT
3348 - Nomogram to Predict Risk of Early Mortality Following Definitive or Adjuvant Radiation and Systemic Therapy for Head and Neck CancerLocation: Hall B2Presenter: – Weill Cornell Medicine/New York Presbyterian
Gabriel Raab, MD – Weill Cornell Medicine/New York Presbyterian ### 1972896###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Weill Cornell Medicine/New York Presbyterian###Presenter: – Weill Cornell Medicine/New York Presbyterian
### 10:30 AM – 11:45 AM PT
3348 - Nomogram to Predict Risk of Early Mortality Following Definitive or Adjuvant Radiation and Systemic Therapy for Head and Neck CancerLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Kaveh Zakeri, MD, MAS – Memorial Sloan Kettering Cancer Center ### 538153###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 10:30 AM – 11:45 AM PT
3349 - Definitive Chemoradiotherapy for Salivary Gland CancersLocation: Hall B2Presenter: – University of Chicago Medicine
Greeshma Rajeev-Kumar, MD – University of Chicago Medicine ### 575517###Presenter###Disclosures: Employment: University of Chicago:Radiation Oncology Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Chicago Medicine###Presenter: – University of Chicago Medicine
### 10:30 AM – 11:45 AM PT
3350 - A Systematic Review and Meta-Analysis of Toxicity in Oropharyngeal Cancer Patients Treated with Proton TherapyLocation: Hall B2Presenter: – Wake Forest School of Medicine
Niema Razavian, MD – Wake Forest School of Medicine ### 1972949###Presenter###Disclosures: Employment: Wake Forest Baptist Health:House Officer:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: American College of Radiation Oncology:Resident Committee Chair###Wake Forest School of Medicine###Presenter: – Wake Forest School of Medicine
### 10:30 AM – 11:45 AM PT
3351 - Secondary Analysis of RRx-001 on the Incidence of Related Toxicities in Patients Treated with Concomitant Chemoradiation for Locally Advanced Head and Neck CancerLocation: Hall B2
Tony Reid ### 1972911###Presenter#########Presenter:
### 10:30 AM – 11:45 AM PT
3352 - A Multicenter Study of Clinician and Patient Reported Acute and Late Toxicity after Radical (Chemo)Radiotherapy for Non-Endemic Nasopharyngeal CancerLocation: Hall B2Presenter: – The Royal Marsden Hospital
Romelie Rieu, FRCR MSc – The Royal Marsden Hospital ### 1972965###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Royal Marsden Hospital###Presenter: – The Royal Marsden Hospital
### 10:30 AM – 11:45 AM PT
3353 - MRI, FDG-PET/CT and Image-Guidance for Re-Irradiation of Locoregionally Recurrent or Second Primary Head-and-Neck Squamous Cell Carcinoma Patients - Results of a Multicenter Cohort StudyLocation: Hall B2Presenter: – University of Leipzig, Medical Center
Alexander Ruhle, MD – University of Leipzig, Medical Center ### 1972952###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Leipzig, Medical Center###Presenter: – University of Leipzig, Medical Center
### 10:30 AM – 11:45 AM PT
3354 - Combined Pulsed Radiotherapy ("QUAD SHOT" regimen) with Immune Checkpoint Inhibition (ICI) to Enhance Immune Response for LAHNSCC in Patients Considered Ineligible for Curative Intent TherapyLocation: Hall B2Presenter: – Thomas Jefferson University
Olga Russial, DO, MBA – Thomas Jefferson University ### 1972983###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 10:30 AM – 11:45 AM PT
3355 - Outcomes of Head and Neck Cutaneous Angiosarcoma Treated in the IMRT EraLocation: Hall B2Presenter: – Tata Medical Center
Saheli Saha, MD – Tata Medical Center ### 1972913###Presenter######Tata Medical Center###Presenter: – Tata Medical Center
### 10:30 AM – 11:45 AM PT
3356 - Multi-Specialty Physician Performance in Predicting Radiographic Extranodal Extension in Nodal Metastases of Oropharyngeal Squamous CarcinomaLocation: Hall B2Presenter: – McGovern Medical School
Onur Sahin, PhD, MS – McGovern Medical School ### 1972974###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGovern Medical School###Presenter: – McGovern Medical School
### 10:30 AM – 11:45 AM PT
3357 - Comparison of the Direct Power Consumption for Different Linac Treatment Parameters in External Beam Radiation TherapyLocation: Hall B2Presenter: – Orlando Health Cancer Institute
Jessica Salazar, PhD, MBA – Orlando Health Cancer Institute ### 1972935###Presenter######Orlando Health Cancer Institute###Presenter: – Orlando Health Cancer Institute
### 10:30 AM – 11:45 AM PT
3357 - Comparison of the Direct Power Consumption for Different Linac Treatment Parameters in External Beam Radiation TherapyLocation: Hall B2Presenter: – Orlando Health
Tomas Dvorak, MD – Orlando Health ### 1972928###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Orlando Health###Presenter: – Orlando Health
### 10:30 AM – 11:45 AM PT
3358 - Initial Clinical Experience Using Daily Artificial Intelligence-Assisted Adaptive Radiotherapy on Cone-Beam CT for Cancer of the Head and NeckLocation: Hall B2Presenter: – Hadassah Medical Center
Ayman Salhab, MD – Hadassah Medical Center ### 1972908###Presenter######Hadassah Medical Center###Presenter: – Hadassah Medical Center
### 10:30 AM – 11:45 AM PT
3359 - Analysis of the Cancer Imaging Archive for Patterns of Locoregional Failure in Relation to the Mucous Membranes among Patients with Head and Neck Squamous Cell Carcinoma: Potential Organ at Risk that Location: Hall B2Presenter: – University of Arkansas for Medical Sciences (UAMS)
Santanu Samanta, MD – University of Arkansas for Medical Sciences (UAMS) ### 593749###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Arkansas for Medical Sciences (UAMS)###Presenter: – University of Arkansas for Medical Sciences (UAMS)
### 10:30 AM – 11:45 AM PT
3360 - Automated Sarcopenia Assessment and Outcomes in Head and Neck Cancer with Deep Learning Analysis of Cervical Neck Skeletal MuscleLocation: Hall B2Presenter: – Brigham and Women's Hospital/Dana-Farber
Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber ### 537850###Presenter###Disclosures: Employment: Brigham Womens Hospital:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Brigham and Women's Hospital/Dana-Farber###Presenter: – Brigham and Women's Hospital/Dana-Farber
### 10:30 AM – 11:45 AM PT
3361 - A Pilot Study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation (PBM) Device while Undergoing IMRT Demonstrates Tolerability, Safety, and Preliminary Efficacy for RedLocation: Hall B2Presenter: – St. Elizabeth Medical Center
Catherine Holtzapfel, MSN – St. Elizabeth Medical Center ### 2131823###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###St. Elizabeth Medical Center###Presenter: – St. Elizabeth Medical Center
### 10:30 AM – 11:45 AM PT
3362 - Impact of Surveillance Imaging in Patients with HPV-Associated Oropharyngeal Carcinomas Treated with Definitive Radiation and ChemotherapyLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Trisha Shang, BA – Memorial Sloan Kettering Cancer Center ### 1972904###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 10:30 AM – 11:45 AM PT
3363 - Potential Predictive Value of Intravoxel Incoherent Motion Magnetic Resonance for Xerostomia of Nasopharyngeal CarcinomaLocation: Hall B2
Mingjun Shen, MS ### 1972922###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3364 - Environmental Toxicity of Driving Distance to External Beam Radiotherapy (EBRT) for Head and Neck Cancer PatientsLocation: Hall B2Presenter: – Duke University Hospital
Rachel Shenker, MD – Duke University Hospital ### 537870###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University Hospital###Presenter: – Duke University Hospital
### 10:30 AM – 11:45 AM PT
3365 - Distance Traveled by Patients Globally to Access Radiotherapy: A Systematic ReviewLocation: Hall B2Presenter: – Michigan State University College of Human Medicine
Sierra Silverwood, BS – Michigan State University College of Human Medicine ### 1972923###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Michigan State University College of Human Medicine###Presenter: – Michigan State University College of Human Medicine
### 10:30 AM – 11:45 AM PT
3366 - The Role of Stereotactic Radiotherapy in Deferring the Need for Systemic Therapies in Patients with Progressive Oligometastatic Iodine-Refractory Thyroid CancerLocation: Hall B2
Gabriele Simontacchi, MD – Aou Careggi ### 1972984###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Aou Careggi###Presenter: – Aou Careggi
### 10:30 AM – 11:45 AM PT
3367 - Prognostic Value of Depth of Invasion in Squamous Cell Carcinoma of the Oral Cavity of Size 4 cm or LessLocation: Hall B2Presenter: – Seoul National University Hospital
Jun Yeong Song, BS – Seoul National University Hospital ### 1972541###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University Hospital###Presenter: – Seoul National University Hospital
### 10:30 AM – 11:45 AM PT
3368 - Rising Gas Prices & Financial Toxicity Related to Radiation TreatmentLocation: Hall B2Presenter: – SUNY Upstate
Rui Song, MD – SUNY Upstate ### 1972930###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###SUNY Upstate###Presenter: – SUNY Upstate
### 10:30 AM – 11:45 AM PT
3369 - Trends in the Utilization and Outcomes of Brachytherapy vs. Proton Therapy in Localized Uveal Melanoma in the United StatesLocation: Hall B2Presenter: – University of Luebeck
Tamer Soror, MD – University of Luebeck ### 1972967###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Luebeck###Presenter: – University of Luebeck
### 10:30 AM – 11:45 AM PT
3370 - Plasma EBV DNA in Nasopharyngeal Cancer (NPC) Treated with Definitive Radiotherapy (RT)Location: Hall B2Presenter: – Princess Margaret Cancer Centre
Eric Stutheit-Zhao, MD, PhD – Princess Margaret Cancer Centre ### 1972903###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
### 10:30 AM – 11:45 AM PT
3371 - Use of Explainable AI Algorithm Revealing Longitudinal Changes in Practice Patterns and Toxicity ModelsLocation: Hall B2Presenter: – University of Michigan
Shiqin Su, PhD – University of Michigan ### 1972946###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 10:30 AM – 11:45 AM PT
3372 - Patient Impressions of Telemedicine in Radiation OncologyLocation: Hall B2Presenter: – MD Anderson Cancer Center
Wasif Talpur, MD – MD Anderson Cancer Center ### 1972937###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:30 AM – 11:45 AM PT
3373 - Determining the Optimal Sequence of Immunotherapy and Lymph Node Irradiation among Patients with Cancer: A Propensity Score Matched AnalysisLocation: Hall B2Presenter: – Stanford Health Care
Kekoa Taparra, MD, PhD – Stanford Health Care ### 535869###Presenter###Disclosures: Employment: Stanford Health Care:Resident Physician:Employee | Compensation: Lancet: Other, Honoraria-End Date: 6/2022 ;Stanford CARE: Other, Honoraria-End Date: 3/2023 ;MDACC: Other, Honoraria-End Date: 5/2023 | Ownership: none | Leadership: none###Stanford Health Care###Presenter: – Stanford Health Care
### 10:30 AM – 11:45 AM PT
3374 - The Role of Radiomics Model to Predict Early Xerostomia in Head and Neck Cancer after RadiotherapyLocation: Hall B2Presenter: – UPMC Hillman Cancer Center
Meysam Tavakoli, PhD – UPMC Hillman Cancer Center ### 1972888###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UPMC Hillman Cancer Center###Presenter: – UPMC Hillman Cancer Center
### 10:30 AM – 11:45 AM PT
3375 - Investigation of Ensemble Learning Method in Predicting Early Xerostomia Using Radiomics Features from CT and MRILocation: Hall B2Presenter: – UPMC Hillman Cancer Center
Meysam Tavakoli, PhD – UPMC Hillman Cancer Center ### 1972888###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UPMC Hillman Cancer Center###Presenter: – UPMC Hillman Cancer Center
### 10:30 AM – 11:45 AM PT
3376 - Prevalence and Risk Factors for Retropharyngeal and Retro-Styloid Lymph Node Metastasis in Hypopharyngeal CarcinomaLocation: Hall B2Presenter: – Nagasaki University
Ryo Toya, MD, PhD – Nagasaki University ### 1972958###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Nagasaki University###Presenter: – Nagasaki University
### 10:30 AM – 11:45 AM PT
3377 - Reducing the Risk of Post-RT Aspiration by Sparing Specific Aspiration Related Organs at RiskLocation: Hall B2Presenter: – University of Groningen Medical Center
Hans Paul van der Laan, PhD – University of Groningen Medical Center ### 536017###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Groningen Medical Center###Presenter: – University of Groningen Medical Center
### 10:30 AM – 11:45 AM PT
3378 - Deep Learning Based Prognostic Prediction in Oropharyngeal Cancer Patients Using Multiparametric MRI InputsLocation: Hall B2Presenter: – MD Anderson Cancer Center
Mohamed Naser, PhD – MD Anderson Cancer Center ### 2135948###Presenter######MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:30 AM – 11:45 AM PT
3378 - Deep Learning Based Prognostic Prediction in Oropharyngeal Cancer Patients Using Multiparametric MRI InputsLocation: Hall B2Presenter: – MD Anderson Cancer Center
Kareem Wahid, PhD, BS – MD Anderson Cancer Center ### 1972966###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 10:30 AM – 11:45 AM PT
3379 - Paging Dr. Google: Characterizing Direct to Consumer Internet Advertisements from Oncology Treatment CentersLocation: Hall B2Presenter: – Banner MD Anderson Cancer Center
Gary Walker, MD, MS, MPH – Banner MD Anderson Cancer Center ### 535779###Presenter###Disclosures: Employment: Banner MD Anderson Cancer Center:Radiation Oncologist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Banner MD Anderson Cancer Center###Presenter: – Banner MD Anderson Cancer Center
### 10:30 AM – 11:45 AM PT
3380 - Comparison and Breakdown of Cost in Head and Neck Cancer Radiation Therapy and Adaptive ReplanningLocation: Hall B2Presenter: – University of Virginia School of Medicine
Robert Walls, BSE – University of Virginia School of Medicine ### 1972886###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Virginia School of Medicine###Presenter: – University of Virginia School of Medicine
### 10:30 AM – 11:45 AM PT
3381 - Distribution Pattern of Metastatic Lymph Nodes in 870 Cases of Nasopharyngeal Carcinoma: A Clue for Individualized Elective Prophylactic Neck IrradiationLocation: Hall B2
Lei Wang, MD ### 1972944###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3382 - Weekly vs. Bolus Cisplatin Concurrent with Definitive Radiotherapy for Squamous Carcinoma of the Head and Neck: A Systematic Review and Network Meta-AnalysisLocation: Hall B2Presenter: – Levine Cancer Institute
Matthew Ward, MD – Levine Cancer Institute ### 1972969###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Levine Cancer Institute###Presenter: – Levine Cancer Institute
### 10:30 AM – 11:45 AM PT
3383 - The Profile of the Oncological Refugee Patient from Ukraine ? Single Institution ExperienceLocation: Hall B2Presenter: – Lower Silesian Oncology Center
Natalia Wisniewska, MD – Lower Silesian Oncology Center ### 1972939###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Lower Silesian Oncology Center###Presenter: – Lower Silesian Oncology Center
### 10:30 AM – 11:45 AM PT
3384 - Cross-Sectional Muscle Area Change in Head and Neck Magnetic Resonance Imaging Defined Sarcopenic State and Survival in Nasopharyngeal Cancer PatientsLocation: Hall B2Presenter: – Taipei Municipal WanFang Hospital
Jeng-You Wu, MD, MBA – Taipei Municipal WanFang Hospital ### 537452###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Taipei Municipal WanFang Hospital###Presenter: – Taipei Municipal WanFang Hospital
### 10:30 AM – 11:45 AM PT
3385 - Insurance Plan Coverage Modeling of the Marginal Costs from One Week vs. Three Week Radiation Therapy in Standard-Of-Care Treatment of Post-Lumpectomy Early-Stage Breast Cancer Across Medicaid and MedLocation: Hall B2Presenter: – Case Western Reserve School of Medicine
Victoria Wu, BA – Case Western Reserve School of Medicine ### 1972948###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Case Western Reserve School of Medicine###Presenter: – Case Western Reserve School of Medicine
### 10:30 AM – 11:45 AM PT
3386 - Occult Lymph Node Metastasis in cN0 Tongue Squamous Cell Carcinoma: A Prospective Observational StudyLocation: Hall B2
Zheng Wu, MD ### 1972905###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 10:30 AM – 11:45 AM PT
3387 - The Short-Term Efficacy and Safety of Induction Chemotherapy Combined with PD-1 Inhibitor or Anti-EGFR in Locoregionally Advanced Nasopharyngeal CarcinomaLocation: Hall B2
Xiaoyong Xiang, MD ### 1972985###Presenter#########Presenter:
### 10:30 AM – 11:45 AM PT
3388 - Cost Analysis of MR-Guided vs. CT-Guided Radiation Therapy for Locally Advanced Pancreatic CancerLocation: Hall B2Presenter: – McGaw Medical Center of Northwestern University
Amulya Yalamanchili, MD – McGaw Medical Center of Northwestern University ### 1972929###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###McGaw Medical Center of Northwestern University###Presenter: – McGaw Medical Center of Northwestern University
### 10:30 AM – 11:45 AM PT
3389 - Dosimetric Benefits of Online Adaptive Radiotherapy in Nasopharyngeal CarcinomaLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Yu-Xian Yang, MD – Sun Yat-Sen University Cancer Center ### 1972979###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 10:30 AM – 11:45 AM PT
3390 - Projected Lifetime Earnings of a Radiation OncologistLocation: Hall B2Presenter: – University Hospitals Case Medical Center
Nicholas Zaorsky, MD, MS – University Hospitals Case Medical Center ### 535741###Presenter###Disclosures: Employment: University Hospitals:Radiation Oncologist:Employee | Compensation: American Cancer Society: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;NIH: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 2022 ;American College of Radiation Oncology: Consultant, Compensation Payment-End Date: present ;Springer Nature: Remuneration Other-End Date: 2021 | Ownership: none | Leadership: none###University Hospitals Case Medical Center###Presenter: – University Hospitals Case Medical Center
### 10:30 AM – 11:45 AM PT
3391 - All-in-One Online Radiotherapy for Nasopharyngeal Carcinoma: Preliminary Results of Treatment Time, Contouring Accuracy, Treatment Plan Quality and Patient ComplianceLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Guan-Qun Zhou, PhD – Sun Yat-Sen University Cancer Center ### 1972981###Presenter######Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 10:30 AM – 11:45 AM PT
3392 - Real-World Treatment Patterns of Older Adults with Locally Advanced SCCHN Using SEER-MedicareLocation: Hall B2
David Fox, MS, PharmD – Genentech ### 2010638###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Genentech###Presenter: – Genentech
### 12:30 PM – 1:45 PM PT
3393 - Feasibility and Clinical Implementation of Electron FLASH Radiation Therapy in the Yorkshire Swine ModelLocation: Hall B2Presenter: – The University of Texas M.D. Anderson Cancer Center
Chike Abana, MD, PhD – The University of Texas M.D. Anderson Cancer Center ### 1971969###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of Texas M.D. Anderson Cancer Center###Presenter: – The University of Texas M.D. Anderson Cancer Center
### 12:30 PM – 1:45 PM PT
3394 - Multimodality Dosimetric Evaluation for the Treatment of Recurrent Brain TumorsLocation: Hall B2Presenter: – University Hospitals
Ala Amini, MS – University Hospitals ### 1973020###Presenter######University Hospitals###Presenter: – University Hospitals
### 12:30 PM – 1:45 PM PT
3395 - Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate CancerLocation: Hall B2Presenter: – Medical College of Wisconsin
Asma Amjad, PhD – Medical College of Wisconsin ### 747926###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 12:30 PM – 1:45 PM PT
3396 - Radiosensitizer-Releasing Fiducial Nanofiducial: A New Concept in RadiotherapyLocation: Hall B2Presenter: – Ankara Ataturk Chest Diseases, Chest Surgery Training and Research Hospital
Ipek Pınar Aral, MD – Ankara Ataturk Chest Diseases, Chest Surgery Training and Research Hospital ### 1973150###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ankara Ataturk Chest Diseases, Chest Surgery Training and Research Hospital###Presenter: – Ankara Ataturk Chest Diseases, Chest Surgery Training and Research Hospital
### 12:30 PM – 1:45 PM PT
3397 - Technical Infrastructure for Clinical Translation of Electron FLASHLocation: Hall B2Presenter: – Stanford Radiation Oncology
Muhammad Ramish Ashraf, PhD – Stanford Radiation Oncology ### 1973039###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Radiation Oncology###Presenter: – Stanford Radiation Oncology
### 12:30 PM – 1:45 PM PT
3398 - Target Re-Delineation in Daily Online Adaptive Radiotherapy of Bladder Cancer: AI vs. AdaptersLocation: Hall B2
Lina Åström, MS ### 1973064###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3399 - The Effect of Deep Inspiration Breath-Hold Technique on Right Coronary Artery, Heart, and Liver Doses in Right Breast Cancer RadiotherapyLocation: Hall B2
Barbaros Aydin, MD ### 747316###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3400 - Knowledge Based Planning Evolution: Multi-Criteria Optimization of Prostates. Is There Always a Better Model?Location: Hall B2Presenter: – Northern Sydney Cancer Centre - Royal North Shore Hospital
Laura Baker, CMD, RT – Northern Sydney Cancer Centre - Royal North Shore Hospital ### 1973087###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northern Sydney Cancer Centre - Royal North Shore Hospital###Presenter: – Northern Sydney Cancer Centre - Royal North Shore Hospital
### 12:30 PM – 1:45 PM PT
3401 - Evaluation of Daily Patient Position Accuracy and Calculation of Setup Errors with Skin Markers and Surface-Guided Radiotherapy (SGRT) in Breast CancerLocation: Hall B2
Gizem Bakıcıerler ### 1973119###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3402 - Evaluation of Plan Quality and Complexity for Automated Intracranial SBRT VMAT Treatment PlansLocation: Hall B2Presenter: – Scripps MD Anderson Cancer Center, John J. Hopkins
Garrett Baltz, MS – Scripps MD Anderson Cancer Center, John J. Hopkins ### 1973153###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Scripps MD Anderson Cancer Center, John J. Hopkins###Presenter: – Scripps MD Anderson Cancer Center, John J. Hopkins
### 12:30 PM – 1:45 PM PT
3403 - Assessing Displacement of Plastic Interstitial Catheters in Image-Guided Gynecological HDR BrachytherapyLocation: Hall B2Presenter: – Long Beach Memorial Medical Center
Michael Campbell, MS – Long Beach Memorial Medical Center ### 2086550###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Long Beach Memorial Medical Center###Presenter: – Long Beach Memorial Medical Center
### 12:30 PM – 1:45 PM PT
3404 - Equivalent Uniform Dose (EUD) and the Evaluation of Cell Survival in Spatially Fractionated Radiotherapy (SFRT)Location: Hall B2
Stefan Bartzsch, PhD ### 1973077###Presenter#########Presenter:
### 12:30 PM – 1:45 PM PT
3405 - Dosimetric Analysis of Patients Treated with Stereotactic Body Radiation Therapy for Malignant Portal Vein Tumor Thrombosis Using MRI-Guided vs. CT-Guided Linear AcceleratorLocation: Hall B2Presenter: – University of Virginia
Hanna Batchelor, BS – University of Virginia ### 1973018###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Virginia###Presenter: – University of Virginia
### 12:30 PM – 1:45 PM PT
3406 - Clinical Feasibility of Daily Online Adaptive Bladder Cancer Radiotherapy with Cone Beam CT, Using Fiducial MakersLocation: Hall B2Presenter: – Amsterdam University Medical Center (AUMC)
Arjan Bel, PhD – Amsterdam University Medical Center (AUMC) ### 1973034###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Amsterdam University Medical Center (AUMC)###Presenter: – Amsterdam University Medical Center (AUMC)
### 12:30 PM – 1:45 PM PT
3407 - Dosimetry Validation of MR-Only Treatment Planning Based upon the Synthetic MRCAT Pelvis with Continuous Hounsfield Units in Prostate CancerLocation: Hall B2Presenter: – Sheba Medical Center
Maoz Benayun, PhD – Sheba Medical Center ### 1973002###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sheba Medical Center###Presenter: – Sheba Medical Center
### 12:30 PM – 1:45 PM PT
3408 - Comparison of Dynamic Trajectory Radiotherapy and Volumetric Modulated Arc Therapy for Loco-Regionally Advanced Oropharyngeal CancerLocation: Hall B2Presenter: – Inselspital Bern University Hospital
Jenny Bertholet, PhD – Inselspital Bern University Hospital ### 1973152###Presenter###Disclosures: Employment: Insel Gruppe AG:postdoc:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: ASTRO:Associate section editor;SASRO:Member of the executive committee;ESTRO:young committee member###Inselspital Bern University Hospital###Presenter: – Inselspital Bern University Hospital
### 12:30 PM – 1:45 PM PT
3409 - Intra Fraction Organs at Risk Movements in Adaptive Radiotherapy of Upper-Abdominal Stereotactic Body Radiotherapy on 0.35 T MR-LinacLocation: Hall B1Presenter: – Centre Georges-Francois Leclerc
Igor Bessieres, PhD – Centre Georges-Francois Leclerc ### 1973011###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Centre Georges-Francois Leclerc###Presenter: – Centre Georges-Francois Leclerc
### 12:30 PM – 1:45 PM PT
3409 - Intra Fraction Organs at Risk Movements in Adaptive Radiotherapy of Upper-Abdominal Stereotactic Body Radiotherapy on 0.35 T MR-LinacLocation: Hall B2Presenter: – Centre Georges François LECLERC
Alexandre Beige, MD – Centre Georges François LECLERC ### 2082529###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Centre Georges François LECLERC###Presenter: – Centre Georges François LECLERC
### 12:30 PM – 1:45 PM PT
3410 - Computed Tomography-Based Delta-Radiomics for Early Prediction of Short-Term Response to Concurrent Chemoradiotherapy in Patients with NSCLCLocation: Hall B2Presenter: – Hubei Cancer Hospital
Jianping Bi, MD, PhD – Hubei Cancer Hospital ### 1973040###Presenter######Hubei Cancer Hospital###Presenter: – Hubei Cancer Hospital
### 12:30 PM – 1:45 PM PT
3411 - EPIDEEP: Using a Deep Learning Model to Predict In Vivo Electronic Portal Imaging Device (EPID) Transit ImagesLocation: Hall B2Presenter: – University of California San Diego
Casey Bojechko, PhD – University of California San Diego ### 1973058###Presenter###Disclosures: Employment: University of California San Diego:Assistant Clinical Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of California San Diego###Presenter: – University of California San Diego
### 12:30 PM – 1:45 PM PT
3412 - Robustness Analysis of Reference Surfaces for Surface Guided Radiation Therapy of the BreastLocation: Hall B2Presenter: – University of Washington
Victoria Bry, PhD – University of Washington ### 2082530###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 12:30 PM – 1:45 PM PT
3413 - A Free, Open-Source Toolkit to Produce 3D Bolus in the ClinicLocation: Hall B2Presenter: – Mayo Clinic Arizona
Courtney Buckey, PhD – Mayo Clinic Arizona ### 524887###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Arizona###Presenter: – Mayo Clinic Arizona
### 12:30 PM – 1:45 PM PT
3414 - Defining the Role of Intensity Modulation in Electron Conformal Therapy for the Treatment of Head and Neck CancerLocation: Hall B2Presenter: – Montefiore Einstein Cancer Center
Jonathan Cabrera, MS – Montefiore Einstein Cancer Center ### 1973079###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Montefiore Einstein Cancer Center###Presenter: – Montefiore Einstein Cancer Center
### 12:30 PM – 1:45 PM PT
3415 - Towards Biology-Guided Radiotherapy Planning and Delivery on a Novel O-Ring PET-Linac Platform: Extended Beyond Bone and Lung LesionsLocation: Hall B2Presenter: – University of Texas Southwestern Medical Center
Bin Cai, PhD – University of Texas Southwestern Medical Center ### 619899###Presenter###Disclosures: Employment: University of Texas Southwestern Medical Center:Associate Professor:Employee | Compensation: Reflexion Medical: Other, Travel Expenses-End Date: June 16,2022 ;Varian Medical System: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Feb 2021 | Ownership: none | Leadership: none###University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 12:30 PM – 1:45 PM PT
3416 - Evaluation of Patient-Specific Quality Control (QC) for Markerless Dynamic Tumor Tracking (MDTT) DeliveriesLocation: Hall B2Presenter: – BC Cancer - Vancouver Centre
Marie-Laure Camborde, MSc – BC Cancer - Vancouver Centre ### 1972992###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###BC Cancer - Vancouver Centre###Presenter: – BC Cancer - Vancouver Centre
### 12:30 PM – 1:45 PM PT
3418 - Parametric Response Mapping of Co-Registered Ivim MRI and PET to Identify Radioresistant Sub-Volumes in Locally Advanced Cervical Carcinoma Undergoing CCRTLocation: Hall B2
Dante Capaldi, PhD – UCSF ### 1973061###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSF###Presenter: – UCSF
### 12:30 PM – 1:45 PM PT
3419 - New Advantage in Stereotactic Treatment of Lung and Pancreatic Cancer. Performance of Ultra-High Energy Electron (VHEE) Therapy Adjuvanted to the FLASH Effect: Clinical Implications and Treatment PlanLocation: Hall B2Presenter: – Universita di Roma Sapienza
Daniele Carlotti, MD, PhD – Universita di Roma Sapienza ### 1973098###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Universita di Roma Sapienza###Presenter: – Universita di Roma Sapienza
### 12:30 PM – 1:45 PM PT
3420 - Estimating Potential Benefits of Online Adaptive Proton Therapy for Head-and-Neck Cancer: A Retrospective StudyLocation: Hall B2Presenter: – Emory University
Chih-Wei Chang, PhD – Emory University ### 1972840###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University###Presenter: – Emory University
### 12:30 PM – 1:45 PM PT
3421 - Development of the Independent Dose Verification Method for the Ring Gantry PET/CT LinacLocation: Hall B2Presenter: – University of Pittsburgh Medical Center
Jina Chang, PhD – University of Pittsburgh Medical Center ### 1973142###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pittsburgh Medical Center###Presenter: – University of Pittsburgh Medical Center
### 12:30 PM – 1:45 PM PT
3422 - Daily Head and Neck Treatment Assessment for Optimal Proton Planning RobustnessLocation: Hall B2Presenter: – Johns Hopkins University
Leslie Chang, MD – Johns Hopkins University ### 1972059###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 12:30 PM – 1:45 PM PT
3423 - Use of Radiomics to Predict Treatment Response in CNS, Head, Neck and Lung TumorsLocation: Hall B2Presenter: – University of Virginia Health Systems
Yhana Chavis, DO – University of Virginia Health Systems ### 1973130###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Virginia Health Systems###Presenter: – University of Virginia Health Systems
### 12:30 PM – 1:45 PM PT
3424 - Dosimetric Analysis of Proton Beam Therapy vs. Photon Radiotherapy for Cardiac Tumors with or without Deep Inspiratory Breath Holding: A Case ReportLocation: Hall B2
DongJie Chen, MM ### 1973106###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3426 - Improving Interfraction Robustness for IMPT Treatment Planning for Lung Cancer Using Multiple-CT Incorporated Robust OptimizationLocation: Hall B2Presenter: – Shanghai Jiao Tong University
Mei Chen, MS – Shanghai Jiao Tong University ### 1973102###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shanghai Jiao Tong University###Presenter: – Shanghai Jiao Tong University
### 12:30 PM – 1:45 PM PT
3427 - Artificial Intelligence-Assisted Automated Applicator Digitization for Fully-Automated Gynecological High-Dose Rate Brachytherapy Treatment PlanningLocation: Hall B2Presenter: – University of Cincinnati Medical Center/College of Medicine
Samuel Chen, MD – University of Cincinnati Medical Center/College of Medicine ### 1973082###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Cincinnati Medical Center/College of Medicine###Presenter: – University of Cincinnati Medical Center/College of Medicine
### 12:30 PM – 1:45 PM PT
3428 - Deep Learning-Based Dose Prediction Model for Automated Spot-Scanning Proton Arc PlanningLocation: Hall B2Presenter: – Corewell Health William Beaumont University Hospital
Shupeng Chen, PhD – Corewell Health William Beaumont University Hospital ### 1973070###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Corewell Health William Beaumont University Hospital###Presenter: – Corewell Health William Beaumont University Hospital
### 12:30 PM – 1:45 PM PT
3429 - Tumor Treatment Response Assessed During the Concurrent Chemoradiotherapy for Nasopharyngeal PatientsLocation: Hall B2Presenter: – West China Hospital of Sichuan University
Xiao Qiang Chen, PhD – West China Hospital of Sichuan University ### 1973010###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West China Hospital of Sichuan University###Presenter: – West China Hospital of Sichuan University
### 12:30 PM – 1:45 PM PT
3430 - A Comparison of Two Plan Optimization Methods in Three-Dimensional Brachytherapy for Cervical CancerLocation: Hall B2Presenter: – West China Second University Hospital
Yazheng Chen, PhD – West China Second University Hospital ### 746627###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###West China Second University Hospital###Presenter: – West China Second University Hospital
### 12:30 PM – 1:45 PM PT
3432 - The Robotic System for the Treatment of Locally Advanced Cervical Cancer with Stereotactic Body Radiotherapy Boost: Results of a Phantom-Based and Preliminary StudyLocation: Hall B2
Yuangui Chen, MD, PhD ### 1973114###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3433 - Relationship Between Spatial Distribution Tumor Location and Dosimetric Outcomes in Patients Receiving Definitive Proton Therapy for Locally Advanced Lung CancerLocation: Hall B2Presenter: – University of Maryland Medical Center
Hua-Ren Cherng, MD – University of Maryland Medical Center ### 1972307###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Medical Center###Presenter: – University of Maryland Medical Center
### 12:30 PM – 1:45 PM PT
3434 - Radio-Immune Response of Spatially Fractionated Radiotherapy for VMAT Lattice PlansLocation: Hall B2Presenter: – Cleveland Clinic
Young-Bin Cho, PhD – Cleveland Clinic ### 1973072###Presenter###Disclosures: Employment: Cleveland Clinic:Medical Physicist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Cleveland Clinic###Presenter: – Cleveland Clinic
### 12:30 PM – 1:45 PM PT
3435 - Radio-Immune Response Model for Radiotherapy Plans with Heterogeneous Dose DistributionLocation: Hall B2Presenter: – Cleveland Clinic
Young-Bin Cho, PhD – Cleveland Clinic ### 1973072###Presenter###Disclosures: Employment: Cleveland Clinic:Medical Physicist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Cleveland Clinic###Presenter: – Cleveland Clinic
### 12:30 PM – 1:45 PM PT
3436 - Development of Novel Focal Irradiation Tool for High-Precision Irradiation Using Clinical Brachytherapy SystemLocation: Hall B2Presenter: – Seoul National University Hospital
Chang Heon Choi, PhD – Seoul National University Hospital ### 1973121###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University Hospital###Presenter: – Seoul National University Hospital
### 12:30 PM – 1:45 PM PT
3437 - Clinical Feasibility of Deep Learning-Based CT during Treatment CBCT Tumor Registration-Segmentation in Thoracic Radiotherapy (RT)Location: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Chloe Choi, MS – Memorial Sloan Kettering Cancer Center ### 1973137###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 12:30 PM – 1:45 PM PT
3438 - Determining the Dosimetric Accuracy of Deep Learning-Based Fully Automated Registration-Segmentation Approach for Thoracic Cancer Organs-at-Risk ContouringLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Chloe Choi, MS – Memorial Sloan Kettering Cancer Center ### 1973137###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 12:30 PM – 1:45 PM PT
3439 - Assessment of Bladder Filling Type on Radiation Dose to Organs at Risk in MR-Guided Intracavity Brachytherapy for Cervical CancerLocation: Hall B2Presenter: – Keimyung University School of Medicine
Euncheol Choi, MD, MS – Keimyung University School of Medicine ### 1973117###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Keimyung University School of Medicine###Presenter: – Keimyung University School of Medicine
### 12:30 PM – 1:45 PM PT
3440 - The Effect of Filament Density on the Build-Up Region Responsiveness of 3D Printed Boluses in High-Energy Photon RadiotherapyLocation: Hall B2Presenter: – Ovidius Clinical Hospital
Andreea Ciobanu, PhD – Ovidius Clinical Hospital ### 1973007###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Ovidius Clinical Hospital###Presenter: – Ovidius Clinical Hospital
### 12:30 PM – 1:45 PM PT
3441 - Application of a Novel Methodology for Efficient Optimization of Hippocampal Avoidance Whole-Brain RadiotherapyLocation: Hall B2Presenter: – Davidoff Cancer Center, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel
Ruth Dadush Azuz, MSc – Davidoff Cancer Center, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel ### 1973116###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Davidoff Cancer Center, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel###Presenter: – Davidoff Cancer Center, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel
### 12:30 PM – 1:45 PM PT
3442 - Reinforcement Learning Powered Station Parameter Optimized Radiation Therapy (SPORT): A Novel Treatment Planning and Beam Delivery TechniqueLocation: Hall B2Presenter: – Stanford University
Xianjin Dai, PhD – Stanford University ### 1973089###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 12:30 PM – 1:45 PM PT
3443 - An Investigation of High-Z Material for Bolus in Electron Beam TherapyLocation: Hall B2Presenter: – Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine
Indra Das, PhD, FASTRO – Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine ### 524968###Presenter###Disclosures: Employment: Northwestern Memorial Hospital:Director of Medical Physics:Employee | Compensation: CRC/ Taylor and Francis: Other, Remuneration Other-End Date: present ;Springer nature: Other, Remuneration Other-End Date: present | Ownership: none | Leadership: AAPM:Committee Member;Br J Radiology:Associate Editor;Journal of radiation Research:Associate editor;Medical Physics:Sr AE;J Clinical Medicine:Editor;IOP, Publishing:Chair of the Board###Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine###Presenter: – Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine
### 12:30 PM – 1:45 PM PT
3444 - Can a 10 MV-FFF Photon Beam be Used in Stereotactic Thalamotomy to Reduce Beam Delivery Times: A Dosimetric EvaluationLocation: Hall B2Presenter: – Vanderbilt University Medical Center
George Ding, PhD – Vanderbilt University Medical Center ### 747977###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Vanderbilt University Medical Center###Presenter: – Vanderbilt University Medical Center
### 12:30 PM – 1:45 PM PT
3445 - Adaptive Auto-Segmentation for MRI-Guided Online Adaptive Radiotherapy of Cervical CarcinomaLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Shouliang Ding, MS – Sun Yat-Sen University Cancer Center ### 1972317###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 12:30 PM – 1:45 PM PT
3446 - Patient-Specific 3D CT Images Reconstruction from 2D KV Images Via Vision Transformer-Based Deep-LearningLocation: Hall B2
Yuzhen Ding, PhD ### 1973012###Presenter#########Presenter:
### 12:30 PM – 1:45 PM PT
3447 - Potential Dosimetric Predictors of Patient-Reported Quality of Life for Head and Neck Cancer Following Chemoradiation IMRTLocation: Hall B2
Lyna Dinh, BS – UCLA ### 1973138###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA###Presenter: – UCLA
### 12:30 PM – 1:45 PM PT
3448 - Performance of Adaptive Deep Learning Models for Dose Predictions on High-Quality Cone-Beam Computed Tomography ImagesLocation: Hall B2Presenter: – Washington University in St. Louis
Zehao Dong, PhD – Washington University in St. Louis ### 1973024###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University in St. Louis###Presenter: – Washington University in St. Louis
### 12:30 PM – 1:45 PM PT
3449 - Closing the Loop: Toward Sustainable 3D Print Recycling in the ClinicLocation: Hall B2Presenter: – Stanford University
Piotr Dubrowski, MS, MCCPM – Stanford University ### 1972990###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 12:30 PM – 1:45 PM PT
3450 - Novel Dose Criteria for Lung Cancer SBRT to Improve Local Control in Patients Treated to 50 Gy/5 Fractions Using Deep Learning Methods and Explainability TechniquesLocation: Hall B2Presenter: – Moffitt Cancer Center
Denis Dudas, PhD – Moffitt Cancer Center ### 1973047###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Moffitt Cancer Center###Presenter: – Moffitt Cancer Center
### 12:30 PM – 1:45 PM PT
3451 - Multi-Criteria Optimization and RapidPlan for Improved Organs at Risk Sparing in Treatment Planning of Malignant Pleural MesotheliomaLocation: Hall B2Presenter: – Mount Sinai School of Medicine
Vishruta Dumane, PhD – Mount Sinai School of Medicine ### 536078###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mount Sinai School of Medicine###Presenter: – Mount Sinai School of Medicine
### 12:30 PM – 1:45 PM PT
3452 - Single Institution Preliminary Evaluation of a National Study for the Development of Daily Online Magnetic Resonance Image Guided RadiotherapyLocation: Hall B2Presenter: – The Christie NHS Foundation Trust
Cynthia Eccles, PhD, RT, BS – The Christie NHS Foundation Trust ### 536011###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Christie NHS Foundation Trust###Presenter: – The Christie NHS Foundation Trust
### 12:30 PM – 1:45 PM PT
3453 - Longitudinal Monitoring of Quantitative Imaging Kinetics of Primary Tumor and Nodal Volumes Using the MR-Linac Device in Head and Neck Cancer PatientsLocation: Hall B2Presenter: – MD Anderson Cancer Center
Dina El-Habashy, MD – MD Anderson Cancer Center ### 1973085###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:30 PM – 1:45 PM PT
3454 - Adaptation of a Clinical Proton Pencil Beam Scanning System for FLASH ExperimentsLocation: Hall B2Presenter: – University of Washington
Danielle Erickson, PhD – University of Washington ### 1973092###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 12:30 PM – 1:45 PM PT
3455 - Automated Lattice Treatment Planning for Bulky TumorsLocation: Hall B2Presenter: – University of Cincinnati
Andrew Frankart, MD – University of Cincinnati ### 747309###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Cincinnati###Presenter: – University of Cincinnati
### 12:30 PM – 1:45 PM PT
3456 - Imaging Performance of the PET Scan on a Novel Ring Gantry-Based PET/CT Linear Accelerator System in the First-in-Human Study of Biology-Guided RadiotherapyLocation: Hall B2Presenter: – UT Southwestern Medical Center
Aurelie Garant, MD – UT Southwestern Medical Center ### 536119###Presenter###Disclosures: Employment: UT Southwestern Medical Center:Assistant Professor:Employee | Compensation: Reflexion Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Teleflex Medical: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 12:30 PM – 1:45 PM PT
3457 - Investigation of the Relationship between Aperture Use for Treating Small and Shallow Brain Lesions in Proton Therapy with Different Spot Size Variations in Three Proton Therapy SystemsLocation: Hall B2Presenter: – Cleveland Clinic
Tara Gray, PhD, MS – Cleveland Clinic ### 2082528###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic###Presenter: – Cleveland Clinic
### 12:30 PM – 1:45 PM PT
3458 - Decay Series Dose Delivery Validation of a Biology-Guided Radiotherapy (BgRT) MethodologyLocation: Hall B2
Andrew Groll, PhD ### 1973088###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3460 - Statistical Analysis to Determine the Predictors of Liver Segmental Hypertrophy Observed Post-RadiotherapyLocation: Hall B2Presenter: – MD Anderson Cancer Center
Kristy Brock, PhD, FASTRO – MD Anderson Cancer Center ### 524478###Presenter###Disclosures: Employment: The University of Texas MD Anderson Cancer Center:Professor:Employee | Compensation: RaySearch Laboratories: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: Present | Ownership: RaySearch Laboratories:Copyright | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:30 PM – 1:45 PM PT
3461 - Motion Effects on Spatially Fractionated Lattice TherapyLocation: Hall B2Presenter: – Salinas Radiation Oncology Center
Jonathan Ha, PhD – Salinas Radiation Oncology Center ### 1973043###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Salinas Radiation Oncology Center###Presenter: – Salinas Radiation Oncology Center
### 12:30 PM – 1:45 PM PT
3462 - Impact of Stomach Deformability on PTV Coverage in Patients with Gastric MALTs Treated with Deep Inspiration Breath Hold (DIBH) and Daily CT-based Image-guided Radiation Therapy (IGRT)Location: Hall B2Presenter: – Washington University School of Medicine
Gideon Haber, MD, MS – Washington University School of Medicine ### 1973013###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University School of Medicine###Presenter: – Washington University School of Medicine
### 12:30 PM – 1:45 PM PT
3463 - Patient-Adaptive Automated Segmentation in Daily kVCT Images for Radiotherapy of Head and Neck and Prostate CancerLocation: Hall B2Presenter: – Stanford University
Bin Han, PhD – Stanford University ### 536002###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 12:30 PM – 1:45 PM PT
3464 - Characterization of Biology-Guided Radiotherapy Accuracy as a Function of PET Tracer UptakeLocation: Hall B2
Jeffrey Schmall, PhD ### 2134201###Presenter###Disclosures: Employment: Reflexion Medical:Senior PET Scientist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: Reflexion Medical:Stock, Stock Options | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3464 - Characterization of Biology-Guided Radiotherapy Accuracy as a Function of PET Tracer UptakeLocation: Hall B2Presenter: – Stanford University
Bin Han, PhD – Stanford University ### 536002###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 12:30 PM – 1:45 PM PT
3465 - Dosimetric Study of Total Marrow and Lymphoid Irradiation on a Ring Gantry-Based Medical Linac with a Two-Layer Multi-Leaf CollimatorLocation: Hall B2Presenter: – City of Hope National Medical Center
Chunhui Han, PhD – City of Hope National Medical Center ### 525345###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:30 PM – 1:45 PM PT
3466 - Reproducibility and Repeatability of Pelvic Radiomics Features with Daily Imaging on a Novel Biology-Guided Radiotherapy Machine Compared to Daily Imaging on Other Radiotherapy Delivery SystemsLocation: Hall B2Presenter: – City of Hope National Medical Center
Chunhui Han, PhD – City of Hope National Medical Center ### 525345###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:30 PM – 1:45 PM PT
3467 - Comparison of AI-Based Auto-Segmentation Quality with Different Daily IGRT Imaging Modalities for Adaptive Radiotherapy Treatment PlanningLocation: Hall B2Presenter: – City of Hope National Medical Center
Chunhui Han, PhD – City of Hope National Medical Center ### 525345###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:30 PM – 1:45 PM PT
3468 - Real-Time Spinal Cord Motion Tracking for MR-guided Spine SBRT (A Pilot Study)Location: Hall B2Presenter: – MD Anderson Cancer Center
Eun Young Han, PhD – MD Anderson Cancer Center ### 1973081###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:30 PM – 1:45 PM PT
3469 - Proton Online Adaptation Using Novel Cone-Beam Computed Tomography SystemLocation: Hall B2Presenter: – Washington University in St. Louis
Yao Hao, PhD – Washington University in St. Louis ### 1973133###Presenter###Disclosures: Employment: Washington University School of Medicine:Dr.:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Washington University in St. Louis###Presenter: – Washington University in St. Louis
### 12:30 PM – 1:45 PM PT
3470 - Radiobiological Insights of Staged Brachytherapy Using Eye Plaque for Large Uveal MelanomaLocation: Hall B2Presenter: – University of Mississippi Medical Center
Rui He, PhD – University of Mississippi Medical Center ### 535994###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Mississippi Medical Center###Presenter: – University of Mississippi Medical Center
### 12:30 PM – 1:45 PM PT
3471 - The Feasibility of Fast, Four-Dimensional Computed Tomography-Based O-Ring Linac Plans for Stereotactic Body Radiotherapy in Patients with Poor Performance StatusLocation: Hall B2Presenter: – Korea University
Eun Jeong Heo, MS – Korea University ### 1973149###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Korea University###Presenter: – Korea University
### 12:30 PM – 1:45 PM PT
3472 - Improving Ultrasound Visualization of Catheters During Interstitial BrachytherapyLocation: Hall B2Presenter: – Indiana University School of Medicine
Jordan Holmes, MD, MPH – Indiana University School of Medicine ### 538053###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Indiana University School of Medicine###Presenter: – Indiana University School of Medicine
### 12:30 PM – 1:45 PM PT
3473 - A Comparative Study of Measuring Bladder Volume in Patients with Pelvic Tumor Receiving Radiotherapy Using a Portable Bladder Scanner Made in China and CT Analog Positioning MachineLocation: Hall B2
Qiu Hu, MS ### 1973022###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3474 - Dose Coverage Variation Caused by Setup Uncertainties in VMAT-TBI TreatmentLocation: Hall B2Presenter: – Indiana University School of Medicine
Ke (Colin) Huang, PhD, MS – Indiana University School of Medicine ### 588471###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Indiana University School of Medicine###Presenter: – Indiana University School of Medicine
### 12:30 PM – 1:45 PM PT
3475 - Low Tesla MR Imaging for Spine with HardwareLocation: Hall B2Presenter: – University of Florida Proton Therapy Institute
Soon Huh, PhD – University of Florida Proton Therapy Institute ### 1973027###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida Proton Therapy Institute###Presenter: – University of Florida Proton Therapy Institute
### 12:30 PM – 1:45 PM PT
3476 - Assessment of Daily Target Motion to Optimize ITV Margins in Online Adaptive Plan for Liver and Pancreatic SBRT on MR-LINACLocation: Hall B2Presenter: – Allegheny Health Network
Min-Sig Hwang, PhD – Allegheny Health Network ### 538096###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Allegheny Health Network###Presenter: – Allegheny Health Network
### 12:30 PM – 1:45 PM PT
3477 - Dosimetric Comparison of Automated Non-Coplanar Volumetric-Modulated Arc Therapy and Intensity-Modulated Proton Therapy in Angiosarcoma of the ScalpLocation: Hall B2Presenter: – Osaka International Cancer Institute
Shoki Inui, PhD – Osaka International Cancer Institute ### 1973148###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Osaka International Cancer Institute###Presenter: – Osaka International Cancer Institute
### 12:30 PM – 1:45 PM PT
3478 - Standardizing LT Chest Wall Radiotherapy Treatment Planning in a Low- or Middle- Income Country Radiotherapy Clinic Using Knowledge Based PlanningLocation: Hall B2Presenter: – Liga Nacional Contra el Cancer
Milton Ixquiac, MS – Liga Nacional Contra el Cancer ### 1972919###Presenter######Liga Nacional Contra el Cancer###Presenter: – Liga Nacional Contra el Cancer
### 12:30 PM – 1:45 PM PT
3479 - An Online AI-Powered Interactive Histological Image Annotation Platform for Analyzing Intestinal Regenerating Crypts in Post-Irradiated MiceLocation: Hall B2
Hao Jiang ### 1973069###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3480 - Scatter Corrected Cone-Beam CT for Radiomics in SBRT: A Feasibility StudyLocation: Hall B2
Yangkang Jiang ### 1973147###Presenter#########Presenter:
### 12:30 PM – 1:45 PM PT
3481 - Feasibility and Safety of Single-Isocenter/Multi-Lesion (SIML) HyperArc Brain SRT: Clinical Implementation and Early OutcomesLocation: Hall B2Presenter: – University of Kentucky
Jeremiah Johnson, MD, MS – University of Kentucky ### 1973004###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kentucky###Presenter: – University of Kentucky
### 12:30 PM – 1:45 PM PT
3482 - Clinical Outcomes of Synchronous Lung Stereotactic Body Radiation Therapy Lesions via Single-Isocenter/Multi-Lesion TreatmentsLocation: Hall B2Presenter: – University of Kentucky
Mark Kenamond, MD – University of Kentucky ### 1973046###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kentucky###Presenter: – University of Kentucky
### 12:30 PM – 1:45 PM PT
3483 - Dynamic Contrast Enhanced MRI as a Biomarker of Tumor Response and Oncologic Outcomes in Head and Neck Cancer: Results of a Single Institution Prospective Imaging StudyLocation: Hall B2Presenter: – Beaumont Health
Yomna Khamis, MD – Beaumont Health ### 1973037###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beaumont Health###Presenter: – Beaumont Health
### 12:30 PM – 1:45 PM PT
3484 - Comprehensive Beam Modeling, Secondary Dose Computations and Treatment Planning for a 1.5 T MRgRT SystemLocation: Hall B2Presenter: – Radiotherapiegroep
Roel G.J. Kierkels, PhD, MSc – Radiotherapiegroep ### 2125547###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Radiotherapiegroep###Presenter: – Radiotherapiegroep
### 12:30 PM – 1:45 PM PT
3485 - Superiority of BNCT Treatment Planning Metrics Achieved Using Novel vs. Reference (BPA-F) Pharmaceuticals in Head and Neck LocationsLocation: Hall B2Presenter: – TAE Life Sciences
Chad Lee, PhD – TAE Life Sciences ### 2029572###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###TAE Life Sciences###Presenter: – TAE Life Sciences
### 12:30 PM – 1:45 PM PT
3486 - Knowledge Based Planning for Lung SBRT: Model Transferability between Treatment Systems and Calculation AlgorithmsLocation: Hall B2Presenter: – Magee Womens Hospital of University of Pittsburgh Medical Center and Hillman Cancer Center
Hayeon Kim, PhD – Magee Womens Hospital of University of Pittsburgh Medical Center and Hillman Cancer Center ### 538168###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Magee Womens Hospital of University of Pittsburgh Medical Center and Hillman Cancer Center###Presenter: – Magee Womens Hospital of University of Pittsburgh Medical Center and Hillman Cancer Center
### 12:30 PM – 1:45 PM PT
3487 - Hippocampal Sparing Whole Brain Radiation Therapy: 2 Arc Coplanar and 4 Arc Noncoplanar Planning ComparisonLocation: Hall B2Presenter: – City of Hope National Medical Center
Ji Kim, MD – City of Hope National Medical Center ### 1973145###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:30 PM – 1:45 PM PT
3488 - Developing a 4-D Dynamic Model for GammaTile Dose DistributionLocation: Hall B2
Sean King, BS ### 1973103###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3489 - Accuracy of Electron Density Mapping of a Novel kVCBCT System Designed for PlanningLocation: Hall B2
Brandon Koger, PhD ### 1973097###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3490 - Intrafraction Dosimetric Evaluation of Biology-Guided Radiotherapy to a Target Under Respiratory MotionLocation: Hall B2Presenter: – Stanford Cancer Institute Palo Alto
Nataliya Kovalchuk, PhD – Stanford Cancer Institute Palo Alto ### 1973095###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Cancer Institute Palo Alto###Presenter: – Stanford Cancer Institute Palo Alto
### 12:30 PM – 1:45 PM PT
3491 - Robustness Settings for a Plan-of-the-Day IMPT Strategy for Locally Advanced Cervical CancerLocation: Hall B2Presenter: – Erasmus MC Cancer Institute
Sander Kuipers, MS – Erasmus MC Cancer Institute ### 1973118###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Erasmus MC Cancer Institute###Presenter: – Erasmus MC Cancer Institute
### 12:30 PM – 1:45 PM PT
3492 - Enhancing Clinical Accuracy in DIBH Pattern Detection with a Combined Ultrasonic and IR Sensor SystemLocation: Hall B2Presenter: – North Mississippi Medical Center
Jae Kwag, PhD, CMD – North Mississippi Medical Center ### 1973063###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###North Mississippi Medical Center###Presenter: – North Mississippi Medical Center
### 12:30 PM – 1:45 PM PT
3493 - Assessment of Cardiac Radiation Dose in the Co-60 Prone Based Stereotactic Partial Breast Irradiation (CP-sPBI) Using the Distance from the Heart to the Planning Treatment Volume as a Surrogate MarkerLocation: Hall B2Presenter: – University of Texas Southwestern Medical Center at Dallas
Young Suk Kwon, MD – University of Texas Southwestern Medical Center at Dallas ### 1972836###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas Southwestern Medical Center at Dallas###Presenter: – University of Texas Southwestern Medical Center at Dallas
### 12:30 PM – 1:45 PM PT
3494 - Hybrid-Supervised Deep Learning for Proton-Acoustic Reconstruction for 3D In Vivo Proton Dose VerificationLocation: Hall B2
Yankun Lang ### 1973084###Presenter#########Presenter:
### 12:30 PM – 1:45 PM PT
3495 - Validation of a Fast-Helical Free-Breathing CT-Based Ventilation Technique Using Ventilation/Perfusion SPECT ImagingLocation: Hall B2Presenter: – UCLA Radiation Oncology
Ricky Savjani, MD, PhD – UCLA Radiation Oncology ### 1972797###Presenter###Disclosures: Employment: UCLA:Resident Physician:Employee | Compensation: Varian - A Siemens Healthineers Company: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 06/30/2021 | Ownership: none | Leadership: none###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 12:30 PM – 1:45 PM PT
3496 - Beam Delivery and Patient Alignment: Perspective of the Innovative Cycloton 400MEV/u Multi-Ion SystemLocation: Hall B2Presenter: – Normandy Hadrontherapy
Virgile Letellier, PhD – Normandy Hadrontherapy ### 1973128###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Normandy Hadrontherapy###Presenter: – Normandy Hadrontherapy
### 12:30 PM – 1:45 PM PT
3497 - Noninvasive Radiation Markers Based on Lung Cancer CT Images and Dosimetry Features to Predict the Immune Response to Radiotherapy in Tumor MicroenvironmentLocation: Hall B2
Guang Li, PhD ### 1973065###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3498 - Challenges of Treating Lung Cancer Patients at MR-Linac Using MR-Based Synthetic CT Calculation in the Adaptive WorkflowLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Jie Li, PhD, MS, Prof – Sichuan Cancer Hospital and Institute ### 537803###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 12:30 PM – 1:45 PM PT
3499 - Deep-Learning Based Auto-Segmentation for Liver Yttrium-90 Selective Internal Radiation TherapyLocation: Hall B2Presenter: – Thomas Jefferson University
Jun Li, PhD – Thomas Jefferson University ### 1973110###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 12:30 PM – 1:45 PM PT
3500 - Stakeholder Model for Standard Operating Procedure of Radiation Safety Practice in Radiopharmaceutical TherapyLocation: Hall B2Presenter: – Varian Medical Systems, A Siemens Healthineers Company
Kaile Li, PhD, MS, DABR MHA – Varian Medical Systems, A Siemens Healthineers Company ### 747800###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Varian Medical Systems, A Siemens Healthineers Company###Presenter: – Varian Medical Systems, A Siemens Healthineers Company
### 12:30 PM – 1:45 PM PT
3501 - Exploring the Benefits of 3D-Printed Bolus in Cone Beam CT for Modified Radical Mastectomy Breast CancerLocation: Hall B2Presenter: – Chung Shan Medical University Hospital
Shao-Ti Li, MS – Chung Shan Medical University Hospital ### 1972997###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chung Shan Medical University Hospital###Presenter: – Chung Shan Medical University Hospital
### 12:30 PM – 1:45 PM PT
3502 - Small Samples and Low-Cost Auto-Segmentation Method for Pelvic Organ-at-Risk Segmentation in Magnetic Resonance Images Using Deep-LearningLocation: Hall B2Presenter: – Peking University People's Hospital
Xianan Li, MD – Peking University People's Hospital ### 1972996###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking University People's Hospital###Presenter: – Peking University People's Hospital
### 12:30 PM – 1:45 PM PT
3503 - Preserving Structural Consistency in the Generation of Synthetic CT in Pelvic MR-Only Radiation Treatment PlanningLocation: Hall B2Presenter: – Peking University People's Hospital
Xianan Li, MD – Peking University People's Hospital ### 1972996###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking University People's Hospital###Presenter: – Peking University People's Hospital
### 12:30 PM – 1:45 PM PT
3504 - Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy (SBRT): A Robust Single Institution ExperienceLocation: Hall B2Presenter: – New York Proton Center
Dong Han, PhD – New York Proton Center ### 2131824###Presenter######New York Proton Center###Presenter: – New York Proton Center
### 12:30 PM – 1:45 PM PT
3505 - First Implementation of Full-Workflow Automation for Online Adaptive Radiotherapy of Nasopharyngeal CarcinomaLocation: Hall B2Presenter: – Sun Yat-Sen University Cancer Center
Li Lin, MD, PhD – Sun Yat-Sen University Cancer Center ### 535809###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 12:30 PM – 1:45 PM PT
3506 - Simulation-Omitted Replan with Cone Beam Computed Tomography based Adaptive Online Radiotherapy System ? Transferring Adapted Plan to Non-Adaptive Ring Gantry Linear Accelerator for Image Guided RadioLocation: Hall B2Presenter: – UT Southwestern Medical Center
Mu-Han Lin, PhD – UT Southwestern Medical Center ### 746652###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 12:30 PM – 1:45 PM PT
3507 - Dosimetric Plan Evaluation of Biology Guided Radiotherapy Using [18F]-DCFPyL PSMA Radiotracer in Patients with Prostate CancerLocation: Hall B2Presenter: – City of Hope National Medical Center
Bo Liu, PhD – City of Hope National Medical Center ### 1973052###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:30 PM – 1:45 PM PT
3508 - Cardiopulmonary Protection for Bilateral Breast Irradiation: A Dosimetric Comparison between Proton and Photon PlansLocation: Hall B2Presenter: – Taipei Medical University Hospital
Cheng Sheng Liu, MD – Taipei Medical University Hospital ### 747366###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Taipei Medical University Hospital###Presenter: – Taipei Medical University Hospital
### 12:30 PM – 1:45 PM PT
3509 - The Interplay Effect and Mitigations with Cyclotron and Linac Proton Beam Scanning for Lung SBRTLocation: Hall B2Presenter: – Cleveland Clinic
Chieh-Wen Liu, PhD – Cleveland Clinic ### 1973127###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic###Presenter: – Cleveland Clinic
### 12:30 PM – 1:45 PM PT
3510 - End-to-End Verification and Dosimetric Comparative Study of Brainlab Monte Carlo and Eclipse Acuros XB Photon Dose Calculation Algorithm for VMAT SRS PlanningLocation: Hall B2
Han Liu, MS – Mayo Clinic ### 1973132###Presenter###Disclosures: Employment: VCUHS:Medical Physics Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: Virginia Commonwealth University Health System (VCUHS):Chief Resident in Medical Physics;The American Association of Physicists in Medicine (AAPM) Medical Physics Leadership Academy (MPLA):Cohort K Member of MPLA;AAPM:Guest member###Mayo Clinic###Presenter: – Mayo Clinic
### 12:30 PM – 1:45 PM PT
3511 - The Impact of Intra-Fraction Bowel Motion on Luminal Gastrointestinal Organ at Risk Dosimetry When Using Stereotactic Adaptive Radiotherapy for Abdominal MalignanciesLocation: Hall B2Presenter: – Washington University School of Medicine in St. Louis
Weiren Liu, MD, MS – Washington University School of Medicine in St. Louis ### 1973071###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University School of Medicine in St. Louis###Presenter: – Washington University School of Medicine in St. Louis
### 12:30 PM – 1:45 PM PT
3513 - A Feasibility Study of Dose Band Prediction in Radiotherapy: Predicting a Dose SpectrumLocation: Hall B2Presenter: – School of Physics, Beihang University
Yaoying Liu, PhD – School of Physics, Beihang University ### 1973060###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###School of Physics, Beihang University###Presenter: – School of Physics, Beihang University
### 12:30 PM – 1:45 PM PT
3514 - Deep Learning-Based Esophageal Tumor Identification on CT SliceLocation: Hall B2
Saiquan Lu ### 1973051###Presenter#########Presenter:
### 12:30 PM – 1:45 PM PT
3515 - Prediction Analysis of Dose Verification Based on Plan Complexity Metrics during RadiotherapyLocation: Hall B2Presenter: – Chongqing University Cancer Hospital
Huanli Luo, PhD – Chongqing University Cancer Hospital ### 748009###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###Presenter: – Chongqing University Cancer Hospital
### 12:30 PM – 1:45 PM PT
3516 - Dose Rate Assessment of Spot-Scanning Very High Energy Electrons FLASH Radiotherapy Driven by Laser Plasma AccelerationLocation: Hall B2
Jianfeng Lv, PhD ### 1973154###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3517 - Treatment Delivery Gating of MRI-Guided Stereotactic Radiotherapy for Prostate Cancer: An Exploratory Analysis of a Phase III Randomized Trial of CT-Vs. MR-Guided Radiotherapy (MIRAGE)Location: Hall B2
John Neylon, PhD – UCLA Health ### 2017345###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCLA Health###Presenter: – UCLA Health
### 12:30 PM – 1:45 PM PT
3518 - The Feasibility of Adaptive CT Simulation-Free Radiation TherapyLocation: Hall B2Presenter: – Nova Scotia Health Authority
R. Lee MacDonald, PhD, MS, BS, MCCPM – Nova Scotia Health Authority ### 748018###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Nova Scotia Health Authority###Presenter: – Nova Scotia Health Authority
### 12:30 PM – 1:45 PM PT
3519 - Offline Verification of Daily Adaptive Therapy for Locally Advanced Lung CancerLocation: Hall B2Presenter: – University of Alabama at Birmingham
Spencer MacLeod, BS – University of Alabama at Birmingham ### 1973025###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alabama at Birmingham###Presenter: – University of Alabama at Birmingham
### 12:30 PM – 1:45 PM PT
3520 - GTV Based Automatic Delineation of Clinical Target Volume for Cervical CancerLocation: Hall B2Presenter: – Perception Vision Medical Technology Co Ltd
Shufan Mao, MS – Perception Vision Medical Technology Co Ltd ### 1973032###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Perception Vision Medical Technology Co Ltd###Presenter: – Perception Vision Medical Technology Co Ltd
### 12:30 PM – 1:45 PM PT
3523 - A Dosimetric Assessment of Sexual Organ Sparing Proton Radiotherapy in Female Pelvic Cancer PatientsLocation: Hall B2Presenter: – Icahn School of Medicine at Mount Sinai
Deborah Marshall, MD, MAS – Icahn School of Medicine at Mount Sinai ### 747622###Presenter###Disclosures: Employment: Icahn School of Medicine at Mount Sinai:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Icahn School of Medicine at Mount Sinai###Presenter: – Icahn School of Medicine at Mount Sinai
### 12:30 PM – 1:45 PM PT
3524 - Identifying and Re-Planning Challenging Retrospective SRS Patients to Evaluate the Potential for a White Matter Tract Sparing Knowledge-Based Planning ModelLocation: Hall B2Presenter: – Sylvester Comprehensive Cancer Center, University of Miami
Danilo Maziero, PhD – Sylvester Comprehensive Cancer Center, University of Miami ### 1973135###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sylvester Comprehensive Cancer Center, University of Miami###Presenter: – Sylvester Comprehensive Cancer Center, University of Miami
### 12:30 PM – 1:45 PM PT
3525 - Planning Target Volume Margin Quantification of Retroperitoneal Tumors Using Robotic Stereotactic Body Radiotherapy with Spine TrackingLocation: Hall B2Presenter: – University of Louisville
Grant McKenzie, MD – University of Louisville ### 1972986###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Louisville###Presenter: – University of Louisville
### 12:30 PM – 1:45 PM PT
3526 - Quantifying Cardiac Chamber Motion for Noninvasive Stereotactic Cardiac Radiosurgery Using Deformable Image RegistrationLocation: Hall B2Presenter: – Duke University
Trevor McKeown, MS, BS – Duke University ### 1973030###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University###Presenter: – Duke University
### 12:30 PM – 1:45 PM PT
3527 - Anatomically Realistic 3D Printed Mouse Phantom for Multi-Institutional Benchmarking of FLASH and CONV IrradiationLocation: Hall B2Presenter: – Stanford University
Stavros Melemenidis, PhD – Stanford University ### 1972478###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 12:30 PM – 1:45 PM PT
3528 - Treatment Plan Creation and Delivery with and without BgRT for Static and Motion TrajectoriesLocation: Hall B2
Ayan Mitra, PhD ### 1973023###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3529 - Changes in Target Coverage and Dose to the Normal Brain during Fractionated Stereotactic Radiotherapy for Metastatic Brain TumorsLocation: Hall B2Presenter: – Hiroshima High-Precision Radiotherapy Cancer Center
Hideharu Miura, PhD – Hiroshima High-Precision Radiotherapy Cancer Center ### 538090###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hiroshima High-Precision Radiotherapy Cancer Center###Presenter: – Hiroshima High-Precision Radiotherapy Cancer Center
### 12:30 PM – 1:45 PM PT
3530 - The Development and Evaluation of an All-Purpose Bolus for RadiotherapyLocation: Hall B2Presenter: – Kindai University
Hajime Monzen, PhD – Kindai University ### 1973111###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kindai University###Presenter: – Kindai University
### 12:30 PM – 1:45 PM PT
3531 - Pelvis Treatment Plan Dose Comparison for Proton Therapy Using Single Energy and Dual Energy Computed Tomography Simulation MethodsLocation: Hall B2Presenter: – University of Maryland School of Medicine, Baltimore
Sina Mossahebi, PhD – University of Maryland School of Medicine, Baltimore ### 1973083###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland School of Medicine, Baltimore###Presenter: – University of Maryland School of Medicine, Baltimore
### 12:30 PM – 1:45 PM PT
3532 - Feasibility Study of Robust Treatment Planning in VMAT for Head and Neck CancerLocation: Hall B2Presenter: – National Cancer Center Hospital East
Kana Motegi, PhD – National Cancer Center Hospital East ### 1973105###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center Hospital East###Presenter: – National Cancer Center Hospital East
### 12:30 PM – 1:45 PM PT
3533 - Alternating Tumor Treating Fields (TTFields) Layouts for Reduced Risk of Skin Irritation during Treatment of Solid Tumors in the Epigastric RegionLocation: Hall B2Presenter: – Novocure (Israel) Ltd
Avishai Nahshoni, MD – Novocure (Israel) Ltd ### 1972709###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Novocure (Israel) Ltd###Presenter: – Novocure (Israel) Ltd
### 12:30 PM – 1:45 PM PT
3533 - Alternating Tumor Treating Fields (TTFields) Layouts for Reduced Risk of Skin Irritation during Treatment of Solid Tumors in the Epigastric RegionLocation: Hall B2
Nadav Shapira ### 2086547###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3534 - Prospective Dosimetric Comparison Study Between Volumetric Modulated Arc Therapy and Intracavitary Brachytherapy for Cervical CancerLocation: Hall B2Presenter: – Komazawa University
Yujiro Nakajima, PhD – Komazawa University ### 1973056###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Komazawa University###Presenter: – Komazawa University
### 12:30 PM – 1:45 PM PT
3535 - Data Driven Approach to Exactrac Setup Parameters after CBCT for Cranial RadiotherapyLocation: Hall B2Presenter: – Virginia Mason Medical Center
Sreeram Narayanan, MD, PhD – Virginia Mason Medical Center ### 1972995###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Virginia Mason Medical Center###Presenter: – Virginia Mason Medical Center
### 12:30 PM – 1:45 PM PT
3536 - Integrating a Tool to Automatically Determine Necessity of Online Adaptive ReplanningLocation: Hall B2Presenter: – Froedtert and Medical College of Wisconsin
Haidy Nasief, PhD, MS – Froedtert and Medical College of Wisconsin ### 536056###Presenter###Disclosures: Employment: Froedtert and Medical college of Wisconsin:Faculty:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: ASTRO SWRO:Vice Chair, Medical Physics SWRO Subcommittee;AAPM:Social media representative###Froedtert and Medical College of Wisconsin###Presenter: – Froedtert and Medical College of Wisconsin
### 12:30 PM – 1:45 PM PT
3537 - Clinical Implementation of Weak Magnetic Field Generator in Radiation TherapyLocation: Hall B2Presenter: – University of California, Los Angeles
Louise Naumann, BS – University of California, Los Angeles ### 1973143###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, Los Angeles###Presenter: – University of California, Los Angeles
### 12:30 PM – 1:45 PM PT
3538 - Acute Gastrointestinal and Genitourinary Toxicity Results from a Prospective Randomized Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for EndometriLocation: Hall B2Presenter: – St Luke’s Radiation Oncology Network
Killian Nugent, MD – St Luke’s Radiation Oncology Network ### 1973036###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###St Luke’s Radiation Oncology Network###Presenter: – St Luke’s Radiation Oncology Network
### 12:30 PM – 1:45 PM PT
3539 - Commissioning and Initial Validation of Commercial Treatment Planning System for the Electron FLASH Research ExtensionLocation: Hall B2Presenter: – University of Nebraska
Kyuhak Oh, PhD – University of Nebraska ### 1972994###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Nebraska###Presenter: – University of Nebraska
### 12:30 PM – 1:45 PM PT
3540 - Plan Comparison of Left Breast Postmastectomy Radiotherapy: Halcyon IMRT and VMAT Plan vs. Truebeam Fixed-Jaws PlanLocation: Hall B2
Hailun Pan, MS ### 1973104###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3541 - Dosimetric Impact of Intrafraction Prostate Motion and Interfraction Anatomical Changes in Dose-Escalated Linac-Based SBRTLocation: Hall B2
Denis Panizza, MS – ASST Monza ### 1973014###Presenter######ASST Monza###Presenter: – ASST Monza
### 12:30 PM – 1:45 PM PT
3542 - Evaluation of Usefulness of Yeast-Based Biological Phantom and Preliminary Study for Verification of Hypoxic Effect of Flash RadiotherapyLocation: Hall B2Presenter: – The Catholic University of Korea
Chan Beom Park, MS – The Catholic University of Korea ### 1973006###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Catholic University of Korea###Presenter: – The Catholic University of Korea
### 12:30 PM – 1:45 PM PT
3543 - CT-on-Rails Utilization for Image Guidance and Plan Adaptation at a Single-Room Proton Therapy CenterLocation: Hall B2Presenter: – University of Utah
Adam Paxton, PhD – University of Utah ### 1973029###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Utah###Presenter: – University of Utah
### 12:30 PM – 1:45 PM PT
3544 - What MRI Sequences are Necessary for Automated Neural Network-Based Metastasis Segmentation ? An Ablation StudyLocation: Hall B2Presenter: – Technical University Munich
Jan Peeken, MD – Technical University Munich ### 791594###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Technical University Munich###Presenter: – Technical University Munich
### 12:30 PM – 1:45 PM PT
3545 - Optimal Fractionation and Timing of Weekly Cone-Beam CT in Daily Surface-Guided Radiotherapy for Breast CancerLocation: Hall B2Presenter: – Chongqing University Cancer Hospital
Haiyan Peng, MS – Chongqing University Cancer Hospital ### 1973113###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###Presenter: – Chongqing University Cancer Hospital
### 12:30 PM – 1:45 PM PT
3546 - Comparison of Plan Quality Metrics after Left Anterior Descending Coronary Artery Sparing in VMAT Esophageal RadiotherapyLocation: Hall B2Presenter: – Stanford Health Care
Daniel Pham, PhD, CMD, RT – Stanford Health Care ### 1972819###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Health Care###Presenter: – Stanford Health Care
### 12:30 PM – 1:45 PM PT
3547 - Cherenkov and Plan Integration for Real-Time Delivery Verification: The Opportunity for Automated Visualization and Guidance of All Treatments in EBRTLocation: Hall B2Presenter: – University of Wisonsin School of Medicine and Public Health
Brian Pogue, PhD – University of Wisonsin School of Medicine and Public Health ### 1973094###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisonsin School of Medicine and Public Health###Presenter: – University of Wisonsin School of Medicine and Public Health
### 12:30 PM – 1:45 PM PT
3548 - kV-CBCT-Guided Daily Adaptation Improves Target Coverage and Spares Normal Tissue for Accelerated Partial Breast IrradiationLocation: Hall B2Presenter: – University of Alabama at Birmingham
Dennis Stanley, PhD – University of Alabama at Birmingham ### 2134202###Presenter###Disclosures: Employment: The University of Alabama at Birmingham:Assistant Professor:Employee | Compensation: Varian Medical systems: Consultant, Education Meeting Faculty, Research Grants, Research Funding, Research Salary Support, Honoraria, Travel Expenses-End Date: to present | Ownership: none | Leadership: none###University of Alabama at Birmingham###Presenter: – University of Alabama at Birmingham
### 12:30 PM – 1:45 PM PT
3548 - kV-CBCT-Guided Daily Adaptation Improves Target Coverage and Spares Normal Tissue for Accelerated Partial Breast IrradiationLocation: Hall B2Presenter: – University of Alabama at Birmingham
Joel Pogue, PhD – University of Alabama at Birmingham ### 1973057###Presenter######University of Alabama at Birmingham###Presenter: – University of Alabama at Birmingham
### 12:30 PM – 1:45 PM PT
3549 - Commissioning and Assessment of Radiation Field and Dose Inhomogeneity for a Dual X-Ray Tube Cabinet Irradiator: To Ensure Accurate Dosimetry in Radiation Biology ExperimentsLocation: Hall B2Presenter: – Virginia Commonwealth University Health System
Mitchell Polizzi, MS – Virginia Commonwealth University Health System ### 2032564###Presenter######Virginia Commonwealth University Health System###Presenter: – Virginia Commonwealth University Health System
### 12:30 PM – 1:45 PM PT
3550 - Clinical Evaluation of an Automated Iterative Optimization System for Radiation OncologyLocation: Hall B2
Matthew Price, MS, BS – GenesisCare ### 1973073###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###GenesisCare###Presenter: – GenesisCare
### 12:30 PM – 1:45 PM PT
3551 - Radiomics Model for Predicting Pulmonary Metastasis in Sarcoma PatientsLocation: Hall B2Presenter: – Medical College of Wisconsin
Phillip Prior, PhD – Medical College of Wisconsin ### 535998###Presenter###Disclosures: Employment: Medical College of Wisconsin:Assistant Professor of Medical Physics:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 12:30 PM – 1:45 PM PT
3552 - Feature Selection Based on Unsupervised Clustering Mechanism on Multiple-Sequence MRIs for Predicting Neoadjuvant Chemoradiation Response in Locally Advanced Rectal CancerLocation: Hall B2Presenter: – UCLA Radiation Oncology
Xiangrong Qi, PhD – UCLA Radiation Oncology ### 524962###Presenter###Disclosures: Employment: Department of Radiation Oncology, UCLA:Associate professor:Employee | Compensation: Varian Inc.: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present | Ownership: none | Leadership: AAPM Journal of Medical Physics:Deputy editor of the Journal of Med Phys###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 12:30 PM – 1:45 PM PT
3553 - Adaptive Dose-Staged Stereotactic Ablative Body Radiotherapy is Beneficial for Treatment of Large Central NSCLC Lung Tumors: A Dosimetric Simulation StudyLocation: Hall B2Presenter: – Kaiser Permanente Los Angeles Medical Center
Javad Rahimian, PhD – Kaiser Permanente Los Angeles Medical Center ### 747914###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaiser Permanente Los Angeles Medical Center###Presenter: – Kaiser Permanente Los Angeles Medical Center
### 12:30 PM – 1:45 PM PT
3554 - Hypoxia Informed RBE-Weighted Beam Orientation Optimization for Intensity Modulated Proton Therapy Using [18F]-FMISO-PET Estimation of pO2Location: Hall B2Presenter: – University of California Los Angeles
Pavitra Ramesh, MS – University of California Los Angeles ### 1973059###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California Los Angeles###Presenter: – University of California Los Angeles
### 12:30 PM – 1:45 PM PT
3555 - Comparison of a Pre-Trained AI Contouring Model to Unseen Institutional DataLocation: Hall B2Presenter: – University of Alberta
Satyapal Rathee, PhD – University of Alberta ### 1973017###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alberta###Presenter: – University of Alberta
### 12:30 PM – 1:45 PM PT
3556 - How Linear Elastic Material Properties Affect Lung Tumor Motion and Deformation: A Finite Element AnalysisLocation: Hall B2Presenter: – University of Maryland, Baltimore County
Noelle Ray, MS, BS – University of Maryland, Baltimore County ### 1973031###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland, Baltimore County###Presenter: – University of Maryland, Baltimore County
### 12:30 PM – 1:45 PM PT
3557 - Pelvic Nodal Auto-Segmentation Using a Deep Image to Image Network (DI2IN) Auto-Segmentation Algorithm: Comparing Male vs. Female PelvisLocation: Hall B2Presenter: – Columbia University Irving Medical Center
Kareem Rayn, MD – Columbia University Irving Medical Center ### 1973101###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Columbia University Irving Medical Center###Presenter: – Columbia University Irving Medical Center
### 12:30 PM – 1:45 PM PT
3558 - Evaluation of a Deep Image to Image Network (DI2IN) Auto-Segmentation Algorithm across a Network of Cancer CentersLocation: Hall B2Presenter: – Columbia University Irving Medical Center
Kareem Rayn, MD – Columbia University Irving Medical Center ### 1973101###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Columbia University Irving Medical Center###Presenter: – Columbia University Irving Medical Center
### 12:30 PM – 1:45 PM PT
3559 - Using Scorecards to Tune Ethos Directive Templates: An ARTIA Cervix Dosimetric Planning StudyLocation: Hall B2Presenter: – Columbia University Irving Medical Center
Kareem Rayn, MD – Columbia University Irving Medical Center ### 1973101###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Columbia University Irving Medical Center###Presenter: – Columbia University Irving Medical Center
### 12:30 PM – 1:45 PM PT
3560 - Feasibility of EPID Based In Vivo Dosimetry for On-Couch Adaptive RadiotherapyLocation: Hall B2Presenter: – University Hospital Wuerzburg
Gary Razinskas, PhD – University Hospital Wuerzburg ### 1973076###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospital Wuerzburg###Presenter: – University Hospital Wuerzburg
### 12:30 PM – 1:45 PM PT
3561 - 1.5T MR-Guided Daily Adaptive Radiotherapy: Preliminary Clinical Report of the First 5000 FractionsLocation: Hall B2
Michele Rigo, MD ### 1972998###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3562 - Feasibility of Acquiring Radiotherapy Linac Commissioning Data with a Three-Dimensional Cubic Electronic Detector ArrayLocation: Hall B2Presenter: – Mission Viejo Radiation Oncology
Dante Roa, PhD – Mission Viejo Radiation Oncology ### 524429###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mission Viejo Radiation Oncology###Presenter: – Mission Viejo Radiation Oncology
### 12:30 PM – 1:45 PM PT
3563 - Dosimetric Implications of Weekly On-Line MR-Guided Adaptive Radiotherapy (RT) for Glioblastomas (GBM) Growing during RTLocation: Hall B2Presenter: – Sunnybrook Health Sciences Centre
Mark Ruschin, PhD – Sunnybrook Health Sciences Centre ### 1972991###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sunnybrook Health Sciences Centre###Presenter: – Sunnybrook Health Sciences Centre
### 12:30 PM – 1:45 PM PT
3564 - A Novel Approach to Support Quality Assurance (QA) of Intensity Modulated Neutron Therapy (IMNT)Location: Hall B2Presenter: – Univeristy of Washington
George Sandison, PhD, PhD, FCCPM, FAAPM – Univeristy of Washington ### 1973140###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Univeristy of Washington###Presenter: – Univeristy of Washington
### 12:30 PM – 1:45 PM PT
3565 - Is Robust Optimization Essential When Planning Pencil Beam Scanned Proton Therapy for Intracranial Lesions?Location: Hall B2Presenter: – University of Utah Huntsman Cancer Institute
Vikren Sarkar, PhD, MBA – University of Utah Huntsman Cancer Institute ### 538143###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Utah Huntsman Cancer Institute###Presenter: – University of Utah Huntsman Cancer Institute
### 12:30 PM – 1:45 PM PT
3566 - Image-Guided IORT after Surgical Resection of Brain Malignancies: A Feasibility StudyLocation: Hall B2Presenter: – University Hospital Bonn
Gustavo Sarria, MD – University Hospital Bonn ### 762227###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospital Bonn###Presenter: – University Hospital Bonn
### 12:30 PM – 1:45 PM PT
3567 - A Novel Analytic Method of Automatically Assessing Beamline Geometric Range Variations for CBCT-Guided Intensity-Modulated Proton Therapy (IMPT) for Localized Prostate CancerLocation: Hall B2
Grant Evans, MS – SFPTI ### 2117582###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###SFPTI###Presenter: – SFPTI
### 12:30 PM – 1:45 PM PT
3568 - Prostate Tumor Regression during Radiation Therapy in Relation to Image Derived Estimates of Fibrosis Using Ultrashort Echo Time MRILocation: Hall B2Presenter: – Johns Hopkins University School of Medicine
Khadija Sheikh, PhD, MS – Johns Hopkins University School of Medicine ### 536006###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University School of Medicine###Presenter: – Johns Hopkins University School of Medicine
### 12:30 PM – 1:45 PM PT
3569 - A New Treatment Planning Method for Efficient Proton ARC Therapy with Direct Minimization of Number of Energy JumpsLocation: Hall B2Presenter: – University of Kansas Medical Center
Hao Gao, PhD – University of Kansas Medical Center ### 746653###Presenter###Disclosures: Employment: University of Kansas:Associate Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 12:30 PM – 1:45 PM PT
3570 - Automatic Treatment Planning for Multi-focal Dynamic Conformal Arc GRID Therapy for Late Stage Lung Cancer: A Feasibility StudyLocation: Hall B2Presenter: – Duke University Medical Center
Yang Sheng, PhD – Duke University Medical Center ### 1973055###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University Medical Center###Presenter: – Duke University Medical Center
### 12:30 PM – 1:45 PM PT
3571 - First-Year Experience of IMRT/SBRT Treatments Using a Novel Biology-Guided Radiation Therapy SystemLocation: Hall B2Presenter: – University of California, Irvine
Mengying Shi, PhD – University of California, Irvine ### 1973044###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, Irvine###Presenter: – University of California, Irvine
### 12:30 PM – 1:45 PM PT
3572 - Left Anterior Descending Coronary Artery-Optimized Knowledge-Based Radiotherapy Planning in Patients with Locally Advanced Non-Small Cell Lung CancerLocation: Hall B2Presenter: – Cedars-Sinai Medical Center
Alex Shin, BS – Cedars-Sinai Medical Center ### 1973045###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 12:30 PM – 1:45 PM PT
3573 - Temporospatial Feathering of Hot Spots for Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Ultra-Central ThoraxLocation: Hall B2Presenter: – Washington University School of Medicine in St. Louis
Emily Sigmund, BS – Washington University School of Medicine in St. Louis ### 1972987###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University School of Medicine in St. Louis###Presenter: – Washington University School of Medicine in St. Louis
### 12:30 PM – 1:45 PM PT
3574 - Clinical Review on Head and Neck CBCT ImagesLocation: Hall B2Presenter: – National Cancer Centre Singapore
Sze Yarn Sin, MS – National Cancer Centre Singapore ### 1973124###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Centre Singapore###Presenter: – National Cancer Centre Singapore
### 12:30 PM – 1:45 PM PT
3575 - Quantifying the Dosimetric Impact of Tissue Hounsfield Unit Assignment in Deep Learning-based Synthetic CT Images For MRI-Only Radiation Therapy Of The Head And NeckLocation: Hall B1
Kamal Singhrao, PhD – UCSF ### 746614###Presenter######UCSF###Presenter: – UCSF
### 12:30 PM – 1:45 PM PT
3575 - Quantifying the Dosimetric Impact of Tissue Hounsfield Unit Assignment in Deep Learning-based Synthetic CT Images For MRI-Only Radiation Therapy Of The Head And NeckLocation: Hall B2Presenter: – University of California San Francisco
Catherine Dugan, BA – University of California San Francisco ### 2059406###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 12:30 PM – 1:45 PM PT
3576 - Tumor Treatment Response Assessed During the Chemo-Radiotherapy for Locally Advanced NSCLCLocation: Hall B2
YINGPENG SONG, PhD ### 1973066###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3577 - Implementation of a Patient Specific QA Protocol for a Novel Dedicated Stereotactic Radiosurgery Linear AcceleratorLocation: Hall B2
Carlos Rodrigues ### 2098782###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3578 - A Working Framework for TTFields Treatment Planning and DosimetryLocation: Hall B1Presenter: – Novocure (Israel) Ltd
Kirill Stepovoy, MS – Novocure (Israel) Ltd ### 1973100###Presenter######Novocure (Israel) Ltd###Presenter: – Novocure (Israel) Ltd
### 12:30 PM – 1:45 PM PT
3578 - A Working TTFields Therapy Framework for Patient-Specific Segmentation-Based Treatment Planning and DosimetryLocation: Hall B2Presenter: – Novocure - Williamsburg
Brian Berger, MD – Novocure - Williamsburg ### 1972335###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Novocure - Williamsburg###Presenter: – Novocure - Williamsburg
### 12:30 PM – 1:45 PM PT
3579 - Evaluating the Use of SGRT and Abdominal Compression Device for Improved Patient Positioning in Liver Cancer RadiotherapyLocation: Hall B2
Lin Su, MS ### 1973109###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3580 - An Efficient Transformer Model for Synthesizing Dual Energy CT from Single Energy ScannerLocation: Hall B2Presenter: – Stanford University School of Medicine
Liyan Sun, PhD – Stanford University School of Medicine ### 1973112###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 12:30 PM – 1:45 PM PT
3581 - Dosimetric Accuracy of Multi-Target Biology-Guided Radiotherapy Treatments in a Single SessionLocation: Hall B2Presenter: – Stanford University School of Medicine
Murat Surucu, PhD – Stanford University School of Medicine ### 747898###Presenter###Disclosures: Employment: Stanford University:Chief of Clinical Physics and Clinical Assocaite Professor:Employee | Compensation: RefleXion Medical Inc.: Research Grants, Research Funding, Research Salary Support, Speaker's Bureau, Grant Research Funding, Honoraria-End Date: Present | Ownership: none | Leadership: none###Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 12:30 PM – 1:45 PM PT
3581 - Dosimetric Accuracy of Multi-Target Biology-Guided Radiotherapy Treatments in a Single SessionLocation: Hall B2
Jeffrey Schmall, PhD ### 2134201###Presenter###Disclosures: Employment: Reflexion Medical:Senior PET Scientist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: Reflexion Medical:Stock, Stock Options | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3582 - Evaluation of Treatment Interruptions and Recovery during Biology-Guided Radiotherapy DeliveryLocation: Hall B2Presenter: – Stanford University School of Medicine
Murat Surucu, PhD – Stanford University School of Medicine ### 747898###Presenter###Disclosures: Employment: Stanford University:Chief of Clinical Physics and Clinical Assocaite Professor:Employee | Compensation: RefleXion Medical Inc.: Research Grants, Research Funding, Research Salary Support, Speaker's Bureau, Grant Research Funding, Honoraria-End Date: Present | Ownership: none | Leadership: none###Stanford University School of Medicine###Presenter: – Stanford University School of Medicine
### 12:30 PM – 1:45 PM PT
3583 - Validation of Hypoxia Detection Sequences on the MR LinacLocation: Hall B2Presenter: – The Christie NHS Foundation Trust
Martin Swinton, MBBChir – The Christie NHS Foundation Trust ### 1973035###Presenter######The Christie NHS Foundation Trust###Presenter: – The Christie NHS Foundation Trust
### 12:30 PM – 1:45 PM PT
3583 - Validation of Hypoxia Detection Sequences on the MR LinacLocation: Hall B2Presenter: – The Christie NHS Foundation Trust
Ananya Choudhury, PhD, MA MRCP FRCR – The Christie NHS Foundation Trust ### 524736###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The Christie NHS Foundation Trust###Presenter: – The Christie NHS Foundation Trust
### 12:30 PM – 1:45 PM PT
3584 - Dosimetric Evaluation of Targets and Organs at Risk in Dose Escalation Study for Total Marrow and Lymphoid IrradiationLocation: Hall B2Presenter: – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Takuto Takizawa, MS – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital ### 1972989###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital###Presenter: – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
### 12:30 PM – 1:45 PM PT
3585 - Evaluation of a Deep-Learning Auto-Segmentation Model of Cardiac SubstructuresLocation: Hall B2Presenter: – City of Hope National Medical Center
Andrew Tam, MD – City of Hope National Medical Center ### 1972573###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###City of Hope National Medical Center###Presenter: – City of Hope National Medical Center
### 12:30 PM – 1:45 PM PT
3586 - A Multicenter Study of Clinical to Planning Target Volume Margins for Adjuvant Partial Breast Irradiation Delivered on the 1.5T MR-Linear AcceleratorLocation: Hall B1
Ian Zing Tan, MBBS ### 1973099###Presenter#########Presenter:
### 12:30 PM – 1:45 PM PT
3586 - A Multicenter Study of Clinical to Planning Target Volume Margins for Adjuvant Partial Breast Irradiation Delivered on the 1.5T MR-Linear AcceleratorLocation: Hall B2Presenter: – Royal Marsden NHS Foundation Trust
Anna Kirby, MD – Royal Marsden NHS Foundation Trust ### 1974947###Presenter###Disclosures: Employment: Royal Marsden/ Institute of Cancer Research:Consultant Oncologist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: European Society of Radiotherapy and Oncology:President 2022-24###Royal Marsden NHS Foundation Trust###Presenter: – Royal Marsden NHS Foundation Trust
### 12:30 PM – 1:45 PM PT
3587 - Effectiveness of Bladder Filling Control during Online MR-Guided Adaptive Radiotherapy for Rectum CancerLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Bin Tang, PhD, MS – Sichuan Cancer Hospital and Institute ### 748043###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 12:30 PM – 1:45 PM PT
3588 - Clinical Utility of Dual Phase FDG PET for Distinguishing Tumor Progression from Radionecrosis in the Modern EraLocation: Hall B1Presenter: – Mass General Brigham
Trenton Taros, MD – Mass General Brigham ### 1973078###Presenter######Mass General Brigham###Presenter: – Mass General Brigham
### 12:30 PM – 1:45 PM PT
3588 - Clinical Utility of Dual Phase FDG PET for Distinguishing Tumor Progression from Radionecrosis in the Modern EraLocation: Hall B2Presenter: – Brigham and Women's/Dana Farber Cancer Institute
Luke Peng, MD, MS – Brigham and Women's/Dana Farber Cancer Institute ### 535991###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brigham and Women's/Dana Farber Cancer Institute###Presenter: – Brigham and Women's/Dana Farber Cancer Institute
### 12:30 PM – 1:45 PM PT
3590 - A Hybrid Intelligence (HI) System for Segmenting Rectoprostatic Spacer Gel and Key OARs on CT Images for Prostate Cancer Radiation Therapy PlanningLocation: Hall B2Presenter: – Palette Life Sciences
Michelle Svatos, PhD – Palette Life Sciences ### 2135850###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Palette Life Sciences###Presenter: – Palette Life Sciences
### 12:30 PM – 1:45 PM PT
3590 - A Hybrid Intelligence (HI) System for Segmenting Rectoprostatic Spacer Gel and Key OARs on CT Images for Prostate Cancer Radiation Therapy PlanningLocation: Hall B2
Joe Camaratta, MS, BS – Quantaras ### 2082531###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Quantaras###Presenter: – Quantaras
### 12:30 PM – 1:45 PM PT
3591 - Agreement among Radiation Oncologists and Radiologist in Contouring GTV on Planning and Mid-Treatment MRI for Locally Advanced Oropharynx CancerLocation: Hall B2
Marion Tonneau, MD ### 1973042###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3591 - Agreement among Radiation Oncologists and Radiologist in Contouring GTV on Planning and Mid-Treatment MRI for Locally Advanced Oropharynx CancerLocation: Hall B2Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
Houda Bahig, MD, PhD – Centre Hospitalier de l'Universite de Montreal (CHUM) ### 525114###Presenter###Disclosures: Employment: Centre Hospitalier de l'Université de Montréal:Radiation Oncologist:Employee | Compensation: Astra Zeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: present ;Astra Zeneca: Education Meeting Faculty, Compensation Payment-End Date: present ;Varian Medical Systems: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Sanofi: Consultant, Honoraria-End Date: September 2022 ;Astra Zeneca: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 2022 | Ownership: none | Leadership: none###Centre Hospitalier de l'Universite de Montreal (CHUM)###Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
### 12:30 PM – 1:45 PM PT
3592 - Feasibility of Using a Single Planning MRI for Two-Insertion Intracavitary Brachytherapy for Cervical CancerLocation: Hall B2Presenter: – Memorial Sloan Kettering Cancer Center
Michael Trager, MS – Memorial Sloan Kettering Cancer Center ### 1973126###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 12:30 PM – 1:45 PM PT
3594 - Difference in Radiotherapeutic Plan of HyperArc-Based and Cyberkinfe-Based Stereotactic Radiotherapy (SRT) Techniques for Multiple Brain MetastasesLocation: Hall B2Presenter: – Chi-Mei Medical Center
Chia-Jen Tsai, MD – Chi-Mei Medical Center ### 1973123###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chi-Mei Medical Center###Presenter: – Chi-Mei Medical Center
### 12:30 PM – 1:45 PM PT
3595 - Combined Radiotherapy Using a Method for Biologically Informed IMRT PlanningLocation: Hall B2
Adam Turner, PhD ### 1973141###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3596 - Online Adaptive Radiotherapy for Pharyngeal Cancer: Dose-Volume Histogram Analysis between Adapted and Scheduled PlanLocation: Hall B2Presenter: – Kindai University Faculty of Medicine
Takuya Uehara, MD – Kindai University Faculty of Medicine ### 747236###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kindai University Faculty of Medicine###Presenter: – Kindai University Faculty of Medicine
### 12:30 PM – 1:45 PM PT
3597 - Decision Tool to Select Prostate Patients for Fully Adaptive Prostate Treatment vs. Intra-Fractional Monitoring and InterventionLocation: Hall B2Presenter: – Zuidwest Radiotherapeutisch Instituut
Frank Van Den Heuvel, PhD, FAAPM – Zuidwest Radiotherapeutisch Instituut ### 1973049###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Zuidwest Radiotherapeutisch Instituut###Presenter: – Zuidwest Radiotherapeutisch Instituut
### 12:30 PM – 1:45 PM PT
3598 - Prioritizing Toxicities in Automated Outcome-Directed Treatment Plan OptimizationLocation: Hall B2Presenter: – University of Groningen Medical Center
Hans Paul van der Laan, PhD – University of Groningen Medical Center ### 536017###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Groningen Medical Center###Presenter: – University of Groningen Medical Center
### 12:30 PM – 1:45 PM PT
3599 - Cross-Platform Assessment of CBCT-Based Dose Evaluations for Head and Neck Cancer Proton TherapyLocation: Hall B2Presenter: – Danish Center for Particle Therapy
Nadine Vatterodt, MS – Danish Center for Particle Therapy ### 1972999###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Danish Center for Particle Therapy###Presenter: – Danish Center for Particle Therapy
### 12:30 PM – 1:45 PM PT
3600 - Rapid Mechanical Ventilation Superior to Rapid Jet Ventilation for Diaphragm Motion Reduction in RadiotherapyLocation: Hall B2Presenter: – Amsterdam University Medical Center (AUMC)
Johannes Veldman, MS – Amsterdam University Medical Center (AUMC) ### 1973075###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Amsterdam University Medical Center (AUMC)###Presenter: – Amsterdam University Medical Center (AUMC)
### 12:30 PM – 1:45 PM PT
3601 - Comparison of Four Software Packages for Automated ContouringLocation: Hall B2Presenter: – Peter MacCallum Cancer Centre
Neil Wallace, MB BCh BaO – Peter MacCallum Cancer Centre ### 537924###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peter MacCallum Cancer Centre###Presenter: – Peter MacCallum Cancer Centre
### 12:30 PM – 1:45 PM PT
3602 - Sub-Grouping Strategy for Improving Atlas-Based Segmentation PerformanceLocation: Hall B2Presenter: – Zhejiang Cancer Hospital
Binbing Wang, MS – Zhejiang Cancer Hospital ### 1973139###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Zhejiang Cancer Hospital###Presenter: – Zhejiang Cancer Hospital
### 12:30 PM – 1:45 PM PT
3603 - Predicting Dosimetry of Stereotactic Ablative Radiotherapy for the Treatment of Multiple Lung LesionsLocation: Hall B2Presenter: – Western University
Edward Wang – Western University ### 1973041###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Western University###Presenter: – Western University
### 12:30 PM – 1:45 PM PT
3604 - Application of the Integrated Deep Reinforcement Learning Solution in Automatic IMRT Planning for Gastric CancerLocation: Hall B2
Hanlin Wang ### 1973050###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3605 - Proton Therapy for Ocular Melanoma: A Dosimetric Comparison of Three Different Delivery SystemsLocation: Hall B2Presenter: – Northwestern Medicine
Hazel Wang, MS – Northwestern Medicine ### 1973019###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwestern Medicine###Presenter: – Northwestern Medicine
### 12:30 PM – 1:45 PM PT
3606 - Proton Based Stereotactic Radiotherapy for Skull Base Patients: Dosimetric Comparison to 4 Modern Radiation Treatment ModalitiesLocation: Hall B2Presenter: – MD Anderson Cancer Center
He Wang, PhD – MD Anderson Cancer Center ### 537998###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:30 PM – 1:45 PM PT
3607 - Application of the Ion Chamber Array in Magnetic Resonance Accelerator QALocation: Hall B2
Jiaxin Wang, PhD ### 1973038###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3608 - Balancing Quality and Efficiency of Head and Neck Contour Revision for Online Adaptive RadiotherapyLocation: Hall B2Presenter: – University of Texas Southwestern Medical Center
Siqiu Wang, PhD – University of Texas Southwestern Medical Center ### 1973026###Presenter######University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 12:30 PM – 1:45 PM PT
3609 - CBCT Guided Interfraction Absolute Displacement and Setup Error Assessment during Breast Prone RadiotherapyLocation: Hall B2Presenter: – Shandong Anti-Cancer Association
Wei Wang, MD, PhD – Shandong Anti-Cancer Association ### 1973107###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Anti-Cancer Association###Presenter: – Shandong Anti-Cancer Association
### 12:30 PM – 1:45 PM PT
3610 - Study on Dosimetric Benefits of Adaptive Brachytherapy in the Treatment of Postoperative Cervical Cancer PatientsLocation: Hall B2Presenter: – Sichuan Cancer Hospital and Institute
Xianliang Wang, PhD – Sichuan Cancer Hospital and Institute ### 748069###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 12:30 PM – 1:45 PM PT
3611 - Creation and Implementation of an Interdisciplinary Workflow for CBCT-Based Online Adaptive RadiotherapyLocation: Hall B2Presenter: – Columbia University College of Physicians and Surgeons
Yi-Fang Wang, PhD, MS – Columbia University College of Physicians and Surgeons ### 525416###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Columbia University College of Physicians and Surgeons###Presenter: – Columbia University College of Physicians and Surgeons
### 12:30 PM – 1:45 PM PT
3612 - Performance Evaluation in Automatic Plan Generation for Ethos Intelligent Optimization EngineLocation: Hall B2
Qun Wang, MS ### 1973120###Presenter#########Presenter:
### 12:30 PM – 1:45 PM PT
3613 - First Demonstration of the Commissioning of a New Multi-Modality Radiotherapy PlatformLocation: Hall B2
Zhongfei Wang, MD ### 1973151###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3614 - Develop and Evaluate a Dose Calculation Strategy Using Electron Density Maps from Spectral CTLocation: Hall B2Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Ning Wen, PhD, MBA – Ruijin Hospital, Shanghai Jiaotong University School of Medicine ### 524931###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Ruijin Hospital, Shanghai Jiaotong University School of Medicine###Presenter: – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
### 12:30 PM – 1:45 PM PT
3615 - Retrospective Assessment of Surface Imaging Set up Accuracy for Intensity Modulated Proton Therapy of Comprehensive Breast IrradiationLocation: Hall B2Presenter: – Miami Cancer Institute
Andrew Wroe, PhD – Miami Cancer Institute ### 1996705###Presenter###Disclosures: Employment: Miami Cancer Institute:Director of Proton Physics:Employee | Compensation: Ion Beam Applications: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: 12/31/2022 | Ownership: none | Leadership: none###Miami Cancer Institute###Presenter: – Miami Cancer Institute
### 12:30 PM – 1:45 PM PT
3616 - Evaluation of Flattening-Filter-Free and Flattening Filter Dosimetric and Radiobiological Criteria for Lung SBRT: A Volume-Based AnalysisLocation: Hall B2
Junxiang Wu, MS ### 1972988###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3617 - From Protons to Picasso: Recreating Famous Paintings Using Proton Beams as a "Paintbrush"Location: Hall B2Presenter: – New York Proton Center
Jin Sup(Andy) Shim, CMD, BS – New York Proton Center ### 2086552###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###New York Proton Center###Presenter: – New York Proton Center
### 12:30 PM – 1:45 PM PT
3619 - Adaptive Radiotherapy with Dose Fractionation PaintingLocation: Hall B2Presenter: – William Beaumont Hospital
Di Yan, DSc – William Beaumont Hospital ### 524637###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###William Beaumont Hospital###Presenter: – William Beaumont Hospital
### 12:30 PM – 1:45 PM PT
3620 - A Feasible Study for Auto Planning and Auto Re-Planning for Nasopharyngeal Carcinoma (NPC) Adaptive Radiation Therapy (ART)Location: Hall B2
Xin Yang, PhD ### 1972777###Presenter#########Presenter:
### 12:30 PM – 1:45 PM PT
3621 - Clinical Implementation of an Automated IMRT/VMAT Treatment Planning ToolLocation: Hall B2Presenter: – Stanford University
Yong Yang, PhD – Stanford University ### 536077###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 12:30 PM – 1:45 PM PT
3622 - Optimizing the Imaging Scheme of Small-Dose Contrast Agent in 4D-CT Localization Enhancement Scan for Radiotherapy of Liver CancerLocation: Hall B2Presenter: – radiotherapy department
Wei Yao, RT – radiotherapy department ### 1973108###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###radiotherapy department###Presenter: – radiotherapy department
### 12:30 PM – 1:45 PM PT
3623 - Study on the Clinical Use of a Respiratory Navigator Combined with Breath-Hold for MRI- Guided Liver SBRTLocation: Hall B2
Xinghong Yao, PhD ### 1973091###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3624 - Clinical Experience with Commissioning a GRID Collimator for Spatially Fractionated Radiation TherapyLocation: Hall B2Presenter: – Montefiore Medical Center
Ravindra Yaparpalvi, MS – Montefiore Medical Center ### 538181###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Montefiore Medical Center###Presenter: – Montefiore Medical Center
### 12:30 PM – 1:45 PM PT
3625 - Evaluation of a Novel Metal Artifact Reduction Algorithm for Reconstruction of Cone Beam CT (CBCT) Images Acquired on a New Imaging SystemLocation: Hall B2Presenter: – Dalhousie University
Abby Yashayaeva, MS, BS – Dalhousie University ### 1973016###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Dalhousie University###Presenter: – Dalhousie University
### 12:30 PM – 1:45 PM PT
3626 - Accelerating Volumetric CT and MRI Imaging by Reference-Free Deep Learning Transformation from Low-Resolution to High-ResolutionLocation: Hall B2Presenter: – Stanford University
Siqi Ye, PhD – Stanford University ### 1973146###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 12:30 PM – 1:45 PM PT
3627 - Enough and Some to Spare: Improved OAR Sparing with Daily Online Cone Beam Adaptive Radiation Therapy (OnC-ART) of the CervixLocation: Hall B2Presenter: – UT Southwestern Medical Center
Allen Yen, MD, BS – UT Southwestern Medical Center ### 1973067###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### 12:30 PM – 1:45 PM PT
3628 - Liver Regeneration Following Radiation Therapy in Hepatocellular Carcinoma Patients: Insights from Functional Liver ImagingLocation: Hall B2Presenter: – University of Washington
Peter Zaki, MD – University of Washington ### 1972035###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 12:30 PM – 1:45 PM PT
3630 - Biological Effective Dose (BED) in Evaluation of Rectal Dose in Prostate Cancer Patients with Hydrogel Spacer Who Underwent an EBRT with Different Fractionation SchemesLocation: Hall B2Presenter: – Northwell Health
Honglai Zhang, PhD, CMD – Northwell Health ### 538099###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health###Presenter: – Northwell Health
### 12:30 PM – 1:45 PM PT
3631 - Respiratory Motion Compensation Using Xsight Diaphragm Tracking for Liver Tumor in CK Synchrony Treatment: A Feasibility StudyLocation: Hall B2
Jianping Zhang, MD ### 1973028###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 12:30 PM – 1:45 PM PT
3632 - Implementation of L4 Automation for Patient-Specific Quality Assurance Using the AUTOFRAME Platform and a Robotic MechanismLocation: Hall B2Presenter: – Northwell Health
Jenghwa Chang, PhD – Northwell Health ### 537979###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health###Presenter: – Northwell Health
### 12:30 PM – 1:45 PM PT
3633 - Auto Assistant VMAT Planning with HID AutomationLocation: Hall B2Presenter: – Northwell Health
Jenghwa Chang, PhD – Northwell Health ### 537979###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health###Presenter: – Northwell Health
### 12:30 PM – 1:45 PM PT
3634 - Variation in Left Anterior Descending Coronary Artery Accumulated Dose Estimates during Breast Cancer RadiotherapyLocation: Hall B2Presenter: – Cedars-Sinai Medical Center
Samuel Zhang, MD – Cedars-Sinai Medical Center ### 747678###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 12:30 PM – 1:45 PM PT
3635 - Dosimetric Validation of 3D-Printed Bolus at Different Printing Infill Percentage in VMAT PlanLocation: Hall B2
Te Zhang, MD ### 1973008###Presenter#########Presenter:
### 12:30 PM – 1:45 PM PT
3636 - Virtual-Collimator Based Spatial Dose Modulation for Proton GRID TherapyLocation: Hall B2Presenter: – University of Kansas Medical Center
Hao Gao, PhD – University of Kansas Medical Center ### 746653###Presenter###Disclosures: Employment: University of Kansas:Associate Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 12:30 PM – 1:45 PM PT
3637 - Vertex Position Optimization for LATTICE TherapyLocation: Hall B2Presenter: – University of Kansas Medical Center
Yuting Lin, PhD – University of Kansas Medical Center ### 2122124###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 12:30 PM – 1:45 PM PT
3638 - 2V-CBCT: Two-Orthogonal-Projection Based CBCT Reconstruction and Dose Calculation from Real CBCT Projection DataLocation: Hall B2Presenter: – University of Kansas Medical Center
Wangyao Li, PhD – University of Kansas Medical Center ### 1972052###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 12:30 PM – 1:45 PM PT
3639 - Introducing an Experimental Approach to Predict Spot Scanning Time Parameters for a Superconducting Cyclotron Proton Therapy MachineLocation: Hall B2Presenter: – Peking University First Hospital
Peilin Liu, MD, MS – Peking University First Hospital ### 2011728###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peking University First Hospital###Presenter: – Peking University First Hospital
### 12:30 PM – 1:45 PM PT
3640 - An In Silico study of a One-Day One-Machine Workflow for Definitive Radiotherapy Cases on a Novel Simulation and Treatment PlatformLocation: Hall B2Presenter: – Washington University School of Medicine
Tianyu Zhao, PhD – Washington University School of Medicine ### 747058###Presenter######Washington University School of Medicine###Presenter: – Washington University School of Medicine
### 12:30 PM – 1:45 PM PT
3641 - Accuracy of Electron Density and Planning Dosimetry in a Novel High-Quality CBCT Imaging SystemLocation: Hall B2Presenter: – Washington University School of Medicine
Tianyu Zhao, PhD – Washington University School of Medicine ### 747058###Presenter######Washington University School of Medicine###Presenter: – Washington University School of Medicine
### 12:30 PM – 1:45 PM PT
3642 - Preheating Thermoplastic Membrane Reduce Setup Error in Patients with Thoracic Cancer Undergoing Radiation Therapy: A Prospective Randomized Controlled StudyLocation: Hall B2
Liu Zixuan, BS, MBBS ### 1973096###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
###